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Delirium, or “acute confusion” is a common and serious acute neuropsychiatric 
syndrome mainly affecting older people. It is associated with multiple adverse 
outcomes, including an increased risk of developing dementia and increased 
mortality. The underlying mechanisms of delirium are poorly understood, and there 
are currently no specific treatments. This thesis investigated the roles of the 
hypothalamic-pituitary adrenal axis and inflammation in the pathophysiology of 
delirium, persistent delirium and cognitive decline following delirium. It investigated 
whether levels of cortisol in blood and cerebrospinal fluid (CSF) are elevated in 
delirium, with elevated pro-inflammatory and reduced anti-inflammatory cytokines. 
It also investigated whether there is loss of cortisol diurnal rhythm (in saliva) with 
elevated afternoon cortisol levels. The thesis investigated whether any 
hypercortisolaemia was sustained during the year after delirium, and whether this 
was associated with deterioration in cognition during the year after hip fracture. 
Finally, it also tested whether there are high levels of a marker of central nervous 
system damage (S100B) and of a dementia marker (tau) in CSF in delirium. 
 
A prospective observational cohort study was conducted in N=108 patients aged over 
60 who had sustained a hip fracture, in whom 40% developed delirium. Participants 
gave informed consent or if they lacked capacity to give informed consent, this was 
given by their next of kin. Participants were assessed regularly for delirium, 
according to DSM IV criteria, during the two weeks after hip fracture. A sample of 
CSF was collected during the spinal anaesthetic performed for the operation to repair 
their fracture. Samples of blood and saliva were collected during the two weeks after 
the hip fracture operation. Participants were visited three, six and twelve months 
after their hip fracture for further delirium assessment, and a cognitive test battery 




The study found evidence of high levels of cortisol and of S100B in CSF in those 
with active delirium, but there were no differences in levels of tau or cytokines in 
CSF. Those with delirium had elevated serum cortisol during the perioperative 
period, and elevated afternoon salivary cortisol, suggesting flattening of cortisol 
diurnal rhythm with failure to reach the normal diurnal nadir. After adjusting for 
confounders in a multivariate logistic regression analysis, serum cortisol was still 
predictive of delirium, but salivary cortisol AM:PM ratio had a trend towards 
significance. Those who had persistent delirium features in the months after hip 
fracture had significantly higher serum cortisol three months after hip fracture. There 
was a change in serum inflammatory profile in those with delirium, with a shift 
towards a pro-inflammatory state. Testing the study hypotheses surrounding 
cognition after delirium was very challenging, due to patient attrition and other 
factors. Some participants showed a trajectory of cognitive improvement, which was 
probably due to resolution of delirium during the year after hip fracture. Those with 
resolved delirium had deficits in verbal and visual memory. This study has improved 
understanding of the mechanisms of delirium, suggested further avenues for research 




Delirium, or “acute confusion” is a common and serious syndrome which mainly 
affects older people when they become unwell. It is associated with multiple adverse 
outcomes, including an increased risk of developing dementia and of death. The 
underlying mechanisms of delirium in the body and the brain are not well 
understood, and we have no specific treatments. This thesis investigated whether 
there are increased levels of the stress hormone cortisol and inflammatory markers 
released in delirium, both into the blood and into cerebrospinal fluid (CSF), which 
bathes the brain and spinal cord. It also investigated whether there is loss of the 
natural rhythm of cortisol in the body. The thesis investigated whether any high 
levels of cortisol were sustained during the year after delirium, and whether this was 
associated with decline in thinking and memory tested during that year. Finally, it 
also tested whether there are high levels of a protein marker of brain damage 
(S100B) and of a dementia marker (tau) in the cerebrospinal fluid in delirium. 
 
A study was conducted in one hundred and eight older people who had sustained a 
hip fracture, in whom 40% developed delirium. Participants gave informed consent 
or if they were unable to fully understand the study, this was given by their next of 
kin. Participants were assessed regularly for delirium, with short tests of thinking and 
memory, during the two weeks after their hip fracture. A sample of CSF was 
collected when they had the spinal anaesthetic performed for the operation to repair 
their fracture. Samples of blood and saliva were collected during the two weeks after 
the hip fracture operation. Participants were visited three, six and twelve months 
after their hip fracture and they were tested again for delirium, and completed more 
detailed thinking and memory tests. Further samples of blood and saliva were 
collected at these visits.  
 
The study found that there were high levels of cortisol and the brain damage marker 
S100B in CSF in those with active delirium, but there were no differences in the 
dementia marker tau or inflammatory proteins. Those with delirium had higher levels 
 
ii 
of cortisol in blood, and higher levels in saliva in the afternoons, suggesting some 
loss of the natural daily rhythm of cortisol. Those who still had symptoms of 
delirium in the months after hip fracture also had higher levels of cortisol in the 
blood. There was a change in the pattern of inflammatory markers in the blood in 
those with delirium, with a shift towards markers that increase the inflammatory 
response. It was difficult to test the changes in thinking and memory after delirium. 
Some participants showed improvement, which was probably because they had had 
delirium but recovered from it during the year after hip fracture. This study have 
improved our understanding of the mechanisms of delirium, and suggested further 
avenues for research and new treatments that could be trialled. 
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1 Chapter 1: General Introduction 
1.1 Delirium 
In this section, delirium will be defined, and its epidemiology described. Its features 
will be described, as will methods of assessment and problems often encountered in 
clinical and research settings with delirium assessment and diagnosis. Outcomes of 
delirium will also be discussed. 
 
1.1.1 Delirium Definition 
Delirium is a serious acute neuropsychiatric condition. It has been recognized for at 
least two millennia with the term “delirium” deriving from the Latin ‘lira’ meaning 
to wander from one’s furrow. Prior to DSM-III (1980) delirium suffered from 
terminological chaos, with multiple descriptive terms used in different settings  
(acute organic brain syndrome, acute confusional state, brain failure, toxic 
encephalopathy, septic encephalopathy, intensive care psychosis). However, these 
terms do not necessarily describe different pathological processes. Delirium is now 
the umbrella term in current International Classification of Diseases (ICD) and 
Diagnostic and Statistical Manual (DSM) classification schemes that subsume these 
multiple synonyms. This simplification has allowed for a more coherent research 
effort and a consistent approach to detection and management. Moreover, the use of 
the label delirium has led to greater appreciation of the considerable impact upon 
outcomes and independent need for treatment as a brain disorder beyond only 
treating its underlying aetiological precipitants. The American Psychiatric 
Association’s DSM IV definition will be used here. This describes delirium as a 
syndrome characterised by an acute and often fluctuating change in mental status 
with inattention (a difficulty in focussing, shifting or sustaining attention), and the 
presence of a medical cause (APA 2000). The ICD-10 definition is similar but not 
used here (WHO 1993). Table 1.1 shows the DSM-IV and ICD-10 criteria for 
delirium. 
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Table 1.1 Diagnostic and Statistical Manual version IV and International 
Classification of Diseases version 10 criteria for diagnosis of delirium 
DSM IV criteria for delirium (APA 2000) 
(a) A disturbance of consciousness (reduced clarity of awareness of the environment, with reduced ability to 
focus, sustain, or shift attention) 
(b) A change in cognition (eg. memory impairment) or a perceptual disturbance 
(c) Onset of hours to days, and tendency to fluctuate  
(d) Evidence from the history, physical examination or laboratory findings that the disturbance is caused by 
the direct physiological consequences of a general medical condition 





















1.1.2 Delirium Epidemiology 
Delirium is very common, with a prevalence in the Emergency Department (ED) of 
around 9% (Elie, Rousseau et al. 2000, Kennedy, Enander et al. 2014) and in general 
medical in-patients of 11-42% (Siddiqi, House et al. 2006). In surgical settings, the 
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rate is 4-53% in patients with hip fracture, 4-28% in elective orthopaedic patients 
(Bruce, Ritchie et al. 2007) and 3-72% following cardiac surgery (Sockalingam, 
Parekh et al. 2005). It is also very common in ICU patients, with rates reported 
around 30% (Ouimet, Kavanagh et al. 2007) and up to 80% (Ely, Margolin et al. 
2001). The difference in incidence rates in different settings is likely due to different 
underlying patient characteristics, illness severity and co-morbidity.  
 
Despite being common, delirium is often missed, and a missed diagnosis is highly 
detrimental: non-detection in an ED is associated with higher mortality, with a 
hazard ratio of 8.22 (95% CI 1.69-39.89) compared to non-delirious patients 
(Kakuma, Galbaud du Fort et al. 2003). Two studies, one in elderly patients in an ED 
setting (Elie, Rousseau et al. 2000), and one in acute elderly admissions (Collins, 
Blanchard et al. 2010) found a broadly similar poor rate of detection, with a 
sensitivity in the Elie study of 35.3% and a missed diagnosis in the Collins study of 
72%. This is due at least in part to delirium’s heterogeneous and fluctuating nature, 
but several issues contribute. Since underlying dementia or cognitive impairment is 
one of the strongest risk factors for delirium with an odds ratio of 5.2 (Elie, Cole et 
al. 1998), these two conditions often co-exist in hospital in-patients, leading to 
difficulties in diagnosis. Patients with hypoactive delirium are more often missed, 
particularly if they are in a surgical setting (Meagher and Cullen 2012). Clinicians 
may lack training, experience and confidence in diagnosing delirium, which 
contributes to poor detection rates (Davis and MacLullich 2009). Busy clinical 
settings with high patient throughput also make detection, diagnosis and 
documentation of delirium challenging (Collins, Blanchard et al. 2010).  
 
Multiple risk factors have been identified for delirium; a recent systematic review 
and meta-analysis found dementia, illness severity, urinary catheterisation, visual 
impairment, low albumin level and length of hospital stay to be the factors most 
strongly associated with delirium in older medical in-patients (Ahmed, Leurent et al. 
2014).  
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1.1.3 Delirium Features 
The features essential for DSM IV diagnosis are shown in Table 1.1 (APA 2000). 
Other features commonly seen (in descending order of frequency) are sleep-wake 
cycle disturbance, short or long-term memory disturbance, poor visuospatial ability, 
disorientation, psychomotor agitation or retardation, abnormalities in the 
understanding and use of language, disorganised thinking, lability of affect, and 
perceptual disturbances with hallucinations or delusions (Meagher, Moran et al. 
2007). 
 
1.1.4 Delirium Assessment 
Delirium is a complex syndrome that can include a wide range of neuropsychiatric 
and cognitive features. No single feature is pathognomonic or specific to delirium but 
the pattern of symptoms that indicates widespread disturbance of brain functions 
along with the characteristic context (i.e. acute onset, fluctuating course and presence 
of physical morbidity) are highly suggestive. There are different methods of delirium 
assessment used in research. Many involve a combination of observation and a semi-
structured interview with cognitive testing and tests of conscious level and attention. 
There are specific tools for delirium diagnosis such as the Confusion Assessment 
Method (CAM) (Inouye, Vandyck et al. 1990) and its ICU version the CAM-ICU 
(Ely, Margolin et al. 2001), and tools that can be used to diagnose delirium and 
assess severity, such as the Delirium Rating Scale Revised ’98 (DRS-R98) 
(Trzepacz, Mittal et al. 2001) and the Memorial Delirium Assessment Scale (MDAS) 
(Breitbart, Rosenfeld et al. 1997). The CAM essentially operationalises the DSM III 
criteria for delirium, and is based on an interview with the patient, often supported by 
testing of attention (e.g. digit span) and cognitive testing. A period of training is 
important since the sensitivity of the CAM is poor without training. The CAM-ICU 
has been designed for use in ventilated, non-verbal patients, with clearly defined 
tasks assessing attention and disorganised thinking, and the Richmond Agitation 
Sedation Scale is used to assess conscious level. Some training and resources are 
required to use the CAM-ICU. Outwith critical care settings, the CAM-ICU has been 
shown to agree moderately well with the original CAM, but it may not be sensitive 
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enough for routine use in other settings (Neufeld, Hayat et al. 2011). The DRS-R98 
is a detailed assessment of delirium symptomatology and severity, consisting of 13 
items (sleep–wake cycle disturbance, perceptual disturbances, delusions, lability of 
affect, language and thought process abnormalities, motor agitation or retardation, 
orientation, attention, short and long-term memory and visuospatial ability) with 
three additional diagnostic items (temporal onset, symptom fluctuation and physical 
disorder). It involves a semi-structured interview with cognitive testing and 
assessment of attention, and is usually administered by psychiatrists or trained 
specialists. The MDAS is a severity instrument that is designed for physician use, 
and for repeated use within 24h. There are also tools to determine delirium subtype, 
such as the Delirium Symptom Interview and Delirium Motor Subtype Scale.  
 
Assessment using these tools needs to be combined with information from 
supporting sources such as casenotes, nursing and medical staff and family members 
to ascertain baseline level of cognition, the acuity of change, fluctuation and 
evidence of additional features such as hallucinations or delusions. The frequency of 
observation is also important to consider, due to the fluctuation of delirium 
symptoms. Some delirium screening tools are embedded into routine nursing 
assessments, for example in ICU settings, and are performed once or twice daily. 
Depending on the patient cohort and setting, there may be “high risk” periods, such 
as the first few postoperative days following orthopaedic or cardiac surgery, when 
delirium is most likely to occur, therefore daily assessment during this period is 
ideal. It is important in research studies of delirium to balance accurate delirium 
diagnosis and “capture” of delirium episodes by frequent review, without over-
burdening research participants. 
  
1.1.5 Delirium Outcomes 
It has become increasingly recognised that delirium has multiple adverse 
consequences. A systematic review included 19 mainly prospective cohort studies 
examining mortality following delirium and found an overall mortality rate at 
discharge of 14-37% (Siddiqi, House et al. 2006). The best quality study in the 
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review found an increased mortality at discharge and a two-fold independent increase 
in mortality at one year, with an adjusted hazard ratio of 2.11, using three measures 
of illness burden and severity (McCusker, Cole et al. 2002). Furthermore, a meta-
analysis showed that delirium is associated with an increased risk of mortality which 
persists post-hospital discharge and is independent of age, sex, co-morbid illness and 
baseline dementia (Witlox, Eurelings et al. 2010). Some studies have found an 
association with increased hospital length of stay, and delirium is also associated 
with an increased risk of institutionalisation, both on discharge and 12 months later 
(Siddiqi, House et al. 2006, Kennedy, Enander et al. 2014). Delirium is also often 
distressing, both for the patient themselves, their caregivers and loved ones, and for 
the nursing staff caring for them (Breitbart, Gibson et al. 2002). For example, the 84 
year-old Pulitzer Prize-winning historian Justin Kaplan described his delirious 
hallucinations which included thousands of weapon-carrying tiny creatures on 
horseback as “a lot of unpleasantness” (Belluck 2010).  
 
1.1.6 Conclusions 
In summary, delirium is a common, serious acute neuropsychiatric syndrome with 
multiple adverse outcomes. It is underdiagnosed, and its accurate assessment 
involves a semi-structured interview with testing of attention, level of arousal and 
cognition, and further information on acuity of onset and fluctuation. 
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1.2 Delirium and its relationship to cognitive dysfunction 
1.2.1 Definitions 
Dementia, along with older age, is one of the strongest risk factors for delirium 
(Young and Inouye 2007, Juliebo, Bjoro et al. 2009), with risk of developing incident 
delirium increasing proportionately with worse cognitive impairment (Davis, Skelly 
et al. 2015). There is also a significantly increased risk of developing dementia 
following delirium (MacLullich, Beaglehole et al. 2009, Witlox, Eurelings et al. 
2010). A systematic review in 2004 reviewed nine studies, and despite 
methodological difficulties, concluded that delirium is associated with an increased 
risk of long-term cognitive impairment (LTCI) (Jackson, Gordon et al. 2004). A 
subsequent systematic review in 2009 reviewed a further nine studies from the 
intervening years and reached the same conclusion, with a relative risk of LTCI of 2-
3.5 (MacLullich, Beaglehole et al. 2009). A meta-analysis demonstrated an adjusted 
odds ratio of developing dementia following delirium of 9.42 (Witlox, Eurelings et 
al. 2010). 
It is unclear at present whether delirium ‘unmasks’ a pathological process which had 
already begun in the brain or whether delirium sparks a new pathological process 
leading to cognitive decline in an otherwise healthily aging brain. There is evidence 
that an episode of delirium may worsen the trajectory of dementia; Fong et al 
examined the cognitive trajectory of a large cohort of patients with Alzheimer’s 
Dementia, and compared the trajectory of patients with a delirium episode identified 
by a validated chart review method with patients confirmed not to have had delirium. 
They found a significant acceleration of the rate of change of cognitive scores in the 
group with delirium (Fong, Jones et al. 2009). Davis et al employed the Vantaa 85+ 
study, a population-based cohort of the oldest-old, to examine first whether delirium 
increased the risk of incident dementia, and second whether in those with dementia, a 
history of delirium increased the degree of standard dementia neuropathology 
(amyloid plaques, infarcts, lewy body disease). They found that delirium increased 
the risk of incident dementia with an OR of 8.7, and that it was associated with 
worsening dementia severity and function. Interestingly, they also found that while 
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the standard neuropathologies examined were associated with dementia in those with 
no history of delirium, in those with delirium and dementia, no relationship was 
found with several markers of classical dementia neuropathology, that is, β-amyloid, 
α-synucleinopathy,  neuronal loss in the substantia nigra and infarcts  (Davis, Muniz 
Terrera et al. 2012). This suggests that there may be alternative pathology involved 
in dementia that follows delirium. 
 
Delirium in the context of critical illness has been shown to be predictive of LTCI 
(Girard, Jackson et al. 2010). Imaging in these patients has shown evidence of 
cerebral atrophy, with ventricular enlargement (Morandi, Jackson et al. 2009), 
suggesting possible loss of neurons. Longer duration of delirium in critical illness is 
also associated with smaller brain volumes, and these smaller brain volumes 
measured on MRI three months after critical illness are associated with LTCI after 
one year (Gunther, Morandi et al. 2012). A recent large (N=821) study in medical 
and surgical intensive care patients in which 74% developed delirium and only 6% 
had cognitive impairment at baseline (according to the Informant Questionnaire on 
Cognitive Decline in the Elderly) found significant rates of LTCI in the year after 
critical illness, with 24% of patients having scores consistent with mild Alzheimer’s 
disease at one year. This occurred in both older and younger patients, and longer 
duration of delirium was independently associated with both worse global cognition 
and executive dysfunction (Pandharipande, Girard et al. 2013). 
 
In patients undergoing cardiac surgery, Saczynski et al performed a prospective 
cohort study to examine the impact of delirium on cognitive trajectory over one year 
(Saczynski, Marcantonio et al. 2012). They enrolled N=225 patients, of whom 
N=103 developed delirium according to the CAM or CAM-ICU. Those who 
developed delirium had a lower Mini-Mental State Examination (MMSE) score at 
baseline, and had a greater drop in MMSE score on day 2 postoperatively. A 
difference in MMSE scores between the groups persisted to one year postoperatively, 
although after adjusting for the difference at baseline, this was significant at 30 days 
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postoperatively but not thereafter. Patients with postoperative delirium were less 
likely to have returned to their baseline cognitive level at 6 months postoperatively. 
 
1.2.2 Postoperative cognitive dysfunction 
An important construct related to postoperative delirium is postoperative cognitive 
dysfunction (POCD). There is a lack of consensus as to exactly how POCD should 
be defined, and it does not form part of formal classification systems such as ICD or 
DSM. This has caused difficulties for research in this area since differing definitions 
may give different incident rates and outcomes. However, POCD is generally seen as 
cognitive dysfunction occurring after elective or emergency surgery. It may occur in 
the hours or days post-surgery or it may be detected weeks or months later. It tends 
to be viewed as having longer duration (often weeks to months and perhaps longer) 
than delirium. Impaired attention may be present, but unlike in delirium it is not a 
core diagnostic feature. POCD may affect a wide range of cognitive domains, though 
some authors specify deterioration in memory as the primary complaint (Krenk and 
Rasmussen 2011). Alteration in conscious level, and the range of neuropsychiatric 
features that commonly complicate delirium (altered sleep-wake cycle, changes to 
motor activity, affective changes and psychotic features) are typically not included in 
the concept of POCD.  
 
There is also an argument that some surgeries, particularly elective operations 
designed to improve quality of life, alleviate pain or inflammation, may even lead to 
postoperative cognitive improvement (Nadelson, Sanders et al. 2014). Factors that 
may affect perioperative cognitive trajectory include underlying age and any 
dementia process, inflammation, pain, change in medication (e.g. no longer needing 
pain medication or cardiac drugs), postoperative complications such as pneumonia or 
acute kidney injury, delirium, cardiopulmonary bypass, general vs. regional 
anaesthesia, mood and quality of life (Nadelson, Sanders et al. 2014). Postoperative 
cognitive improvement would be more plausible following certain types of elective 
surgery, but would be unlikely following acute hip fracture, which is urgent 
unplanned surgery for a traumatic event in a frail population. 
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1.2.3 Cognitive decline 
The term cognitive decline is usually used to describe deterioration in one or more 
domains of cognition. It is defined differently in different studies, depending on the 
methods used to test cognition. It may lead to mild cognitive impairment or 
dementia, which are now described. 
 
1.2.4 Mild Cognitive Impairment 
Mild cognitive impairment is best described in Alzheimer’s disease, where there is a 
growing consensus that a spectrum exists from an asymptomatic phase to a 
symptomatic predementia phase (MCI or mild cognitive impairment) to dementia 
onset. The core clinical criteria for MCI due to Alzheimer’s disease are (1) concern 
regarding a change in cognition, (2) impairment in one or more cognitive domains, 
(3) preservation of independence in functional abilities and (4) absence of dementia 
(Albert, DeKosky et al. 2011). More than 50% of patients with MCI go on to develop 
dementia (NICE 2006). 
 
1.2.5 Dementia 
Dementia is a clinical syndrome characterised by a chronic impairment in cognition, 
accompanied by functional decline. DSM IV diagnostic criteria for a dementia 
syndrome are the presence of an acquired impairment in memory, associated with 
impairment in one or more cognitive domains, including executive function, 
language, praxis (learned motor sequences) or gnosis (the ability to recognise faces, 
objects or other sensory information). These impairments in cognition must be severe 
enough to interfere with work, usual social activities or relationships with others, and 
delirium and other major psychiatric disorders must be excluded (APA 2000, 
McKhann, Knopman et al. 2011). Dementia syndromes include Alzheimer’s 
dementia, Vascular dementia, Frontotemporal dementia, Dementia with Lewy Bodies 
and Dementia associated with Parkinson’s disease, and aetiologically mixed 
presentations where patients meet the core criteria for Alzheimer’s dementia but also 
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have cerebrovascular disease, features of Dementia with Lewy Bodies or other 
neurological disease (McKhann, Knopman et al. 2011). 
 
1.2.6 Conclusions 
In summary, delirium has a complex relationship with mild cognitive impairment 
and dementia. Prior dementia is one of the strongest risk factors for delirium. 
Delirium increases the risk of subsequent dementia, and may worsen the trajectory of 
existing dementia. Dementia that follows delirium may have an alternative 
neuropathology to established dementia neuropathology. Delirium is common in 
surgical settings, and postoperative cognitive dysfunction is an important related 
construct. 
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1.3 Delirium pathophysiology 
The aim of this section is to introduce and discuss the leading hypotheses in delirium 
pathogenesis. 
 
1.3.1 Direct brain insults 
The pathophysiology of delirium is incompletely understood (MacLullich, Ferguson 
et al. 2008) and previously little researched, although the number of studies in this 
area has increased in the past decade. Certain direct insults to the brain cause 
sufficient global or regional impairment in brain function to induce delirium. These 
insults primarily cause energy deprivation (hypoxia, ischaemia, hypoglycaemia), 
metabolic abnormality (hyponatraemia, hypercalcaemia), or in the case of certain 
drugs, directly disrupt neurotransmission (anticholinergics, L-Dopa) (MacLullich, 
Ferguson et al. 2008).  
 
1.3.2 Neurotransmitter disruption 
Disruption in the functioning of several neurotransmitter systems has been 
hypothesised to be involved in delirium pathophysiology (Trzepacz 2000).  
Acetylcholinergic neurotransmission is involved in many of the brain functions 
affected in delirium including arousal, attention, sleep, perception and orientation. 
Anti-cholinergic medication may precipitate delirium, and acetylcholine deficiency is 
an established mechanism in dementia (Trzepacz 2000). Small early studies 
measuring serum anticholinergic activity (SAA) levels in delirium have had mixed 
results (Trzepacz 2000); a more recent larger longitudinal serum study in N=142 
patients with hip fracture found higher SAA in the delirium group, however this was 
confounded by cognitive impairment and IL-6 levels, and the authors concluded that 
any independent relationship of SAA and delirium was unlikely (van Munster, 
Thomas et al. 2012). Serotoninergic neurotransmission has been implicated in both 
deficiency and excess (Flacker and Lipsitz 1999, Trzepacz 2000). Dopaminergic 
neurotransmission is also involved in many of the features of delirium including 
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attention, thought, perception, motivation and motor activity. Delirium in patients 
with Parkinson’s disease may be precipitated by their L-dopa medication, and often 
involves hallucination, and current standard treatment of delirium symptoms is with 
neuroleptic medication such as the dopamine D2 receptor blocker Haloperidol 
(Trzepacz 2000). Elevated levels of CSF homovanillic acid, a breakdown product of 
dopamine, have been associated with psychotic features of delirium (Ramirez-
Bermudez, Ruiz-Chow et al. 2008). 
 
1.3.3 Aberrant stress responses 
One of the major hypotheses in delirium pathophysiology has been that delirium 
represents an aberrant response to stress, both of the Hypothalamic-Pituitary-Adrenal 
(HPA) axis, and the immune system (Olsson 1999, MacLullich, Ferguson et al. 
2008). Multiple different stressors such as trauma, surgery, infection, acute illness 
and even psychological stress may precipitate delirium (Fong, Tulebaev et al. 2009). 
Ageing and dementia may both be associated with an increased and prolonged 
cortisol response to stressors due to impaired negative feedback, and consequently 
“shut-off” of the HPA axis (Lupien and McEwen 1997, Olsson 1999, Ferrari and 
Magri 2008). This is tied in with the idea of sickness behaviour, and it has been 
argued that delirium may be a maladaptive form of sickness behaviour. This thesis 
will discuss evidence that delirium involves exaggerated stress system and 
inflammatory activity. The two systems are of course intertwined, and given recent 
evidence that glucocorticoids may be pro-inflammatory in the central nervous system 
(CNS) (Sorrells and Sapolsky 2007), it seems plausible that any abnormal CNS 
glucocorticoid and inflammatory response in delirium could potentially become 
damaging if sustained. 
Cortisol and inflammation in delirium and long-term cognitive decline after hip fracture 
General Introduction 14 
1.4 The glucocorticoid hypothesis of delirium  
 
1.4.1 The Hypothalamic-Pituitary-Adrenal (HPA) axis 
Primary control of cortisol level in the blood is by the HPA axis. Cortisol, the 
primary endogenous glucocorticoid in humans, is secreted into the blood from the 
adrenal cortex in response to Adrenocorticotropic Hormone (ACTH) from the 
pituitary (Chapman and Seckl 2008). The pituitary gland is in turn stimulated to 
release ACTH by Corticotropin-Releasing Hormone from the paraventricular nucleus 
of the hypothalamus, and negative feedback is exerted on the anterior pituitary gland 
and hypothalamus by circulating cortisol levels. Higher cortical feedback is exerted 
by the hippocampus, limiting stress-induced HPA axis activation (Ferrari and Magri 
2008). In health, cortisol has roles in multiple immune, metabolic and neuronal 
pathways. Myriad stressors including trauma, infection and psychological stress lead 
to a rapid activation of the HPA axis and rise in blood levels of cortisol. Cortisol 
circulates in the blood bound to the high-affinity, saturable transporter corticosteroid-
binding globulin (CBG), with albumin acting as an additional low-affinity 
transporter. Free, unbound cortisol may also be measured in saliva, although at much 
lower levels. Levels of salivary cortisol have been shown to correlate with serum 
cortisol, including in older adults (Reid, Intrieri et al. 1992).  
 
1.4.2 Cortisol in the central nervous system 
Corticosteroids are highly lipid-soluble, and the major source of CNS cortisol is 
diffusion from the blood across the blood-brain barrier (BBB) (Herbert, Goodyer et 
al. 2006, Mason, Pariante et al. 2010). There may also be a small amount of local 
synthesis (Herbert, Goodyer et al. 2006). Glucocorticoid transporters such as the 
multi-drug resistance P-glycoprotein transporter and the organic anion transporter 
polypeptide family are present in different brain regions and export cortisol from the 
brain, but are not thought to play a major role in access of cortisol to the brain 
(Herbert, Goodyer et al. 2006, Mason, Pariante et al. 2010). Levels in CSF are 
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usually around 5% of those in the periphery (95% of blood cortisol is bound to 
CBG), and sudden peripheral rises in cortisol in response to stress may lead to 
disproportionate rises in CSF cortisol due to the limited binding capacity of CBG 
(Herbert, Goodyer et al. 2006). CSF cortisol rises with age in some people (Herbert, 
Goodyer et al. 2006).  In vitro, hydrocortisone has been shown to strengthen 
mechanical properties of the BBB (Schrot, Weidenfeller et al. 2005, Weidenfeller, 
Schrot et al. 2005), but in vivo, acute immobilization stress has also been shown in 
rats to increase BBB permeability by activating brain mast cells (Esposito, Gheorghe 
et al. 2001). In neurological patients with evidence of BBB disruption on CT 
scanning, elevated serum cortisol was associated with increased BBB disruption, 
along with increased blood pressure and temperature (Tomkins, Kaufer et al. 2001).  
 
There are two types of intracellular receptors for glucocorticoids within the brain, 
high affinity mineralocorticoid receptors (MR) and low affinity glucocorticoid 
receptors (GR) (Ferrari and Magri 2008). MR are activated at low basal levels of 
cortisol, having a 10-fold higher affinity for cortisol (Gil-Bea, Aisa et al. 2010) 
whereas GR are activated once MR are saturated, in the presence of peak cortisol 
levels, during stress or the peak of the circadian rhythm (Ferrari and Magri 2008). 
MR are expressed in high numbers in the hippocampal-limbic area. GR are more 
widespread, being found in the pituitary, hypothalamus and thalamus, prefrontal 
cortex and cortex, with a dense population in the hippocampus (Ferrari and Magri 
2008). Within the brain there is a further level of regulation of glucocorticoid levels, 
namely the activity of 11ß-hydroxysteroid dehydrogenase (11ß-HSD). The two 
isoforms of this enzyme work in opposing directions, 11ß-HSD-1 generating active 
cortisol or corticosterone from inert 11-keto derivatives and 11ß-HSD-2 inactivating 
them. 11ß-HSD-1 is widespread in the brain as well as in liver and adipose tissue. By 
contrast there is little brain activity of 11ß-HSD-2; it is predominantly found in 
epithelial cells of the kidney, colon and salivary glands (Seckl and Walker 2004). 
The relative activity of these enzymes is thought to have a significant impact on the 
exposure of the brain to glucocorticoids, as shown by studies in knock-out rodent 
models. 11ß-HSD-1 knockout mice with a 129/MF1 background have increased 
basal corticosterone levels and exaggerated stress responses, but corticosterone levels 
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are lower within the hippocampus, and they are resistant to the decline in the ability 
to learn a hippocampal-dependent water maze task seen in some normal older mice 
(Yau, Noble et al. 2001). However, there is heterogeneity, with 11βHSD-1 knockout 
mice with other genetic backgrounds such as C57Bl/6J showing unaltered basal 
corticosterone levels, suggesting inter-individual variation in the role of 11βHSD-1 
in HPA axis regulation (Carter, Paterson et al. 2009). In humans, two small 
randomized controlled trials have shown that 11ß-HSD inhibition using 
carbenoxolone improved verbal fluency in healthy older men and verbal memory in 
older men with type II diabetes, without alteration in plasma cortisol (Sandeep, Yau 
et al. 2004). 
 
1.4.3 Cortisol diurnal rhythm 
There is a diurnal rhythm of cortisol levels, which track the body’s daily cycle of 
activity and rest during the hours of light and darkness. This is linked to a central 
clock in the hypothalamus, the suprachiasmatic nucleus. Peripheral levels of cortisol 
may vary up to eight-fold in this circadian rhythm, and it is present in all humans 
except in certain pathological states (Herbert, Goodyer et al. 2006). In addition to the 
diurnal rhythm of cortisol, there is also seasonal variation, with basal cortisol levels 
higher in May than in November (Arsenault-Lapierre, Chertkow et al. 2010). A large 
(N=2802) population-based study of older people, the Whitehall II study, identified 
two common patterns of cortisol diurnal rhythm. These were the “normative curve” 
and the “raised curve”, with the raised curve showing higher waking and daytime 
cortisol and a flatter slope. Those with a raised curve were more likely to be male, a 
smoker, sleep for a shorter period and report more stress (Kumari, Badrick et al. 
2010). Disruption of the circadian rhythm is found in several disorders including 
depression, Cushing’s disease and Alzheimer’s dementia, where the sleep-wake 
cycle and cortisol rhythm may no longer be in harmony (Herbert, Goodyer et al. 
2006). Sleep-wake cycle disturbance is an almost universal feature of delirium 
(Meagher, Leonard et al. 2010). 
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1.4.4 Stress and the HPA axis 
The natural circadian rhythm of cortisol allows room for increased activity during 
daylight hours, with declining levels in the evening. Multiple external and internal 
stressors exert effects through the HPA axis, stimulating an increase in cortisol 
release from the adrenal gland in the short term to aid the response of the organism to 
the insult. Stressors relevant to the current study, that all patients were exposed to 
greater or lesser degrees, include trauma (both the initial fall and hip fracture and the 
ensuing surgery), fasting, dehydration, pain, anaesthesia, and psychological stress. 
The Trier Social Stress Test, commonly used to induce psychological stress in 
humans, causes an HPA axis response in all age groups. Kudeilka et al compared the 
responses of children, young adults and healthy older adults to the test; younger 
adults had a greater ACTH response to stress, although there was no difference 
between plasma cortisol levels. Older women had higher cortisol levels overall, 
although older men had higher salivary cortisol levels (Kudielka, Buske-Kirschbaum 
et al. 2004). In addition to the clear effects of acute stressors, chronic stress (resulting 
in increased exposure of the brain to glucocorticoids), is thought to have detrimental 
effects on brain structure and cognitive function (Lee, Glass et al. 2007). 
 
1.4.5 The effect of trauma on the HPA axis 
Elderly women with hip fracture have been shown to have an abnormally persistent 
trauma-induced elevation in cortisol levels. This has been shown at two to three 
weeks to be a greater increase in cortisol than young subjects with a comparable 
injury (Frayn, Stoner et al. 1983), shown to persist for at least eight weeks (Roberts, 
Barton et al. 1990, Barton, Horan et al. 2001) compared to elderly but probably 
healthier women, and increased compared with frail bedridden elderly patients 
without fracture (Roberts, Barton et al. 1990). This rise is not suppressed by 
dexamethasone (Roberts, Barton et al. 1990). Further examination of the cortisol 
kinetics in a group of thirteen elderly women with hip fracture showed a lower 
cortisol metabolic clearance rate after hip fracture, leading to a threefold increase in 
plasma cortisol bioavailability three weeks post fracture (Barton, Horan et al. 2001). 
Patients were not assessed for delirium in these early studies; given the high 
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prevalence of delirium after hip fracture it may have been present or patients may 
have been recovering from it in these studies, enough to give informed consent to 
participate.  
 
Cortisol and Dehydroepiandrosterone sulphate (DHEAS) work in interplay. The role 
of DHEAS is not fully understood, but it generally acts to enhance immunity. 
Cortisol was previously thought of as anti-inflammatory, and steroids are used to 
treat many immune and inflammatory diseases, however endogenous cortisol and 
stress itself have more varied and subtle effects on the immune system and 
inflammation depending on the context and concentration of glucocorticoids, acting 
both to activate or prepare the immune response and to shut it down (Sorrells and 
Sapolsky 2007, Cruz-Topete and Cidlowski 2014). DHEAS levels fall variably with 
age, while cortisol levels mainly stay static or rise. Butcher et al tested the hypothesis 
that an increase in the cortisol:DHEAS ratio in elderly patients following trauma (hip 
fracture) would be involved in the immunosuppression and increased susceptibility 
to infection frequently seen in this frail population (Butcher, Killampalli et al. 2005). 
They monitored a small cohort of elderly patients with hip fracture (N=35) for 
infection in a six-week postoperative period, and compared them with a group of 
young trauma patients. Thirteen of the elderly cohort developed predominantly 
bacterial infections. The young trauma patients had higher serum DHEAS levels, 
while the elderly patients had higher cortisol levels, and on calculating the ratios of 
these hormones, they confirmed that, strikingly, the elderly trauma patients had an 
almost seven-fold higher cortisol:DHEAS ratio than the young trauma patients 
(Butcher, Killampalli et al. 2005). Comparing these ratios with healthy young and 
elderly controls, they found that there was no significant difference between the 
healthy young and injured young ratios (the young trauma patients having 
proportionate rises in both hormones), however, the healthy elderly ratio was higher 
than both young groups but lower than the injured elderly group. Furthermore, those 
in the elderly trauma group who developed a postoperative infection had an even 
greater imbalance in the cortisol:DHEAS ratio (Butcher, Killampalli et al. 2005). 
They found that although the elderly patients had a comparable neutrophilia response 
to injury, neutrophil function (superoxide release) was impaired. Cortisol was shown 
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in vitro to be capable of causing this impairment in neutrophil function, and co-
incubation with DHEAS was shown to overcome it (Butcher, Killampalli et al. 
2005). This suggests therefore that the cortisol and DHEAS response to trauma is 
profoundly different in young and elderly patients. Persistent elevation of cortisol 
with a consequent “catabolic” state is likely to hinder recovery (Frayn, Stoner et al. 
1983). There are also important consequences for neutrophil function, and 
susceptibility to infection. However, there is still a lack of clarity as to the 
mechanisms of action of DHEAS, and further work is needed in this area. 
 
1.4.6 The relationship between age and the HPA axis 
Cortisol levels, particularly in the evening, generally rise with age, although there is 
some heterogeneity (Deuschle, Gotthardt et al. 1997, Otte, Hart et al. 2005, 
Varadhan, Walston et al. 2008, Vreeburg, Kruijtzer et al. 2009). In the healthy 
elderly, cortisol response to challenge is greater than in young controls. A meta-
analysis of studies comparing the cortisol response to either a pharmacological or 
psychological challenge in young vs. old healthy volunteers found that overall, age 
increases the HPA axis response to challenge, defined as either a stronger response to 
stimulation or less inhibition in a test of HPA axis suppression (Otte, Hart et al. 
2005). Lupien et al suggested the existence of three subgroups in a longitudinal study 
over 3-6 years in N=51 healthy elderly people. The authors measured cortisol 
circadian rhythm yearly, and then measured the slope of cortisol changes over time. 
One subgroup showed a rise in cortisol, a further subgroup showed a fall and the 
final subgroup had no change (Lupien, Roch Lecours et al. 1996). Some of the 
heterogeneity in HPA axis responses with age may be related to gender and frailty. 
The effect of aging on the response of cortisol to challenge is 3-fold greater in 
women than men (Otte, Hart et al. 2005). Frailty also impacts on cortisol levels and 
circadian rhythm. Varadhan et al made detailed measurements of cortisol circadian 
rhythm in a cohort of N=214 community-dwelling women aged 80-90. They found 
higher evening cortisol levels and blunted diurnal variation in women with a greater 
frailty burden than women with lesser frailty scores, after adjusting for important 
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confounders such as age, education, cognition, depression, diabetes and 
cardiovascular disease (Varadhan, Walston et al. 2008). 
 
It has been debated whether the rise in cortisol with age seen in some people is 
adaptive or pathological (Herbert, Goodyer et al. 2006). Physiological aging has been 
associated with hippocampal atrophy, which is more exaggerated in the presence of 
chronic glucocorticoid excess (Ferrari and Magri 2008). The hippocampus is 
particularly vulnerable to the effects of excess glucocorticoids due to the density of 
glucocorticoid receptors. More recent studies have demonstrated that hippocampal 
volume loss in this context is primarily due to loss of dendrites and synapses (Tata 
and Anderson 2010). This can lead to persistent stress-induced activation of the 
HPA-axis and hypercortisolaemia as we age, due to loss of negative feedback 
(Ferrari and Magri 2008).  
 
1.4.7 The relationship between cognitive impairment or 
dementia and the HPA axis 
The majority of evidence suggests that there is hyperactivity of the HPA axis in 
dementia, but again there is heterogeneity among studies. In the CNS, an increase in 
CSF cortisol has been demonstrated in post mortem samples from patients with 
dementia (Swaab, Raadsheer et al. 1994), and in living subjects (Gil-Bea, Aisa et al. 
2010), where CSF cortisol correlated negatively with MMSE score (worse cognition 
with higher cortisol) (Gil-Bea, Aisa et al. 2010). A relationship between CSF cortisol 
levels and ApoE genotype has also been demonstrated (Peskind, Wilkinson et al. 
2001), with a stepwise increase in levels in Alzheimer’s dementia patients from 
E3/E3 to E3/E4 to E4/E4 (Peskind, Wilkinson et al. 2001). CSF cortisol has not been 
shown to be elevated in patients with MCI, however (Popp, Schaper et al. 2009, Gil-
Bea, Aisa et al. 2010). A post mortem brain study has shown an increase in MR 
expression in the frontal cortex in Alzheimer’s dementia, along with a reduction in 
GR expression (Gil-Bea, Aisa et al. 2010). Johansson et al did not find elevated CSF 
cortisol in a group of older patients with newly diagnosed cognitive impairment, but 
did find this in the female subgroup (Johansson, Johansson et al. 2011).  
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Dementia has been associated with HPA axis dysregulation by means of positive 
dexamethasone suppression tests, where administration of the steroid dexamethasone 
fails to suppress endogenous secretion of cortisol (Giubilei, Patacchioli et al. 2001, 
Robertsson, Blennow et al. 2001). An inverted-U shape has been demonstrated in 
serum cortisol levels in dementia, with highest levels in those with moderate 
dementia, and lower levels in those with mild or severe dementia (Robertsson, 
Blennow et al. 2001). Where serum studies are used for assessment of cortisol 
circadian rhythm, this requires repeated sampling which may be burdensome  
(Giubilei, Patacchioli et al. 2001). The first study to measure salivary cortisol in 
Alzheimer’s dementia found it to be elevated both in the morning and evening in 
those with dementia compared to age- and sex-matched controls. This study also 
showed that morning salivary cortisol correlated with both the severity of cognitive 
impairment and the degree of cerebral atrophy on CT (Giubilei, Patacchioli et al. 
2001). In Nursing Home residents with advanced dementia, a study using salivary 
measurements of cortisol circadian rhythm has demonstrated heterogeneity in 
cortisol patterns (Woods, Kovach et al. 2008). Whilst some residents had a loss of 
circadian rhythm with a flattened profile and elevated evening values, others had 
both a morning and evening rise, and some had a relatively normal diurnal rhythm 
despite significant dementia pathology. Where serum cortisol has been examined in 
relationship to ApoE genotype, although higher morning serum cortisol levels were 
found in groups with cognitive-impairment-no-dementia and dementia compared to 
healthy elderly controls, there was no relationship found with ApoE genotype (Lara, 
Caramelli et al. 2013), in contrast to the relationship found between CSF cortisol and 
ApoE status (Peskind, Wilkinson et al. 2001). Greater baseline HPA axis activity 
(morning plasma cortisol) has also been shown to be associated with more rapid 
deterioration in scores on a neuropsychological test battery over 4 years in patients 
with Alzheimer’s dementia (Csernansky, Dong et al. 2006).  
 
Results in mild cognitive impairment (MCI) have been more mixed. One study found 
no difference in salivary cortisol levels in MCI compared to healthy elderly and 
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young adult controls (Wolf, Convit et al. 2002). A further study found no difference 
in basal salivary cortisol levels but a did find greater cortisol awakening reponse in 
MCI patients compared with healthy elderly controls, including after adjusting for 
age, since the control group was significantly older (Lind, Edman et al. 2007). After 
controlling for seasonal variation, a further study has shown higher salivary cortisol 
in MCI and dementia patients compared to healthy elderly controls, with levels in 
MCI patients between healthy controls and dementia (Arsenault-Lapierre, Chertkow 
et al. 2010). Souza-Talarico et al compared salivary cortisol levels between groups of 
healthy elderly, MCI and mild probable Alzheimer’s dementia. They found similar 
cortisol levels between groups, however higher cortisol levels were associated with 
better memory performance in healthy elderly, but with worse performance in the 
group with MCI, and there was no relationship in the group with probable dementia. 
The authors suggested that the inverse association between memory performance and 
cortisol between those with and without a diagnosis of cognitive impairment may 
have been related to GR and MR receptor occupancy, with saturated receptor 
occupancy in MCI patients with a degree of hippocampal atrophy (Souza-Talarico, 
Chaves et al. 2010).  
 
In population-based studies, the KORA-Age study of older adults in Germany, which 
classified participants as normal (N=599), or having MCI (N=101) or dementia 
(N=33) based on a telephone-administered cognitive test, examined salivary cortisol 
measures in relation to cognition. The study found lower morning cortisol levels and 
a trend towards elevated evening levels (which was significant in men) in groups 
with MCI and dementia. After adjusting for covariates with a multiple linear 
regression analysis, they found that those with lower morning cortisol and higher 
evening cortisol were more likely to be cognitively impaired. When stratified for 
gender, this relationship was significant for men but not for women (Johar, Emeny et 
al. 2015). In another population based study where participants were free from 
dementia at baseline, there was no association found between baseline serum cortisol 
and subsequent incident dementia (Schrijvers, Direk et al. 2011).  
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In summary, CSF cortisol is elevated in dementia but this is not universal, and may 
be related to the severity or stage of the dementia process. There appears to be 
hyperactivity of the HPA axis in dementia, and this is related to severity of disease 
and cerebral atrophy, and predictive of disease progression. Findings are less clear in 
MCI, which may be related to the diagnostic criteria used. Finally, it is unclear if this 
increased activation of the HPA axis is a cause or a consequence of the dementia 
process, that is whether hippocampal damage from other pathological processes leads 
to loss of higher cortical feedback of the HPA axis and increased activation, or 
whether it is a consequence of the disease process itself (Gil-Bea, Aisa et al. 2010).  
 
1.4.8 Cortisol and delirium 
1.4.8.1 Behavioural effects of corticosteroid use in clinical practice and 
“steroid psychosis” 
Short-term corticosteroid use in clinical practice has been shown to be associated 
with psychological effects in around 5% of patients, including altered mood, 
hyperactivity, insomnia and psychosis (Buchman 2001), all component symptoms of 
delirium. “Steroid psychosis” usually occurs in those taking at least 40mg of 
prednisolone, within the first five days of treatment (Buchman 2001). “Dementia in 
the absence of psychosis” has also been described, along with decreased attention, 
concentration and verbal memory (Buchman 2001). Delirium may also occur after 
corticosteroid withdrawal (Campbell and Schubert 1991), along with sleep and mood 
disturbance (Buchman 2001). Higher doses of steroids are more likely to be 
associated with behavioural symptoms, but there is much individual variability in the 
type and severity of reactions that may occur (Wolkowitz, Reus et al. 1997).  
 
Wolkowitz et al (Wolkowitz 1994) conducted a series of animal and human 
experiments in the 1980s designed to elucidate the mechanisms of steroid psychosis 
and the behavioural effects of steroids. They first administered healthy male 
Sprague-Dawley rats either corticosterone or placebo for 7 days, and measured levels 
of neurotransmitter metabolites in the caudate. They found increases in the dopamine 
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metabolite homovanillic acid (HVA), and a trend to increased levels of the serotonin 
metabolite 5-hydroxyindole-acetic acid. These changes were accompanied by 
behavioural changes in keeping with activation of those neurotransmitter systems 
(Wolkowitz 1994). They later showed that pre-treatment with lithium blocked all 
these effects (Wolkowitz 1994). Of note, later human studies of CSF in delirium 
have shown increased HVA associated with psychotic features of delirium (Ramirez-
Bermudez, Ruiz-Chow et al. 2008) and increased 5-hydroxyindole-acetic acid has 
been found in subgroups of delirium (Hall, Shenkin et al. 2011). 
 
Wolkowitz et al also performed two studies in healthy human volunteers. They first 
examined the effects of a single dose of corticosteroid, namely 1mg of 
dexamethasone administered at 2300 hours, on neurotransmitter metabolites and 
behaviour. They found that HVA levels rose following dexamethasone 
administration, but not MHPG (3-methoxy-4-hydroxypheylglycol) (Wolkowitz 
1994). The second study involved administration of placebo for five days, then 
prednisolone at 80mg od for five days followed by placebo for seven days. Serial 
blood tests, lumbar punctures (in a subgroup of the participants) and quantitative 
electroencephalograms were also performed, and mood and behavioural changes 
were documented (Wolkowitz 1994). Seventy-five percent of the study group 
reported various mild behavioural and mood changes, such as tearfulness, irritability, 
insomnia, confusion, mood elevation or depression and increased energy (Wolkowitz 
1994). They found that some changes in neurotransmitters or their metabolites in 
CSF were associated with changes in mood and behaviour (Wolkowitz 1994). 
Quantitative electroencephalogram showed an increase in central theta activity, 
meaning a slowing of brain wave activity, during steroid administration, and 
decreases in alpha wave activity (also representing slowing) associated with the 
increase in theta activity (Wolkowitz 1994). The authors also conducted a test of 
verbal vigilance and attention in both groups of participants, at baseline and 
following steroid administration. There was no change in overall attention, but both 
steroid-treated groups demonstrated increases in “errors of commission”, whereby 
they were less able to filter out irrelevant information (Wolkowitz 1994).  
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1.4.8.2 Glucocorticoids and thinking and memory 
Glucocorticoid actions within neurons, via their nuclear receptors, alter the 
transcription of various enzymes involved in the activity of neurotransmitters and 
catecholamines (Wolkowitz 1994), with additional effects on neuronal metabolism, 
receptor expression and glial functions (Bellavance and Rivest 2014). When a 
learning task is being performed, a transient increase in circulating corticosteroids 
facilitates consolidation of the memory (Buchanan and Lovallo 2001, Abercrombie, 
Kalin et al. 2003). Learning and memory retrieval may be disrupted, however, by the 
administration of systemic glucocorticoids (Roozendaal, Williams et al. 1999). In 
adults with Cushing’s syndrome, a correlation between volume of the hippocampal 
formation and scores on tests of verbal learning and memory has also been 
demonstrated, but this was not correlated with IQ score (Starkman, Gebarski et al. 
1992).  
 
1.4.9 Clinical studies of serum cortisol in delirium 
 
1.4.9.1 Postoperative delirium: cardiac surgery 
A meta-analysis of studies examining predisposing and precipitating risk factors for 
delirium following cardiac surgery found elevated serum cortisol to be a precipitating 
risk factor (Lin, Chen et al. 2012), based on the results of studies by Mu et al (Mu, 
Wang et al. 2010) and Plaschke et al (Plaschke, Fichtenkamm et al. 2010). 
 
Mu et al (Mu, Wang et al. 2010) conducted a prospective cohort study examining the 
role of serum cortisol, measured on the first postoperative day, in delirium in patients 
undergoing elective coronary-artery bypass grafting. In their cohort of N=243, 50.6% 
developed postoperative delirium according to CAM-ICU, at a median time of 
postoperative day 1, and 97% developed symptoms within 3 days of surgery. The 
delirium group had higher serum cortisol levels, and also had higher APACHE II 
scores, longer surgery and spent longer on mechanical ventilation, and developed 
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more postoperative complications. Following logistic regression analysis, serum 
cortisol level remained an independent predictor of postoperative delirium with an 
odds ratio of 3.09. 
 
Plaschke et al (Plaschke, Fichtenkamm et al. 2010) examined serum cortisol as a 
measure of the stress response to surgery and the bispectral index (BIS, an electro-
encephalography based measure of cortical brain activity) in a cohort of N=114 
patients on the first postoperative day following cardiac surgery, of whom 28% 
developed postoperative delirium. Blood samples were collected once, immediately 
after BIS measurement. Cortisol levels were higher in the delirium group. There was 
no difference in timing or length of surgery between groups, nor medication 
administered. However, the authors only tested for delirium once on the morning of 
the first postoperative day, and may therefore have missed some cases. They also 
excluded those with a prior diagnosis of dementia, depression, schizophrenia, stroke 
or alcohol abuse. Since there was no baseline or informant assessment of cognitive 
impairment, undiagnosed cognitive impairment may have been a confounding factor. 
 
Kazmierski et al have shown that higher preoperative serum cortisol, along with 
major depression, predicted development of postoperative delirium after coronary-
artery bypass surgery, after controlling for other factors in a multivariate analysis 
(Kazmierski, Banys et al. 2013). In the same cohort, the authors examined the 
influence of a diagnosis of mild cognitive impairment (MCI) (preoperative MoCA 
score of 25 or less, and fulfils National Institute on Aging and Alzheimer’s 
Association criteria) on risk factors for development of postoperative delirium 
(Kazmierski, Banys et al. 2014). They found that those with MCI were more likely to 
develop delirium and had higher pre- and postoperative (day 1) serum cortisol levels. 
It is therefore difficult to assess causal relationships between MCI, higher cortisol 
levels and delirium. 
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1.4.9.2 Postoperative delirium: non-cardiac surgery 
In a small (N=7) cohort of middle-aged men undergoing elective surgery, McIntosh 
et al studied cortisol circadian rhythm in relation to delirium (McIntosh, Bush et al. 
1985). They sampled blood four-hourly over a 24-hour period two days prior to 
surgery and again for a 24-hour period on the second postoperative day. The authors 
demonstrated a rise in postoperative serum cortisol and β-endorphin levels in the 
three patients who developed delirium diagnosed according to DSM III criteria. This 
study was the first to suggest that those who developed postoperative delirium had 
loss of the normal circadian rhythm of both cortisol and β-endorphin during delirium. 
 
In a cohort of N=80 elderly patients undergoing elective abdominal surgery for 
resection of stage I or II malignant tumours, Kudoh et al found that those who 
developed postoperative delirium according to DSM IIIR criteria had higher 
postoperative serum cortisol levels, in samples collected at the end of surgery and 24 
and 48 hours later (Kudoh, Takese et al. 2005). There was no difference in 
preoperative levels. Cortisol levels were higher in the group who developed delirium 
in samples collected at the end of surgery, 24h and 48h later. There was also no 
difference in postoperative pain levels or preoperative cognition as assessed by the 
MMSE score. This suggests that there might be a difference in the HPA axis 
response to surgery in those who develop delirium, although causation cannot be 
inferred from this observational study. 
 
The same investigators also examined the effects of local (epidural) anaesthesia for 
perioperative pain relief in postoperative confusion in patients with chronic 
schizophrenia, and the involvement of cortisol in these processes (Kudoh, Takese et 
al. 2003). Patients with chronic schizophrenia are at high risk of postoperative 
delirium. They randomised N=70 patients with chronic schizophrenia who were 
undergoing abdominal surgery to receive either epidural plus general anaesthesia, or 
general anaesthesia alone. A further control group without schizophrenia (N=35) 
received general anaesthesia for their procedures. Postoperative emergence psychosis 
was diagnosed by psychiatrists, and ‘postoperative confusion’ was assessed daily 
Cortisol and inflammation in delirium and long-term cognitive decline after hip fracture 
General Introduction 28 
with the CAM until postoperative day 7. Blood samples for cortisol were collected 
before anaesthesia, 15 minutes after incision, at the end of surgery, 24 hours and 48 
hours later. Postoperative confusion occurred in 21% of the schizophrenia group who 
were receiving epidural anaesthesia, 30% in those with schizophrenia without an 
epidural and 3% of the control group. Cortisol levels were lower 15 minutes post-
incision and at the end of surgery in the epidural group compared to the other 
schizophrenia group, and lower at the end of surgery in the epidural group than the 
control group. Within-group comparisons found postoperative confusion was 
associated with higher cortisol levels at 15 minutes post-incision and at the end of 
surgery in patients with schizophrenia who had solely general anaesthesia. There 
were no differences in plasma cortisol levels in the epidural group between those 
who did and did not develop confusion (Kudoh, Takese et al. 2003). These results 
suggest there may be a lesser HPA axis response with epidural anaesthesia. 
However, it is difficult to generalise these findings as the pathogenesis of 
postoperative confusion or delirium may be different in patients with chronic 
schizophrenia, either due to their underlying psychotic disorder or their antipsychotic 
medication, which all patients were receiving. Also, subgroup numbers within groups 
comparing those with and without confusion were quite small. 
 
In surgical ICU patients who had undergone non-cardiac surgery, Shi et al conducted 
a study examining risk factors for and incidence of postoperative delirium, and the 
relationship between delirium and serum cortisol levels (Shi, Wang et al. 2010). In 
their fairly large cohort of N=164 patients, 30.5% developed delirium while still in 
surgical ICU, and 44.5% during their hospital stay. High serum cortisol on the first 
postoperative day was identified as a risk factor for postoperative delirium in a 
logistic regression analysis. 
 
Cerejeira et al (Cerejeira, Batista et al. 2013) studied cortisol and inflammatory 
profile in a cohort of N=101 patients without dementia undergoing elective hip 
arthroplasty. Morning blood samples were collected on the day before surgery and 
the first postoperative day. Delirium assessments were on the evening of the day of 
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surgery and on the second and third postoperative days. They excluded patients who 
were delirious preoperatively; 36.6% met DSM-IV-TR criteria for delirium 
postoperatively. They found that those who developed postoperative delirium had a 
greater rise between pre- and postoperative cortisol levels compared with those who 
did not develop delirium (Cerejeira, Batista et al. 2013). Due to the timing of samples 
and assessments and the observational nature of the study, it is difficult to know 
whether a greater rise in cortisol predisposes to delirium or is a consequence. The 
greater rise in serum cortisol in those who developed delirium may be due to 
predisposition to disruption of the HPA axis with a consequential greater rise in 
cortisol due to stress in those who were more prone to delirium, or may be because 
those who had a more complicated or physically stressful surgical episode with 
greater rise in cortisol were also more likely to develop delirium. This study is 
discussed further in section 1.6.6.2. 
 
Deiner et al performed a prospective cohort study investigating the relationship 
between anaesthetic choice, stress response and incidence of postoperative delirium 
(Deiner, Lin et al. 2014). They hypothesised that total intravenous anaesthesia 
(TIVA) with propofol compared to inhalational anaesthesia would lead to a lesser 
stress response and lower incidence of delirium. N=76 elderly patients underwent 
elective non-cardiac surgery under either TIVA or gas anaesthetic, determined by the 
clinical anaesthetic team, according to the requirements of the procedure. On the day 
of surgery, 4h after surgery started and 2h after surgery, blood was collected for 
measurement of cortisol, epinephrine and norepinephrine. Delirium was assessed 
using CAM in the recovery room and daily postoperatively. Cortisol levels were 
higher at all timepoints in the gas group, and levels of epinephrine were higher 
intraoperatively and postoperatively, and norepinephrine was higher intraoperatively. 
There was no difference in delirium incidence between groups. The gas group was 
older, more of the group were ASA 3 or 4, more had malignancy, MMSE score was 
lower (median 27 vs. 29), and they were undergoing a greater range of procedures; 
all but four of the N=40 TIVA group underwent spinal surgery. A multivariable 
logistic regression modelling postoperative delirium as the outcome found that 
predictors were diabetes, surgical duration and postoperative norepinephrine level.  
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1.4.9.3 Acute illness and medical ICU delirium 
Higher early morning serum cortisol on the first morning after admission has been 
shown in a relatively small study (N=52) to predict incidence of delirium in patients 
with acute coronary syndrome admitted to a coronary care unit (Colkesen, Giray et 
al. 2013). There was also a significant correlation between cortisol levels and 
delirium severity. The authors found 48% of their cohort, with a mean age in their 
60s, developed delirium according to DSM IV.  
 
Pfister et al examined several biomarkers including serum cortisol, and measures of 
cerebral blood flow and oxygenation, in a small cohort of ICU patients with sepsis-
associated delirium (Pfister, Siegemund et al. 2008). Biomarkers were measured at 
the same time as cerebral blood flow measurement, within 48 hours of admission and 
stabilisation. In their cohort of critically ill patients with extracranial sepsis, 12/16 
developed delirium according to the CAM-ICU, and serum cortisol levels were 
significantly higher in the delirium group. However, the authors did not control for 
other factors such as illness severity, so those who were more unwell or who had a 
greater systemic stress or inflammatory response may have had higher cortisol levels 
and also developed delirium. Also, several patients received hydrocortisone as part of 
their therapy. 
 
Van den Boogaard et al examined multiple biomarkers including cortisol in a cohort 
of ICU patients who they split into “inflamed” and “non inflamed” (van den 
Boogaard, Kox et al. 2011). They monitored patients for delirium using the CAM-
ICU three times daily, and 50% of the 100 patients included in the study developed 
delirium. They divided those with delirium into “inflamed” and “non-inflamed”; 
“inflamed” was defined as a positive culture for which the patient was given 
antibiotics, and “non-inflamed” as the absence of proven or suspected infection, and 
having no more than one systemic inflammatory response syndrome criterion. The 
control group were likewise split into “inflamed” and “non-inflamed”. Cortisol level, 
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collected once within 24 hours of development of delirium, was associated with 
delirium in both subgroups of “inflamed” and “non inflamed” patients in a univariate 
logistic regression analysis, however not in a multivariate analysis.  
 
Nguyen et al performed a prospective observational cohort study in N=140 ICU 
patients to study the effect of cortisol on “brain dysfunction”, encompassing coma 
and delirium, in severe sepsis and septic shock (Nguyen, Huyghens et al. 2014). 
They looked at the predictive value of cortisol and of the CNS damage marker 
S100B. Dementia was amongst the exclusion criteria. They assessed brain 
dysfunction using the Glasgow Coma Scale, the CAM-ICU and the RASS, and it was 
considered present if GCS was ≤13, or if CAM-ICU was positive. Serum cortisol and 
S100B were measured, first within 6-12 hours of admission and stabilisation, and 
then each morning for four consecutive days. Twelve patients who died while still 
sedated were excluded, N=22 patients remained comatose, 107/128 patients 
developed “brain dysfunction”, and delirium developed in 85/107 (80%) of patients. 
Cortisol levels throughout the measurement period were higher in those with brain 
dysfunction than those without, after adjusting for age and gender, but over time the 
cortisol levels in the brain dysfunction group fell while those in the non-brain 
dysfunction group rose. Using logistic regression analysis, they found two risk 
factors for delirium in severe sepsis, which were cortisol level and cortisol combined 
with age. 
 
1.4.9.4 Hip fracture 
Bisschop, van Munster et al studied the role of cortisol, insulin and glucose in a 
cohort of N=143 elderly patients with acute hip fracture, using serial blood sampling, 
before during and after delirium (Bisschop, de Rooij et al. 2011). They showed using 
a linear mixed models approach that the group who developed perioperative delirium 
(N=70) had higher plasma cortisol levels. However, this relationship was no longer 
significant after adjusting for prior cognitive impairment (as defined by the 
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Informant Questionnaire on Cognitive Decline in the Elderly or a prior history) in a 
multivariate analysis. 
  
1.4.9.5 Dexamethasone suppression tests  
Robertsson et al examined the HPA axis response in a cohort of patients admitted for 
assessment of dementia, with no acute medical illness. In those with DSM-III-R 
delirium superimposed on dementia, the authors found the highest basal serum 
cortisol levels in those with mild delirium, with lower levels in those with no or 
moderate-to-severe delirium. There was no relationship between cortisol levels and 
age or differences between different aetiologies of dementia, but those with moderate 
severity dementia had the highest basal cortisol levels, and the authors also found 
increasing HPA axis dysfunction with increasing severity of dementia. They also 
found that the strong relationship between delirium and positive dexamethasone 
suppression test results was independent of age and dementia severity (Robertsson, 
Blennow et al. 2001). 
 
Impaired negative feedback of the HPA axis, as demonstrated by positive 
dexamethasone suppression tests in patients with delirium, has also been 
demonstrated in patients with lower-respiratory tract infection (O'Keeffe and Devlin 
1994). In sixteen consecutive patients admitted to an acute geriatric ward with a 
lower respiratory tract infection, the authors found that in 7/9 patients who had 
delirium (in the absence of dementia or depression), dexamethasone failed to 
suppress cortisol levels, compared to 1/7 patients without delirium, despite 
comparable illness severity. Furthermore, in six patients who had had delirium and a 
positive dexamethasone suppression test who they were able to follow-up eight 
weeks later, although their delirium and acute illness had resolved, 5/6 still had a 
positive test. Since this was an observational study, causation cannot be established. 
This may indicate that these patients had underlying HPA axis pathology and were 
very prone to developing high cortisol levels in response to acute illness and to 
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developing delirium. It may be that the delirium process led to abnormal HPA axis 
activity which persisted after resolution of the delirium. 
 
1.4.9.6 Genetic predisposition; glucocorticoid receptor signalling 
Glucocorticoid receptor (GR) signalling may be of importance in the risk of delirium 
development; homozygous carriage of GR haplotype BclI and TthIIII was found to 
be associated with a 92% decreased risk of delirium in a cohort of elderly patients 
with acute hip fracture (Manenschijn, van Rossum et al. 2011). 
 
1.4.9.7 CSF cortisol 
Pearson et al undertook a prospective cohort study in patients over the age of 60 
undergoing spinal anaesthetic for repair of a hip fracture, with the aim of determining 
if CSF cortisol levels are elevated in delirium (Pearson, de Vries et al. 2010). N=27 
patients were assessed for delirium preoperatively with an assessment battery which 
informed completion of the Confusion Assessment Method, but only N=20 could be 
included due to change to general anaesthetic or blood contamination of the sample. 
A blood sample was collected at the same time. CSF specimens were taken at the 
onset of spinal anaesthetic, before administration of the anaesthetic agent. The 
investigators found CSF cortisol levels to be higher in those with delirium than those 
without. Plasma cortisol was also significantly higher in cases than controls. This 
suggests an association between elevated CSF cortisol and delirium, although 
causation could not be inferred in this cross-sectional, observational study. As the 
authors comment, dementia, severity of co-morbid disease and physiological stress 
are potential confounding factors which should be assessed in future studies. 
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1.4.10 Glucocorticoids and sleep 
In clinical practice, steroids are not generally administered late in the day due to the 
potential for sleep disruption. Both Cushing’s syndrome and major depressive 
disorder which display hypercortisolism are associated with sleep disorders (Shipley, 
Schteingart et al. 1992), which are also a very common feature of delirium (Meagher, 
Leonard et al. 2010). Shipley et al have shown using polysomnography that both 
disorders are associated with similar sleep problems, including taking longer to reach 
stage 2 sleep, and shorter total sleep time and poorer efficiency (Shipley, Schteingart 
et al. 1992). Those with Cushing’s had even lighter sleep than those with major 
depression. It has also been demonstrated that sleep continuity and the level of blood 
cortisol are well correlated, with lighter sleep when cortisol levels are higher in the 
morning and deeper sleep when levels are lower in the evening in normal subjects 
(Shipley, Schteingart et al. 1992). Older age is commonly associated with a variety 
of sleep problems, with as many as 50% of older adults complaining of difficulty 
falling asleep or maintaining sleep (Crowley 2011). This poor night-time sleep has 
been shown in a small cohort of healthy older adults to be associated with higher 
serum cortisol and interleukin-6 than healthy younger adults who had normal sleep 
patterns, and cortisol level was shown to be negatively associated with the amount of 
REM sleep in both young and older adults (Vgontzas, Zoumakis et al. 2003). 
Salivary cortisol level on wakening is significantly lower in middle-aged patients 
with primary insomnia, and lower waking cortisol correlates with poorer sleep 
quality (Backhaus, Junghanns et al. 2004). 
 
1.4.11 Cortisol in cognitive decline and dementia 
Chronic elevation of glucocorticoid levels has been shown to be associated with 
cognitive impairment, depression, structural CNS abnormalities including 
hippocampal atrophy and neuroendocrine abnormalities (Chapman and Seckl 2008). 
 
The Baltimore Memory Study is an epidemiological study (N=967) looking at risk 
factors for cognitive decline in urban residents. At a single timepoint in the study, 
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researchers collected four salivary cortisol samples during study visits which 
included cognitive testing (deemed as a mild psychosocial stress), before, during and 
after the testing and finally at the end of the visit. They found in multivariable 
analyses that higher cortisol was significantly associated with poorer performance in 
cognitive testing, independent of age, gender, education and other covariates. The 
authors concluded that there was a dose-response relationship between cortisol 
exposure, potentially due to chronic stress, and worse cognitive performance in 
domains encompassing the hippocampus and neocortex (Lee, Glass et al. 2007). A 
smaller (N=79) longitudinal study assessed the relationship between cognition and 
cortisol diurnal rhythm annually for three years in healthy older adults. They found 
that higher average and 23.00h cortisol level were both associated with poorer 
performance on tests of declarative memory and executive function. They also found 
that higher salivary cortisol levels predicted decline in verbal memory over three 
years (Li, Cherrier et al. 2006). 
 
Elevation in glucocorticoids, precipitated by the significant stressor of a surgical 
procedure, has been hypothesised to be involved in postoperative cognitive 
dysfunction (POCD). Rasmussen et al performed a study investigating the hypothesis 
that changes in perioperative cortisol secretion are involved in POCD (Rasmussen, 
O'Brien et al. 2005). They included N=187 patients from ten centres, and performed 
a neuropsychological test battery preoperatively, on day 7 postoperatively and at 3 
months, along with diurnal salivary cortisol measurements at the same timepoints 
plus the first postoperative day. There was no specific testing for postoperative 
delirium. POCD was defined according to their criteria, that 2/7 Z scores from 
individual tests or the combined Z score was greater than 1.96. 18.8% of tested 
patients had POCD at one week, and 15.2% at three months. Morning and afternoon 
salivary cortisol increased after surgery, with a statistically significant increase in 
both values on the first postoperative day and in the afternoon value at one week, 
with flattening of the normal diurnal variation. There was a trend towards a lower 
am/pm salivary cortisol ratio in those who developed POCD. Log transformation of 
the non-normally distributed am/pm ratio, examined in a linear interaction model, 
found a significant change over time in the ratio, and that this was related to POCD 
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at one week but not at three months (Rasmussen, O'Brien et al. 2005). It is interesting 
that the association found between loss of normal diurnal rhythm of cortisol and 
POCD was demonstrated acutely but not at longer-term follow-up. It is impossible to 
know how many of those patients had also developed postoperative delirium, and 
whether this might have impacted on cognitive testing, or whether the same 
mechanisms are in play for the development of postoperative delirium and POCD. 
 
1.4.12 Cortisol and neuronal toxicity 
In clinical practice, glucocorticoids are used for their anti-inflammatory and immune-
suppressing qualities. However, there is some evidence that they may worsen the 
excitotoxic insult in some inflammatory brain injury states, and clinical trials of 
steroids in cerebral oedema after stroke and traumatic brain injury have found them 
to worsen rather than improve outcomes (Sorrells and Sapolsky 2007). Exposure of 
neurons to excess cortisol increases their vulnerability to damage and cell death from 
various insults such as glutamate excess, hypoxia, hypoglycaemia and oxidative 
stress (Kimonides, Spillantini et al. 1998, Herbert, Goodyer et al. 2006), with 
hippocampal neurons seemingly particularly vulnerable (Dinkel, MacPherson et al. 
2003). Recent studies have also challenged the traditional view that steroids are anti-
inflammatory in the central nervous system (Sorrells and Sapolsky 2007). In a rat 
model comparing the effects of low (adrenalectomy), intact and high (corticosteroid 
treatment) glucocorticoid levels on a kainic acid-induced brain injury, Dinkel et al 
showed that endogenous glucocorticoids had an overall pro-inflammatory effect on 
cellular infiltrate and anti-inflammatory effect on synthesis of mRNA for cytokine 
production. They also found that chronically high glucocorticoids had pro-
inflammatory effects in the CNS (Dinkel, MacPherson et al. 2003). Stress, via 
glucocorticoids, has also been shown to be capable of priming pro-inflammatory 
responses of microglia in an animal model; rats were given a stressor (an inescapable 
tail shock), and then microglia isolated from their hippocampi were exposed to LPS, 
and this potentiated the pro-inflammatory response, e.g. expression of IL-1β gene. 
Pre-treating the rats in vivo with a glucocorticoid antagonist (RU486) or removing 
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the adrenal glands, prevented the potentiation of the response (Frank, Thompson et 
al. 2012).  
 
1.4.13 Conclusions 
In summary, cortisol is a steroid hormone with roles in multiple homeostatic 
mechanisms and is central to the body’s response to stress. Cortisol and its circadian 
rhythm may be influenced by age and dementia, although this is heterogeneous. 
Exposure to high levels of cortisol and exogenous steroids acutely may lead to 
psychosis, and chronic exposure may be associated with depression, dementia and 
hippocampal atrophy. Several studies have found evidence of elevated cortisol levels 
in delirium in medical, surgical and critical care settings.   
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1.5 The inflammatory hypothesis of delirium 
1.5.1 Definitions 
The immune response has two main components, comprising the innate and humoral 
immune responses. Innate immunity involves cells which respond to insults using 
receptors that do not need gene rearrangement for their activity. These cells include 
neutrophils, which circulate in the blood and macrophages which are resident in 
tissues (microglia in the brain), and they initiate an inflammatory response including 
phagocytosis, and recruit dendritic cells involved in adaptive immunity. Dendritic 
cells present antigens to prime specific T-lymphocytes. Neutrophils and 
macrophages interact; macrophages activate neutrophils, and neutrophils produce the 
chemokines interleukin-8, MIP-1α and MIP-1β which recruit and activate 
macrophages (Solana, Tarazona et al. 2012).  
 
There has been interest in the potential role of an abnormal inflammatory response in 
delirium (Perry, Cunningham et al. 2007, MacLullich, Ferguson et al. 2008). 
Peripheral infection is a common precipitant of delirium, although the pathway from 
a seemingly minor infection without significant systemic upset to the 
neuropsychiatric symptoms of delirium is unclear. In clinical practice, evidence for 
possible urinary tract infection is often sought in delirium, and a recent systematic 
review found that there is an association between delirium and urinary tract infection, 
but the studies looking specifically at this are methodologically flawed (Balogun and 
Philbrick 2014). Sepsis is also a common precipitant of ICU delirium in young, fit 
patients; this is sometimes referred to as “septic encephalopathy”. 
 
Cytokines form an integral part of the metabolic response to stress, as well as to 
infection. After administration of endotoxin, Tumour Necrosis Factor (TNF)- is the 
first cytokine to appear (Stouthard 1996) and is involved in inducing a catabolic or 
septic state with changes to glucose, protein and fat metabolism. Interleukin(IL)-6 is 
released following TNF-α administration, and is therefore thought to be another 
Cortisol and inflammation in delirium and long-term cognitive decline after hip fracture 
General Introduction 39 
primary mediator of this process. Stouthard et al studied the metabolic effects of 
recombinant human (rh)IL-6 administration in N=8 patients with metastatic renal cell 
carcinoma, who were receiving it as part of a phase II clinical trial; each patient also 
received a saline infusion at a different time, and acted as their own control 
(Stouthard, Romijn et al. 1995). Infusion of rhIL-6 induced a febrile response and 
release of norepinephrine, cortisol, glucagon and plasma free fatty acids. Resting 
energy expenditure increased.  
 
The effects of the administration of the bacterial endotoxin lipopolysaccharide (LPS) 
in order to induce a transient state of low-grade inflammation, on emotional and 
cognitive aspects of sickness behaviour, have been studied in healthy adult men. In a 
study by Reichenberg et al, the administration of bacterial endotoxin or saline IV to 
N=20 healthy adult men, increased serum levels of cortisol, TNF-α, soluble TNF 
receptors, IL-6 and IL-1-receptor antagonist (Reichenberg, Yirmiya et al. 2001). 
Following endotoxin administration, the subjects had heightened anxiety, depressed 
mood and decreased verbal and non-verbal memory on neuropsychological testing 
(Reichenberg, Yirmiya et al. 2001). 
 
Grigoleit et al found that intravenous injection of LPS caused a transient rise in body 
temperature, inflammatory cytokines including TNF-α and IL-6, neutrophils, salivary 
and plasma cortisol, and ACTH, in a cohort of N=24 healthy young men (Grigoleit, 
Oberbeck et al. 2010). They observed that LPS did not induce any change in 
performance on the revised Wechsler Memory Scale-R nor in its subscales (including 
attention), nor in the Stroop colour test which tests executive function. There was a 
correlation between attention subscale scores in the LPS treated group and plasma 
prolactin (Grigoleit, Oberbeck et al. 2010). It is possible that the inflammatory insult 
was too mild or too short lived to see any significant effect on the memory tasks, 
particularly in a cohort of cognitively resilient young adults. 
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1.5.2 Sickness behaviour syndrome 
The mental status changes often referred to as ‘sickness behaviour syndrome’, are 
thought to represent a coordinated set of behavioural changes which, in health, 
promote survival. The features of sickness behaviour; malaise, somnolence, 
decreased locomotion and cognition, and anorexia (Perry, Cunningham et al. 2007), 
are similar to hypoactive delirium, and delirium in older patients may represent an 
exaggerated and pathological response to an infective or immune stressor.  
 
1.5.3 Animal modeling 
This section will discuss animal (mouse and rat) experiments that explicitly aim to 
model delirium.  
 
Cunningham and Perry were among the first to use an animal model to examine the 
role of inflammation in delirium pathophysiology. They have predominantly 
employed the ME7 prion disease mouse model to study the role of inflammation in 
chronic neurodegeneration. The ME7 model is produced by injecting female 
C57BL/6 mice in the dorsal hippocampus with either normal mouse brain 
homogenate (control) or infected ME7 mouse brain homogenate. The ME7 mice then 
have a predictable course of deterioration of neurological function over weeks, and 
experiments are usually performed just before clinical signs develop at 19 weeks. 
This research group first demonstrated in 2005 that microglia (the resident 
macrophages in the brain) are “primed”, probably by the ongoing neurodegenerative 
pathology, to produce a greater response to subsequent inflammatory challenges. The 
microglia have morphological changes suggesting that they are active, but they do 
not produce inflammatory cytokines such as IL-1. However, even a low-moderate 
dose peripheral challenge of LPS (bacterial endotoxin lipopolysaccharide) in the 
form of an intraperitoneal injection leads to the exaggerated production of IL-1, IL-
6 and TNF- in the brain, along with exaggerated sickness behaviour responses. 
Importantly, there was also associated neuronal cell death (Combrinck, Perry et al. 
2002, Cunningham, Wilcockson et al. 2005).  
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Further investigation of the effects of these peripheral inflammatory challenges 
(100μg/kg LPS injected intraperitoneally) showed that in the ME7 mice, they lead to 
transient and reversible deteriorations in working memory as assessed by a T-maze 
task where the mice are walking in shallow water and need to remember to turn in 
the opposite direction to the previous trial in order to exit the maze (Murray, 
Sanderson et al. 2012). The group have also shown that after these inflammatory 
challenges, the rate of deterioration in the prion-induced neurodegenerative disease 
accelerates in the ME7 mice (Cunningham, Campion et al. 2009). The authors 
postulated that this might be a similar process to when patients with dementia 
develop delirium, since delirium is commonly triggered by infection and infections 
have been shown to accelerate the progression of dementia. 
 
This group have recently adopted a model of cholinergic deficiency, in which mice 
are lesioned with murine-p75-saporin immunotoxin in the basal forebrain to induce 
chronic cholinergic depletion similar to early dementia. Interestingly, this lesion did 
not induce microglial priming. When these mice are given a systemic inflammatory 
challenge with LPS injection (100μg/kg), they display transient deficits in working 
memory compared to unlesioned mice and lesioned mice that had a saline challenge. 
Interestingly, the central inflammatory response was similar in lesioned and 
unlesioned controls. Peripherally administered donepezil, given shortly after the 
infective challenge, was partially protective against the working memory deficits. 
These experiments support the hypothesis that chronic cholinergic deficiency may 
predispose to delirium as well as acutely-induced cholinergic deficiency, but that 
there might be some protection from acetylcholinesterase inhibitors (Field, Gossen et 
al. 2012). 
 
In aged animals, similar processes have been demonstrated. Godbout et al have 
shown in aged mice (20-24 months old, where natural lifespan is 26 months) that 
peripheral LPS injection at a dose which usually causes mild transient sickness 
behaviour in young adult mice, led to greater anorectic responses and greater 
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reduction in social behaviour, which lasted longer than young adult mice. They also 
found a protracted and exaggerated neuroinflammatory response, with increased 
production of IL-1 and IL-6 in the brains of the aged mice. This response was not 
found to the same extent in the periphery (Godbout, Chen et al. 2005). 
 
Culley et al also set out to study inflammatory mechanisms in an animal model of 
delirium (Culley, Snayd et al. 2014). They used a task that tested attention and 
executive function in rats, the attentional set-shifting task (AST); this task involves 
the prefrontal and parietal cortex, and uses cholinergic neurotransmission, giving it 
relevance for attention in human delirium. They used older (24 month old) Fischer-
344 rats, and gave them a peripheral inflammatory stimulus with an intraperitoneal 
injection of lipopolysaccharide (50μg/kg) or saline. The rats were trained in the AST, 
given either LPS or saline, and then tested on different aspects of the attentional task 
for three consecutive days. TNF- and CCL-2 were measured in plasma and 
prefrontal cortex of a further group of age-matched rats given either LPS or saline, at 
2, 24 and 48 hours. Analysis of variance testing demonstrated a main effect of LPS 
on behaviour, selectively impairing performance on tasks involving shifting 
attention. Plasma levels of TNF- and CCL-2 rose 2h after LPS, and levels of TNF-
 had returned to control levels by 24h, whereas CCL-2 returned to control levels by 
48h. TNF- levels did not rise significantly above control levels in prefrontal cortex, 
whereas CCL-2 rose in LPS treated animals at 2h only. These results suggest that in 
aged rats, peripheral inflammatory stimuli are capable of selectively impairing 
attention and executive function. Associative learning was not affected, and LPS 
only impaired more complex attentional tasks requiring cognitive flexibility. The 
deficits were also present after the measured inflammatory responses had resolved; 
this is often seen in human delirium when an infection triggers delirium that persists 
after the infective insult has been treated. 
 
1.5.4 Effects of directly administered cytokines 
Direct administration of cytokines used for cancer chemotherapy, such as Interferon 
(IFN)-α (Capuron, Ravaud et al. 2004) and Interleukin (IL)-2 (Rosenberg, Lotze et 
Cortisol and inflammation in delirium and long-term cognitive decline after hip fracture 
General Introduction 43 
al. 1989, Walker, Wesnes et al. 1996, Walker, Walker et al. 1997), can lead to acute 
mental status change, such as disorientation, somnolence, reduced reaction times 
(Rosenberg, Lotze et al. 1989, Walker, Wesnes et al. 1996, Walker, Walker et al. 
1997) and depressive symptoms (Capuron, Ravaud et al. 2004). The neurotoxicity 
associated with interferons has been observed to include delirium, depression and 
“sickness behaviour” type symptoms, as well as manic and psychotic syndromes, but 
not always falling within usual psychiatric diagnostic criteria (Patten 2006). 
Disordered serotonin metabolism is thought to be involved in the pathogenesis of 
IFN--induced depression. Serotonin reuptake inhibitors are helpful in its 
management, and IFN- can activate pathways involved in serotonin processing 
(Miller 2009). IFN- may also alter the metabolism of dopamine, with potential 
consequences of fatigue, psychomotor slowing and sleep-wake cycle disturbance. It 
can also cause hypomanic symptoms, irritability and hyperactivity (Miller 2009). 
 
1.5.5 Human studies of inflammation in delirium 
1.5.5.1 Postoperative delirium: cardiac surgery 
Rudolph et al examined the hypothesis that delirium is a CNS response to a systemic 
inflammatory insult in a state of blood-brain barrier compromise in a cohort of 
patients undergoing cardiac surgery (Rudolph, Ramlawi et al. 2008). A prospective 
cohort of N=42 patients without preoperative delirium underwent surgery under 
cardiopulmonary bypass. Blood samples were collected preoperatively, and 6 hours 
and 4 days postoperatively. Patients were assessed for delirium preoperatively and 
daily from the second postoperative day. Twelve patients developed postoperative 
delirium, and were matched according to age, duration of surgery and baseline 
MMSE score. They found no differences in baseline inflammatory profile between 
groups. At 6 hours postoperatively, levels of chemokines (EOTAXIN, RANTES, 
CCL-2 and IL-8) were increased in those who went on to develop delirium, but there 
was no difference by day 4. At day 4 there was a trend towards lower levels of 
cytokines promoting T-helper 1 and 2 activity. 
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Kazmierski et al performed a prospective cohort study of the role of mild cognitive 
impairment in the development of postoperative delirium after coronary artery 
bypass grafting, and the relationship with cortisol, cytokines, cobalamin and 
homocysteine (Kazmierski, Banys et al. 2014). This study is also described in section 
1.4.9.1. A blood sample for IL-2 and TNF- was collected on the morning of the 
first postoperative day. Both cytokines were elevated in the delirium group compared 
to those who did not develop delirium. However, these associations were lost after 
the results were entered into a multivariate analysis. The MCI group had higher IL-2 
levels after surgery. Further analysis of this cohort, examining whether postoperative 
delirium is associated with raised pro-inflammatory cytokines (IL-2 and TNF-α), and 
examining whether any relationship between inflammation and delirium is mediated 
by surgical, anaesthetic, or premorbid disease factors has also been described 
(Kazmierski, Banys et al. 2014). Those with raised pro-inflammatory cytokines were 
at increased risk of postoperative delirium, including after controlling for other 
variables that were positive in the univariate analysis (trend for TNF-α; other 
variables included AF, depression, dose of midazolam, reperfusion time, trail-making 
B time). Several of the medical and surgical factors under investigation correlated 
with inflammatory cytokine levels, including correlations with advancing age, poorer 
MoCA score, and poorer trail-making scores, and longer perfusion and reperfusion 
time (with IL-2 only).  
 
Plaschke et al (Plaschke, Fichtenkamm et al. 2010) examined serum IL-6 and CRP as 
measures of the inflammatory response to surgery and the bispectral index (BIS, a 
measure of cortical brain activity) in a cohort of N=114 patients on the first 
postoperative day following cardiac surgery, of whom 28% developed postoperative 
delirium. This study also measured cortisol, the results of which were discussed in 
section 1.4.9.3. Blood samples were collected once, immediately after BIS 
measurement. They found that both cortisol and IL-6 levels were higher in the 
delirium group, but the markers themselves were not correlated. CRP was measured 
at the same timepoint, and there was no difference between groups.  
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Bokesch et al studied a large cohort (total N=557) of high-risk patients undergoing 
cardiac surgery with cardiopulmonary bypass, looking at risk factors for neurological 
complications including delirium or stroke/TIA (Bokesch, Izykenova et al. 2006). 
Little information is provided on how delirium was assessed, however. The majority 
(49/55) of those encountering neurological complications developed “moderate-
severe confusion or delirium”. The authors found no association between 
preoperative CRP level and postoperative neurological complications. A higher 
preoperative S100B level was associated with an increased risk of neurological 
complications, but those with a higher NMDA receptor antibody concentration 
preoperatively were at much higher risk. 
 
Delirium has also been studied as a predictor for other postoperative complications 
including sepsis. Martin et al used a retrospective data review of patients in two 
cardiac surgery data registries to identify patients who had had both delirium 
(defined as per the Society of Thoracic Surgeons as “mental disturbance marked by 
illness, confusion, cerebral excitement, and having a comparatively short course”) 
and sepsis (Martin, Buth et al. 2010). Sepsis was the primary outcome of interest. 
Patients were considered to be delirious first if they had those symptoms for 48 hours 
prior to the signs of sepsis. Of just over 14,000 patients on the registry, 981 
developed delirium, 227 became septic and 70 were also delirious. Patients who 
developed delirium were more likely to develop pneumonia, urinary tract infections, 
deep sternal wound infections and sepsis. Thirty-four patients were delirious 2-10 
days prior to developing sepsis. Logistic regression analysis found that delirium was 
associated with the development of postoperative sepsis, with an adjusted odds ratio 
of 2.32. This finding suggests that delirium may increase the risk of developing 
sepsis. The authors discuss that this may be because of an increase in the need for 
instrumentation, e.g. of the urinary tract due to self-removal of catheters, the use of 
sedating agents which reduce the ability to self care and clear secretions, and poor 
oral intake and malnutrition increasing patients’ vulnerability to infection (Martin, 
Buth et al. 2010). Delirium in this context may also be an early marker of sepsis, and 
should prompt clinicians to search for infection. Delirium here was defined 
differently to DSM-IV or ICD 10. The Society of Thoracic Surgeons definition is 
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still likely to be describing delirium but with a bias towards hyperactive subtypes, so 
some patients with hypoactive delirium may not have been included. 
 
1.5.5.2 Postoperative delirium: non-cardiac surgery 
Liu et al conducted a large prospective cohort study examining the role of IL-6 in 
delirium following major non-cardiac surgery (Liu, Ya-wei et al. 2013). They 
enrolled N=338 patients over the age of 60 who were due to undergo elective non-
cardiac surgery. They excluded those with prior dementia, Parkinson’s disease and 
schizophrenia, severe liver or renal dysfunction and those who appeared delirious 
preoperatively. Patients were assessed twice daily for delirium (CAM-ICU) on the 
first three postoperative days, and blood samples were collected to measure IL-6 
before anaesthesia and on the first postoperative morning. Fifty patients (14.8%) 
developed postoperative delirium. High pre- and postoperative IL-6 levels were 
associated with delirium. Multivariate Cox regression analysis identified high 
postoperative IL-6 as an independent predictor of delirium, along with age, poor 
preoperative NYHA class, MMSE <24 and high postoperative pain scores.  
 
In a cohort of N=101 cognitively healthy patients aged over 60 undergoing elective 
arthroplasty, Cerejeira et al screened for postoperative delirium and measured 
markers of both inflammation and the cholinergic system (Cerejeira, Nogueira et al. 
2012). Blood samples were collected on the day before surgery and the first 
postoperative day, and delirium assessments were on the evening of the operation 
day and on days 2 and 3. The surgical trauma itself induced an increase in CRP, IL-6, 
IL-8 and IL-10, and an increase in the ratio of pro/anti-inflammatory cytokines in 
both groups. Thirty-seven patients developed delirium, and they found that those 
who developed delirium had lower preoperative plasma esterase levels. There were 
no differences in the inflammatory markers measured (IL-1β, IL-6, IL-8, IL-10, CRP 
and TNF-α) between those who did and did not develop delirium, but the delirium 
group had a higher pro/anti-inflammatory ratio postoperatively. They also found 
correlations between preoperative plasma esterase activity and change in levels of 
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CRP, IL-6 and pro/anti-inflammatory ratio in the delirium group only (Cerejeira, 
Nogueira et al. 2012). Plasma Insulin-like Growth Factor-1 (IGF-1) was also 
measured in this cohort, and they did not find a significant difference between 
groups. The elevation in cortisol described in section 1.4.9.2 correlated with IL-6 and 
IL-10 in those with postoperative delirium, but not in those without delirium 
(Cerejeira, Batista et al. 2013).  
 
In their study of postoperative delirium in patients undergoing abdominal surgery, 
Kudoh et al examined cortisol, IL-6, CRP and norepinephrine levels before 
anaesthesia, at the end of surgery, on the next day and on the day following that 
(Kudoh, Takese et al. 2005). This study has been described in more detail in section 
1.4.9.2. The authors found no difference in baseline IL-6 levels, but found that levels 
were higher in those with delirium at all 3 postoperative timepoints. They observed 
the same pattern in cortisol levels, and found that the two were positively correlated 
at all postoperative timepoints in the delirium group, but only in the sample at the 
end of surgery in the group without delirium. No differences were detected in 
norepinephrine and CRP levels between groups. 
 
The same investigators also examined the effects of local (epidural) anaesthesia for 
perioperative pain relief in postoperative confusion in patients with chronic 
schizophrenia, and the involvement of IL-6 and cortisol in these processes (Kudoh, 
Takese et al. 2003). This study has been discussed in more detail in section 1.4.9.2. 
Blood samples for IL-6 and cortisol were collected before anaesthesia, 15 minutes 
after incision, at the end of surgery, 24 hours and 48 hours later. Postoperative 
confusion occurred in 21% of the schizophrenia group who were receiving epidural 
anaesthesia, 30% in those with schizophrenia without an epidural and 3% of the 
control group. No differences were found in levels of IL-6 between treatment groups. 
The epidural group had lower IL-6 levels at the end of surgery and 24 hours later 
than the control group without schizophrenia. Patients with schizophrenia who 
developed postoperative confusion had higher IL-6 levels at the end of surgery and 
24 hours later than those who did not. These results suggest there may be an 
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association between higher IL-6 and cortisol levels and postoperative confusion. 
However, it is difficult to generalise these findings as the pathogenesis of 
postoperative confusion or delirium may be different in patients with chronic 
schizophrenia, either due to their underlying psychotic disorder or their antipsychotic 
medication, which all patients were receiving. Indeed, high serum IL-6 levels have 
been documented in schizophrenia (Naudin, Mege et al. 1996). Also, subgroup 
numbers within groups comparing those with and without confusion were quite 
small. 
 
Pol et al performed a prospective cohort study in N=277 consecutive patients 
undergoing vascular surgery, with the aim of examining whether there is a 
inflammatory basis to postoperative delirium in vascular surgery (using CRP levels), 
and what the main risk factors were for delirium in that setting  (Pol, van Leeuwen et 
al. 2014). The rate of postoperative delirium in the study was relatively low at 6%. In 
univariate analyses, they found that the presence of multiple co-morbidities, elevated 
CRP postoperatively, intensive care admission, and open aortic or amputation 
procedures were related to postoperative delirium. CRP level was shown to be 
related to the development of postoperative delirium in a multivariate logistic 
regression analysis, but the odds ratio was only 1.01 (95% confidence interval 1.00-
1.03, p=0.04). Compared with a normal CRP level of 5, a CRP level of 50 was 
associated with a 35% increased risk of postoperative delirium, and a level of 100 
with a 90% increased risk. 
 
Capri et al performed a secondary analysis of a subcohort of patients from a case-
control study into postoperative delirium to examine the predictive role of 
preoperative “inflammageing” cytokines in delirium (Capri, Yani et al. 2014). In 
their original cohort of N=351 patients aged over 65 years and without known 
dementia, who underwent any emergency or elective general or transplant surgery, 
N=47 developed postoperative delirium. N=37 of these patients were age- and sex-
matched with controls who did not develop delirium, and a panel of cytokines (TNF-
α, IL-1β, IL-2, IL-6, IL-8, and IL-10) was measured with ELISA, in a serum sample 
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taken on the day of hospital admission. The authors found that IL-1β and TNF-α 
were largely undetected, there was no difference in IL-8 or IL-10 levels, but IL-2 
was lower and IL-6 was higher in the group that went on to develop delirium. After 
adjusting for potential confounders (age, co-morbidity, functional level, anxiety and 
depression, benzodiazepine use) with logistic regression analysis, IL-2 was no longer 
significantly associated with delirium, but IL-6 was still predictive of delirium. There 
was no mention of assessment of preoperative delirium, although given that 28/37 
patients in the delirium group had emergency surgery, some may have developed 
delirium preoperatively. 
 
1.5.5.3 Hip fracture 
Van Munster et al examined the time-course of cytokine changes in relation to 
delirium in a cohort of patients with acute hip fracture, and related this to delirium 
subtype (van Munster, Korevaar et al. 2008). They prospectively recruited a cohort 
of N=221 patients, and assessed them daily for delirium on weekdays, using the 
Delirium Symptom Interview to ascertain subtype and the DRS-R98 to assess 
severity. Blood samples were collected a maximum of four times, on weekdays, at 
11am. Levels of TNF-, IL-1, IL-6, IL-8, IL-10 and IL-12 were measured with a 
cytometric bead array immunoassay. In order to examine the time-course, samples 
were classed as either “non-delirious”, or “before”, “during” or “after” delirium. 
N=98 patients could be included in the analysis. Unfortunately, TNF-, IL-1 and 
IL-10 were undetected for the majority of samples. The authors found that IL-6 and 
IL-8 were significantly higher in the delirium group. Comparing the kinetics of the 
cytokines over time in those who were continuously delirious, non-delirious or 
delirious for a discrete period postoperatively, it can be seen that levels of these 
cytokines start high, presumably a response to the hip fracture trauma and subsequent 
operation, with an exaggerated rise in those with delirium, with a degree of dose-
dependency. Levels fall over the coming days but remain slightly higher for longer in 
the delirium group (van Munster, Korevaar et al. 2008). The authors also found that 
IL-6 levels were higher in those with hyperactive or mixed subtypes of delirium.  
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Van Munster et al also examined IL-6 and IL-8 levels (along with cortisol as 
described in section 1.4.9.4) in a cohort of patients with acute hip fracture (van 
Munster, Bisschop et al. 2010). They included N=120 patients, of whom 52% 
developed delirium. Patients had up to four blood samples taken during the 
perioperative period, at 11am on weekdays, with blood samples classed as “non-
delirious”, “before” “during” or “after” delirium. Using a linear mixed models 
approach, IL-6 and IL-8 were both associated with delirium, and were both 
influenced by surgery, and IL-8 was affected by age. In a multivariate analysis, log 
IL-6 was associated with delirium but log IL-8 was not. After adjusting for 
premorbid cognitive impairment, log IL-6 was no longer associated with delirium. 
 
Beloosesky et al conducted a prospective cohort study in elderly patients with acute 
hip fracture, aiming to examine the relationships between cytokines and the 
inflammatory marker C-reactive protein (CRP) over the month after hip fracture, 
postoperative complications including delirium, and mortality at 6 months 
(Beloosesky, Hendel et al. 2007). They stratified the cohort by MMSE score, due to 
the hypothesis that there is a state of chronic inflammation in dementia. In N=41 
patients, 27% developed delirium according to the CAM. Comparing kinetics curves 
for the different cytokines and CRP (timepoints: within 10 hours of fracture and pre-
surgery, 48-60 hours, day 7, day 30), the authors found different kinetics curves for 
CRP and IL-8 between those with delirium and those without complications. In the 
subgroup of patients with “impaired mental status”, defined as an MMSE score 
(measured at baseline, at stabilisation and during rehabilitation, with the higher score 
used) of 23 or less, those who developed postoperative complications had higher 
CRP than those who did not develop complications. Patients with impaired mental 
status also had higher IL-6, IL-8 and IL-10, related to the impaired cognition and 
independent of complications. This is a relatively small study, although the use of 
longitudinal measures increases its power. 
 
Cortisol and inflammation in delirium and long-term cognitive decline after hip fracture 
General Introduction 51 
Lemstra et al examined the association between cytokines and incident delirium in a 
cohort of patients with hip fracture, to see whether elevated cytokines are part of the 
disease state of delirium or whether they form a trait which puts patients at increased 
risk of delirium (Lemstra, Kalisvaart et al. 2008). This cohort was originally part of a 
prospective nested case control trial of haloperidol prophylaxis for delirium. Blood 
samples were collected preoperatively within 12 hours of admission and IL-6, IGF-1 
and CRP were measured. Patients who developed incident delirium within 5 days of 
admission were matched with a control group who did not. Two hundred and fifty-
two participants had a blood sample stored. Twenty-eight developed postoperative 
delirium, and were matched with fifty patients who did not. No differences were 
found in levels of any of the inflammatory markers between those who did or did not 
go on to develop delirium. IL-6 was negatively correlated with MMSE score. 
 
1.5.5.4 Elderly medical in-patients 
Adamis et al examined the role of physical illness severity in delirium in elderly 
medical in-patients, studying whether ApoE4 as a predisposing factor and levels of 
CRP and cytokines were involved in the perpetuation of delirium (Adamis, Treloar et 
al. 2007). Patients were assessed for delirium every three days on four occasions and 
then 28 days after admission. Blood tests were taken in the morning at the same time 
as the clinical assessments, and levels of IL-1α, IL-1β, IL-1ra, IL-6, TNF-α, Insulin 
Growth Factor (IGF)-1, IFN-γ and LIF (Leukaemia inhibitor factor) measured with 
ELISA. For financial reasons only 60 of 116 patients who consented to blood 
withdrawal could be included, from a total cohort of 164. Lower serum IGF-1 was 
associated with prevalent delirium. Those who recovered from prevalent delirium 
had higher initial IFN- levels. No associations were found between levels of the 
other cytokines and development of or recovery from delirium.  
 
In the same cohort, Adamis et al examined the null hypotheses that delirium would 
have no effect on in-hospital and six-month mortality (Adamis, Treloar et al. 2007). 
In the patients where blood samples were available, associations between biological 
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factors involved in inflammation and frailty, and mortality were also tested. Those 
surviving initial hospitalisation who died within 6 months had higher initial IL-6 and 
CRP, and lower albumin levels. The authors’ final predictive model of mortality 
using logistic regression found significant predictors of mortality included lower 
albumin and higher IL-6 and IFN-, as well as cognitive impairment and the 
interaction of MMSE with male gender. In this study, delirium was not associated 
with increased mortality. 
 
In the same cohort of N=164 acutely admitted elderly patients, Adamis et al 
examined the relationship between delirium and functional impairment, and the 
modifying influences on any relationship of inflammatory cytokines and ApoE 
genotype (Adamis, Treloar et al. 2011). The cytokines measured were IL-1α, IL-1β, 
IL-1ra, IL-6, IFN-γ, TNF-α, LIF and IGF-1 as in the preceding study. Delirium was 
assessed using the CAM and the original Delirium Rating Scale. Using multivariate 
analysis, the authors found that function, as measured by the Barthel Index, was 
affected by MMSE, ApoE, IL-1α, IL-6, LIF and TNF-α, but there was no significant 
effect of delirium. There was evidence of functional decline in those with delirium 
only where the delirium did not resolve. 
 
In a prospective cohort of elderly medical in-patients, Adamis et al investigated the 
associations between serum cytokines, IGF-1, ApoE4, illness severity, cognition and 
gender with both delirium presence and severity (Adamis, Lunn et al. 2009). They 
enrolled N=70 elderly medical patients, and assessed them in the morning twice per 
week for three weeks, with blood sampling at the first four assessments. The 
cytokines measured were IL-1α, IL-1β, IL-1ra, IL-6, IFN-γ, TNF-α, LIF and IGF-1. 
They used two types of statistical modelling to examine the relationships between the 
variables under study, Generalised Estimating Equations and Penalised Quasi 
Likelihood methods. They diagnosed prevalent delirium in 37.3% of patients and 
incident delirium in 4.5%. When they examined the effects of their explanatory 
variables on the presence or absence of delirium, they found that MMSE score, IGF-
1 and IL-1ra had significant effects, while the other cytokines tested did not. When 
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they examined the relationships with delirium severity, they found that a high MMSE 
and high IGF-1 were associated with lower DRS-R98 score, while high IFN- was 
associated with high DRS-R98 score. These results suggest that IGF-1 and IL-1ra 
may have neuroprotective properties, and that high IFN- may be associated with 
delirium. 
 
Wilson et al studied the relationship between premorbid IGF-1 levels and 
development of delirium in a cohort of N=100 elderly acute medical in-patients 
(Wilson, Broadhurst et al. 2005). They recruited those with significant physical 
illness, defined as an APACHE II score of >8, and excluded those with prevalent 
delirium or insulin dependent diabetes. Patients were assessed daily for delirium 
using the CAM with confirmation by a psychiatrist according to DSM III. Twelve 
patients developed incident delirium. Multivariate logistic regression found an 
association between incident delirium and IGF-1 (OR 0.82), along with depression 
and IQCODE score (OR 3.26).  
 
De Rooij et al conducted a study among consecutively admitted elderly medical 
patients to examine the expression of pro (IL-1, IL-6, IL-8, TNF-) and anti-
inflammatory (IL-10) cytokines and CRP in relation to delirium (de Rooij, van 
Munster et al. 2007). Patients were reviewed within 48 hours of admission and blood 
samples collected in the morning within 3 days of admission. Sixty-four of the 185 
patients in whom they could measure blood markers developed delirium. They found 
no difference in CRP levels between those with and without delirium. They found 
levels of most cytokines to be below the detection limit of the assays used, but the 
delirium group were more likely to have detectable levels of IL-6 and IL-8, and after 
adjusting for age, cognitive impairment and infection, an IL-6 level of >10pg/ml was 
significantly associated with delirium. 
 
MacDonald et al studied the role of CRP in predicting both incident delirium and 
recovery of delirium (MacDonald, Adamis et al. 2007). They enrolled a cohort of 
N=94 acutely ill elderly medical patients. They were assessed within 3 days of 
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admission with MMSE for cognitive function and CAM for delirium, and then every 
3 days until day 18, and further on day 28. Blood was collected for CRP 
measurement at the first assessment, with a final N=86. Twenty-six patients had 
prevalent delirium and a further six developed incident delirium, with 37.2% of 
patients developing delirium at any stage. Those with prevalent and incident delirium 
had higher CRP levels. In a logistic regression analysis, CRP independently 
predicted the onset of incident delirium. Higher initial MMSE score and low CRP 
predicted recovery from delirium.  
 
White et al tried to replicate these findings in a larger (N=283) cohort of emergency 
elderly medical admissions (White, Eeles et al. 2008). They also found higher 
baseline CRP levels in those with prevalent and incident delirium, but no difference 
between those two delirium groups. In a small number who developed incident 
delirium and where they had CRP levels at baseline and the time of development of 
delirium, there was no significant difference in levels. CRP did not correlate with 
delirium severity nor duration.  
 
Speciale et al found in a cohort of N=110 geriatric patients in a rehabilitation facility 
with delirium, 98 prevalent and 11 incident delirium, that CRP levels were high on 
admission in those with prevalent delirium and low at delirium resolution (Speciale, 
Bellelli et al. 2008). In those with incident delirium, they found it to be low on 
admission, higher at delirium onset and low at resolution. These patients had 
heterogeneous precipitating causes of delirium, and the CRP levels were higher in 
those with “infective” or “surgical” causes of delirium than in those with “non-
infective” causes. 
 
Morandi et al studied the association of CRP with prevalent and incident delirium 
further in a large cohort of elderly sub-intensive care patients (Morandi, Sleiman et 
al. 2007). These patients were critically ill and required higher care levels than on a 
general ward, but did not require “global intensive care”. Of 1,369 patients, 301 
Cortisol and inflammation in delirium and long-term cognitive decline after hip fracture 
General Introduction 55 
developed delirium, 132 prevalent and 162 incident delirium. They found that 
prevalent delirium was associated with higher CRP levels, as well as a worse 
prognosis, health status and higher disability scores than incident delirium. 
 
Ritchie et al retrospectively examined the relationship between CRP, delirium, 
delirium severity and medical diagnosis in a database of patients over the age of 70 
admitted to an acute medical unit (Ritchie, Newman et al. 2014). The database was 
constructed for a study examining the prevalence and mortality of patients with 
dementia admitted acutely, and all patients were assessed for delirium using the 
CAM for both diagnosis and severity within 48 hours. Routine blood tests including 
CRP were recorded. Of the N=710 included participants, 12.3% had delirium within 
72 hours of admission. Raised CRP on admission was associated with delirium, and 
this relationship remained after the authors adjusted for illness severity, co-
morbidity, gender, age and the atropine risk score for medication risk. The 
relationship between CRP and delirium differed depending on the broad category of 
medical diagnosis; there was no relationship between the two variables in those with 
an infective diagnosis, but the relationship was stronger in those with a 
musculoskeletal or metabolic diagnosis. There was no relationship between CRP and 
delirium severity. Although the diagnosis of delirium was made prospectively, the 
retrospective use of the database to perform post hoc analyses limits the study 
somewhat, the use of routine blood tests may introduce bias, and not all (but most) 
patients had CRP measured. 
 
1.5.5.5 Acute stroke 
McManus et al found in a cohort of patients with acute stroke (N=82), of whom 28% 
developed delirium, that high admission CRP (>5mg/L) was independently 
associated with development of delirium, with an odds ratio of 10.2 (McManus, 
Pathansali et al. 2009). Most cases of delirium were present at stroke onset. The 
authors speculate that this may be related to those with a larger stroke being more at 
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risk of delirium and infective complications, although these may not have occurred 
by the first assessment, which was within four days of admission. 
 
1.5.5.6 ICU delirium 
McGrane et al performed a prospective cohort study in critically ill patients (N=83) 
to test the hypothesis that systemic inflammation would lead to a longer duration of 
delirium and acute brain dysfunction, using two inflammatory biomarkers, CRP and 
procalcitonin which is an early marker of sepsis (McGrane, Girard et al. 2011). The 
study was nested within a randomised controlled trial of dexmedetomidine vs. 
lorazepam for sedation in ICU. Blood samples were collected within 24 hours of 
enrolment, and patients were assessed daily for delirium for up to 12 days (CAM-
ICU and RASS). Delirium and coma-free days were the outcomes of interest. 
Proportional odds logistic regression was used to examine the relationship between 
the two inflammatory biomarkers and delirium and coma-free days. Higher baseline 
procalcitonin was associated with more brain dysfunction (fewer delirium and coma-
free days), and higher CRP trended towards the same outcome. This relationship was 
independent of sepsis. Procalcitonin was not associated with other types of organ 
dysfunction, but higher CRP levels were associated with kidney dysfunction in septic 
patients. Inflammation, as identified by higher procalcitonin and CRP levels, may 
therefore contribute to delirium and acute brain dysfunction, independent of sepsis 
and other organ dysfunction.  
 
Zhang et al performed a study in ICU patients with the aim of better defining the 
relationship between CRP and delirium (Zhang, Pan et al. 2014), having found in a 
meta-analysis of critically ill patients that prolonged elevation of CRP is associated 
with higher mortality (Zhang and Ni 2011). They performed a prospective 
observational cohort study in a mixed medical and surgical ICU. They excluded 
those with delirium on admission, and monitored for delirium with the CAM-ICU 
eight-hourly. Plasma CRP was measured routinely on admission to ICU and 24 hours 
later, and the change in the two values was also calculated. Of the N=223 patients 
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eligible, delirium developed in 24%. The mean age was 57 years. The delirium group 
had higher CRP levels, and CRP remained independently associated with delirium 
after adjusting for confounding variables including age, gender, APACHE score, 
intubation status, medical condition, smoking, alcohol, physical restraint, hospital 
length of stay before ICU admission and living alone. Change in CRP was also 
associated with an increased risk of developing delirium. Delirium subtype also had a 
role; patients with mixed or hypoactive subtypes had higher CRP than those without 
delirium.  
 
Pfister et al examined several biomarkers including serum IL-6, CRP, cortisol and 
S100B, and measures of cerebral blood flow and oxygenation, in a small cohort of 
ICU patients with sepsis associated delirium (Pfister, Siegemund et al. 2008). 
Patients with pre-existing central neurological disorders such as dementia were 
excluded, as were patients with delirium felt to be secondary to a cause other than 
sepsis. Biomarkers were measured at the same time as cerebral blood flow 
measurement, within 48 hours of admission and stabilisation. In their cohort of 
critically ill patients with extracranial sepsis, 12/16 developed delirium according to 
the CAM-ICU. They found higher levels of CRP but not IL-6 in the delirium group, 
and CRP correlated positively with disturbance in auto-regulation. S100B and 
cortisol were also elevated, and S100B discriminated between those who survived 
and those who did not. Numbers in the study were small, however, and they did not 
control for other factors such as illness severity. 
 
Girard et al tested the hypothesis that inflammation and deranged coagulation are 
risk factors for delirium in critical illness (Girard, Ware et al. 2012). Mechanically 
ventilated medical ICU patients were recruited to a randomised controlled trial of a 
paired sedation and ventilator weaning strategy, and this study was performed as a 
nested case control study. Blood samples were collected on the morning after 
enrolment and on day 5, and nine intermediates of inflammation or coagulation 
measured; CRP, matrix metalloproteinase-9 (MMP-9), myeloperoxidase, neutrophil 
gelatinase-associated lipocalin, soluble TNF-receptor 1, d-dimer, protein C, 
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plasminogen activator inhibitor type 1 and von Willebrand factor antigen. Patients 
were assessed daily for delirium using the CAM-ICU until death or ICU discharge; 
patients with RASS -4 or -5 were considered to be comatose. N=138 patients were 
included, the majority were aged over 65, and 78% were delirious during their ICU 
stay. After adjusting for age, illness severity and severe sepsis, the group of 
biomarkers studied was found to be associated with delirium. Specifically, higher 
MMP-9 was associated with a reduced probability of delirium, whereas high soluble 
TNF-receptor and low protein C were associated with an increased probability of 
delirium.  
 
Ritter et al tested the hypothesis that the association between systemic inflammation 
and delirium would be different in patients with and without sepsis (Ritter, Tomasi et 
al. 2014). They prospectively enrolled ICU patients and assessed them for delirium 
twice daily for the first 72h after admission with the CAM-ICU. Blood was collected 
within 12h of ICU admission, and TNF-, soluble TNF receptor-1 and -2, 
adiponectin, IL-1, IL-6 and IL-10 were measured. Patients were classed as septic or 
not according to international criteria. Seventy-eight patients were included, of 
whom 31 developed delirium. The delirium group had higher levels of IL-1, soluble 
TNF receptors and adiponectin, and these markers were associated with delirium in a 
multivariate logistic regression analysis. Sepsis did not modify the relationship 
between the markers and delirium. 
 
Van den Boogaard et al examined multiple biomarkers in a cohort of ICU patients 
who they split into “inflamed” and “non inflamed” (van den Boogaard, Kox et al. 
2011). This study has also been discussed in section 1.4.9.3. They monitored patients 
for delirium using the CAM-ICU three times daily, and 50% of the 100 patients 
included in the study developed delirium. They divided those with delirium into 
“inflamed” and “non-inflamed”; inflamed was defined as a positive culture for which 
the patient was given antibiotics, and absence of inflammation as the absence of 
proven or suspected infection, and having no more than one SIRS criterion. The 
control group were likewise split into “inflamed” and “non-inflamed”. In addition to 
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cortisol, the pro-inflammatory intermediates they measured were TNF-, IL-1, IL-
6, IL-8, IL-17, IL-18 and macrophage migration inhibitory factor (MIF), the anti-
inflammatory intermediates were IL-1ra, IL-10, and also the chemotactic marker 
MCP-1. They also measured CRP and pro-calcitonin as indicators of the acute phase 
response, and plasma defensin (human neutrophil peptide-1). Finally, they measured 
amyloid1-40 and amyloid1-42 as well as their truncated forms, and S100B and tau. 
The delirium group had higher levels of TNF-, IL-6, IL-8, MIF, IL-1ra, IL-10, 
MCP-1 and procalcitonin. No difference was found between groups in levels of IL-
1, IL-17, IL-18, plasma defensin or CRP. Of the brain specific proteins, the ratios of 
amyloid1-42/40 and amyloidN-42/40 were lower in the delirium group, and truncated 
amyloidN-40 levels were higher. No differences were found in S100B, tau and the 
other amyloid isoforms. In inflamed patients, several biomarkers were associated 
with delirium, but in a multivariate logistic regression analysis, only IL-8 (OR 9.0) 
was associated with delirium in inflamed patients. In the non-inflamed group, 
multivariate logistic regression analysis found associations between the ratio of 
amyloid1-42/40 (OR 0.03) and IL-10 (OR 2.6) with delirium in non-inflamed patients. 
Given the differences between the biomarker profiles in “inflamed” and “non-
inflamed” delirious patients, the authors suggest that there are different pathogenetic 
mechanisms for delirium in these types of patients. However, this was an exploratory 
study with relatively small numbers for the number of biomarkers measured. 
 
1.5.5.7 CSF cytokines 
Katsumata et al conducted a prospective cohort study recruiting 59 patients with 
SLE, acutely admitted for assessment or treatment to the Rheumatology Unit of a 
General Hospital in Tokyo, Japan (Katsumata, Harigai et al. 2007). Patients were 
grouped according to whether or not they had CNS manifestations of SLE, and in the 
CNS group, the presence or absence of delirium according to DSM criteria. They 
examined pro-inflammatory cytokines in the CSF of these patients with the aim of 
developing a diagnostic tool for delirium in this context. They measured IL-6, IL-8 
and IFN-, plus IgG index, an indicator of intrathecal immunoglobulin synthesis and 
Q-albumin, a measure of blood-brain-barrier function. Katsumata et al found IL-6 to 
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be higher in the delirious group compared to those with no CNS features of SLE. IL-
6 also positively correlated with the SLE Disease Activity Index (SLEDAI) when 
this score included CNS syndrome but not when the score did not. IL-8 and IFN- 
were not significantly different in delirium. The rate of positive IgG index was 
higher in delirium suggesting that there may be intrathecal production of 
immunoglobulins, perhaps signaling damage or providing protection against attack, 
or augmenting the inflammatory response (that might then worsen any CNS 
damage). There was also a trend towards higher Q-albumin in delirium, suggesting 
subtle blood-brain-barrier dysfunction.  
 
MacLullich et al undertook a prospective cohort study in patients over the age of 60 
undergoing hip fracture repair under spinal anaesthesia, with the aim of investigating 
whether CNS pro-inflammatory cytokines are elevated in delirium (MacLullich, 
Edelshain et al. 2011). Thirty-six patients in two centres (Edinburgh and Amsterdam) 
were assessed for delirium preoperatively and 3-4 days postoperatively using the 
CAM. CSF specimens were taken at the onset of spinal anaesthesia prior to the 
administration of anaesthetic agent. They measured TNF-α, IL-1β, IL-6, IL-8, IL-10 
and IL-12p70 by cytometric bead array. The investigators found IL-8 to be detected 
in 33/36 CSF samples, and IL-6 in 3/36 samples. The other cytokines were not 
detected. CSF IL-8 was significantly higher in cases than controls. Cases also had 
higher serum IL-6 levels. Dementia was not associated with raised IL-8, and when 
the investigators excluded patients with known dementia from the analysis, the 
pattern of results did not change. These results suggest an association between 
delirium and elevated CSF IL-8, although causation cannot be implied in this cross-
sectional, observational study. 
 
Westhoff et al performed an exploratory study in patients with acute hip fracture, 
with the hypothesis that those with a dysfunctional immune response would be more 
vulnerable to postoperative delirium (Westhoff, Witlox et al. 2013). The 
investigators monitored for delirium using the CAM, with severity scoring using the 
DRS-R98 until day 5 postoperatively, or longer if delirium was still present at that 
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time. They collected blood preoperatively to measure CRP, IL-6 and ESR 
(erythrocyte sedimentation rate). CSF was collected at the onset of spinal anaesthetic, 
and a panel of 42 cytokines and chemokines measured using a Luminex assay. Some 
of the cytokines and chemokines were not detectable in the majority of samples, and 
they compared levels of each marker where there was sufficient detected (16 
markers) between those who did and did not develop delirium postoperatively using 
Mann Whitney U test. Of N=122 patients enrolled, N=61 patients were included in 
the analysis due to a change to general anaesthesia, the exclusion of those with 
preoperative delirium and logistical reasons. The authors found that those who 
developed postoperative delirium had lower levels of CSF IL-6, IL-1ra and Flt-3L 
(FMS-like tyrosine kinase 3 ligand) preoperatively. However, the delirium group had 
higher levels of serum IL-6 preoperatively. They found no difference in CRP and 
ESR levels. There is no comment on whether there was any correlation between 
serum and CSF levels of IL-6, but there is also no information on how IL-6 was 
measured in serum, since if this was by a different assay technique they would be 
harder to compare.  
 
1.5.5.8 Genetic polymorphisms 
In a cohort of N=881 elderly patients, some with acute hip fracture and some acutely 
unwell medical patients, van Munster et al examined whether genetic polymorphisms 
in the genes for IL-6, IL-8 and the IL-6 receptor were associated with delirium (van 
Munster, Zwinderman et al. 2011). Delirium was diagnosed with the CAM, and the 
incidence was 50% in the patients with hip fracture and 34% in the medical patients. 
The single nucleotide polymorphisms the authors examined were not associated with 
delirium. 
 
1.5.5.9 Autopsy studies 
The presence of neuroinflammation in delirium has been assessed in an autopsy 
study by van Munster et al, looking for the presence of microglial, astrocyte and 
cytokine activation in those who died with delirium compared to those who did not. 
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N=9 cases with delirium were compared with N=6 age-matched controls (van 
Munster, Aronica et al. 2011). Those with CNS infection were excluded. The 
diagnosis of delirium had been made pre-morbidly by a member of a team of 
geriatricians following patients with delirium in their centre, however in the controls 
the absence of delirium could only be confirmed by retrospective case-note review. 
Using immunocytochemistry, they found more active microglia in the brains of those 
who died with delirium, and more astrocyte activity in the dentate gyrus. There was 
also more IL-6 immunoreactivity but IL-1 was not detectable. 
 
Lemstra et al performed a case control autopsy study to test the hypothesis that 
peripheral infection induces microglial activation in the brain (Lemstra, Groen in't 
Woud et al. 2007). This has previously been demonstrated in a rat model by Semmler 
et al (Semmler, Okulla et al. 2005), and it is thought that activated microglia are 
involved in inducing sickness behaviour changes associated with sepsis. Thirteen 
cases who died with sepsis and had an absence of CNS infection or other 
supratentorial pathology, were compared with 17 controls who had no signs of 
infection 0-3 days prior to death or at autopsy. Using immunohistochemistry, the 
authors demonstrated activated microglia in the brains of the patients who died with 
sepsis from a peripheral source. These patients were sourced from the autopsies 
performed at their centre where permission was given for use in research, and no 
information is given on delirium, although it is speculated that microglial activation 
in this context may be involved in delirium (Lemstra, Groen in't Woud et al. 2007).  
 
1.5.6 Summary of human studies of inflammation in delirium 
In summary, delirium has been shown to be associated with several different 
derangements in inflammatory cytokines and chemokines, but results for individual 
cytokines and cytokine families are mixed, and this may depend on the factors 
precipitating the delirium, the timing of the samples and covariates taken into 
account. There seems to be a generally pro-inflammatory and pro-chemotactic milieu 
in delirium. Some studies find a lack of anti-inflammatory cytokines such as IL-1ra 
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and IL-10, and some find higher levels. Findings for each group of markers are now 
summarised. 
 
1.5.6.1 Interleukin-1 family 
Serum IL-1α, IL-1β and IL-1ra were not different in elderly medical patients with 
delirium (Adamis, Treloar et al. 2007), but IL-1ra level was shown to be a protective 
modifier of delirium risk (Adamis, Lunn et al. 2009). IL-1β has been shown to be 
associated with ICU delirium after controlling for covariates (Ritter, Tomasi et al. 
2014). A further study in those with critical illness found higher serum IL-1ra but not 
IL-1β (van den Boogaard, Kox et al. 2011). In CSF, lower IL-1ra has been 
demonstrated in delirium after hip fracture (Westhoff, Witlox et al. 2013). 
 
1.5.6.2 Interleukin-2 
After cardiac surgery, elevation of IL-2 is seen in the immediate postoperative period 
in those with postoperative delirium (Kazmierski, Banys et al. 2014). In a cohort 
undergoing general surgery, those with lower IL-2 went on to develop delirium, but 
this was no longer associated after adjusting for covariates (Capri, Yani et al. 2014). 
 
1.5.6.3 Interleukin-6 
Serum interleukin-6 has been shown to be elevated in the immediate postoperative 
period following cardiac surgery (Plaschke, Fichtenkamm et al. 2010), and it has also 
been demonstrated to be an independent predictor of delirium following non-cardiac 
surgery (Liu, Ya-wei et al. 2013, Capri, Yani et al. 2014). It was not different in 
those with delirium following elective arthroplasty (Cerejeira, Nogueira et al. 2012), 
and in one study of delirium after hip fracture (Lemstra, Kalisvaart et al. 2008), but 
three further studies in those with hip fracture found it to be elevated (van Munster, 
Korevaar et al. 2008, MacLullich, Edelshain et al. 2011, Westhoff, Witlox et al. 
2013), but not after adjusting for covariates including prior dementia (van Munster, 
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Bisschop et al. 2010). IL-6 level was a predictor of mortality in elderly medical 
patients (Adamis, Treloar et al. 2007). One study in elderly medical patients found 
higher IL-6 in delirium after adjusting for covariates including prior dementia (de 
Rooij, van Munster et al. 2007), but a further study did not find a difference (Adamis, 
Treloar et al. 2007). In ICU delirium, two studies have not shown a difference in IL-
6 (Pfister, Siegemund et al. 2008, Ritter, Tomasi et al. 2014), but one found it to be 
elevated (van den Boogaard, Kox et al. 2011). Where IL-6 has been measured in 
CSF, it was shown to be higher in delirium associated with SLE (Katsumata, Harigai 
et al. 2007), and lower in those with delirium after hip fracture (Westhoff, Witlox et 
al. 2013). Polymorphisms in the genes for IL-6 and IL-6 receptor were not found to 
be associated with increased risk of delirium (van Munster, Zwinderman et al. 2011). 
An autopsy study also found more IL-6 immunoreactivity in the brains of those whe 
died with delirium than in controls (van Munster, Aronica et al. 2011). 
 
1.5.6.4 Tumour Necrosis Factor 
After cardiac surgery, elevation of TNF-α is seen in the immediate postoperative 
period in those with postoperative delirium (Kazmierski, Banys et al. 2014), but not 
after adjusting for covariates. TNF-α was not shown to be different in elderly 
medical patients with delirium (Adamis, Treloar et al. 2007). Soluble TNF-receptors 
have been shown to be associated with ICU delirium in two studies (Girard, Ware et 
al. 2012, Ritter, Tomasi et al. 2014). Two studies have found elevated TNF-α in ICU 
delirium, but not after controlling for covariates (van den Boogaard, Kox et al. 2011, 
Ritter, Tomasi et al. 2014).  
 
1.5.6.5 Chemokines including IL-8 
After cardiac surgery, chemokines have been found to be raised in those who go on 
to develop delirium (Rudolph, Ramlawi et al. 2008). In patients with hip fracture, IL-
8 has been shown to be elevated in those with delirium (Beloosesky, Hendel et al. 
2007, van Munster, Korevaar et al. 2008), and IL-8 was still associated with delirium 
after adjusting for covariates including prior dementia (van Munster, Korevaar et al. 
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2008, Bisschop, de Rooij et al. 2011). It was not shown to be different preoperatively 
in those who developed delirium after general surgery (Capri, Yani et al. 2014). IL-8 
has also been shown to be elevated in ICU delirium, including after adjusting for 
covariates in those with “inflamed delirium”, and MCP-1 was found to be higher in 
ICU delirium (van den Boogaard, Kox et al. 2011). In CSF, IL-8 has been shown to 
be elevated in delirium after hip fracture (MacLullich, Edelshain et al. 2011). A 
polymorphism in the gene for IL-8 was not shown to be associated with delirium risk 
(van Munster, Zwinderman et al. 2011).  
 
1.5.6.6 Interleukin-10 
IL-10 has been found to be elevated in ICU delirium in two studies (van den 
Boogaard, Kox et al. 2011, Ritter, Tomasi et al. 2014). In one it was no longer 
associated after adjusting for covariates (Ritter, Tomasi et al. 2014), but in a further 
study, those with “non-inflamed” delirium had higher IL-10 following a multivariate 
analysis (van den Boogaard, Kox et al. 2011). It was not found to be different 
preoperatively in those who developed delirium after general surgery (Capri, Yani et 
al. 2014). 
 
1.5.6.7 Balance of pro- and anti-inflammatory cytokines 
In elective arthroplasty, an imbalance of pro and anti-inflammatory cytokines in 




In elderly acute medical patients, IGF-1 has been shown to be lower in prevalent 
delirium, and higher levels of IGF-1 were associated with less severe delirium 
(Adamis, Lunn et al. 2009), and lower risk of incident delirium (Wilson, Broadhurst 
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et al. 2005). After hip fracture, IGF-1 was not associated with incident delirium 
(Lemstra, Kalisvaart et al. 2008).  
 
1.5.6.9 IFN-γ 
Elderly medical patients with higher initial IFN-γ were more likely to recover from 
prevalent delirium (Adamis, Treloar et al. 2007), but IFN-γ also correlated with 
delirium severity (Adamis, Lunn et al. 2009). Higher IFN-γ was a predictor of 
mortality (Adamis, Treloar et al. 2007).   
 
1.5.6.10 CRP 
Multiple studies in different populations have measured C-reactive protein, with very 
mixed results. In ICU delirium, one study found an association between higher CRP 
and delirium in a multivariate analysis (Zhang, Pan et al. 2014), a small study found 
higher levels (Pfister, Siegemund et al. 2008), one study found a trend towards a 
relationship between CRP and brain dysfunction (McGrane, Girard et al. 2011) and 
one study found no difference (Girard, Ware et al. 2012). There was no association 
between CRP and postoperative delirium following cardiac surgery (Bokesch, 
Izykenova et al. 2006, Plaschke, Fichtenkamm et al. 2010), elective arthroplasty 
(Cerejeira, Nogueira et al. 2012) and abdominal surgery (Kudoh, Takese et al. 2005). 
One study found an association with delirium following vascular surgery but with an 
OR of only 1.01 (Pol, van Leeuwen et al. 2014). In delirium after hip fracture, two 
studies found no association between CRP measured at a single timepoint (Lemstra, 
Kalisvaart et al. 2008, Westhoff, Witlox et al. 2013), and a further study did find 
different “CRP kinetics”, over a wide timeframe from 10h to 30 days post-fracture in 
those with delirium (Beloosesky, Hendel et al. 2007). Results in incident and 
prevalent delirium in elderly medical in-patients are more mixed; it has been found to 
be higher in delirium (MacDonald, Adamis et al. 2007, Morandi, Sleiman et al. 2007, 
White, Eeles et al. 2008, Ritchie, Newman et al. 2014), but not always (de Rooij, van 
Munster et al. 2007, Adamis, Lunn et al. 2009), and it has been shown to be an 
independent predictor of incident delirium in elderly patients (MacDonald, Adamis et 
Cortisol and inflammation in delirium and long-term cognitive decline after hip fracture 
General Introduction 67 
al. 2007) and after stroke (McManus, Pathansali et al. 2009). It does differ depending 
on the precipitating illness (Ritchie, Newman et al. 2014), and while some studies 
have suggested CRP may track the onset and resolution of delirium (Speciale, 
Bellelli et al. 2008), others have not (White, Eeles et al. 2008).  
 
1.5.7 Immunosenescence 
There has been an increasing understanding in recent years of the effect of ageing 
primarily on the humoral but also on the innate immune response. This has been 
termed immunosenescence, and more recently the term inflammageing has been 
coined to reflect that the aged immune system is remodelled rather than simply being 
depressed, with some functions static or even increased (Ginaldi, Mengoli et al. 
2007). Drivers of immunosenescence include oxidative stress and a lifetime’s 
accumulation of exposure to antigens. Thymic involution also leads to a reduction in 
numbers of lymphoid precursor T cells and B cells, which are important to the 
adaptive immune response (Malaguarnera, Ferlito et al. 2001, Ginaldi, Mengoli et al. 
2007). There are fewer lymphocyte subgroups, and T cells have diminished 
proliferative capacity. Aged B lymphocytes are qualitatively different, with reduced 
antibody responsiveness, which is of particular importance for immunisation 
(Malaguarnera, Ferlito et al. 2001). Changes to the innate immune response affect 
different cell types. Aged neutrophils and macrophages both exhibit reduced 
chemotaxis, phagocytosis, superoxide production and signal transduction. 
Macrophages also show reduced MHC class II production and cytokine production, 
and increased prostaglandin E2 production (Solana, Tarazona et al. 2012).  
 
1.5.8 Human studies of inflammation and ageing 
Serum levels of chemokine-cytokine factor (sIL-4R, IL-6 and IL-8) have been found 
to be associated with atrophy on cerebral MRI in the Memory and Morbidity in 
Augsberg Elderly study, after adjusting for several co-variates including age, gender, 
education, cardiovascular disease and smoking. No association was found between 
single cytokines and MRI changes such as white matter lesions, atrophy or lacunar 
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infarcts, and it was thought that a pattern of cytokine and chemokine changes may be 
responsible for changes in the ageing brain (Baune, Ponath et al. 2009). 
 
Higher baseline high-sensitivity (hs)CRP has been shown to predict poorer memory 
after 12 years in an epidemiological study in older women. Komulainen et al studied 
N=97 women with an age at baseline of 60-70 years, without dementia, measured 
global cognitive function with the MMSE and collected serum for hsCRP 
(Komulainen, Lakka et al. 2007). Participants were followed-up 12 years later, with 
repeat MMSE and a fuller cognitive test battery with measures of memory and 
cognitive speed. The authors found that higher baseline hsCRP was associated with 
poorer memory at follow-up, including after adjustment for age, education, 
depression, hormone replacement therapy, smoking, serum LDL cholesterol and 
BMI. This population-based study suggests inflammation may be associated with the 
development of cognitive impairment, and the authors suggest hsCRP may be useful 
as a biomarker for risk of cognitive decline.  
 
1.5.9 Human studies of inflammation and POCD 
Visvanathan et al investigated the role of TNF- in postoperative cognitive 
dysfunction (Visvanathan, Sundararajan et al. 2003). They enrolled patients (N=44) 
scheduled to undergo elective cardiac surgery, and collected blood preoperatively. 
Mononuclear cells were stimulated to produce TNF-, and levels measured. They 
tested cognition preoperatively and 6 months postoperatively, with a battery covering 
linguistic function, theory and psychomotor function. Those with a “clinically 
important” decline in their scores on the cognitive tests had a higher preoperative 
stimulated TNF- level. This indicates that those with a greater pro-inflammatory 
state may be more prone to POCD. 
 
1.5.10 Human studies of inflammation in dementia 
In recent years a chronic inflammatory process has been implicated in dementia, with 
a focus on the role of glial cells. They are thought to instigate a cytokine-mediated 
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inflammatory response, following an insult to neurons (Lee, Chung et al. 2009). This 
may lead to the production of acute phase proteins including amyloid precursor 
protein. 
 
Holmes, Cunningham et al performed a study in a cohort of elderly patients with 
Alzheimer’s disease, with the hypothesis that these patients would show evidence of 
permanent cognitive decline following an infection, even in the absence of delirium 
(Holmes, El-Okl et al. 2003). This phenomenon is well known to clinicians, families 
and carers of patients with dementia. Animal modelling in mice with 
neurodegenerative disease has shown that a peripheral inflammatory stimulus 
invokes an exaggerated cytokine response in the CNS from microglia that are already 
“primed” by the ongoing pathology of the neurodegenerative disease. This is 
accompanied by a dip in cognitive functioning mimicking delirium, and with an 
acceleration of the neurodegenerative disease process. The authors suspect that a 
parallel process occurs in the brains of patients with Alzheimer’s dementia. Eighty-
five patients with Alzheimer’s dementia and no evidence of systemic infection at 
baseline were studied, assessed for delirium with the CAM, cognitive function with 
the MMSE and baseline serum IL-1 was measured. The patients and their carers 
were questioned about symptoms or signs of infections in the previous two months, 
and they were assessed again in the same manner two months later. No patients 
fulfilled CAM criteria for delirium at either assessment. They found that the fifteen 
patients with evidence of infection in the two months prior to baseline assessment 
had a higher rate of cognitive decline in the two months between assessments than 
the group without infection. Only six patients had detectable serum IL-1, but these 
patients also had a greater degree of cognitive decline than those with undetectable 
IL-1. Those developing an infection between the two assessments had a trend 
towards greater cognitive decline. Although this is a relatively small study with 
retrospective diagnosis of infection, and low rates of detection of IL-1, it does 
suggest that systemic infection may drive cognitive decline in dementia, even in the 
absence of delirium. 
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Holmes et al (Holmes, Cunningham et al. 2009) performed a prospective cohort 
study in patients with Alzheimer’s disease to test the hypothesis that acute systemic 
inflammatory events, accompanied by a rise in peripheral TNF-, would be 
associated with long-term cognitive decline. They recruited N=300 patients with 
Alzheimer’s disease, and performed a cognitive assessment at baseline designed to 
detect change in cognitive function, and collected a blood sample to measure CRP 
and TNF-. The patient’s caregiver was interviewed about systemic inflammatory 
events in the preceding two months. This procedure was repeated at two-monthly 
intervals for six months, including assessment for delirium using the CAM. N=275 
patients were included, following exclusion of patients with end-stage dementia at 
baseline. N=18 had delirium at baseline, and N=39 patients had had a total of fifty 
systemic inflammatory events in the two months preceding baseline assessment. 
N=222 patients completed follow-up, with N=110 having a total of one-hundred and 
fifty systemic inflammatory events. The authors found no difference in the change in 
cognitive function over six months in those with high vs. low CRP levels at baseline, 
however those with high TNF- levels at baseline suffered a four-fold greater rate of 
cognitive decline. Those who had a systemic inflammatory event during follow-up 
also had a faster rate of cognitive decline than those with no inflammatory events. 
N=25 subjects had delirium diagnosed during the follow-up period, and this was 
more frequent in those with higher baseline TNF-. Systemic inflammatory events 
were associated with cognitive decline independent of delirium. The same group also 
hypothesised that in this cohort of patients with Alzheimer’s disease, serum IL-6 and 
TNF-α, which are involved in initiating sickness behaviour, would be associated with 
the development of neuropsychiatric symptoms similar to sickness behaviour 
(Holmes, Cunningham et al. 2011). Those who developed delirium over the six 
months had higher scores on the Neuropsychiatric Inventory. Those with low TNF- 
or IL-6 also had a lower Neuropsychiatric Inventory score over the six months, and 
the three core symptoms of sickness behaviour (depression, anxiety and apathy) were 
more frequent in those with higher proinflammatory cytokines (Holmes, 
Cunningham et al. 2011).   
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Non-steroidal anti-inflammatory drugs have been suggested as a possible treatment 
for Alzheimer’s disease, following epidemiological data showing lower than 
expected prevalence or delayed onset of the disease in patients on long-term 
NSAIDs. MacKenzie et al (MacKenzie and Munoz 1998) conducted a post-mortem 
study in elderly patients without dementia, comparing those with arthritis who have 
used NSAIDs long-term with those with no diagnosis which would have led to them 
using NSAIDs regularly. The authors did not find any difference in the number of 
amyloid plaques or neurofibrillary tangles, but they found fewer activated microglia 
in the patients with long-term NSAID use, suggesting that prevention of microglial 
activation may be a mechanism by which NSAIDs confer their protective effects.  
 
1.5.11 The immune system and sleep 
There is an important relationship between the immune system and sleep. This is 
pertinent because sleep is often disrupted in hospital settings (Pilkington 2013), and 
sleep-wake cycle disturbance is a very prevalent feature of delirium (Meagher, 
Moran et al. 2007). Levels of IL-6 and TNF- have been shown to be elevated with 
sleep restriction. Vgontzas et al (Vgontzas, Zoumakis et al. 2003) showed by 
comparing two cohorts of older and younger “normal sleepers” that IL-6 levels were 
associated with total waking time, particularly in the older adults, and in the young 
adults that IL-6 was negatively associated with REM sleep. They found no difference 
in TNF- levels between groups. 
 
1.5.12 Conclusions 
In summary, the immune system is integral in the body’s response to trauma and 
infection, and there are important changes with ageing. Some studies have found 
associations between delirium and a pro-inflammatory cytokine milieu or lack of 
anti-inflammatory cytokines. However, the results have been heterogeneous; this 
may reflect the wide range of patient cohorts, underlying delirium aetiology and the 
types of measurement used.  
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1.6 Central nervous system damage in delirium 
1.6.1 Definitions 
As discussed in section 1.1.5, delirium is associated with multiple adverse outcomes 
including an increased risk of institutionalisation and of mortality (Siddiqi, House et 
al. 2006, Witlox, Eurelings et al. 2010), which is independent of age, sex, co-morbid 
illness and baseline dementia (Witlox, Eurelings et al. 2010). There is also a complex 
relationship with long-term cognitive decline (MacLullich, Beaglehole et al. 2009). 
Dementia, along with older age, is one of the strongest risk factors for delirium 
(Young and Inouye 2007, Juliebo, Bjoro et al. 2009, Davis, Muniz Terrera et al. 
2012), and there is a significantly increased risk of developing dementia following 
delirium (MacLullich, Beaglehole et al. 2009, Witlox, Eurelings et al. 2010, Davis, 
Muniz Terrera et al. 2012). It is currently unclear whether delirium is ‘unmasking’ a 
dementia process that had already begun but not been recognised, or whether a new 
pathological process has been sparked in a brain that had otherwise been ageing 
healthily. However, there is evidence that an episode of delirium worsens the 
trajectory of cognitive decline in Alzheimer’s dementia (Fong, Jones et al. 2009). In 
middle-aged patients (median age 58) with ICU delirium, a longer duration of 
delirium has been shown to be associated with smaller brain volumes three months 
after ICU admission (Gunther, Morandi et al. 2012). Although this was an 
observational study and pre-existing ventricular enlargement cannot be excluded, it 
raises the possibility of neuronal loss during delirium. There is also evidence that 
incident dementia that follows an episode of delirium may not be associated with 
standard dementia neuropathologies (Davis, Muniz Terrera et al. 2012). Due to these 
associated deleterious outcomes, an obvious question is whether there is evidence of 
acute damage to the CNS during a delirium episode.  
 
S100B is a Ca2+ binding protein, found in the CNS primarily in astrocytes, 
oligodendrocytes, some neurons and populations of lymphocytes, ependymal cells 
and epithelial cells of the choroid plexus (Steiner, Bernstein et al. 2007). It is also 
found peripherally. It has multiple functions intracellularly, being involved in 
Cortisol and inflammation in delirium and long-term cognitive decline after hip fracture 
General Introduction 73 
cytoskeleton assembly and calcium homeostasis, protein phosphorylation and the 
glycolytic pathway (Donato, Sorci et al. 2009, Donato and Heizmann 2010, Leclerc, 
Sturchler et al. 2010). It is also secreted by astrocytes under conditions of metabolic 
stress, and has cytokine-like properties, transmitting messages among glia and 
between glia and neurons (Steiner, Bernstein et al. 2007).  
 
Due to its cellular location and properties, raised levels of S100B in cerebrospinal 
fluid (CSF) and serum have been seen as a marker of astrocyte damage or 
dysfunction, and of CNS damage. It has been used as a biomarker of traumatic brain 
injury (Bloomfield, McKinney et al. 2007, Petzold 2007), and in stroke it correlates 
with stroke severity score, infarct volume and functional outcome (Brouns, De Vil et 
al. 2010). S100B has also been found to be elevated in CSF in early Alzheimer’s 
disease (Peskind, Griffin et al. 2001), and in CSF and serum in schizophrenia 
(Rothermundt, Ahn et al. 2009). It has been found to be elevated following 
cardiopulmonary bypass, and its level in serum was associated with confusion and 
neurocognitive dysfunction after cardiac surgery (Shaaban Ali, Harmer et al. 2000).  
 
1.6.2 Human studies of markers of CNS damage in delirium 
and POCD 
Herrmann et al (Herrmann, Ebert et al. 2000) examined the predictive value of serum 
S100B and Neuron-Specific Enolase (NSE) for neurocognitive outcomes following 
cardiac surgery. N=113 patients were enrolled, and they had blood samples from 78. 
Patients had a neuropsychological and neuropsychiatric evaluation preoperatively, 
three and eight days postoperatively and at six months. This included assessment for 
delirium based on DSM-III-R criteria. Blood samples were collected before surgery, 
and 1h, 6h, 20h and 30h after skin closure. Seven patients were delirious at three 
days postoperatively, and two were delirious at eight days. S100B levels peaked one 
hour postoperatively and fell back towards preoperative levels thereafter. S100B rose 
higher and the rise lasted longer in those with delirium. This pattern was also the 
case for those with adverse neuropsychological outcomes. 
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Rasmussen et al conducted a prospective cohort surgery in N=35 elderly patients 
undergoing cardiac bypass surgery, with the hypothesis that serum NSE and S100B 
would rise after surgery and correlate with change in cognitive function (Rasmussen, 
Christiansen et al. 1999). Patients had a neuropsychological test battery performed 
preoperatively, at discharge from hospital and three months later. They did not test 
specifically for delirium. Blood samples were collected preoperatively, and 24h and 
48h postoperatively. As expected, levels of these markers of CNS damage rose 
postoperatively, and the level of NSE 24h after surgery correlated with the degree of 
POCD at the time of hospital discharge. S100B level only correlated with the 
duration of cardiopulmonary bypass. 
 
In their study in ICU patients with sepsis associated delirium described in section 
1.4.9.3 and 1.5.5.6, Pfister et al examined S100B in addition to other biomarkers and 
measures of cerebral blood flow and oxygenation (Pfister, Siegemund et al. 2008). 
Biomarkers were measured within 48 hours of admission and stabilisation. In those 
patients with extracranial sepsis, 12/16 developed delirium. S100B levels were 
elevated in the whole sample, and they found that S100B discriminated between 
those who did or did not survive. As previously noted, numbers in the study were 
small, however, and they did not control for other confounders. 
 
Rasmussen et al conducted a prospective cohort study with the hypothesis that serum 
S100B and NSE would be increased in elderly patients after abdominal surgery, and 
that that increase would correlate with POCD (Rasmussen, Christiansen et al. 2000). 
N=65 patients were assessed for delirium according to DSM III criteria for the first 
three mornings postoperatively, and a neuropsychological test battery was performed 
preoperatively, and at one week and three months postoperatively. Patients were only 
included if their preoperative MMSE was >23/30. Blood samples were collected for 
S100B and NSE preoperatively, and at 24, 48 and 72 hours postoperatively. The 
authors found that 8/65 (12.3%) patients developed delirium postoperatively, 17/52 
(32.7%) had POCD one week postoperatively, and 5/53 (9.4%) at three months. 
There was a postoperative rise in S100B, and this rise was greater at 48 hours in the 
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delirium group, but this was no longer significant after applying Bonferroni’s 
correction. They found no correlation between the degree of POCD and either 
biomarker. 
 
Van Munster et al examined S100B levels in a cohort of patients with acute hip 
fracture (van Munster, Bisschop et al. 2010). They included N=120 patients, of 
whom 52% developed delirium. Patients had up to four blood samples taken during 
the perioperative period, at 11am on weekdays, with blood samples classed as “non-
delirious”, “before” “during” or “after” delirium. Using a linear mixed models 
approach, they showed that S100B was associated with delirium, and influenced by 
surgery. In a multivariate analysis, S100B was associated with delirium even after 
adjusting for premorbid cognitive impairment. A further paper from this group 
reports more detailed associations with S100B levels, and they found that delirious 
state, day of blood sampling, pre- or postoperative condition and type of fracture 
were associated with S100B levels (van Munster, Korse et al. 2009). There was no 
association with delirium subtype. They also measured NSE, but no difference was 
found in NSE in those with and without delirium.  
 
van Munster et al also examined S100B levels in elderly general medical in-patients 
(van Munster, Korevaar et al. 2010). They approached all general medical 
admissions aged over 65 within 48 hours, and assessed daily for delirium using the 
CAM, subtype with the delirium symptom interview and severity using DRS-R98. 
Blood samples were collected in the morning, within one week of admission. Four 
hundred and twelve patients were included, for whom they had blood samples and 
the CAM assessment was known for the day of blood sampling. One hundred and 
twenty-six patients developed delirium. Blood samples were classed as either 
“during”, “after” or “without” delirium. In the cognitively intact subgroup, levels of 
S100B were higher in those during and after delirium. The highest levels were found 
in the oldest patients with infection and pre-existing cognitive impairment, after 
delirium. However, S100B was only independently associated with delirium in the 
group without prior cognitive impairment, and not in those with prior disease. 
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Infection led to higher S100B levels, after adjustment for age, prior cognition and 
delirium. There was no difference in S100B levels between subtypes, nor was there 
any correlation with severity.  
 
Grandi et al aimed to determine the relationship between serum levels of Brain 
Derived Neurotrophic Factor (BDNF), NSE and S100B and delirium in critically ill 
patients in ICU (Grandi, Tomasi et al. 2011). A prospective cohort of N=130 patients 
were recruited in ICU and monitored for delirium with CAM-ICU. N=30 developed 
delirium, and they were retrospectively matched for gender, age, disease severity, 
sedation use, mechanical ventilation, hypotension and vasopressor therapy with 
N=30 controls. Due to the relatively small cohort, there was some imbalance in the 
case-control matching. Daily blood samples were collected, and levels of the three 
biomarkers were measured on the day of ICU admission and the day before delirium 
diagnosis (or the corresponding day post-admission for control patients). In 
univariate analyses, BDNF and NSE were higher on admission in the group who 
went on to develop delirium, but there was no difference in S100B levels. Levels of 
the markers fell during ICU stay. This is a relatively small cohort and levels of 
delirium are relatively low for an ICU cohort, as the authors state. Given that they 
had collected daily blood samples, a longitudinal analysis would have been very 
interesting and potentially more informative. 
 
Khan et al examined the hypothesis that S100B could act as a biomarker in delirium, 
with higher levels predicting longer duration of delirium. They performed a 
prospective observational cohort study in ICU patients with CAM-ICU delirium, 
collecting two blood samples for S100B one week apart, on days 1 and 8 after 
enrolment. They used a cut-off of an S100B level of greater than 0.1ng/ml as 
abnormal, based on a previous population-based study. They found a trend towards 
longer delirium duration in those with abnormal S100B levels after adjusting for age, 
cognitive impairment and illness severity. Although a small sample, this provides 
further evidence towards elevation of S100B in delirium and suggests it may be 
Cortisol and inflammation in delirium and long-term cognitive decline after hip fracture 
General Introduction 77 
useful as a prediction marker, if confirmed in a larger study (Khan, Farber et al. 
2013). 
 
1.6.3 Biomarkers of CNS damage in CSF 
Caplan et al (Caplan, Kvelde et al. 2010) undertook a prospective cohort study with 
the aim of comparing CSF, blood and clinical markers of delirium and neuronal cell 
death between patients with persistent delirium and an external control group of 
outpatients with known Alzheimer’s Dementia but no delirium. There were N=20 
patients in each group. The two groups were relatively well-matched, however the 
average IQCODE in the delirium group was the same as in the dementia group (3.7 
in both groups) suggests a high prevalence of dementia in the delirium group. 
Delirium was diagnosed using the CAM and Delirium Index. The Acute Physiology, 
Age, Chronic Health Evaluation (APACHE III) score was significantly higher in the 
delirium group. Lumbar puncture was performed during the delirium episode or on 
an outpatient basis for the dementia group. Lactate, protein, glucose, S100B and NSE 
were measured in CSF. The investigators found higher CSF lactate in the inpatient 
group with delirium compared to the outpatient group with Alzheimer’s dementia, 
lower NSE, higher protein, and no difference in S100B and glucose. In all 
participants, CSF lactate correlated positively with APACHE III score, CAM and 
Delirium Index. NSE correlated negatively with CAM and Delirium Index. Those 
within the delirium group who died in hospital had higher CSF lactate than those 
discharged home, and those who required institutional care had an intermediate level. 
The finding that CSF lactate was higher in persistent delirium, and was also 
associated with poorer outcomes, suggested that delirium may be associated with 
neuronal injury, or failure of normal aerobic energy metabolism such as ischaemia. 
However, here the group with delirium was acutely unwell, compared to the group 
with dementia who were stable outpatients, therefore differences may be due to acute 
illness rather than delirium. A third group with acute illness but without delirium 
would have strengthened the study, as the group comment. The somewhat surprising 
finding of lower NSE in delirium in the context of high lactate was explained by the 
investigators as possibly due to lactate suppressing NSE. This could occur via 
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glutamate stimulation suppressing glycolysis in neurons, which instead gain energy 
from astrocytic lactate, as per the shuttle hypothesis (Caplan, Kvelde et al. 2010), but 
these findings require replication. 
 
1.6.4 S100B in severe sepsis and “septic encephalopathy” 
Nguyen et al performed a cohort study aiming to examine serum levels of S100B and 
NSE in early sepsis, relate these to any septic encephalopathy and brain injury 
observed, and see whether the two markers were relevant in predicting outcome 
compared with Glasgow Coma Scale (GCS) (Nguyen, Spapen et al. 2006). Patients 
with severe sepsis and severe septic shock according to standard definitions were 
recruited. They diagnosed two different types of encephalopathy; type A 
characterised by “agitation, disorientation, confusion, irritability or seizures”, and 
type B, characterised by “somnolence stupor and coma”, when two or more of the 
symptoms were persistently observed during the 72 hours after weaning from 
sedation. They do not use the term delirium and no delirium specific monitoring or 
diagnostic tools were used, although the two types of encephalopathy described are 
likely to be analogous to delirium. Blood samples for S100B and NSE were collected 
within 24 hours of admission and stabilisation, and repeated daily for four days. Of 
N=170, almost half had GCS scores >13 on admission. S100B was elevated in 42% 
and NSE in 53% of the cohort. There was a non-significant trend to an inverse 
correlation between GCS score and S100B level. The highest levels of both 
biomarkers were found in participants who died early. Multivariate analysis found 
that S100B and age were the most powerful predictors of ICU survival. N=27 (16%) 
patients were diagnosed with encephalopathy after withdrawal of sedation, and 
elevation of S100B was associated with type B encephalopathy.  
 
Nguyen et al conducted a further study to examine the predictive value of both 
S100B and cortisol in “brain dysfunction” , encompassing coma and CAM-ICU 
delirium, in severe sepsis and septic shock (Nguyen, Huyghens et al. 2014). This 
study has also been discussed in section 1.4.9.3. They found S100B (measured 
serially over four consecutive days) to be elevated in brain dysfunction, with the 
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highest levels in those with coma. A logistic regression analysis did not find S100B 
level to be predictive of brain dysfunction. 
 
S100B has been found to be elevated in CSF and serum in children with sepsis and 
evidence of septic encephalopathy, compared to children with sepsis but without 
encephalopathy and to healthy children (Hamed, Hamed et al. 2009). Piazza et al did 
not find elevated CSF S100B in a small number of adult patients (N=4) with septic 
encephalopathy, but did find it to be elevated in serum in three of the four (Piazza, 
Cotena et al. 2009).  
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1.7 Dementia neuropathology markers in delirium 
 
1.7.1 CSF studies of dementia neuropathology markers in 
delirium 
Witlox et al examined levels of -amyloid1-42, tau and phosphorylated tau in CSF 
as pathological indicators of cognitive impairment, with the hypothesis that -
amyloid1-42 would be low and tau and phosphorylated tau would be elevated in 
patients who developed delirium, due to the high risk of delirium in those with 
cognitive impairment (Witlox, Kalisvaart et al. 2011). They recruited N=122 patients 
with acute hip fracture to a trial of taurine vs. placebo in reducing 1-year morbidity 
and mortality of patients with hip fracture. They collected CSF from N=76 patients, 
N=30 of whom developed delirium postoperatively. None had syndromal delirium 
preoperatively. The investigators found no significant difference in levels of any of 
the dementia markers between those who did or did not develop delirium 
postoperatively, although the levels of all three markers were different between 
groups in the directions hypothesised. They also examined the ratios between -
amyloid1-42 to tau and to phosphorylated tau, and there was no difference in either 
ratio between groups.  
 
Xie et al performed a prospective cohort study in older patients undergoing elective 
orthopaedic surgery, to investigate whether there is an association between the ratio 
of -amyloid-40 or -amyloid-42 to tau protein in CSF at baseline and both the 
incidence and severity of postoperative delirium (Xie, Swain et al. 2014). Given that 
tau is usually elevated in dementia and -amyloid-40 and -42 proteins are usually 
lowered, they hypothesised that lower -amyloid-40/tau and β-amyloid-42/tau ratios 
preoperatively would be associated with greater delirium incidence and severity. 
They enrolled N=244 participants into the study and were able to analyse samples 
from N=153. CSF was collected at the onset of spinal anaesthesia, and participants 
had standardised perioperative care. They were assessed for delirium on the first and 
second postoperative days only, using the CAM (Inouye, Vandyck et al. 1990) and 
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MDAS (Breitbart, Rosenfeld et al. 1997); delirium developing later in the 
postoperative course may therefore have been missed. Although the investigators 
excluded patients with known dementia or other neurological or psychiatric disease, 
they did not include an informant interview such as IQCODE (Jorm and Jacomb 
1989), or baseline cognitive testing to assess for undiagnosed dementia; the authors 
qualify this by describing the study as a proof of concept study. Thirty-one 
participants (20%) were diagnosed with postoperative delirium. There was no 
significant difference in CSF -amyloid-42/tau ratio or -amyloid-40/tau ratio 
between groups with and without delirium. When they examined quartiles of -
amyloid/tau ratios, they found a higher incidence of delirium in those in the lowest 
quartile for both ratios. They also found that the median MDAS score in the group 
within the lowest quartile -amyloid-40/tau ratio was higher than the median score in 
the other three quartiles. Using linear regression, they also found an inverse 
association between MDAS score and both -amyloid/tau ratios, which remained 
significant after adjusting for age and gender. This study suggests that lower -
amyloid/tau ratio is associated with increased risk of developing delirium 
postoperatively; it seems likely that this would be related to the presence of incipient 
or active dementia, and future studies should take this into account. 
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1.8  Hip fracture 
Peripheral trauma is a major cause of morbidity and mortality in the elderly; hip 
fracture is the clearest example of this. There are estimated to be 1.26 million hip 
fractures per year worldwide, projected to increase to 2.6 million in 2025 (Gullberg, 
Johnell et al. 1997). In the UK, there are around 65,000 hip fractures per year 
according to the National Hip Fracture Database (NHFD) (Boulton, Burgon et al. 
2014), with around 6,000 in Scotland (SIGN 2009). It is a serious and costly injury 
for older patients. The average hospital cost for each patient over the age of 60 is 
£12,163 (SIGN 2009). It often heralds deterioration in mobility and functional 
independence (Keene, Parker et al. 1993). Mean length of stay in orthopaedic wards 
is 15.3 days, and in acute hospitals 19.8 days. Hip fracture mortality has changed 
little in the past four decades. Thirty day mortality following hip fracture is around 
8% (Boulton, Burgon et al. 2014), 11-23% at 6 months and 22-29% at 12 months 
(Haleem, Lutchman et al. 2008).  
 
Risk factors for mortality after hip fracture include the use of diuretics, a history of 
coronary artery disease, male gender, functional dependence identified by a Barthel 
index of ≤18/20, heart rate >100 and body mass index <20, whereas the use of statins 
may be protective (Juliebo, Krogseth et al. 2010). A large prospective study (N=1000 
consecutive proximal femoral fractures in N=972 patients) has also identified that 
extracapsular fractures are associated with higher morbidity and mortality at one year 
than intracapsular (38% vs. 29%). However, those with extracapsular fractures were 
older, less mobile and less independent at the time of their fracture, and these 
confounding factors were not accounted for, nor was there any assessment of co-
morbidity or cognitive status (Keene, Parker et al. 1993).  
 
 
Cortisol and inflammation in delirium and long-term cognitive decline after hip fracture 
General Introduction 83 
1.8.1 Types of hip fracture 
Hip fractures can be either intracapsular or extracapsular. Intracapsular fractures 
occur within the fibrous capsule which encloses the hip joint, and contains much of 
the joint’s blood supply; these fractures cause more disruption in blood supply and 
may lead to necrosis of the femoral head if not treated. Extracapsular fractures may 
be either intertrochanteric or subtrochanteric (Boulton, Burgon et al. 2014).  
 
1.8.2 Surgical and anaesthetic options 
The UK NICE guidelines recommend that patients are offered a choice between 
general or regional anaesthetic techniques, after discussing risks and benefits (NICE 
2011). The NHFD found no difference in 5 or 30 day mortality among those who 
received general or spinal anaesthesia, after adjusting for age and physical status. 
NICE also recommends that patients have surgery on the day of, or the day after 
fracture. Extracapsular fractures are repaired with a screw and plate (e.g. dynamic 
hip screw), or an intramedullary nail if the fracture is more complex. Intracapsular 
fractures are usually repaired with a hemiarthroplasty or total hip arthroplasty 
(Boulton, Burgon et al. 2014).  
 
1.8.3 Delirium, cognitive impairment and hip fracture 
Delirium is common after hip fracture, with rates ranging from 4 to 61% 
(Schuurmans, Duursma et al. 2003, Juliebo, Bjoro et al. 2009). Cognitive impairment 
is also very common in patients with hip fracture. Gruber-Baldini et al found in a 
large (N=674) cohort of community-dwelling patients with hip fracture that 50% had 
some form of cognitive impairment, with 28% having prefracture dementia or 
reduced MMSE score, 8% had cognitive impairment detected preoperatively and a 
further 14% had impairment detected postoperatively (Gruber-Baldini, Zimmerman 
et al. 2003). 
 
Delirium present on admission or developing preoperatively may have a different 
profile of causative factors to delirium developing postoperatively. Those with 
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preoperative delirium may have fallen due to an intercurrent illness. Postoperative 
delirium may be related to the surgical procedure, anaesthetic and postoperative 
complications. Risk factors for preoperative delirium include male gender, cognitive 
impairment, previous delirium, indoor injury, anticholinergic drugs, fever and 
preoperative waiting time (Edlund, Lundstrom et al. 2001, Juliebo, Bjoro et al. 
2009). Risk factors for postoperative delirium include age, male gender, cognitive 
impairment or psychiatric disorders, indoor injury, premorbid ADL dependency, 
abnormal serum sodium, having several co-morbidities, perioperative fall in blood 
pressure, infective postoperative complications and body mass index below 20 
(Edlund, Lundstrom et al. 2001, Galanakis, Bickel et al. 2001, Schuurmans, Duursma 
et al. 2003, Juliebo, Bjoro et al. 2009). Analysis of the probable causes of delirium in 
patients with hip fracture according to a classification instrument (drug-induced, 
infection-induced, fluid-electrolyte disturbance, metabolic/endocrine disturbance, 
intracranial process, cardiopulmonary compromise and/or hypoxia, alcohol and drug 
withdrawal, sensory/environmental) has shown that many episodes have several 
causes. However, the rate of delirium was low in this study at 9.3%, and the 
information used to guide classification is dependent on assessments and 
investigations performed by clinical staff, which may be heterogeneous or 
incomplete (Brauer, Morrison et al. 2000). 
 
The presence of dementia has been identified as an independent risk factor for 
mortality following hip fracture, but results for delirium are mixed (Juliebo, Krogseth 
et al. 2010). A study by Juliebø et al which aimed to recruit a natural population of 
patients with hip fracture, including patients with dementia and severe dementia, 
aimed to address this question. In their cohort of N=331, the estimated mortality at 
one year was 20.5%, which was higher in those with delirium at any stage (28.0%), 
and particularly in those with delirium preoperatively (42.0%). Delirium was 
associated with mortality in univariate analyses, however, when they adjusted for the 
presence of prior dementia (IQCODE), the relationship disappeared. Severity of prior 
dementia, assessed using the IQCODE, was associated with mortality post-hip 
fracture. Kaplan-Meier plots showed a cumulative effect of delirium and dementia on 
mortality (Juliebo, Krogseth et al. 2010). Dolan et al also found that delirium on 
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admission was not a significant predictor of mortality after adjusting for age, gender, 
race, co-morbidity and functional status. They did find that delirium, in the absence 
of prior cognitive impairment, was associated with poorer physical, cognitive and 
affective functioning at 6 months, and slower recovery post-fracture, after adjusting 
for confounding factors (Dolan, Hawkes et al. 2000). There may be a difference in 
outcomes following prevalent (preoperative) and incident (postoperative) delirium; 
Edlund et al found that patients with preoperative delirium were more likely to be 
discharged to an institution and had poorer mobility than those with only 
postoperative delirium, which was often shorter in duration (Edlund, Lundstrom et 
al. 2001). Givens et al examined the individual and cumulative effects of delirium, 
dementia and depression on outcomes post-hip fracture (Givens, Sanft et al. 2008). In 
N=126 patients, they found that depression increased the odds of new nursing home 
admission or death at one month, prior dementia increased these odds and the 
likelihood of decline in mobility, and delirium increased the likelihood of all of these 
poor outcomes and of decline in function. They also found a cumulative effect of the 
three psychiatric disorders, where the stepwise addition of each increased the 
likelihood of poor functional outcomes (Givens, Sanft et al. 2008). Nightingale et al 
also examined the effects of delirium, dementia and depression on mortality after hip 
fracture. In N=731 patients, only 28% were psychiatrically “well”, 40% had 
dementia, 15% had delirium and 13% had depression, and 4% had other psychiatric 
diagnoses. At 2 years, 53% were alive with no loss to follow-up; a multivariate 
survival analysis demonstrated hazard ratios for death of 2.62 for dementia, 2.40 for 
delirium and 1.57 for depression (Nightingale, Holmes et al. 2001).  
 
Delirium has also been shown to be a risk factor for the development of dementia 
after hip fracture. A prospective study by Krogseth et al aimed to assess the impact 
of delirium in hip fracture patients on the risk of dementia at 6 months, adjusted for 
prior cognitive impairment (Krogseth, Wyller et al. 2011). They assessed patients for 
perioperative delirium using the CAM, and used informant history via the IQCODE 
as a proxy for prefracture cognitive impairment. Patients were followed-up at 6 
months with a series of cognitive tests, and two expert clinicians then decided 
whether each patient fulfilled the DSM-IV criteria for dementia both at baseline and 
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at 6 months. Of their cohort of N=266, N=92 were lost to follow-up, around half due 
to death, N=174 were seen at 6 months and N=106 were deemed free from 
prefracture dementia. In a multivariate logistic regression analysis in the group free 
from prefracture dementia, delirium perioperatively was shown to be the strongest 
risk factor for dementia at six months. 
 
1.8.4 Physiological responses to trauma 
The body’s response to trauma, leading to protein loss and fatigue which can be 
persistent, is likely to contribute to poor outcomes in the elderly following hip 
fracture. Injury or trauma is associated with neuroendocrine, inflammatory and 
metabolic responses (Hill 2000, Chuang, Power et al. 2005). The first stages of injury 
lead to hypoperfusion and then reperfusion of the injured tissues, with activation of 
afferent peripheral nerves and the involvement of factors from vascular endothelium 
(Hill 2000). Events are then controlled on two levels, in the CNS and at a local tissue 
level. Early hormonal release of glucocorticoids, catecholamines and glucagon leads 
to lipolysis and nitrogen loss. It is now thought that this neuroendocrine response is 
an initiating event, with the subsequent involvement of a complex cascade of pro- 
and anti-inflammatory cytokines, oxygen free radicals and arachidonic acid 
metabolites. The results of these CNS and local processes are anorexia, pyrexia and 
immobility in the initial stages, and in the later stages protein loss, organ dysfunction 
and persistent fatigue which may last several months (Hill 2000).  
 
There is also evidence that peripheral injury such as hip fracture may invoke a CNS 
inflammatory response. Chuang et al (Chuang, Power et al. 2005) measured 
inflammatory cytokines in CSF and serum of elderly women undergoing either hip 
fracture repair or elective joint replacement. They found the pro-inflammatory 
cytokines IL-8 in CSF and IL-6 in serum to be higher in trauma patients compared to 
elective patients. Of note, however the trauma group were significantly older than the 
elective group (81 years vs. 69 years), and they make no comment on the presence or 
absence of delirium. This neuroinflammation, apparently induced by trauma, with 
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what the authors conclude to be intrathecal cytokine synthesis, is very intriguing 
given the high rate of delirium after hip fracture and the overall poor outcomes. 
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1.9 Clinical trials in the prevention and management of 
delirium 
 
This section will briefly discuss the current evidence for interventions aimed at 
preventing or managing delirium, with a particular focus on interventions which 
target the HPA axis or inflammation. 
 
1.9.1 Multicomponent interventions 
Much of the early evidence for delirium prevention comes from multicomponent 
interventions such as proactive geriatric consultation. Inouye et al developed a 
multicomponent intervention termed the Hospital Elder Life Program (HELP), which 
was aimed at reducing delirium incidence in elderly medical in-patients. The 
intervention involved protocols to manage six delirium risk factors; cognitive 
impairment, sleep deprivation, visual impairment, hearing impairment and 
dehydration. In N=852 patients, the intervention reduced delirium incidence from 
15.0% in the usual care group to 9.9% in the intervention group, with an odds ratio 
for delirium of 0.60 (Inouye, Bogardus et al. 1999). The elements of the HELP 
program have been further adapted and shown to reduce delirium incidence and 
improve quality of care where they are integrated into clinical practice (Vidan, 
Sanchez et al. 2009).  
 
Marcantonio et al have shown in a prospective randomized blinded single-centre trial 
that proactive geriatric consultation compared with usual care can reduce delirium 
incidence (odds ratio 0.64) and cases of severe delirium in patients with acute hip 
fracture (Marcantonio, Flacker et al. 2001). The intervention included targeted 
recommendations such as oxygen delivery, fluid balance, medication review, pain 
management and regulation of bladder and bowel function. Lundstrom et al have 
shown that a multicomponent intervention involving postoperative care of patients 
with hip fracture in a specialized geriatric ward can reduce delirium incidence, 
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duration and length of stay (Lundstrom, Olofsson et al. 2007). However, a recent 
single-centre trial in Oslo, Norway, examined whether orthogeriatric care in a 
dedicated unit staffed by geriatric nurses and geriatricians, with comprehensive 
geriatric assessment, might prevent perioperative delirium and longer-term cognitive 
decline, compared to standard orthopaedic care. Three-hundred and twenty-nine 
patients with acute hip fracture were randomised to care in an acute geriatric ward or 
standard orthopaedic care. Primary outcome was cognitive function four months after 
hip fracture, and secondary outcomes were pre- and postoperative delirium, delirium 
severity and duration, mortality and mobility. No significant differences were found 
between treatment groups in delirium rates, severity or duration, in cognitive 
outcomes at four months, nor in mortality (Watne, Torbergsen et al. 2014). 
 
Although multi-component interventions have been shown to be effective in 
preventing delirium, they are not always effective at managing cases of delirium or 
shortening its duration once delirium has developed. Cole et al performed two 
randomized controlled trials to evaluate whether the systematic detection of delirium 
in elderly medical in-patients, followed by a consultation with a geriatrician and 
liaison nurse follow-up would lead to cognitive improvement. In the first trial of 
N=88, the intervention led to small improvements in the Short Portable Mental 
Status Questionnaire and Crichton Behavioural Rating Scale (Cole, Primeau et al. 
1994). However, the second trial of N=227 found no significant difference in time to 
or rate of improvement in the Delirium Index or other outcome measures such as 
length of stay, function or survival (Cole, McCusker et al. 2002). A randomized 
controlled trial of a multicomponent intervention with tailored geriatrician input in 
N=174 elderly medical patients in Finland has shown a significantly faster reduction 
in delirium severity, as measured by the MDAS, in the intervention group, but did 
not impact on rates of mortality or institutionalization (Pitkala, Laurila et al. 2006). 
Nurse-led detection of delirium in post-acute care facilities has been shown to 
increase delirium detection, but a subsequent multicomponent intervention in cases 
to address delirium causes and complications and restore function was not effective 
(Marcantonio, Bergmann et al. 2010). 
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1.9.2 Anti-psychotic medication 
Typical and atypical anti-psychotic medications are commonly used in clinical 
practice for the management of delirium symptoms, particularly agitation and 
psychotic features. The current UK NICE guidance is to consider short-term use of 
an anti-psychotic such as haloperidol or olanzapine where patients are at risk of harm 
to themselves or others, and where other de-escalation techniques have failed (NICE 
2010). Evidence for the efficacy of anti-psychotics in delirium is modest. A 
Cochrane review comparing haloperidol with atypical antipsychotics in the 
management of delirium and the incidence of adverse reactions identified three trials 
comparing haloperidol to risperidone, olanzapine and placebo. The studies were 
small, and the conclusions limited. Low dose haloperidol decreased delirium severity 
and duration in postoperative patients, although not incidence, when compared to 
placebo. There were no significant differences when low dose haloperidol was 
compared to the atypical antipsychotics, nor were there more adverse effects with its 
use (Lonergan, Britton et al. 2007). Prophylactic use of anti-psychotic medication 
may be more promising. A recent meta-analysis of trials examined prophylactic use 
of anti-psychotic medication in high-risk surgical populations, and identified five 
randomized prospective clinical trials with a total of N=1491 elderly participants. 
Three trials compared haloperidol to placebo, one olanzapine to placebo and one 
risperidone to placebo, across a range of surgical populations. The pooled analysis 
suggested antipsychotic prophylaxis reduced delirium incidence, with an odds ratio 
of 0.42 (Gilmore and Wolfe 2013). The Hope-ICU trial however did not find any 
benefit in early use of haloperidol versus placebo in decreasing duration of delirium 
or coma in N=141 critically ill patients (Page, Ely et al. 2013).  
 
1.9.3 Cholinesterase inhibitors 
Since one of the hypotheses of delirium pathogenesis is that there is a deficiency in 
acetylcholine neurotransmission, cholinesterase inhibitors have been trialled in its 
therapy. A single-centre double-blind randomized controlled trial of prophylactic 
rivastigmine versus placebo in N=120 elderly patients undergoing elective cardiac 
Cortisol and inflammation in delirium and long-term cognitive decline after hip fracture 
General Introduction 91 
surgery found no difference in delirium incidence between groups (Gamberini, 
Bolliger et al. 2009).Pilot studies of cholinesterase inhibitors have been performed in 
several settings. When donepezil was piloted versus placebo in delirium after hip 
fracture, there were no differences in delirium duration or severity, and those 
receiving donepezil suffered more side effects and adverse events (Marcantonio, 
Palihnich et al. 2011). A pilot study of oral rivastigmine in severe and persistent 
delirium after stroke concluded that in the N=17 patients included, rivastigmine was 
safe and well-tolerated (Oldenbeuving, de Kort et al. 2008). A double-blind 
randomized pilot study of rivastigmine (N=8) versus placebo (N=7) in established 
delirium in elderly medical patients found no difference in delirium duration but it 
was suggested that rivastigmine was safe in this setting (Overshott, Vernon et al. 
2010). A pilot double-blind randomized placebo-controlled trial of donepezil in 
delirium prevention in N=33 patients undergoing elective hip arthroplasty found that 
donepezil was well tolerated with no adverse events. There was no difference in 
delirium incidence between groups (Sampson, Raven et al. 2007). A multicentre, 
randomized double-blind placebo controlled trial of rivastigmine as an adjunct to 
usual care with haloperidol in patients with delirium associated with critical illness 
had to be stopped early due to a higher mortality rate in the rivastigmine arm. N=104 
patients were included compared to N=440 planned. Median duration of delirium 
was longer in the rivastigmine group (van Eijk, Roes et al. 2010).  
 
1.9.4 Melatonin 
Melatonin is a hormone released from the pineal gland which in health promotes 
sleep (Uchida, Aoki et al. 1999). Due to the characteristic sleep-wake cycle 
disturbance in delirium, Melatonin has been trialled as prophylaxis against delirium 
in the hope of preserving sleep-wake cycle. Al Aama et al performed a randomized 
placebo-controlled trial of melatonin in elderly patients admitted to an acute medical 
unit. N=145 patients were randomized but due to loss to follow-up they were only 
able to analyse date for N=121. Delirium occurrence was lower in the melatonin 
group (number needed to treat 6.4), including after excluding a small proportion who 
were delirious at enrolment (Al-Aama, Brymer et al. 2011). De Jonghe et al 
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performed a multicentre randomized placebo-controlled trial of melatonin as 
prophylaxis for delirium in N=378 patients with acute hip fracture; the study was 
possibly underpowered due to post-randomization exclusions. No difference was 
observed in delirium incidence between groups. Median delirium duration was the 
same at two days, but a smaller proportion of patients in the melatonin group had 
long-lasting delirium (> 2 days) (de Jonghe, van Munster et al. 2014). In ICU and 
general medical wards, Hatta et al trialled Ramelteon, a melatonin agonist, in N=67 
elderly patients as prophylaxis against delirium. Delirium incidence was significantly 
lower in the treatment group, at 3% compared with 32% in the placebo group. 
Although N=1059 screened patients did not meet inclusion criteria, primarily due to 
expected length of stay of <48h or intubation, the numbers in each arm of the study 
met those in their power calculation (Hatta, Kishi et al. 2014). A prospective clinical 
observational study examined the role of melatonin prophylaxis in delirium 
prevention in elective or urgent cardiac surgery. The first group of N=250 served as 
controls, and the second group of N=250 received melatonin. The melatonin group 
experienced less delirium but also had significantly lower levels of alcoholism and 
spent less time on cardiopulmonary bypass. The study design may also have meant 
that delirium rates were lower in the second group, recruited later, due to increased 
staff awareness and knowledge of delirium in their unit. Melatonin was not 
associated with less delirium in their multivariate analysis (Artemiou, Bily et al. 
2015). Results for melatonin have therefore been mixed; a recent meta-analysis of 
four randomized controlled trials of its use for delirium prevention found a trend 
towards effectiveness, with a subgroup analysis of use in elderly medical patients 
showing benefit (Chen, Shi et al. 2015). 
 
1.9.5 Dexmedetomidine 
Dexmedetomidine is an α2-adrenoreceptor agonist which has also been shown to 
have anti-inflammatory properties, enhancing macrophage phagocytosis and 
bacterial clearance (Pandharipande, Sanders et al. 2010, Ji, Li et al. 2013). In post-
operative delirium and delirium in critical illness, there has been recent evidence that 
sedation or anaesthesia using dexmedetomidine reduces the duration or incidence of 
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delirium. A large retrospective observational study of N=1134 patients has shown in 
a multivariate analysis that dexmedetomidine reduced delirium incidence after 
cardiac surgery, with an adjusted odds ratio of 0.53 (Ji, Li et al. 2013). A recent 
meta-analysis examined twenty studies with N=2612 patients where 
dexmedetomidine was tested in anaesthesia or sedation with regard to beneficial 
effects on neurocognitive dysfunction, which included delirium. The authors 
concluded that dexmedetomidine use was associated with less neurocognitive 
dysfunction, but not in subgroup analyses when delirium according to the CAM-ICU 
was the outcome (Li, Wang et al. 2015). A meta-analysis of trials comparing 
dexmedetomidine to propofol sedation for mechanical ventilation in ICU examined 
ten trials with N=1202 patients and concluded that dexmedetomidine reduced ICU 
length of stay and incidence of delirium, but did not influence ICU mortality, and 
was associated with increased hypertension (Xia, Chen et al. 2013). Pandharipande et 
al specifically hypothesised that sedation for mechanical ventilation with 
dexmedetomidine compared to lorazepam would be beneficial, particularly in 
patients with sepsis, due to its anti-inflammatory effects. They performed an a priori 
subgroup analysis of septic and non-septic patients from a randomized double-blind 
placebo controlled trial of sedation with dexmedetomidine or lorazepam. They found 
that in the N=63 patients with sepsis, those receiving dexmedetomidine (N=31) had 
on average 3.2 more delirium or coma-free days, and had a lower risk of developing 
delirium or of death. The beneficial effects of dexmedetomidine were more 
pronounced in the group with sepsis (Pandharipande, Sanders et al. 2010). 
 
1.9.6 Drugs which disrupt the HPA axis 
A search of the literature found no studies testing pharmacological agents such as the 
11-β-HSD inhibitor carbenoxolone or experimental 11β-HSD-1 inhibitors which 
would limit the HPA axis response as prophylaxis or treatment in delirium. Case 
reports only reported the use of metyrapone in patients with delirium or other 
neuropsychiatric complications of Cushing’s disease. 
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1.9.7 Anti-inflammatory agents 
1.9.7.1 Corticosteroids 
Since there are also multiple threads of evidence of an inflammatory nature to 
delirium, as discussed in detail in section 1.5, some investigators have tried to tackle 
this inflammatory response by administering dexamethasone. Mardani et al studied 
the effects of intravenous dexamethasone administration in N=93 patients 
undergoing coronary-artery bypass grafting and recovering in ICU (Mardani and 
Bigdelian 2012, Mardani and Bigdelian 2013). Patients were given dexamethasone 
preoperatively and for two days postoperatively. They demonstrated that those who 
did not receive dexathethasone were 1.2 fold more likely to develop postoperative 
delirium. However, their methods for capturing delirium were flawed, since they 
screened using the MMSE, which is an insensitive tool for delirium detection, and 
only conducted further psychiatric interviews to make a diagnosis of delirium 
according to DSM IV criteria if the MMSE score was 23 or below. Also, it is unclear 
who and how well matched the control group were. Sauer et al conducted a single 
centre substudy nested within a larger placebo controlled randomised controlled trial, 
hypothesising that the administration of high dose dexamethasone intraoperatively 
would reduce the rate of postoperative delirium by reducing the inflammatory 
response associated with CABG surgery and cardiopulmonary bypass (Sauer, Slooter 
et al. 2014). Patients were randomised to receive either 1mg/kg dexamethasone or 
placebo at the onset of anaesthesia, and they were monitored for delirium daily 
postoperatively for four days using the CAM-ICU or CAM after ICU stepdown. Of 
N=768 patients, N=737 had complete data. The incidence of delirium was similar in 
both the treatment and placebo group (around 14% in both groups), as was the 
median duration of delirium (2 days in both groups). Surrogate markers including the 
use of restraint and the administration of haloperidol, benzodiazepines and opioids 
were also similar in both groups. Dexamethasone administration therefore did not 
alter the incidence or duration of postoperative delirium in the four days following 
CABG. The steroids in cardiac surgery trial examined whether administration of 
methylprednisolone as an anti-inflammatory versus placebo would improve 
outcomes in patients undergoing cardiopulmonary bypass. Their primary outcome 
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was thirty-day mortality and one of the secondary safety outcomes was delirium on 
postoperative day three. The investigators found no difference in incidence of 
delirium between groups, nor in mortality nor major morbidity (Whitlock, Devereaux 
et al. 2015). 
 
There is, therefore, very little evidence of a beneficial effect of dexamethasone 
prophylaxis or treatment in delirium, where it is used as an anti-inflammatory agent. 
As already discussed, steroid use in clinical practice is historically associated with 
delirium (Wolkowitz, Reus et al. 1997). Steroid administration in a critical care 
setting has been shown in a multivariate analysis to be independently associated with 
increased likelihood of transitioning into delirium in patients with acute lung injury 
(Schreiber, Colantuoni et al. 2014). A systematic literature review of N=14 
prospective studies investigating the association between medication use and 
delirium risk found that there was uncertainty with steroid use, however, with only 
one included low quality study examining steroids, with an odds ratio of 0.50 (Clegg 
and Young 2011).  
 
1.9.7.2 Non-steroidal anti-inflammatory drugs (NSAIDs) including COX II 
inhibitors 
A review of the literature did not find any studies testing whether non-steroidal anti-
inflammatory drugs, including newer COX II inhibitors or biological agents are 
useful in the prophylaxis or treatment of delirium. Use of NSAIDs in the elderly is 
with great caution, due to the risk of side effects including acute kidney injury and 
gastrointestinal haemorrhage. The systematic literature review cited above which 
investigated the association between medication use and delirium risk found that 
there was also uncertainty with NSAID use, with one low quality study reporting an 
odds ratio of 0.40 (Clegg and Young 2011). COX II inhibitors were found in one 
case report to induce delirium (MacKnight and Rojas-Fernandez 2001). 
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1.9.7.3 N-3 fatty acids 
N-3 fatty acids are proposed to alter the balance between pro- and anti-inflammatory 
mediators in favour of anti-inflammatory pathways, in the hope that this modulation 
of the inflammatory response will be beneficial in severe sepsis and sepsis-associated 
delirium. A small randomized study of IV therapy with n3 fatty acids versus placebo 
in N=50 ICU patients with sepsis found no effect on incidence of delirium, nor in 
plasma levels of the CNS damage markers S100B and NSE nor in CRP or 
inflammatory mediators. The study population was small and heterogeneous, around 
half of the intervention group could not receive the full dose of n3 fatty acids due to 
high triglyceride levels, and some delirium assessments were missing, limiting the 
conclusions that can be drawn (Burkhart, Dell-Kuster et al. 2014). 
 
1.9.7.4 Ketamine 
The anaesthetic agent ketamine has been proposed to have neuroprotective effects, 
potentially by reducing excitotoxic injury and limiting CNS inflammatory responses 
to injury (Hudetz, Patterson et al. 2009). A small prospective randomized study 
examined whether the administration of a single IV dose of ketamine compared to 
saline during anaesthetic for surgery under cardiopulmonary bypass would reduce 
the inflammatory response and incidence of postoperative delirium. Hudetz et al 
found in N=58 patients that the ketamine group had a significantly lower incidence 
of delirium (3% versus 31%), and while preoperative serum CRP was not 
significantly different between groups, postoperative CRP on day 1 was significantly 
higher in the placebo group, suggesting a greater peripheral inflammatory response. 
There was no difference in CRP between those who did or did not develop delirium, 
however. This is an interesting study, but the effect of ketamine may not be anti-
inflammatory, since it may exert neuroprotective effects through other mechanisms 
and is also an NMDA receptor antagonist (Hudetz, Patterson et al. 2009). A further 
small randomized double-blind study has examined the role of ketamine in reducing 
early post-operative cognitive dysfunction, within one week of surgery, in N=56 
elderly patients undergoing elective orthopaedic surgery. Patients were not tested for 
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delirium. The investigators found no difference in POCD nor in CRP level in the 
week after surgery (Lee, Kim et al. 2015).  
 
1.9.8 Summary 
In summary, there is good evidence for delirium prevention using multi-component 
interventions, which usually involve attention to detail and good medical and nursing 
care. There is less evidence that this approach proves successful once delirium is 
established. There is modest evidence that anti-psychotic medication is helpful in 
delirium, but it may be more promising when used in low doses prophylactically. 
Anti-cholinesterase inhibitors have not been proven in delirium and may be harmful. 
Melatonin may be helpful in delirium prevention, particularly in elderly medical 
patients. In anaesthesia and sedation, dexmedetomidine appears to be beneficial in 
reducing incidence of delirium, and whether this effect is through immune-
modulating pathways needs to be further investigated. A small number of trials have 
examined different anti-inflammatory targets, with no clear beneficial results; the use 
of corticosteroids as anti-inflammatory agents may be counteracted by the risk of 
dexamethasone itself inducing delirium. There have been no interventions tested 
which address excess or prolonged cortisol production. 
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1.10  Summary and outline of research questions 
This PhD aims to investigate the roles of deranged cortisol and inflammatory 
responses to stress in delirium and long-term cognitive decline in patients with hip 
fracture, who are very prone to delirium as outlined above. It is not currently known 
whether delirium is associated with hypercortisolaemia or attenuated circadian 
responses after 2-3 days, and indeed cortisol levels may be high for up to eight weeks 
post hip-fracture (Roberts, Barton et al. 1990). The relationship between prolonged 
high cortisol, inflammation and long-term cognitive decline is also not known. 
Patients with hip fracture commonly undergo fracture repair under spinal 
anaesthesia, which affords an excellent opportunity to sample cerebrospinal fluid in a 
group of patients vulnerable to delirium, with minimal upset for the patients 
themselves as the procedure is a necessary one. This allows for the examination of 
CSF levels of cortisol, inflammatory markers and markers of CNS damage in 
delirium. A power calculation was performed for the main analyses of the study, i.e. 
comparisons of cortisol and cytokine levels between patients with (~N=40) and 
without (~N=80) delirium. Setting alpha at p=0.05 we have > 80% power to detect 
medium-sized (Cohen’s d=0.5) differences for these analyses with N=120 
participants. 
 
1.10.1 Aims and Objectives 
(A1) To systematically review the literature on CSF biomarkers in delirium, in order 
to summarise existing knowledge and to provide a basis for future studies.  
(A2) To determine if high cortisol levels (in saliva and serum) in the two weeks after 
hip fracture are associated with delirium in older patients.  
(B1) To determine if high cortisol levels in the first two weeks after acute hip 
fracture predict persistent delirium and/or deterioration in thinking and memory at 
intervals up to one year.  
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(B2) To determine if high cortisol levels seen in acute delirium are sustained up to 
one year after acute hip fracture and, if so, to determine any relationships with 
cognition.  
(B3) To determine if levels of cortisol in cerebrospinal fluid (CSF) sampled at the 
onset of spinal anaesthesia are associated with delirium and with longer−term 
cognitive decline.  
(B4) To determine the relationships between delirium after hip fracture and 
peripheral and CSF markers of acute inflammation and examine whether these relate 
to cortisol levels.  
(B5) To determine if CSF markers of acute central nervous system damage are 
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2 Chapter 2: General Methods 
2.1 Study populations 
The primary study reported in this thesis includes a cohort of community-dwelling 
patients in Edinburgh with acute hip fracture (CDHIP). The cerebrospinal fluid 
studies reported in Chapters 4 and 5 involve collaboration with another research 
group in Oslo, Norway. The Oslo cohort was an elderly cohort (median age 85) with 
acute hip fracture enrolled to the Oslo Orthogeriatric Trial (Watne, Torbergsen et al. 
2014), who had cerebrospinal fluid collected at spinal anaesthetic, and perioperative 
delirium assessment and many other measures collected in the same way as the 
CDHIP study cohort. As these studies are difficult to perform, and many of the 
salient features of the cohorts are the same, we combined these cohorts in order to 
increase statistical power to answer the research questions. The other study cohort 
will be described in the methods section and it will be clearly indicated in each 
chapter where it was included 
 
2.2 CDHIP Study Recruitment 
Patients with hip fracture were admitted via Accident and Emergency to the 
Orthopaedic wards of the New Royal Infirmary, Edinburgh. On the mornings and 
afternoons of assessment, I identified potential participants who met inclusion 
criteria by asking Nursing Staff on the ward or from the Trauma theatre list. 
Exclusion criteria were sought through discussion with Nursing Staff who could 
examine patient case-notes.  
 
Inclusion criteria:  
 Over the age of 60  
 Acute hip fracture, before surgery 
 For spinal anaesthesia  
 Patients with apparently normal cognition and cognitive impairment included 
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Exclusion criteria:  
 Nursing Home resident  
 Inhaled / oral steroids in last 10 weeks  
 Active malignancy, co−morbid disease such that prognosis is less than one year  
 Significant Parkinson's disease  
 Major communication difficulties: aphasia, English not first language  
 
A lower age limit of 60 years was included given age-related risk of delirium, as 
young patients with acute hip fracture are unusual and less likely to develop 
delirium. All patients needed to have had acute hip fracture and were recruited 
preoperatively in order to have a baseline preoperative assessment of delirium and 
the opportunity to collect CSF and blood samples at the time of spinal anaesthetic. 
Patients planned for spinal anaesthetic were included, or those where there was no 
anaesthetic plan if they had not yet been reviewed, to allow the collection of CSF at 
spinal anaesthetic; if the anaesthetic plan later changed to general anaesthetic, 
patients were not excluded. Community-dwelling patients with known cognitive 
impairment were not excluded due to the higher risk of delirium, to avoid the 
possibility that only low rates of delirium would be detected in a cohort who was 
exclusively cognitively intact premorbidly. 
 
Patients from Nursing Homes were excluded due to the high rates of frailty and 
dementia in this population, since the proposed 12 month follow-up with cognitive 
testing would most likely lead to high rates of attrition and missing data in these 
patients. Those on steroid medication were excluded as this can interfere with 
measurement of cortisol in biological samples. Those with a projected prognosis of 
less than one year due to known malignancy or co-morbid disease were excluded due 
to the planned 12 month follow-up, to limit rates of attrition. Those with significant 
Parkinson’s disease were excluded due to the difficulty in differential diagnosis of 
delirium or features such as hallucinations in these patients, and the likelihood that 
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there might be a specific aetiology such as L-dopa related delirium. Patients with 
major communication difficulties were excluded due to the challenges relating to 
cognitive testing in these patients. 
 
Potential participants were approached in alphabetical order or, if this was not 
possible (e.g. patients were being washed or prepared for theatre) or in the interests 
of time, in the order of the theatre list. The first approach was made by a member of 
the patient’s usual care team, who introduced me. I explained the study, checking at 
each stage that the patient could hear and understood the explanation. If no further 
exclusion criteria were discovered, I asked if the patient had any questions and if 
they would be interested in taking part in the study. If so, I provided them with the 
patient information sheet to read through. If the patient had poor eyesight or did not 
have their glasses, I read out the information sheet (Appendix 4). I asked if the 
patient had any further questions, or if they would like more time to decide. If the 
patient would like to take part, I assessed their capacity to give informed consent; 
much of this information could be gained from the interaction of explaining and 
discussing the study. I checked that the patient understood and could weigh, retain 
and communicate the following information about the study: 
 
 they are being asked to help with a research project  
 the project is looking at the causes of thinking and memory problems  
 they will be asked to answer some questions on thinking and memory 
 a sample of their spinal fluid and a blood sample will be collected at the time 
of surgery, and further samples of blood and saliva will be taken in the two 
weeks following their surgery  
 I will look at the patient’s casenotes and will also discuss their case with staff 
to find out how they have been doing  
 with their permission, the information in the study will be passed to the 
hospital staff  
 I will follow them up over the next year  
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 I will contact the participant’s GP with their consent to inform him/her of 
their participation in the study and prior to follow-up contact 
 the study is voluntary and they can withdraw at any time 
 participation in the study will not change the management for their broken 
hip 
 
If the patient demonstrated capacity to decide to take part in the study, he or she was 
taken through the consent form and asked to sign it (Appendix 4). If the patient was 
willing to take part but did not demonstrate capacity, I asked if I could return to 
discuss the study with the patient and their next of kin. Due to the time-pressures of 
hip fracture repair, this was sometimes not possible. If the patient’s next of kin was 
happy for the patient to participate in the study, he or she was asked to give informed 
consent on their behalf. 
 
Photocopies of the consent form were placed in the medical notes and given to the 
participant. A letter was written to the participant’s GP informing him or her of their 
recruitment to the study, outlining what the study entailed. 
 
Once the participant had a place on the trauma theatre list, I contacted the 
Anaesthetist for the list and asked that CSF and blood tests were taken during the 
onset of anaesthesia. 
 
2.3 Preoperative Assessment 
Participants were first assessed for delirium preoperatively. There follows a summary 
of the structure and tools used for delirium assessment, and then each tool is 
described in more detail. A full schedule of assessments is included in Appendix 1. 
Delirium assessment comprised a semi-structured interview with additional cognitive 
testing which took 10-15 minutes (Appendix 1). This allowed the completion of the 
Confusion Assessment Method (CAM) (Inouye, Vandyck et al. 1990), Delirium 
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Rating Scale Revised ’98 (DRS-R-98) (Trzepacz, Mittal et al. 2001), Mini Mental 
State Examination (MMSE) (Folstein, Folstein et al. 1975) and a brief test of 
attention using the Edinburgh Delirium Test Box-1 (EDTB-1) (Brown, Fordyce et al. 
2010). Level of arousal was assessed with the Richmond Agitation Sedation Scale 
(RASS) (Sessler, Gosnell et al. 2002) and an in-house assessment the Observational 
Scale of Level of Arousal (OSLA) (Tieges, McGrath et al. 2013). I also discussed 
any signs of delirium with nursing staff and sought evidence in the casenotes. This 
format was chosen to provide a brief but reliable assessment of delirium presence 
and severity using well-established and well-validated research tools based on DSM 
III and DSM IV criteria (Inouye, Vandyck et al. 1990, Trzepacz, Mittal et al. 2001). 
The assessment was tailored pragmatically to take account of patient fatigue, pain 
and other factors. 
 
2.3.1 The Confusion Assessment Method 
The CAM is a diagnostic algorithm which operationalizes the DSM III diagnostic 
criteria for delirium (Inouye, Vandyck et al. 1990). It assesses four features: (i) Acute 
onset and/or fluctuating course, (ii) Inattention, (iii) Disorganised thinking and (iv) 
Altered level of consciousness. Delirium is deemed to be present if the patient has 
features (i) and (ii), and either feature (iii) or (iv). The CAM algorithm is informed 
by a semi-structured interview. Assessment of attention and disorganised thinking is 
through interview and sometimes cognitive testing (e.g. digit span), some general 
cognitive testing (often by the Mini-Mental State Examination) and questioning of 
nursing staff and carers. With the requisite mental status testing the CAM typically 
takes 10-12 minutes to administer. A period of training is required to gain 
competence in administering the CAM. During this period, I assessed multiple 
patients in acute geriatric wards, alone and with an experienced rater (AMJM) until 
competency was achieved. I also read the training manual. A systematic review of 
research on the CAM highlighted the importance of training (Wei, Fearing et al. 
2008) because sensitivity of the tool is poor without training (Lemiengre, Nelis et al. 
2006, Sands, Dantoc et al. 2010). 
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2.3.2 The Delirium Rating Scale - Revised ‘98 
The DRS-R98 is a detailed assessment of delirium symptomatology and severity, 
consisting of 13 items (sleep-wake cycle disturbance, perceptual disturbances, 
delusions, lability of affect, language and thought process abnormalities, motor 
agitation or retardation, orientation, attention, short and long-term memory and 
visuospatial ability) with 3 additional diagnostic items (temporal onset, symptom 
fluctuation and physical disorder). Each feature is scored from 0-2 or 0-3 according 
to both its presence and severity. The total possible score is 39 for the severity scale 
and 46 including the diagnostic items, and the cut-off for delirium is a score of 
>15.25 and >17.75 respectively (Trzepacz, Mittal et al. 2001). The assessment 
involves a semi-structured interview with questioning to elicit certain symptoms, 
plus assessment of attention and brief cognitive testing. Additional information from 
nursing staff, carers and casenotes is also gathered wherever possible. The DRS-R98 
was employed here to provide a detailed assessment of delirium severity and 
symptomatology. I had training in its use prior to starting the study from an 
experienced rater (AMJM). Information from the MMSE was used to aid completion 
of short term memory and orientation items. For visuospatial ability, the intersecting 
pentagons item from MMSE was used in addition to a map of Scotland, where 
participants were asked to identify well known cities, in addition to information from 
nurses or casenotes on wandering. 
 
2.3.3 The Mini-Mental State Examination 
The MMSE is a widely used instrument, designed to test global cognition (Folstein, 
Folstein et al. 1975). It assesses orientation, registration and short-term recall, 
attention and calculation, language and praxis. The maximum score is 30, with a 
score below 24 usually indicating significant cognitive impairment. It takes around 5 
minutes to complete, with face-to-face questioning and pen and paper tasks. The 
MMSE is not usually used for diagnosis of delirium, but when serially administered, 
it has been found to be responsive to change in an acute geriatric population 
(O'Keeffe, Mulkerrin et al. 2005). Individual test items were used to aid completion 
of orientation, memory and visuospatial components of the DRS-R98. 
Cortisol and inflammation in delirium and cognitive decline after hip fracture 
General Methods 106 
 
2.3.4 Assessment of level of arousal 
2.3.4.1 Richmond Agitation Sedation Scale 
The RASS is a well-known scale of level of sedation and arousal (Sessler, Gosnell et 
al. 2002). It is bidirectional, and was originally developed for assessment of agitated 
and sedated patients in critical care settings (Sessler, Gosnell et al. 2002). A score of 
zero indicates a normal level of arousal, positive scores indicate a restless or agitated 
state, and negative scores a drowsy or sedated state. It takes a few seconds to a 
minute to complete; the tester first observes the patient and if they are alert scores 
them from 0 to +4. If the patient is not alert the tester says the patient’s name and 
asks them to open their eyes and look at the speaker. The degree to which the patient 
responds to verbal stimuli may then be recorded (-1 to -3). If there is no response to 
verbal stimuli, the tester then physically stimulates the patient by shaking their 
shoulder or rubbing their sternum. The degree of response to physical stimuli can 
then be recorded (-4 to -5) (Sessler, Gosnell et al. 2002). 
 
2.3.4.2 The Observational Scale of Level of Arousal 
I developed the OSLA for use in this study (Tieges, McGrath et al. 2013). This was 
because existing scales of arousal are not very detailed, and do not fully capture the 
spectrum of change in arousal level, particularly mild change, in elderly hospital 
patients. It is a bidirectional scale encompassing four subscales; eye opening, eye 
contact, posture and movement, shown in Table 2.1. An exploratory study in a 
different cohort with acute hip fracture (N=30) found that abnormal level of arousal 
was strongly associated with the presence of delirium. The area under the receiver 
operating curve for the OSLA was 0.89 (95% confidence interval 0.68-0.94), with a 
sensitivity of 0.87 and a specificity of 0.81 (Tieges, McGrath et al. 2013).  
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Table 2.1 The Observational Scale of Level of Arousal 
Subscale Criteria Score 
Eye 
opening 
Open on arrival and remain so, under patient’s control, outlasts stimulus 
Open on arrival but close if stimulus removed 
Open to voice but then outlasts stimulus 
Open to voice but close if stimulus removed 
Open to gentle physical stimulation eg squeezing hand, gentle shake to shoulder 
Open to pain only 










Spontaneously makes and holds eye contact appropriately 
Drowsy and makes eye contact to command but can’t hold it very long 
Alert but eyes wandering, some appropriate eye contact 
Alert but eyes wandering, little or no appropriate eye contact 
Drowsy but makes brief eye contact 







Posture Sitting out in chair or up in bed, holding appropriate posture 
Slumped in chair/bed but attempts to sit upright & sustain posture on request 
Slumped in chair or bed and unable to sustain posture 





Movement Moves spontaneously and purposefully, no restless or agitated movements 
Occasional or mild restless or fidgety movements, no aggressive or vigorous 
movements 
Reduced frequency of movement, mildly slowed up 
Frequent restless or fidgety movements, no aggressive or vigorous movements 
Moderately ↓ frequency & speed of movement, interferes with assessment or 
self-care 
Aggressive or vigorous, recent pulling out of lines 
Overtly combative, violent 









Score range 0-15, 0 represents a normal level of arousal 
 
2.3.5 Assessment of attention 
2.3.5.1 Edinburgh Delirium Test Box 1 
The Edinburgh Delirium Test Box 1 (EDTB 1; figure 2.1) task ‘focussed vigilance 
with  distraction’ was included as an objective test of attention (Brown, Fordyce et 
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al. 2010). The participant is shown the test box, and directed to a large white button 
(button B); they are told that the button will light up, and asked to count how many 
times it lights up. They are told that there will be some red flashing lights on the 
central panel, and told to ignore them. The participant is then shown a series of white 
lights on the button B, of varying duration and frequency, and the number of lights 
they count is noted down. The task includes six trials. The first three are relatively 
short and simple, and the second three are more taxing. The task is scored from 0-6 
according to whether or not the participant gives the right answer for the number of 
lights counted on button B. 
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2.3.6 Baseline information 
Background medical information was collected from the participant’s casenotes. This 
included date, type and side of fracture, date of admission and type of operation 
planned, past medical history, drug history on admission and changes made, baseline 
observations and examination findings, details of any preoperative acute medical 
problems and their treatment, social history including smoking and alcohol intake, 
type of accommodation, details of package of care, baseline mobility, previous 
occupation and years in education, baseline routine blood test results, 
electrocardiograph results and chest x-ray results. This information was also used to 
complete the Rockwood Brief Frailty Score (Rockwood, Stadnyk et al. 1999), the 
APACHE II Score (Acute Physiology and Chronic Health Evaluation II) (Knaus, 
Draper et al. 1985) and the Charlson Co-morbidity Index (Charlson, Pompei et al. 
1987) (Appendix 1) 
 
2.3.6.1 Rockwood Brief Frailty Score 
The concept of frailty as a syndrome combining age, co-morbid illness, function and 
other factors such as nutrition and fitness, has grown significantly in recent years. A 
brief frailty score was used here, from Rockwood et al who have contributed 
significantly to the frailty literature (Rockwood, Stadnyk et al. 1999). The scale, 
based on the Geriatric Status Scale, classifies patients into one of four categories, 
from fitness to frailty; (0) those who walk independently, are independent in personal 
ADLs, are continent and not cognitively impaired, (1) bladder incontinence only, (2) 
one (or two if incontinent) of needing assistance with mobility or ADLs, cognitive 
impairment but not dementia, or bladder or bowel incontinence, and (3) two (three if 
incontinent) of totally dependent for transfers or one or more ADLs, double 
incontinence and dementia. Rockwood et al found that the scale had a dose response 
relationship between the categories of frailty and subsequent institutionalisation in a 
longitudinal study (Rockwood, Stadnyk et al. 1999). It is relatively quick and simple 
to complete. 
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2.3.6.2 Acute Physiology and Chronic Health Evaluation II Score 
The APACHE II score was used here as a measure of illness severity. It uses basic 
physiological parameters and the presence of chronic co-morbidities to stratify 
acutely ill patients according to their risk of death from their current illness, and is 
commonly used for prognostic purposes in ICU (Knaus, Draper et al. 1985). A 
modified version of the APACHE II score was used which did not include arterial 
pH, since arterial blood sampling is not routine preoperatively in patients with hip 
fracture. There is a precedent for this small change in the delirium literature (Adamis, 
Treloar et al. 2007). 
 
2.3.6.3 The Charlson Co-morbidity Index 
The Charlson Co-morbidity Index (CCI) is a widely used measure of co-morbid 
disease burden (Charlson, Pompei et al. 1987). It was designed for use in 
longitudinal studies, to give prognostic information in order to control for the 
influence of co-morbid illness on outcomes. It gives a weighted score to different 
diagnoses, based on the influence each is likely to have on survival. For example, 
peripheral vascular disease scores 1, and a metastatic solid tumour scores 6. The 
scores are added up for each patient’s co-morbid diseases. However, the CCI was 
initially developed in the 1980s and further validated in the 1990s (Charlson, 
Szatrowski et al. 1994), and specific treatment for some of the diseases has changed 
significantly since then. For example, ulcer disease and myocardial infarction have 
had their treatments revolutionised by widespread proton pump inhibitor use, H. 
Pylori eradication and primary percutaneous coronary intervention, and they score 1 
point which is the same as dementia. AIDS scores 6 points, although the advances in 
retroviral therapy mean HIV disease has a much better prognosis than 30 years ago. 
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2.4 Measures of cortisol, inflammation and CSF biomarkers 
 
2.4.1 Salivary cortisol 
Diurnal salivary cortisol samples were collected using a Salivette® (Sarstedt, 
Germany) between 08.00-10.00 and 15.00-17.00. This involved the participant 
chewing on a small sterile cotton swab for 2-3 minutes until it was moist, which was 
then replaced in a sterile plastic container. Samples were collected preoperatively, 
and on days 4, 7 and 10-14 postoperatively. Diurnal saliva samples were also 
collected at each follow-up visit at 3, 6 and 12 months. 
 
2.4.2 Cerebrospinal fluid and baseline serum sample 
At spinal anaesthetic, the anaesthetist withdrew 2-3mls of CSF into a polypropylene 
universal container once the spinal needle was in position and before the 
administration of anaesthetic agent intrathecally. A paired venous blood sample was 
taken at the same time. If the participant had a general anaesthetic for medical 
reasons or by choice, a blood sample only was collected. Once these samples were 
ready, I was contacted and collected the samples on ice as quickly as possible, and 
processed them for storage. Samples were usually processed within one hour of 
collection, with the maximum time being approximately two hours. 
 
2.4.3 Serum for morning cortisol and inflammatory cytokines 
Further venous blood samples for cortisol and inflammatory markers were collected 
between 08.00-10.00 on Day 4 and the visit between Days 10-14. Morning blood 
samples were also collected at each follow-up visit. 
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2.5 Sample processing 
 
2.5.1 CSF 
CSF samples were centrifuged at 1000g for 10 minutes at 4oC. The supernatant was 
stored in 100μl aliquots in labelled polypropylene eppendorfs at -80°C before 
analysis. 
 
To check for blood contamination in the CSF, the pellet was resuspended in 100μl 
phosphate buffer saline followed by a cytospin. To perform the cytospin, a glass-
slide was pre-labelled with a pencil. The glass-slide was placed in a cytospin-holder 
and a white filter paper placed on top, followed by a plastic funnel. The 100μl 
resuspended pellet was pipetted into the cytospin funnel. The cells were centrifuged 
at 300g for 3 minutes in a Shandon Cytospin II (Shandon, UK). The holder was 
carefully opened, the funnel and filter paper removed. The cells were air-dryed for a 
few minutes and then fixed with 100% methanol for 2 minutes at room temperature, 
followed by staining with Diff-quik Red solution (Gamidor Ltd, UK), for 1 minute at 
room temperature and then staining with Diff-quik Blue solution (Gamidor Ltd, UK), 
for 1 minute at room temperature. The slides were rinsed under running distilled-
water, left to air-dry and then cover-slipped and mounted.  
 
2.5.2 Blood 
All blood samples were centrifuged at 3000g for 10 minutes at 4oC. The serum was 




The Salivette® was centrifuged at 1000g for 2 minutes and the supernatant frozen in 
a new polypropylene eppendorf at -80oC. 
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2.6 Perioperative Assessments 
Participants were interviewed, if they felt well enough and capable of interaction, on 
Days 1, 2, 3, 4, 7, and once between Days 10-14 postoperatively or until transfer or 
discharge from the ward. Each assessment lasted around 10-15 minutes and consisted 
of a semi-structured interview which allowed the completion of the CAM, DRS-R98, 
MMSE, RASS and OSLA, and a brief test of attention using the EDTB-1. I discussed 
any symptoms or signs of delirium with nursing staff. If the participant could not be 
interviewed, I informed nursing or medical staff of anything of concern and 
performed the delirium review by completing those assessments which could be 
performed through observation only. I reviewed the casenotes and recorded any 
medication changes, complications, physiological changes and most recent 
observations. I recorded delirium status and MMSE results in the casenotes for the 
benefit of the medical team.  
 
During the perioperative period, I also completed tests of premorbid intelligence (the 
National Adult Reading Test (NART) (Nelson 1982)) and met with the participant’s 
next of kin or nominated family member or friend to complete the Informant 
Questionnaire on Cognitive Decline in the Elderly (IQCODE). These measures were 
taken in order to gain as good a picture as possible of premorbid cognitive ability or 
impairment. The Katz and Lawton scales of activities of daily living are completed 
with information from the patient and / or their next of kin (Katz, Ford et al. 1963, 
Lawton and Brody 1969) to gain baseline information on functional level (Appendix 
1). Length of hospital stay and destination from the trauma ward (i.e. home, 
orthogeriatric rehabilitation, death) were also recorded. 
 
2.6.1 The National Adult Reading Test 
The NART (Nelson 1982) is a test in which the subject is asked to pronounce a series 
of irregularly spelt words such as “chord”, “subtle” and “labile”. This suggests the 
subject is familiar with the word and indicates vocabulary level. Performance on the 
NART correlates highly with full scale IQ as measured by the Wechsler Adult 
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Intelligence Scale (Lezak 1995). The main use of the NART is to estimate 
‘premorbid’ IQ, as scores correlate highly with IQ scores in childhood and adulthood 
(Crawford, Deary et al. 2001). The NART has also been shown to be stable in 
delirium in a population of patients post-CABG (Brown, Ferner et al. 2011).  
 
2.6.2 The Informant Questionnaire on Cognitive Decline in the 
Elderly 
The IQCODE is a widely used and well-validated questionnaire used to screen for 
and aid diagnosis of dementia, with other cognitive testing (Jorm 2004). It asks the 
informant to consider whether there has been any change in the past ten years in the 
subject’s ability regarding a number of situations where they use their memory or 
intelligence, such as recalling conversations, learning how to use new things and 
handling money. The informant then indicates whether there has been “no change” or 
whether they are “a bit” worse or improved, or “much” worse or improved. An 
average score of 3.00 indicates no change in cognition. Studies of use of the 
IQCODE in medical hospital in-patients have established a cut off for evidence of 
prior cognitive impairment of 3.44 (Harwood, Hope et al. 1997). In a large (total 
N=657 for MCI group) Chinese study, a cut-off for mild cognitive impairment and 
for mild cognitive impairment without functional impairment of 3.19 (Li, Jia et al. 
2012) has also been established. 
 
2.6.3 Katz scale of activities of daily living 
The Katz index of independence in activities of daily living (ADLs) is a widely used 
scale of a person’s functional status, which was developed in the 1960s (Katz, Ford 
et al. 1963). It focuses on basic ADLs; bathing, dressing, toileting, transfers, 
continence and feeding (Appendix 5). It can be scored 0-6, with the person scoring 
one point for independence in each domain of function, 0 being dependent and 6 
being independent. It can also be scored in a hierarchical sense from A to G, 
depending on which functions the person has become dependent in, A being 
independent in all functions and G being dependent in all six functions, since Katz et 
al found that independence was usually lost in a predictable order, first in bathing, 
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then dressing etc. (Katz, Ford et al. 1963). In this study, the numerical scoring system 
was used. 
 
2.6.4 Lawton scale of activities of daily living 
The Lawton scale of instrumental activities of daily living assesses the person’s 
ability to perform more complex independent living tasks such as shopping, 
housekeeping and managing finances (Appendix 5) (Lawton and Brody 1969). It is 
scored 0-8 based on the person’s independence in the eight domains tested. The scale 
was devised in 1969, and traditionally women were scored 0-8 and men 0-5, omitting 
food preparation, housekeeping and laundry. In this study, men and women were all 
scored 0-8.  
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2.7 Follow-up Assessments at 3, 6 and 12 months 
I first contacted the participant’s General Practitioner, to check on their health status 
and confirm that it was still appropriate to contact the participant. I then telephoned 
the participant and arranged a date and time in the morning for the visit, with the 
participant’s choice of a home visit or a visit to the Clinical Research Facility (CRF), 
NRIE with travel via taxi arranged. I explained what the visit would entail and asked 
the participant to fast on the morning of the visit prior to the blood test. I sent a letter 
confirming these details, and telephoned the participant 1-2 days prior to the visit for 
a final check.  
 
The follow-up visit lasted 60-80 minutes. I first collected blood samples for fasting 
cortisol and inflammatory markers, and a saliva sample for cortisol. Once the 
participant had had some breakfast, I recorded information on medication changes, 
new medical history, current mobility and completed the Katz and Lawton functional 
scales. A delirium assessment was performed (a semi-structured interview taking 10-
15 minutes which allows completion of the CAM, DRS-R-98, OSLA and RASS, the 
MMSE and EDTB-1 assessment).  
 
The cognitive test battery was then completed, paying particular attention to 
participant fatigue, and this was cut short if the participant tired. The battery took 30-
40 minutes to complete and included Verbal Fluency, Visual Reproduction Recall, 
Delayed Recall and Copy from the Wechsler Memory Scale III, HVLT-R list 
learning, Victoria Stroop, Digit Span Forwards and Backwards and the Digit Symbol 
Substitution Test. The battery was chosen to provide a broad but relatively brief 
assessment of cognition, with particular attention to executive function. Finally, the 
15 item Geriatric Depression Scale, a widely-used screening tool for depression 
(Brown, Woods et al. 2007), the EQ-5D quality of life scale, a very brief but 
increasingly widely used instrument which has performed well in elderly populations 
(Brazier, Walters et al. 1996, Tidermark, Bergstrom et al. 2003) and Apathy 
Evaluation Scale, Clinician Version, the most widely-used and best validated 
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assessment for apathy (Clarke, Van Reekum et al. 2007), were completed (Appendix 
1). 
 
2.7.1 Summary of cognitive test battery 
 
2.7.1.1 Verbal Fluency 
The most commonly-used test of verbal fluency is the Controlled Oral Word 
Association Test (Lezak 1995). The examiner speaks out loud a letter from the 
alphabet and the subject is instructed to speak out loud as many words beginning 
with that letter as possible in one minute, excluding numbers, proper nouns and the 
same word with different suffixes. In this study, the letters F, A and S were used, 
followed by the number of animals the subject could name in one minute. This test 
has been shown to be sensitive to damage to the frontal lobe and is often considered 
a test of ‘executive’ or ‘frontal lobe’ function. Performance on the Controlled Word 
Association Test has been shown to decline with ageing and in dementia (Lezak 
1995). 
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2.7.1.2 Visual Reproduction: Recall, Delayed Recall and Copy 
This test is part of the Wechsler Memory Scale – Revised (Wechsler 1987). In this 
test the subject is shown a series of five geometric designs of increasing complexity. 
An example is shown in Figure 2.2. The participant is given five seconds to look at 
one design, then this is hidden and the subject is asked to draw the design. Thirty 
minutes later, the test is repeated and the participant is asked to draw as many of the 
designs as they can remember, in any order, without having been warned that they 
will be asked to reproduce the designs during the first part of the test. They are then 
shown the designs again and asked to copy them. The participant is given as much 
time as they need to copy the designs. Performance on Visual Reproduction declines 
with age and with dementia (Bak and Greene 1981, Wilson, Bacon et al. 1983, Lezak 
1995). 
 
Figure 2.2: Sample item from Visual Reproduction 
 
 
2.7.1.3 HVLT-R list learning 
The HVLT-R list learning test is a test of verbal learning and memory (Strauss, 
Sherman et al. 2006). The participant is told that they will be read a list of words, and 
they are asked to listen carefully because at the end they will be asked to tell the 
tester as many words as they can remember, in any order. The participant is then read 
a list of twelve words slowly and clearly. The words contain three groups of four 
related words e.g. emerald, sapphire, pearl and opal, with the three groups of words 
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interspersed within the list. The words the participant can remember are noted down. 
There are two further trials in the same manner. The total recall score is the sum of 
the first three learning trials. To test delayed recall, without prior warning, 20-25 
minutes later the participant is asked if they can remember the list of words they tried 
to remember before, and then asked to tell the tester as many words as they can 
remember. The participant is then read a longer list of words, some from the original 
list and some not, and asked to tell the tester whether or not each word was on the 
list. This longer list of words contains six semantically-related false positives (e.g. 
diamond, ruby) and six semantically-unrelated false positives (e.g. balloon, coffee). 
The number of total true positive answers (words from the original list correctly 
identified) minus the number of total false positive answers (both semantically 
related and unrelated) is termed the recognition discrimination index (RDI). Scores 
on the test deteriorate with dementia, in particular the number of false positives 
increases with even early Alzheimer’s dementia due to decline in semantic memory, 
and it has been shown to be valid as a screening test for dementia (Strauss, Sherman 
et al. 2006). 
 
2.7.1.4 Victoria Stroop 
Stroop tests are tests of executive function, measuring selective attention and 
cognitive flexibility (Strauss, Sherman et al. 2006). The Victoria Stroop version is a 
commonly used, brief version of the task. The participant’s colour vision is first 
checked by asking them to name the colours of four coloured dots. If they have no 
difficulty distinguishing the colours, they go on to the main test, which has three 
parts. In the first part, they are asked to name the colours of a series of dots, as 
quickly as they can (part D). The time taken to complete the task is timed, and any 
errors noted. The second part requires the participant to name the colour of a series 
of words as quickly as they can (part W), and again the time taken and any errors are 
noted. In the third part of the test, the participant is asked to name the colour that a 
series of words is printed in, as quickly as they can (part C). In this part of the test, 
the words are colour words printed in a different colour (Figure 2.3). Again, the time 
taken and any errors are noted. If the participant spontaneously corrects a mistake it 
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is scored as correct. The difference score was calculated, which is the difference 
between the time taken to complete the interference card (part C) compared to the 
colour card (part D). This score increases with age, and there is a modest relation 
with educational level (Strauss, Sherman et al. 2006). The interference score was also 
calculated, which is the difference score divided by the time taken to complete the 
colour card. 
 














2.7.1.5 Digit Span Forwards and Backwards 
Digit span is a brief, simple test of attention span. The participant is read strings of 
digits, beginning with two digits, at a rate of one per second, and with a drop in pitch 
on the last digit. For digit span forwards, the participant must then repeat them back 
in turn, and for digit span backwards they must correctly reverse the string of 
numbers. Both tests are halted when the patient fails to correctly repeat or reverse the 
blue yellow red green 
green blue yellow red 
green red blue yellow 
red green yellow blue 
yellow red green blue 
red blue yellow green 
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same length digit string on two occasions. The test is scored according to the total 
number of correct answers and the longest digit string correctly repeated. Digit span 
backwards has been shown to have reasonable sensitivity and specificity for delirium 
versus dementia and cognitively unimpaired controls (O'Keeffe and Devlin 1994). 
Digit span has also been used to monitor delirium over time (Christensen, Bettin et 
al. 1996, Bettin, Maletta et al. 1998), and scores tend to improve, possibly reflecting 
the transient nature of attentional impairment in delirium, or possibly a learning 
effect.  
 
2.7.1.6 Digit Symbol Substitution Test 
The Digit Symbol Substitution Test (DSST) is part of the Wechsler Adult 
Intelligence Scale-Revised (Wechsler 1981). It was used as an indicator of attention 
and processing speed. Subjects are instructed to draw in symbols in blank boxes 
under numbers according to a code given at the top of the answer sheet. The score 
was the number of correct substitutions in 90 seconds. The DSST is highly sensitive 
to age (Wechsler 1981), showing declines from the age of 20, and also shows decline 
in dementia (Lezak 1995). 
 
2.7.2 Geriatric Depression Scale 
The Geriatric Depression Scale (Appendix 6) is a widely used screening 
questionnaire for depression in older adults. The 15-item short form was used. The 
patient is asked a series of questions about their mood and spirits, and asked to give a 
“yes” or “no” answer based on their experiences over the past week. A score of >5 
positive answers is suggestive of depression, and a score of >10 is almost always 
indicative of depression.  
 
2.7.3 EQ-5D 
The EQ-5D (Appendix 7) is a short and simple questionnaire assessment of health 
status (Cheung, Oemar et al. 2009). There are two parts, the descriptive system and 
visual analogue scale. The descriptive system has five dimensions; mobility, self 
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care, usual activities, pain/discomfort and anxiety/depression. The respondent is 
asked to rate their health state according to three levels; no problems, some problems 
or severe problems. Each response corresponds to a single digit answer (1-3) which 
leads to a composite five digit number, e.g. 21121, which represents the participant’s 
health state. The visual analogue scale asks the participant to indicate how good or 
bad their health is that day, with 0 being the worst state they can imagine and 100 
being the best they can imagine, by drawing a line to the scale. This instrument is 
brief and easy to use in elderly patients, and has been shown to be responsive to 
change in patients with hip fracture and suitable for use in assessing quality of life 
outcomes in this population (Tidermark, Bergstrom et al. 2003). 
 
At the end of the visit, I arranged a time to return to collect an afternoon saliva 
sample for cortisol. If the patient was well and mobile enough, they were provided 
with a Salivette®, instructions for taking the sample and a labelled Royal Mail 
Safebox™ to post the Salivette® to the CRF. 
 
2.8 Ethical approval 
The study was reviewed and approved by the Scotland A Research Ethics 
Committee, reference number 09/MRE00/28, and by NHS Research and 
Development, reference number 2009/R/ME/02. 
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2.9 Cerebrospinal fluid assays 
 
2.9.1 Cortisol 
Cortisol was measured in CSF with a commercially available high-sensitivity cortisol 
Enzyme-Linked Immunosorbent Assay (ELISA) (Salimetrics, Pennsylvania, USA). 
This ELISA is designed to measure cortisol in saliva, but was chosen as its detectable 
range for cortisol is low and in line with expected CSF values, and previous in-house 
experience was that it reliably detected cortisol in CSF samples in a pilot study 
(Pearson, de Vries et al. 2010). Samples were stored at -80C in 100μl aliquots until 
the assay. The assay procedure is as described for the salivary cortisol section. CSF 
samples were not diluted and were assayed in singlicate.  
 
2.9.2 Dehydroepiandrosterone (DHEA) and 
Dehydroepiandrosterone Sulphate (DHEAS) 
Dehydroepiandrosterone and Dehydroepiandrosterone Sulphate were measured in 
CSF with separate commercially available Enzyme-Linked Immunosorbent Assays 
(ELISA) (Salimetrics, Pennsylvania, USA). These ELISAs were designed to measure 
DHEA and DHEAS in saliva, but they were chosen as their detectable range for both 
neurosteroids was low and in line with expected CSF values according to the CSF 
literature. Samples were stored at -80C in 100μl aliquots until the assay. CSF 
samples were not diluted and were assayed in singlicate. 
 
2.9.2.1 DHEA assay protocol 
All reagents were brought to room temperature. A plate was provided pre-coated 
with polyclonal anti-DHEA antibodies. Standards were serially diluted from the 
1000pg/ml DHEA concentrate to give a standard curve of 1000, 400, 160, 64, 25.6 
and 10.2pg/ml. Fifty microlitres of standards, high and low controls and unknown 
samples were pipetted into the 96-well plate provided, and assay diluent into “blank” 
and “non-specific binding” wells. A 1:1500 dilution of the conjugate was prepared, 
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and 150μl immediately pipetted into each well. The plate was mixed for 5 minutes at 
500rpm and incubated at room temperature for 3 hours. The plate was washed 4 
times with wash buffer using a plate washer. Two-hundred microlitres of 
tetramethylbenzidine solution was added to each well. The plate was mixed for 5 
minutes at 500rpm and incubated in the dark at room temperature for a further 25 
minutes. Fiftymicrolitres of stop solution (sulphuric acid) was added to each well and 
the plate was mixed for a further 3 minutes at 500rpm. The plate was read on a plate 
reader at 450nm within 10 minutes of adding stop solution. Manufacturer reported 
sensitivity suggests a minimum detectable concentration of 5pg/ml. Intra-assay 
precision as expressed by % coefficient of variation (C.V.) is 5.3% and 5.8%, and 
inter-assay precision is 7.9% and 8.5%. The manufacturers report a 0.063% cross-
reactivity with DHEAS and 0.0378% with androstenedione, but <0.004% with the 
other steroids tested.  
 
2.9.2.2 DHEAS assay protocol 
All reagents were brought to room temperature. A plate was provided pre-coated 
with rabbit anti-DHEAS antibodies. Standards were serially diluted from the 
15300pg/ml DHEAS concentrate to give a standard curve of 15300, 5100, 1700, 
566.7 and 188.9pg/ml. One hundred microlitres of standards, high and low controls 
and unknown samples were pipetted into the 96-well plate provided, and assay 
diluent into “blank” and “non-specific binding” wells. A 1:225 dilution of the 
conjugate was prepared, and 150μl immediately pipetted into each well. The plate 
was incubated at room temperature for 1 hour, constantly mixed at 500rpm on a plate 
shaker. The plate was washed 4 times with wash buffer using a plate washer. Two-
hundred microlitres of tetramethylbenzidine solution was added to each well. The 
plate was mixed for 5 minutes at 500rpm and incubated in the dark at room 
temperature for a further 25 minutes. Fifty microlitres of stop solution (sulphuric 
acid) was added to each well and the plate was mixed for a further 3 minutes at 
500rpm. The plate was read on a plate reader at 450nm within 10 minutes of adding 
stop solution. Manufacturer reported sensitivity suggests a minimum detectable 
concentration of <43pg/ml. Intra-assay precision as expressed by % coefficient of 
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variation (C.V.) is 5.7% and 8.8%, and inter-assay precision is 7.4% and 7.7%. The 
manufacturers report a 0.0844% cross-reactivity with androstenedione and 0.0268% 
with transandrosterone, but <0.004% with the other steroids tested. 
 
2.9.3 Inflammatory human cytokine panel 
A high sensitivity Milliplex MAP human cytokine assay (HSCYTO 13-plex, Merck 
Millipore) was performed using a Luminex 200 reader (Biorad). This measured a 
panel of 13 cytokines, comprising IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, 
IL-12p70, IL-13, Interferon (IFN)-γ, Granulocyte macrophage colony stimulating 
factor (GM-CSF) and Tumour Necrosis Factor (TNF)-α. Seventy-six patients were 
age-matched, 50% who developed delirium at any stage during the perioperative 
period, and 50% who did not. Samples were from the Edinburgh CDHIP cohort and 
the Oslo cohort. CSF samples were assayed in singlicate and were not diluted. All 
reagents were brought to room temperature before use. The high sensitivity human 
cytokine standard was reconstituted with deionised water, vortexed and left for 10-15 
minutes before making up a set of working standards by serial dilution, at 2000, 400, 
80, 16, 3.2, 0.64 and 0.13pg/ml. A filter-bottomed 96-well plate was prewet before 
use by pipetting 200μl of wash buffer into each well and mixing on a plate shaker for 
10 minutes at room temperature. The wash buffer was removed by vacuum. The bead 
bottle containing pre-mixed antibody beads was sonicated for 30 seconds and then 
vortexed for 1 minute. Twenty-five microlitres of the premixed bead solution was 
added to each well, shaking the bead bottle intermittently. The liquid was removed 
from the wells by vacuum. Next, 50μl of standard or control was added to the wells, 
and 50μl of assay buffer to the 0pg/ml background wells and the sample wells. Fifty 
microlitres of serum matrix solution was added to the background, standards and 
control wells. The CSF samples were centrifuged and then 50μl added to the sample 
wells. The plate was sealed and covered with a lid, and incubated with agitation on a 
plate shaker overnight at 4°C. The fluid was removed from the wells by vacuum, and 
the plate washed twice with wash buffer and vacuum filtration. Fifty microlitres of 
detection antibodies was added to each well, and the plate was sealed, covered with a 
lid and incubated at room temperature with agitation on a plate shaker for 1 hour. 
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Fifty microlitres of streptovidin-phycoerythrin was added to each well. The plate was 
sealed and covered again and incubated at room temperature with agitation for 30 
minutes. The contents of the wells was removed by vacuum, the wells washed twice 
with wash buffer, the beads resuspended with 100μl of Luminex sheath fluid and 
agitated on a plate shaker for 5 minutes. The plate was read on a Luminex 200 
machine. Manufacturer reported sensitivity suggests a minimum detectable 
concentration for each cytokine as follows: IL-1β 0.06pg/ml, IL-2 0.16pg/ml, IL-4 
0.13pg/ml, IL-5 0.01pg/ml, IL-6 0.10pg/ml, IL-7 0.12pg/ml, IL-8 0.11pg/ml, IL-10 
0.15pg/ml, IL-12(p70) 0.11pg/ml, IL-13 0.48pg/ml, IFNγ 0.29pg/ml, GM-CSF 
0.46pg/ml and TNF-α 0.05pg/ml. Intra-assay precision, expressed as % C.V. was as 
follows: IL-1β 3.11%, IL-2 4.27%, IL-4 4.16%, IL-5 4.50%, IL-6 3.51%, IL-7 
4.75%, IL-8 3.26%, IL-10 3.31%, IL-12(p70) 4.31%, IL-13 5.86%, IFN-γ 4.88%, 
GM-CSF 4.14% and TNF-α 3.49%. Inter-assay prescision was as follows: : IL-1β 
2.16%, IL-2 7.48%, IL-4 9.12%, IL-5 14.27%, IL-6 4.48%, IL-7 6.24%, IL-8 6.48%, 
IL-10 11.84%, IL-12(p70) 5.08%, IL-13 11.99%, IFN-γ 7.79%, GM-CSF 5.03% and 
TNF-α 3.78% The manufacturers report no or negligible cross-reactivity between 
any other analytes. 
 
2.9.4 S100B 
Levels of S100B in CSF were measured using an in-house Enzyme-Linked 
Immunosorbent Assay (Green, Keir et al. 1997), at the National CJD Surveillance 
Unit, Western General Hospital, Edinburgh, by Alison Green and Mary Andrews. 
Assays were performed, in batches, within 6 months of sample collection to 
minimise marker degradation in storage and maintain uniformity of analysis. 
Sensitivity was 0.04ng/ml. The mean intra-assay precision of the S100B assay is 
9.3% C.V. and 5.6% C.V., and inter-assay precision is 8.9% C.V. and 8.1% C.V. 
Cross-reactivity with S100A was less than 0.006% (Green, Keir et al. 1997).  
 
2.9.5 Tau 
Levels of tau (total) in CSF were measured using a commercially-available Enzyme-
Linked Immunosorbent Assay (Life Technologies, Paisley, UK) at the National CJD 
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Surveillance Unit, by Alison Green and Mary Andrews. The sensitivity of the assay 
was 10pg/ml. Intra-assay precision was 5.9%, and inter-assay precision 9.9%. There 
was no cross-reactivity with human β-amyloid 1-40, β-amyloid 1-42 or α-synuclein. 
Cross-reactivity with mouse tau was <1.3%. 
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2.10  Serum assays 
 
2.10.1 Cortisol 
Serum samples were thawed once and assayed in batches by me using a 
commercially available cortisol ELISA (MP Biomedicals, Germany). All reagents 
were brought to room temperature before use. Cortisol standards were provided at 
concentrations of 50, 20, 10, 4, 1 and 0μg/dl. Twenty-five microlitres of cortisol 
standard, control or unknown sample were pipetted into a 96-well streptavidin coated 
plate. Working cortisol enzyme reagent was made up by adding 0.7ml of cortisol 
enzyme reagent (a cortisol-horseradish peroxides conjugate in a protein-stabilising 
matrix with green dye) to a 7ml vial of steroid conjugate buffer. Next, 50μl of 
working cortisol enzyme reagent was added to each well. The microplate was swirled 
gently for 20-30 seconds to mix. Fifty microlitres of cortisol biotin reagent (anti-
cortisol biotinylated mIgG conjugate in buffer, green dye and reagent) were added to 
each well. The microplate was swirled gently for 20-30 seconds to mix again. The 
plate was covered and incubated at room temperature for 1 hour. The plate was 
washed with wash buffer 3 times on a plate washer. Working substrate solution was 
made up by combining equal quantities of tetramethylbenzidine in buffer and 
hydrogen peroxide in buffer. One-hundred microlitres of this working substrate 
solution was added to each well. The plate was not swirled or shaken, and was 
incubated at room temperature for 15 minutes. Finally, 50μl of stop solution (1N 
HCl) was added to each well, and the plate read on a plate reader at 450nm, within 
30 minutes. Manufacturer reported sensitivity indicates a minimal concentration of 
cortisol that can be distinguished from 0 of 0.25μg/dL (6.9nM/L).  Intra-assay 
precision for high concentration cortisol was 6.1% C.V., and for low concentration 
8.2% C.V. Inter-assay precision for high concentration cortisol was 7.3% C.V. and 
for low concentration 9.7% C.V. The manufacturers report 0.23% cross-reactivity 
with cortisone and 0.18% with corticosterone. 
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2.10.2 Inflammatory cytokines 
Serum samples were thawed once and assayed in batches using a commercially 
available Fluorokine Multi-Analyte Profiling “Luminex” assay (R&D, Abingdon).  I 
performed a test assay and the full set of assays was performed at the SuRF facility 
in the Queen’s Medical Research Institute, University of Edinburgh, by Dr Pam 
Brown and Linda Ferguson. The cytokines and chemokines measured in each 
Luminex assay were Interleukin (IL)-1β, IL-1ra, IL-5, IL-6, IL-8, IL-10, Macrophage 
Inflammatory Protein (MIP)-1a, MIP-1b, Monocyte Chemotactic Protein (MCP)-1 
and Tumour Necrosis Factor (TNF)-α. The manufacturers recommend a 4 fold 
dilution of serum samples. We tested a series of dilutions from 1 to 8-fold, and chose 
to use a 4 fold dilution. Samples were diluted in calibrator diluent. All samples were 
assayed in duplicate. 
 
First, the two standard cocktails were reconstituted with calibrator diluent, and left 
for 30 minutes with gentle agitation. A dilution series was constructed with an 
additional final dilution to aid detection of low levels of cytokines. A filter-bottomed 
96-well microplate was pre-wet with wash buffer, and then the buffer removed 
through the plate by vacuum. Each cytokine or chemokine microparticle concentrate 
vial was centrifuged and then vortexed, and 50μl of each microparticle concentrate 
was added to a vial containing 5ml of diluent. This microparticle cocktail was 
vortexed and 50ul added to each microplate well. Next, 50μl of standard or diluted 
sample was added to each well, ensuring that the plate was pipetted within 15 
minutes. The plate was covered and protected from light. It was incubated at room 
temperature for 3 hours on an orbital shaker at 500rpm. The liquid was then removed 
by vacuum, and the plate washed 3 times with wash buffer, vacuuming each time. 
The biotin antibody cocktail was centrifuged for 30 seconds at 1000g, and then 
gently vortexed. This was diluted by adding 50μl of the concentrate to the 5.5ml vial 
of biotin antibody diluent. Next, 50μl of the diluted antibody cocktail was added to 
each well. The plate was covered with a foil plate sealer and incubated at room 
temperature for one hour on the shaker. The plate was washed again with wash 
buffer 3 times. The Streptavidin-PE concentrate vial was centrifuged for 30 seconds 
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at 1000g and then vortexed, and diluted 100x by adding 55μl to 5.5ml of wash 
buffer. Fifty microlitres of the 1x Streptavidin PE was added to each well, the plate 
covered with a foil plate sealer and incubated for 30 minutes at room temperature on 
the shaker. The plate was washed again 3 times, and the microparticles resuspended 
with 100μl of wash buffer. The plate was incubated for 2 minutes on the shaker and 
then read on a Biorad analyser.  
 
The plates were run in batches, with a standard curve on each plate. Due to 
occasional problems with the standard curves, the best set of standard curves for each 
batch of plates was applied to all plates for that batch. The manufacturers say that 
batches of plates can be run with only one set of standard curves on the first plate, 
however we chose to include a standard curve on each plate and chose the most 
accurate from each batch.  
 
Manufacturer reported sensitivity suggests a mean minimum detectable 
concentration for each cytokine as follows: IL-1β 0.27pg/ml, IL-1ra 4.05pg/ml, IL-5 
0.33pg/ml, IL-6 0.36pg/ml, IL-8 0.39pg/ml, IL-10 0.13pg/ml, MCP-1 0.16pg/ml, 
MIP-1α 8.11pg/ml, MIP-1β 0.44pg/ml and TNF-α 0.60pg/ml. Intra-assay precision, 
expressed as % C.V. was as follows: IL-1β 4.5-5.5%, IL-1ra 2.8-4.4%, IL-5 4.8-
6.4%, IL-6 4.3-4.7%, IL-8 4.6-7.8%, IL-10 5.2-6.4%, MCP-1 3.8-6.4%, MIP-1α 
10.8-15.2%, MIP-1β 4.3-6.0% and TNF-α 3.7-4.8%. Inter-assay prescision was as 
follows: IL-1β 7.4-10.0%, IL-1ra 6.6-10.9%, IL-5 4.5-9.5%, IL-6 5.9-8.8%, IL-8 
11.6-18.7%, IL-10 7.3-10.1%, MCP-1 5.6-11.1%, MIP-1α 4.8-16.6%, MIP-1β 5.0-
15.9% and TNF-α 6.4-7.0% The manufacturers report <0.5% cross-reactivity 
between any other analytes. 
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2.11 Salivary cortisol assays 
Saliva samples were thawed once and assayed in batches by me using a 
commercially available high-sensitivity cortisol ELISA designed for saliva samples 
(Salimetrics). All reagents were brought to room temperature. A plate was provided 
pre-coated with monoclonal anti-cortisol antibodies. Ready to use cortisol standards 
were provided with the kit at concentrations of 82.77, 27.59, 9.19, 3.06, 1.02 and 
0.33 nmol/L. Twenty-five microlitres of standards, high and low controls and 
unknown samples were pipetted into a 96-well plate, and assay diluent into “blank” 
and “non-specific binding” wells. A 1:1600 dilution of the conjugate was prepared, 
and 200μl immediately pipetted into each well. The plate was mixed for 5 minutes at 
500rpm and incubated for a further 55 minutes. The plate was washed 4 times with 
wash buffer using a plate washer. Two-hundred microlitres of tetramethylbenzidine 
solution was added to each well. The plate was mixed for 5 minutes at 500rpm and 
incubated in the dark for a further 25 minutes at room temperature. Fifty-microlitres 
of stop solution (sulphuric acid) was added to each well and the plate was mixed for 
a further 3 minutes at 500rpm. The plate was read on a plate reader at 450nm within 
10 minutes of adding stop solution. Manufacturer reported sensitivity indicates a 
minimal concentration of cortisol that can be distinguished from 0 of <0.003g/dL 
(<0.083nM/L).  Intra-assay precision for high level cortisol concentrations was 
3.35% C.V., and for low concentration 3.65% C.V. Inter-assay precision for high 
concentration cortisol was 3.75% C.V. and for low concentration 6.41% C.V. The 
manufacturers report 0.130% cross-reactivity with cortisone and 0.214% with 
corticosterone. 
 
2.12 Statistical Analysis 
Statistical analysis was performed by me using SPSS version 19.0, except for the 
logistic regression modelling in Chapter 7 which was performed by Dr Dan Davis, 
and the trajectory analysis in Chapter 9 which was performed by Dr Mike Allerhand. 
Specific analyses are detailed in each chapter. 
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3 Chapter 3: A systematic literature review of 
cerebrospinal fluid (CSF) biomarkers in delirium 
3.1 Introduction 
Delirium is a serious, acute neuropsychiatric syndrome affecting 11-42% of general 
medical inpatients (Siddiqi, House et al. 2006). The main features are acute onset and 
fluctuating course, inattention, altered level of arousal with psychomotor agitation or 
retardation, perceptual disturbance, and sleep-wake cycle disturbance (APA 2000, 
MacLullich, Ferguson et al. 2008, Young and Inouye 2008). Delirium is associated 
with increased morbidity and mortality, and a greater risk of long-term cognitive 
decline (MacLullich, Beaglehole et al. 2009, Witlox, Eurelings et al. 2010). 
However, despite its importance, the mechanisms of delirium are under-researched 
and remain largely obscure. 
There are many hypotheses of the pathophysiology of delirium. These include: 
i) Direct brain insults such as hypoxia, ischaemia, metabolic derangement, 
cerebral infarction (MacLullich, Ferguson et al. 2008).  
ii) Neurotransmitter imbalance such as cholinergic deficiency or dopamine 
excess, which may be induced by several classes of drugs (e.g. 
anticholinergics, antidepressants, L-dopa) (Flacker and Lipsitz 1999).  
iii) Dysregulation of the hypothalamic pituitary adrenal axis in the elderly 
leading to sustained high cortisol levels (Olsson 1999, MacLullich, 
Ferguson et al. 2008).  
iv) Hyper-responsiveness of brain immune cells to stimulation from peripheral 
inflammation, leading to increased neuroinflammation and exaggerated 
sickness behaviour syndrome (MacLullich, Ferguson et al. 2008). These 
potential mechanisms are not mutually exclusive.  
Whatever the peripheral or indeed central precipitants are for delirium, understanding 
the central nervous system (CNS) changes associated with the syndrome is crucial. 
Examining cerebrospinal fluid (CSF) for evidence of these changes is potentially 
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highly informative. However, there are obvious ethical and practical difficulties in 
obtaining CSF specimens in patients with delirium and such studies remain relatively 
rare compared with other CNS disorders of comparable prevalence and severity. In 
recent years there has been a blossoming of studies examining CSF in delirium, often 
collecting CSF using the excellent opportunity afforded by spinal anaesthetic 
administration for high risk surgical procedures.  
This systematic literature review asked the following research questions::  
1) What is the current published literature examining CSF in delirium? 
2) What does this tell us about delirium pathophysiology? 
3) What would be a rational basis for future studies?  
This systematic literature review was originally published in Dementia and Geriatric 
Cognitive Disorders in 2011 (Hall, Shenkin et al. 2011), and has been updated for the 
purposes of this thesis. Permission to reproduce it in this thesis is included in 
Appendix 8. 
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3.2 Methods 
Because all studies were observational in design I devised a protocol based on the 
MOOSE (Meta-analysis Of Observational Studies in Epidemiology) (Stroup, Berlin 
et al. 2000) guidelines. 
3.2.1 Study identification 
Two reviewers (RJH and SDS) sought studies published to the 5th of January 2015 
that examined CSF in delirium. Studies were identified using a comprehensive 
textword and MeSH-based electronic search of MEDLINE, EMBASE, PsycINFO, 
Web of Science (including conference proceedings), PubMed and the Evidence 
Based Medicine reviews database (including the Cochrane database of systematic 
reviews and the Cochrane central register of controlled trials). We used terms 
including Delirium or Acute Confusional State, and Cerebrospinal Fluid or Lumbar 
Puncture. For the full search strategy see Appendix 2. A Google™ search was also 
performed using the terms “CSF” and “delirium”. Additional search terms which 
encompassed the main families of biomarkers were also included in the searches in 
MEDLINE and EMBASE but these retrieved very few additional citations, none of 
which were relevant, and therefore the simpler strategy was used. Additionally we 
hand searched the bibliographies of relevant articles (Stroup, Berlin et al. 2000), 
performed a forward citation search in Web of Science for all studies examined, and 
contacted experts in the field via the European Delirium Association. 
3.2.2 Study selection 
Inclusion criteria were (i) that delirium was diagnosed using one of the following 
diagnostic criteria for delirium or acute confusional state: Diagnostic and Statistical 
Manual of Mental Disorders (DSM Third Edition; DSM Third Edition Revised; or 
DSM Fourth Edition) (APA 2000), International Classification of Diseases (1992) or 
validated measures based on these criteria such as the Confusion Assessment Method 
(Inouye, Vandyck et al. 1990), (ii) that we could extract data on biomarker findings 
in CSF in delirium and (iii) studies investigating CSF in neuropsychiatric systemic 
lupus erythematosus (SLE) were included only where delirium was thought to be 
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secondary to a cause other than neuropsychiatric SLE. Exclusion criteria were (i) 
case reports, (ii) studies involving delirium tremens or hepatic encephalopathy, or 
where neuropsychiatric SLE was the primary cause of delirium, due to the specific 
aetiologies and clinical features of those conditions.  
3.2.3 Data extraction and synthesis 
RJH and SDS independently performed the search and extracted the data, which was 
checked by AMJM. We recorded (if available) (a) study design and provenance, (b) 
number and characteristics of patients and controls and comparability of patient and 
control groups, (c) method used to diagnose delirium, (d) delirium severity, (e) 
aetiology of delirium, (f) method of obtaining CSF (i.e. lumbar puncture or spinal 
anaesthetic), (g) biomarkers studied, (h) methods used for analysis, (i) main findings 
of the studies, with numerical data as far as possible, (j) statistical significance, (k) 
statistical methods, and (l) whether biomarker findings were predictive of prognosis 
or other outcomes. 
3.2.4 Assessment of study quality 
Two authors (RJH and SDS) independently assessed all manuscripts that met the 
inclusion criteria. There is no gold standard validated method for assessing the 
quality of observational studies (Sanderson, Tatt et al. 2007), but there is consensus 
that the three most fundamental domains are 1) appropriate selection of participants 
2) appropriate measurement of variables and 3) appropriate control of confounding, 
as well as considering design specific biases. These quality criteria are discussed in 
relation to each study below. 
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3.3 Results 
A total of 4,870 citations were identified (Appendix 3), and following review of the 
title and/or abstract 81 articles were retrieved for detailed analysis. Ninety-four 
further articles were retrieved by hand-searching of reference lists; many of these 
related to neuropsychiatric SLE and were not suitable for inclusion. One Japanese 
paper (Tanaka, Mitsushio et al. 1993) and related abstract (Tanaka 1993) were 
retrieved serendipitously from the bibliography of an unrelated delirium article. One 
hundred and seventy-seven articles were retrieved for detailed evaluation: One-
hundred and fifty-eight were excluded (see Appendix 3). Eight of the remaining 19 
articles report longitudinal data on four biomarkers examined in one study population 
(Koponen, Stenback et al. 1989, Koponen, Stenback et al. 1989, Koponen, 
Reinikainen et al. 1990, Koponen and Riekkinen 1990, Koponen, Sirvio et al. 1991, 
Koponen, Leinonen et al. 1994, Koponen, Lepola et al. 1994, Koponen, Sirvio et al. 
1994). We have included the four articles that report the most complete data set for 
each biomarker (Koponen and Riekkinen 1990, Koponen, Leinonen et al. 1994, 
Koponen, Lepola et al. 1994, Koponen, Sirvio et al. 1994). Therefore 15 articles are 
discussed, reporting data from eight research groups; more recently, several of these 
studies have involved collaborations between these groups (Koponen and Riekkinen 
1990, Koponen, Leinonen et al. 1994, Koponen, Lepola et al. 1994, Koponen, Sirvio 
et al. 1994, Ramirez-Bermudez, Ruiz-Chow et al. 2008, Caplan, Kvelde et al. 2010, 
Pearson, de Vries et al. 2010, MacLullich, Edelshain et al. 2011, Witlox, Kalisvaart 
et al. 2011, Hall, Ferguson et al. 2013, Westhoff, Witlox et al. 2013, Cape, Hall et al. 
2014, Poljak, Hill et al. 2014, Watne, Hall et al. 2014, Xie, Swain et al. 2014)(Table 
3.1-3.3). 
3.3.1 Overview 
The articles included were four papers reporting data from a prospective cohort study 
conducted by Koponen et al (Koponen and Riekkinen 1990, Koponen, Leinonen et 
al. 1994, Koponen, Lepola et al. 1994, Koponen, Sirvio et al. 1994), and 11 papers 
from seven other prospective cohort studies, many of them collaborative (Ramirez-
Bermudez, Ruiz-Chow et al. 2008, Caplan, Kvelde et al. 2010, Pearson, de Vries et 
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al. 2010, MacLullich, Edelshain et al. 2011, Witlox, Kalisvaart et al. 2011, Hall, 
Ferguson et al. 2013, Westhoff, Witlox et al. 2013, Cape, Hall et al. 2014, Poljak, 
Hill et al. 2014, Watne, Hall et al. 2014, Xie, Swain et al. 2014). A total of 353 
patients with delirium and 463 controls were studied, although some are included in 
more than one study. Some studies used lumbar puncture to obtain CSF, but several 
of the more recent studies have collected CSF at the onset of spinal anaesthetic. 
Around 60 different biomarkers were studied, plus proteomics analysis has now been 
performed. Each of the articles relating to Koponen’s study reported only one 
biomarker at various time-points. Most research groups focused on different 
biomarkers, but there is now some overlap for some biomarkers, and the differing 
results in individual studies are therefore discussed. Each unique result was 
considered in the context of the quality of that research study and the supporting 
evidence provided, and studies could not compared to each other for meta-analysis.  
3.3.2 Additional information on individual studies 
A narrative review outlining each study and summarising the main findings is 
presented below. Further detailed results are in Table 3.1-3.3. 
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Table 3.1 Baseline characteristics of included studies 
Study / provenance Design / setting Biomarker(s) studied Causes of delirium Cases Controls 
Koponen et al 
(Koponen and Riekkinen 
1990, Koponen, Leinonen 
et al. 1994, Koponen, 
Lepola et al. 1994, 




Prospective cohort study, with 
external control group  
 
Psychogeriatric Hospital 
Somatostatin-like immunoreactivity (SLI), Beta 
Endorphin-like immunoreactivity, 5-
Hydroxyindole-acetic acid (5-HIAA), Acetyl-
cholinesterase (AChE) 
Stroke (n=15), Infection (n=9), 
Metabolic (n=8), Epileptic fit (n=6), 
Medication (n=6), Life change in 
dementia (n=5), Myocardial infarction 
or ischaemia (n=4), Carcinoma (n=4), 
Functional psychosis (n=2), Subdural 
haematoma (n=2), Intracerebral 
haemorrhage (n=2), Trauma (n=2), 
Cerebral tumour (n=1), Aneurysm of 
basilar artery and hydrocephalus (n=1) 
n=67 for SLI (41.8%male) 
n=69 for other biomarkers 
(42% male) 
n=56 at 2 weeks 
n=33 at 1 year 







male) for BLI 
Ramirez-Bermudez et al 
(Ramirez-Bermudez, 
Ruiz-Chow et al. 2008) 
Mexico 
2008 
Prospective cohort study 
 
General Hospital 
Homovanillic acid (HVA) Primarily acute central nervous system 
(CNS) infection 
n=31 
(54.9% male in whole 
group) 
n=20 
Pearson et al 
(Pearson, de Vries et al. 
2010) 
Scotland 
Prospective cohort study 
 
General Hospital 
Cortisol Hip fracture and consequent surgery n=7 
(25% male in whole 
group) 
n=13 
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2010 
Caplan et al 




Prospective cohort study 
 
General Hospital 
Lactate, Neuron-specific enolase (NSE), 
S100B, Glucose, Protein 
Heterogeneous, acute medical illness n=20 
(% male not stated) 
n=20 
MacLullich et al 
(MacLullich, Edelshain et 
al. 2011) 
Scotland and the 
Netherlands 
2011 
Prospective cohort study 
 
General Hospital 
TNF-α, IL-1β, IL-6, IL-8, IL-10 and IL-12p70 Hip fracture and consequent surgery n=15  
(% male not stated) 
n=21 
Witlox et al 




Prospective cohort study nested 




β-amyloid1-42, tau, hyperphosphorylated tau Hip fracture and consequent surgery n=30 
(33% male) 
n=46 
Westhoff et al 
(Westhoff, Witlox et al. 
2013) 
Prospective cohort study nested 
within a randomised controlled 
trial 
Epidermal Growth Factor (EGF), eotaxin, 
fibroblast growth factor 2 (FGF-2), FMS-like 
tyrosine kinase 3 ligand (Flt-3L), Fractalkine, 
Hip fracture and consequent surgery n=23 
(31.1% male) 
n=38 
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granulocyte colony stimulating factor (G-CSF), 
granulocyte macrophage colony stimulating 
factor (GM-CSF), growth-related oncogene 
(GRO), Interferon(IFN)-α2, IFN-γ, IL-1α, IL-
1β, IL-2, soluble IL-2 receptor-α, IL-3, IL-4, 
IL-5, IL-6, IL-7, IL-8,IL-9, IL-10, IL-12p40, 
IL-12p70, IL-13, IL-15, IL-17, Interferon 
gamma-induced protein 10 (IP-10), monocyte 
chemotactic protein (MCP)-1, MCP-3, 
macrophage-derived chemokine (MDC), 
macrophage inflammatory protein (MIP) 1α 
and 1β,  platelet-derived growth factors (PDGF) 
AA and AB/BB, regulated and normal T-cell 
expressed and secreted (RANTES), soluble 
CD40 ligand, transforming growth factor 
(TGF)-α, tumor necrosis factors (TNF) α and β, 
and vascular endothelial growth factor (VEGF) 
Hall et al 




Prospective cohort study 
 
General Hospital 
S100B Hip fracture and consequent surgery n=19 
(37% male) 
n=36 
Watne et al 
(Watne, Hall et al. 2014) 
Prospective cohort study, part of 
cohort nested within randomised 
Anticholinergic activity Hip fracture and consequent surgery n=72 
n=52 Oslo (25% male) 
n=79 
n=47 Oslo 
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Cape et al 
(Cape, Hall et al. 2014) 
Scotland and the 
Netherlands 
2014 
Prospective cohort study 
 
General Hospital 
IL-1β, IL-1ra, IGF-1, Glial Fibrillary Acidic 
Protein (GFAP), IFN-γ 
Hip fracture and consequent surgery n=19 
(26% male) 
n=24 
Xie et al 
(Xie, Swain et al. 2014) 
USA 
2014 








Hip or knee arthroplasty surgery n=31 
(% male not stated) 
n=122 
Poljak et al 
(Poljak, Hill et al. 2014) 
Australia and Scotland 
2014 
Prospective cohort study 
 
General Hospital 
Proteomics Heterogeneous, acute medical illness 
(Australia) 
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Table 3.2 Summary of results at baseline 
Study N delirious at 
LP 
Main findings in delirious patients at baseline Cases 
Mean (SD) or median 
(range) or (IQR) 
Controls 
Mean (SD) or median 
(range) or (IQR) 
P value 
Koponen et al 
(Koponen, 




↓ SLI in whole delirious group 












↓ BLI in whole delirious group 







Koponen et al 
(Koponen, Lepola 
et al. 1994) 
69/69 
 
↑ in 5-HIAA vs. controls in those with delirium and no CNS disease 
Association between 5-HIAA level and lifespan after delirium (proportional 
hazards modeling) 
168.9nmol/L (56.9) 118.1nmol/L (34.9) <0.05 
0.007 
z = 2.93 
Koponen et al 
(Koponen, Sirvio 
et al. 1994) 
69/69 
 
↑ AChE in delirious patients who died during follow-up vs. rest of cohort 
↑ AChE in those requiring prolonged institutional care 











z = 2.39 
Ramirez-
Bermudez et al 
Not stated; 
LP within 24 
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(Ramirez-
Bermudez, Ruiz-









HVA ↓ with HIV infection 




















0.066 X2 5.45 
Pearson et al 
(Pearson, de Vries 
et al. 2010) 
7/20 ↑ CSF cortisol in delirium vs controls 








Caplan et al 
(Caplan, Kvelde 
et al. 2010) 
20/20 In delirium vs. controls with Alzheimer’s dementia: 
↑ CSF lactate 
↓ CSF NSE 
↑ CSF protein 
S100B no different 



















MacLullich et al 
(MacLullich, 
Edelshain et al. 
Not stated ↑ CSF IL-8 in delirium vs. Controls 
↑ Serum IL-6 in delirium vs. controls 
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2011) 
Witlox et al 
(Witlox, 
Kalisvaart et al. 
2011) 
0/76 β-amyloid1-42 no different 
Tau no different 










Westhoff et al 
(Westhoff, Witlox 
et al. 2013) 
0/61 ↓ Flt-3L in delirium vs. controls 
G-CSF no different 
IFN-α2 no different 
IFN-γ no different 
IL-1α no different 
↓ IL-1ra in delirium vs. controls 
↓ IL-6 in delirium vs.controls  
IL-8 no different 
IL-15 no different 
IP-10 no different 
MCP-1 no different 
MCP-3 no different 
PDGF-AA no different 
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sCD40-L no different 
TGF-α no different 
EGF, eotaxin, FGF-2, Fractalkine, GM-CSF, GRO, IL-1β, IL-2, soluble IL-2 
receptor-α, IL-3, IL-4, IL-5, IL-7, IL-9, IL-10, IL-12p40, IL-12p70, IL-13, IL-17, 
MDC, MIP-1α, MIP-1β,  PDGF AB/BB, TNF-α, TNF-β, and VEGF detected in 







Hall et al 
(Hall, Ferguson et 
al. 2013) 
8/45 ↑ LogS100B in preoperative delirium 







Watne et al 
(Watne, Hall et al. 
2014) 
38/151 Anticholinergic activity no different in Oslo cohort 







Cape et al 
(Cape, Hall et al. 
2014) 
8/43 CSF IL-1β higher in incident delirium vs. prevalent delirium vs. never delirium 
 




GFAP no different in delirium 
 
Prev 0.84pg/ml (0.49-1.57)  
Inc 1.74pg/ml (1.02-1.74) 




Prev 0.81ng/ml (0.33-1.31) 
Inc 0.61ng/ml (0.46-0.76) 
Never 0.66pg/ml (0-1.02) 
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IGF-1 and IFN-γ not detected  
Xie et al 
(Xie, Swain et al. 
2014) 
0/153 β-amyloid-40/tau ratio no different 
β-amyloid-42/tau ratio no different 
↑ Delirium incidence in lowest quartile of Aβ40/tau ratio vs. other 3 quartiles 













Poljak et al 
(Poljak, Hill et al. 
2014) 
17/42 Apolipoproteins, chromogranins and secretogranins downregulated in delirium 
α-2-macroglobulin, fibrinogen, α-1-antitrypsin, α-1-antichymotrypsin, transferrin, 
complement component 3 and haptoglobin upregulated in delirium 
Upregulated α-1-glycoprotein in delirium, with ↑ levels in delirium vs. 
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Table 3.3 Summary of results at follow-up 
Studies: Koponen et al (Koponen and Riekkinen 1990, Koponen, Leinonen et al. 1994, Koponen, Lepola et al. 1994, Koponen, Sirvio et al. 1994) 
Biomarkers: Somatostatin-like immunoreactivity (SLI), Beta-endorphin-like immunoreactivity (BLI), 5-Hydroxyindoleacetic acid (5-HIAA), Acetylcholinesterase (AChE) 
Timepoint N delirious at 
lumbar puncture 
















↓ SLI in whole delirious group 
↓ SLI in delirious group with no central nervous system (CNS) disease 
SLI unchanged in group with resolved delirium 
 
↓ BLI in whole delirious group 
BLI in delirious group with no CNS disease comparable with controls 
BLI unchanged in group with resolved delirium 
 
5-HIAA unchanged in group with resolved delirium 
 


































1 year 0/33 
 
↓ SLI in whole delirious group 







Cortisol and inflammation in delirium and cognitive decline after hip fracture 
A systematic literature review of cerebrospinal fluid (CSF) biomarkers in delirium 148 
SLI correlated with level of daily functioning 
 
↓ BLI in whole delirious group 
BLI in delirious group with no CNS disease comparable with controls 
 
















r = 0.43 
4 years 0/11 
 
↓ SLI in delirious group 
SLI correlated with level of daily functioning 
 
22.9pg/ml (5.8) 37.6pg/ml (9.8) <0.001 
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Table 3.4 Results for 5-Hydroxyindoleacetic acid (5-HIAA), Koponen et al 
(Koponen, Lepola et al. 1994) 
Control group: 5-HIAA = 118.1 nmol/L (SD 34.9), n=13 
 
Table 3.5 Results for Acetylcholinesterase (AChE), Koponen et al (Koponen, Sirvio 
et al. 1994) 
Control group: AChE = 24.3nmol/ml/min (SD 6.2), N=13 
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3.3.2.1 Somatostatin, Beta-endorphin, 5-Hydroxyindoleacetic acid, 
Acetylcholinesterase; Koponen et al 
Koponen et al (Koponen and Riekkinen 1990, Koponen, Leinonen et al. 1994, 
Koponen, Lepola et al. 1994, Koponen, Sirvio et al. 1994) undertook a prospective 
cohort study aiming to characterise the neurochemical features and long-term 
cognitive and functional outcomes of an aetiologically heterogeneous group of older 
patients with delirium admitted to a psychogeriatric hospital in Finland. Participants 
were selected appropriately, since they consecutively recruited 70 older patients, (30 
(42.9%) men), with a mean age of 75 years (range 60-88 years). Diagnosis of 
delirium was based on DSM-III criteria. Patients with delirium tremens were 
excluded. Based on clinical assessment and CT brain scan, patients were categorised 
according to whether they met criteria for probable Alzheimer’s Dementia (20%, 
n=14), multi-infarct dementia (57%, n=40), Parkinson’s Disease (4%, n=3) or 
whether they had no observable CNS disease (19%, n=13). Patients underwent a 
morning fasting lumbar puncture (LP) on the next working day following their index 
admission, two weeks after admission, and at one year and four years. There was no 
information on how long patients had been delirious prior to their admission and 
subsequent index lumbar puncture. Data were only reported for some of the 
biomarkers from initial assessment through to the four year assessment. There was a 
significant rate of attrition, with 66 patients surviving to the LP at two weeks (6% 
mortality), 33 of 44 surviving patients participating in one year follow-up (37% 
mortality), and 16 of 24 surviving patients participating in four year follow-up (66% 
mortality), of whom five refused to have an LP. There was no information on the 
reasons for other loss to follow-up. The control group used was drawn from a 
Healthy Ageing study at Kuopio University. A group of 19 controls was used for the 
beta-endorphin study (Koponen and Riekkinen 1990) and 13 controls for the 
somatostatin, 5-HIAA and acetylcholinesterase studies (Koponen, Leinonen et al. 
1994, Koponen, Lepola et al. 1994, Koponen, Sirvio et al. 1994). Although age- and 
sex- matched, this set of controls was community dwelling and had no evidence of 
dementia and no psychoactive drug use, and therefore as a group differed from the 
delirium group which had a high proportion (n=53/69, 76.8%) of patients with 
probable dementia. Other issues identified in the quality assessment were that there 
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was no evidence that the researcher analysing the CSF samples was blinded to the 
results, and there was no power calculation, although statistical methods used were 
appropriate. 
Koponen et al (Koponen, Leinonen et al. 1994) measured somatostatin-like 
immunoreactivity (SLI) in CSF by radioimmunoassay. Koponen found a reduction in 
mean SLI level for the whole delirious group at index, two weeks, one year and four 
years. They also found that SLI correlated with cognitive and functional 
performance: falling SLI correlated with worsening cognition (Mini-Mental State 
Examination, MMSE) from two weeks to four years, and with the level of daily 
functioning at one and four years. In the group with vascular dementia, SLI rose 
acutely in those with an acute stroke as the probable cause of their delirium; this may 
represent a response to injury or cerebral ischaemia (Koponen, Leinonen et al. 1994). 
In those whose delirium abated within the first two weeks there was no change in the 
level of SLI. In the group with no observable CNS disease who could be seen as the 
closest to a de novo delirium episode, SLI was significantly low up to two weeks, 
rising to a level comparable with the control group at one and four years. In 
summary, loss of somatostatin signaling appears to have a role in dementia and 
transient loss may be implicated in delirium. 
Beta-endorphin like immunoreactivity (BLI) was measured by radioimmunoassay. 
The group found lower levels of mean BLI in the delirious group at index, two weeks 
and one year. BLI was lower in those with “silent” or hypoactive and mixed 
delirium, severe cognitive decline and vascular dementia but not Alzheimer’s 
dementia. However, the numbers for some of these subgroup means were quite small 
(N’s range from four to 40 at baseline and three to 12 at one year) and it is unclear 
whether these were a priori or post hoc analyses. There was also a positive 
correlation between MMSE and BLI within the whole delirious group at the acute 
stage only, and in subgroups with hyperkinetic delirium, moderate cognitive decline 
and in those receiving psychoactive drugs. There was no change in BLI in those 
whose delirium had abated at the two-week point. However, in the group with no 
CNS disease there was a transient and apparently reversible fall in BLI at index, with 
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a rise to levels comparable to controls at one year. In summary, there may be a fall in 
beta-endorphin signaling in delirium, but it is difficult to conclude that these changes 
are related to delirium rather than dementia.   
HPLC (high performance liquid chromatography) with amperometric detection was 
used to measure 5-HIAA, the main metabolite of serotonin (Koponen, Lepola et al. 
1994). Mean 5-HIAA was higher only in delirious subgroups with vascular dementia 
or no apparent CNS disease (Table 3.4). The levels stayed high at two weeks and one 
year in both groups. There was no reduction in 5-HIAA levels in those whose 
delirium abated. There was a positive correlation between 5-HIAA and MMSE in the 
whole delirious population at one year, (i.e. higher 5-HIAA associated with better 
score on MMSE). Interestingly there was also an association between the index 5-
HIAA level and lifespan after delirium (z=2.93, p=0.007), and patients needing 
prolonged institutional care had a lower 5-HIAA level acutely (p=0.01).  
High levels of 5-HIAA in the group with vascular dementia may be related to release 
from ischaemic neurons, and many cases of delirium in the group with vascular 
dementia were attributed to acute stroke (Koponen, Lepola et al. 1994). An 
alternative possibility might be small vessel disease. The findings in the group with 
no CNS disease support a possible role for excess serotoninergic activity or turnover 
in delirium, or perhaps a vascular aetiology for some episodes of delirium in patients 
with vascular dementia. There also seem to be prognostic implications of the 
association between low 5-HIAA in acute delirium and shorter lifespan after delirium 
and the need for prolonged institutional care. 
A modification of a colorimetric method was used to measure Acetylcholinesterase 
(AChE), the enzyme with a major role in metabolising acetylcholine (Koponen, 
Sirvio et al. 1994). There was no association between AChE and delirium in the 
delirious group as a whole. However, there was a fall in levels of AChE between the 
two-week and one year time-points in the delirium subgroups with Alzheimer’s 
dementia, multi-infarct dementia and hyperkinetic delirium (Table 3.5). There was 
also a small but non-significant reduction in levels of AChE in the group with no 
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CNS disease. There was no change in AChE level in those whose delirium abated. 
Higher baseline AChE levels predicted a need for prolonged institutional care, 
shorter life span and death during follow-up. In summary, lower AChE was 
associated with later dementia, but higher AChE was associated with poorer 
outcomes. The discrepancy between these results makes it difficult to conclude 
whether high or low levels of the enzyme AChE is more indicative of delirium and 
poor outcomes. 
3.3.2.2 Homovanillic acid; Ramirez-Bermudez et al 
Ramirez-Bermudez et al (Ramirez-Bermudez, Ruiz-Chow et al. 2008) conducted a 
prospective cohort study with the aim of determining if CSF HVA (homovanillic 
acid, a dopamine metabolite) levels are raised in delirium. They recruited 51 patients 
with acute neurological symptoms requiring lumbar puncture over a three year period 
at a general hospital in Mexico. No exclusion criteria were cited, nor the number 
eligible who did not take part, and there is no evidence that sampling bias was 
minimised or that a power calculation was used. The mean age of the cohort was 
36.4 years, with the range 18-85 years, and 54.9% were male. This cohort had a high 
proportion of CNS infections (43/51 patients). The other eight patients had other 
neurological diagnoses. There was also a relatively high rate of HIV infection (16/51 
patients). These aetiological factors may have confounded the results. The 
investigators used the Spanish translation of the Delirium Rating Scale (DRS) 
(Trzepacz, Baker et al. 1988, Secin, Esponda et al. 1998), and delirium was 
diagnosed based on DSM-IV criteria by a trained clinical neuropsychiatrist. 
Although the assessment included informant history, no comment was made on 
premorbid cognition. The authors stated that age was not significantly different 
between the groups. There was no other external control group. Lumbar puncture 
was performed within 24 hours of neuropsychological assessment. Only the results 
pertaining to CSF HVA levels were reported in the included paper. However, a 
conference abstract from these authors reported that they had also measured 
neurochemical metabolites of serotonin, nitric oxide and the amino acids GABA, 
glutamate, glutamine and glycine but that levels of these were not significantly 
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different in those with delirium or psychotic features (Ramirez-Bermudez, Camilo et 
al. 2008). No further published details of these additional measurements appear to be 
available. 
Ramirez-Bermudez et al (Ramirez-Bermudez, Ruiz-Chow et al. 2008) used HPLC 
(high performance liquid chromatography) with electrochemical detection to 
measure HVA. Although HVA was not significantly different between those with 
and without delirium, HVA was found to be higher with psychotic features such as 
hallucinations and delusions (Table 3.2). HVA was also significantly related to the 
total DRS score and to scores on subtests rating psychotic features, cognitive 
dysfunction and symptom fluctuation. In subgroup analyses, those without anti-
psychotic exposure (n=38) had higher HVA correlated with delusions. In those with 
acute viral encephalitis (n=23), HVA was higher in those with psychotic features. In 
those who were HIV negative (n=35), HVA was higher with psychotic features, 
hallucinations and delusions. Regardless of delirium status, HVA levels were also 
significantly higher in HIV negative patients and in those who had received anti-
psychotic medication. These results suggest excess dopamine signaling may be 
involved in psychotic features, and perhaps in delirium pathogenesis overall 
(Ramirez-Bermudez, Ruiz-Chow et al. 2008). However, this was a cohort study of 
patients requiring lumbar puncture for clinical reasons, therefore those who 
developed delirium and those who did not were not comparable at baseline, and 
causation cannot be inferred.  
3.3.2.3 Cortisol; Pearson et al 
Pearson et al (Pearson, de Vries et al. 2010) undertook a prospective cohort study in 
patients over the age of 60 undergoing spinal anaesthetic for repair of a hip fracture, 
with the aim of determining if CSF cortisol levels are elevated in delirium. The 
setting was a University hospital in Scotland. They recruited 27 patients 
preoperatively, however because of a change to general anaesthetic and blood 
contamination of CSF, 20 patients were included in the analyses. No power 
calculation was stated and they did not attempt to minimise sampling bias. The 
cohort was mainly female (75%) and had a mean age of 80.6 years (range 62-93 
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years). The age of patients with delirium was not significantly different from controls 
(81.4 years SD 7.2 vs. 80.5 years SD 8.7, p=0.88). There was no other comment on 
the comparability of cases and controls although further information on co-morbid 
disease was provided in table format. No external control group was used. Patients 
were assessed for delirium preoperatively with a validated assessment battery which 
informed completion of the Confusion Assessment Method (Inouye, Vandyck et al. 
1990) which is based on DSM-IIIR criteria. There was no assessment made of prior 
cognition. CSF specimens were taken at the onset of spinal anaesthetic, before 
administration of the anaesthetic agent. Cortisol levels were measured by Enzyme-
Linked Immunosorbent Assay (ELISA) and in a paired plasma sample by Cortisol-
125I Radioimmunoassay. The researcher was not blinded to the participants’ 
diagnoses. The investigators found CSF cortisol levels to be higher in those with 
delirium than those without (median (interquartile range) 63.9 (40.4-102.1) nmol/L 
in delirium vs. 31.4 (21.7-43.3) nmol/L in controls), p=0.029). Plasma cortisol was 
also significantly higher in cases than controls (Pearson, de Vries et al. 2010). This 
suggests an association between elevated CSF cortisol and delirium (McIntosh, Bush 
et al. 1985, Kudoh, Takese et al. 2005), although causation could not be inferred in 
this cross-sectional, observational study. As the authors comment (Pearson, de Vries 
et al. 2010), dementia, severity of co-morbid disease and physiological stress are 
potential confounding factors which should be assessed in future studies. 
3.3.2.4 Markers of neuronal cell death; Caplan et al, Hall et al 
Caplan et al (Caplan, Kvelde et al. 2010) undertook a prospective cohort study in a 
Geriatric Medicine Unit in a General Hospital in Australia. Their patient group had 
persistent delirium of longer than five days duration, where further investigation 
including lumbar puncture was deemed to be clinically appropriate and was agreed 
by the patient and/or their proxy. Twenty patients with heterogeneous delirium were 
recruited. Although no power calculation is cited, they attempted to minimise 
sampling bias. The aim was to compare CSF, blood and clinical markers of delirium 
and neuronal cell death between patients with delirium and an external control group 
of outpatients with known Alzheimer’s Dementia but no delirium (n=20). There was 
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no inpatient control group. The two groups were relatively well-matched: age was 
not significantly different (mean 81.6 (SD 7.7) in the delirium group and 81.1 (SD 
6.1) in the dementia group), and Instrumental Activities of Daily Living (IADL), 
Charlson Index (a measure of co-morbidity), Informant Questionnaire on Cognitive 
Decline in the Elderly (IQCODE) and Geriatric Depression Score were not 
significantly different. However, the fact that the average IQCODE in the delirium 
group was the same as in the dementia group (3.7 in both groups) suggests a high 
prevalence of dementia in the delirium group. Delirium was diagnosed using the 
Confusion Assessment Method and Delirium Index. The Acute Physiology, Age, 
Chronic Health Evaluation (APACHE III) score, used for risk prediction in the 
severely ill, was significantly higher in the delirium group. Lumbar puncture was 
performed during the delirium episode or on an outpatient basis for the dementia 
group. CSF lactate, protein and glucose were measured at the local area laboratory 
and S100B and neuron-specific enolase were measured by ELISA, but no comment 
is made on whether there was blinding to participants’ diagnoses. 
The investigators found higher CSF lactate in the inpatient group with delirium 
compared to the outpatient group with Alzheimer’s dementia (1.87mmol/L vs. 
1.48mmol/L, p<0.001), lower neuron-specific enolase (NSE) (4.84ng/ml vs. 
8.98ng/ml, p<0.001), higher protein, and no difference in S100B and glucose 
(Caplan, Kvelde et al. 2010). In all participants, CSF lactate correlated positively 
with APACHE III score, CAM and Delirium Index. NSE correlated negatively with 
CAM and Delirium Index. CSF lactate correlated with a greater deterioration in 
scores of daily function (IADL, and trend to correlation with Barthel index). Those 
within the delirium group who died in hospital had higher CSF lactate than those 
discharged home, and those who required institutional care had an intermediate level. 
The finding that CSF lactate was higher in persistent delirium, and was also 
associated with poorer outcomes, suggested that delirium may be associated with 
neuronal injury, or failure of normal aerobic energy metabolism such as ischaemia. 
However, here the group with delirium was acutely unwell, compared to the group 
with dementia who were stable outpatients, therefore differences may be due to acute 
illness rather than delirium. A third group with acute illness but without delirium 
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would have strengthened the study, as the group comment. The finding of high 
protein is relatively non-specific, and may indicate inflammation, trauma, infection 
or blood contamination (Seehusen, Reeves et al. 2003). The somewhat surprising 
finding of lower NSE in delirium in the context of high lactate was explained by the 
investigators as possibly due to lactate suppressing NSE. This could occur via 
glutamate stimulation suppressing glycolysis in neurons, which instead gain energy 
from astrocytic lactate, as per the shuttle hypothesis (Caplan, Kvelde et al. 2010), but 
these findings require replication in other studies. 
Hall et al conducted a prospective cohort study in patients with acute hip fracture 
who underwent surgery under spinal anaesthetic (Hall, Ferguson et al. 2013). The 
study is included in this thesis in chapter 6. The hypothesis under study was that CSF 
S100B would be elevated in patients with delirium. Forty-five patients had sufficient 
CSF sample to be included, with 66/108 patients having had CSF collected. No 
power calculation is cited and there was no comment on minimising sampling bias. 
There was no external control group. Age was not different between groups. The 
delirium group was more likely to be cognitively and functionally impaired. Six 
patients had dementia according to IQCODE, and all developed delirium. Patients 
were assessed for delirium preoperatively, daily postoperatively to day 4, and on 
postoperative days 7 and 10-14, and delirium was diagnosed with positive CAM or 
DRS-R98 >17.75. S100B was measured using an in-house ELISA at the National 
CJD Surveillance Unit in Edinburgh. S100B concentrations were log-transformed, 
and the authors found that levels were higher in those with acute delirium (n=8), 
although there was no difference between those with and without delirium at any 
stage during the perioperative period (n=19). These results suggest that active 
delirium may be associated with astroglial activation and CNS damage. 
3.3.2.5 Cytokines; MacLullich et al, Westhoff et al, Cape et al 
MacLullich et al undertook a prospective cohort study in patients over the age of 60 
undergoing hip fracture repair under spinal anaesthesia, with the aim of investigating 
whether CNS pro-inflammatory cytokines are elevated in delirium (MacLullich, 
Edelshain et al. 2011). This was on a background of prior studies reporting elevated 
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serum pro-inflammatory cytokines such as IL-6 and IL-8. Thirty-six patients were 
recruited in University-affiliated medical centres in Edinburgh and Amsterdam. No 
power calculation is cited, and there was no comment on whether they attempted to 
minimise sampling bias. The mean age was 81.8 years in the group with delirium and 
82.5 years in the group without, which was not significantly different. Charlson co-
morbidity indices were not significantly different between the groups, but a 
documented history of dementia (n=7) was associated with a higher incidence of 
delirium. There was no external control group. Patients were assessed for delirium 
preoperatively and 3-4 days postoperatively using the CAM. There was no 
assessment of inter-rater reliability between the two centres. CSF specimens were 
taken at the onset of spinal anaesthesia prior to the administration of anaesthetic 
agent. Cytokine analysis of CSF samples, and paired serum samples from the 
Edinburgh patients (n=16), was performed using a Cytometric Bead Array 
immunoassay in the Edinburgh laboratory, although the researcher was not blinded 
to the participants’ diagnoses. This measured TNF-α, IL-1β, IL-6, IL-8, IL-10 and 
IL-12p70. The investigators found IL-8 to be detected in 33/36 CSF samples, and IL-
6 in 3/36 samples. The other cytokines were not detected. CSF IL-8 was significantly 
higher in cases than controls (median 69.8pg/ml vs. 39.6pg/ml, p=0.003). Cases also 
had higher serum IL-6 levels (median 42.4pg/ml vs. 24.3pg/ml, p=0.013). Dementia 
was not associated with raised IL-8, and when the investigators excluded patients 
with known dementia from the analysis, the pattern of results did not change. These 
results suggest an association between delirium and elevated CNS IL-8, although 
causation cannot be implied in this cross-sectional, observational study. 
Westhoff et al performed an exploratory study in patients with acute hip fracture, 
with the hypothesis that those with a dysfunctional immune response would be more 
vulnerable to postoperative delirium (Westhoff, Witlox et al. 2013). The 
investigators monitored for delirium using the CAM, with severity scoring using the 
DRS-R98 until day 5 postoperatively, or longer if delirium was still present at that 
time. There was no power calculation is cited, and there was no comment on whether 
they attempted to minimise sampling bias. Of N=122 patients enrolled, N=61 
patients were included in the analysis due to a change to general anaesthesia, the 
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exclusion of those with preoperative delirium and logistical reasons. There was no 
external control group. They collected blood preoperatively to measure CRP, IL-6 
and ESR (erythrocyte sedimentation rate). CSF and a paired serum sample was 
collected at the onset of spinal anaesthetic, and a panel of 42 cytokines and 
chemokines measured using a Luminex assay (see Table 3.1 for full list). Some of 
the cytokines and chemokines were not detectable in the majority of samples, and 
they compared levels of the 16 markers where there was sufficient (>50% of 
samples) detected between those who did and did not develop delirium 
postoperatively using Mann Whitney U test. There was no difference in the majority 
of the detected inflammatory markers, however the authors found that those who 
developed postoperative delirium had lower levels of CSF IL-6, IL-1ra and Flt-3L 
(FMS-like tyrosine kinase 3 ligand) preoperatively. Of note they detected but found 
no difference in levels of IL-8. However, the delirium group had higher levels of 
serum IL-6 preoperatively. They found no difference in CRP and ESR levels 
(Westhoff, Witlox et al. 2013). There is no comment on whether there was any 
correlation between serum and CSF levels of IL-6, but there is also no information 
on how IL-6 was measured in serum, since if this was by a different assay technique 
they would be harder to compare. 
Cape et al (Cape, Hall et al. 2014) conducted a collaborative prospective cohort 
study in patients with acute hip fracture, and measured several inflammatory markers 
and a marker of astroglial activation (Glial Fibrillary Acidic Protein, GFAP). The 
hypotheses were that interleukin(IL)-1β, insulin-like growth factor-1 (IGF-1), 
interferon (IFN)-γ and GFAP would be elevated and IL-1 receptor antagonist (IL-
1ra) would be reduced in delirium. Participants were drawn from two Edinburgh 
studies, including the study described in this thesis (although this pilot study is not 
included as a results chapter), and a study in Amsterdam. They were recruited 
opportunistically, and no power calculation is cited nor attempt to minimise sampling 
bias. Forty-three patients with hip fracture were included, and CSF was collected 
during spinal anaesthetic. Serum was also collected in Edinburgh, paired with the 
serum sample. There was no external control group. Patients were assessed for 
delirium according to the CAM preoperatively and at least once 3-4 days 
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postoperatively. CSF analysis was performed in Edinburgh, and there was no 
blinding to diagnosis. All the biomarkers were measured using individual 
commercially-available ELISAs. IFN-γ and IGF-1 were not detected in CSF. IL-1β 
was detected in CSF and serum at low concentrations, IL-1ra was detected in CSF 
and serum and GFAP was detected in CSF only. The investigators compared 
delirium present preoperatively (prevalent) to postoperative (incident) to never 
delirium. They found that IL-1β was elevated in those with incident delirium, and IL-
1ra was elevated in prevalent delirium. GFAP was not significantly different between 
groups. In serum, no differences were seen in levels of IL-1β, IL-1ra or IGF-1 
between those with or without delirium at any stage, and IFN-γ and GFAP were not 
detected in serum. The CSF:serum ratio of IL-1β was higher in the delirium group. 
The authors performed a logistic regression analysis to adjust for the presence of 
prior dementia, and the relationship between CSF IL-1β and delirium remained 
significant. This study suggests that there is a role for the IL-1 family in delirium, 
although since it is observational, no causal link can be identified. The higher 
CSF:serum ratio of IL-1β, with no correlation between the two, suggests that the 
source of IL-1β may be within the CNS.  
3.3.2.6 Dementia neuropathology markers; Witlox et al, Xie et al 
Witlox et al conducted a prospective cohort study in patients with acute hip fracture, 
to examine levels of β-amyloid1-42, tau and phosphorylated tau in CSF in delirium. 
These markers are pathological indicators of cognitive impairment, and the 
hypothesis was that β-amyloid1-42 would be low and tau and phosphorylated tau 
would be elevated in patients who developed delirium, due to the high risk of 
delirium in those with cognitive impairment (Witlox, Kalisvaart et al. 2011). They 
recruited N=122 patients with acute hip fracture to a trial of taurine vs. placebo in 
reducing 1-year morbidity and mortality of patients with hip fracture. They were able 
to collect CSF samples from N=76 patients, N=30 of whom developed delirium 
postoperatively. None had full syndromal delirium preoperatively. No power 
calculation is cited, and there was no comment on whether they attempted to 
minimise sampling bias. There was no external control group. The delirium group 
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was older (mean age 84.7 years vs. 82.4 years in no delirium group, p=0.04). The 
delirium group were more likely to be cognitively and functionally impaired 
according to the IQCODE, Barthel index and Lawton IADL score, and they were 
prescribed more regular medication. The investigators found no significant 
difference in levels of any of the dementia markers between those who did or did not 
develop delirium postoperatively, although the levels of all three markers were 
different between groups in the directions hypothesised. They also examined the 
ratios between β-amyloid1-42 to tau and to phosphorylated tau, and there was no 
difference in either ratio between groups. Therefore, although those with evidence of 
prior cognitive impairment in this group of older patients with acute hip fracture 
were more likely to develop delirium, it was not associated with these well-
established markers of dementia neuropathology. 
Xie et al (Xie, Swain et al. 2014) performed a prospective cohort study in older 
patients undergoing elective orthopaedic surgery, to investigate whether there is an 
association between the ratio of β-amyloid-40 or β-amyloid-42 to tau protein in CSF 
at baseline and both the incidence and severity of postoperative delirium (Xie, Swain 
et al. 2014). Given that tau is usually elevated in dementia and β-amyloid-42 proteins 
are usually lowered, they hypothesised that a lower β-amyloid-42/tau ratio 
preoperatively would be associated with greater delirium severity, as would a lower 
β-amyloid-40/tau ratio, and that both ratios would be associated with greater delirium 
incidence. They performed a power calculation and had estimated that a sample size 
of N=150 should be sufficient for their primary hypothesis. They enrolled N=244 
participants into the study and were able to analyse samples from N=153. CSF was 
collected at the onset of spinal anaesthesia, and participants had standardised 
perioperative care. They were assessed for delirium on the first and second 
postoperative days, using the CAM and MDAS; delirium developing later in the 
postoperative course may therefore have been missed. Although the investigators 
excluded patients with known dementia or other neurological or psychiatric disease, 
they did not include an informant interview such as IQCODE, or baseline cognitive 
testing to assess for undiagnosed dementia; the authors qualify this by describing the 
study as a proof of concept study. Thirty-one participants (20%) were diagnosed as 
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delirious postoperatively using the CAM. There was no significant difference in CSF 
β-amyloid-42/tau ratio or β-amyloid-40/tau ratio between groups with and without 
delirium. When they examined quartiles of the β-amyloid/tau ratios, they found a 
higher incidence of delirium in those in the lowest quartile for both ratios. They also 
found that the median MDAS score in the group within the lowest quartile β-
amyloid-40/tau ratio was higher than the median score in the other three quartiles, 
and there was a trend towards elevation of the median MDAS score in the group 
within the lowest quartile of β-amyloid-42/tau ratio. Using linear regression, they 
also found an inverse association between MDAS score and both β-amyloid/tau 
ratios, which remained significant after adjusting for age and gender. This study 
suggests that lower β-amyloid/tau ratio is associated with increased risk of 
developing delirium postoperatively; it seems likely that this would be related to the 
presence of incipient or active dementia, and future studies should take this into 
account. 
3.3.2.7 Anticholinergic activity; Watne et al 
Watne et al (Watne, Hall et al. 2014) performed a prospective cohort study in 
patients with acute hip fracture. Patients were recruited at two general hospitals in 
Oslo and Edinburgh. The Edinburgh patients (n=52) are from the study this thesis is 
based on, but the results are not included in this thesis. The patients in the Oslo study 
(n=99) were part of a randomised controlled trial of orthogeriatric vs. standard 
orthopaedic care. The hypothesis for this study was that higher anticholinergic 
activity in both CSF and serum would be associated with an increased risk of 
perioperative delirium. There was no power calculation cited and no comment on 
minimising sampling bias. There was no external control group. Patients had CSF 
and a paired serum sample collected at spinal anaesthetic. Anticholinergic activity 
was measured in CSF and serum with a muscarinic radio receptor bioassay by an 
operator who was blinded to all clinical data. Patients were assessed for delirium 
preoperatively and postoperatively daily for five days or until delirium resolution 
(Oslo) or preoperatively and on postoperative days 1-4, 7 and once between days 10-
14 (Edinburgh). The CAM was used at both sites, but delirium severity was assessed 
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using the Memorial Delirium Assessment Scale (MDAS) in Oslo and the DRS-R98 
in Edinburgh. In order to standardise delirium severity measurements at both sites, 
MDAS scores were retrospectively calculated for the Edinburgh patients. Delirium 
was diagnosed in 52/99 patients in Oslo and 20/32 patients in Edinburgh. The 
patients from the Oslo study had higher rates of prior dementia and functional 
impairment. The results from the two centres were analysed separately, and in both 
centres, CSF and serum anticholinergic activity were not significantly different in 
delirium. Levels of serum anticholinergic activity were much higher in the Oslo 
patients than in the Edinburgh patients. In patients without prefracture cognitive 
impairment, there was a trend towards a correlation between delirium severity and 
CSF anticholinergic activity in both centres, which was significant in the pooled 
dataset. The results of this study do not support the hypothesis that anticholinergic 
activity in the CNS is involved in delirium pathophysiology, but in those without 
prior cognitive impairment, higher levels of anticholinergic activity may lead to more 
severe delirium.  
3.3.2.8 Proteomics; Poljak et al 
Poljak et al performed the first CSF proteomics study in delirium. Patients were 
recruited in two centres, Sydney and Edinburgh (Poljak, Hill et al. 2014). The 
patients in the Sydney study were elderly patients who had prolonged delirium 
secondary to various causes, which lasted for at least five days, and they had a 
lumbar puncture performed for further investigation and CSF was also collected for 
research purposes. This is the same cohort as Caplan et al (Caplan, Kvelde et al. 
2010). The patients in the Edinburgh study had acute hip fracture, and CSF was 
collected at spinal anaesthetic. These patients are from the study described in this 
thesis, but the results presented in the Poljak paper are not discussed further as part 
of the thesis. Four groups were compared; patients with active delirium from the 
Sydney study, patients with active preoperative delirium from the Edinburgh study, 
patients with acute hip fracture from the Edinburgh study who did not develop 
delirium, and outpatients with Alzheimer’s dementia. CSF was analysed using 
iTRAQ reagents, two-dimensional liquid chromatography-tandem mass 
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spectrometry. An ELISA of α-1-acid glycoprotein-1 was also performed to confirm 
one of the positive results. Two-hundred and seventy-three proteins were identified, 
of which sixteen were dysregulated in eight or more delirium subjects, across both 
cohorts. Apolipoproteins, chromogranins and secretogranins were downregulated in 
the majority of delirium subjects. Several proteins involved in the inflammatory 
response were also upregulated in the majority of those with delirium. These 
included α-1 acid glycoprotein, α-2-macroglobulin, fibrinogen, α-1-antitrypsin, α-1-
antichymotrypsin, transferrin, complement component 3 and haptoglobin. Only one 
isoform of α-1 acid glycoprotein was upregulated, and it was not upregulated in 
either of the control groups, so it has the potential to be a specific biomarker for 
delirium. This was confirmed by ELISA measurement of α-1 acid glycoprotein, with 
higher levels found in delirium (N=12, 277.85μg/ml) compared to Alzheimer’s 
dementia (N= 18, 207.44μg/nl), p=0.026. 
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3.4 Discussion 
This chapter updates the first systematic literature review of studies examining CSF 
biomarkers in delirium, which was originally published in 2011 (Hall, Shenkin et al. 
2011). The quality of all studies is reported in a narrative fashion as there is no 
accepted gold standard tool for assessing quality and susceptibility to bias in 
observational studies (Sanderson, Tatt et al. 2007), and there are potential concerns 
that scoring systems may be spuriously precise (von Elm 2007). All studies were 
prospective studies, designed to investigate CSF biomarkers in delirium, which used 
appropriate statistical methods. Only one study reported a power calculation (Xie, 
Swain et al. 2014), and two studies blinded the researcher analysing the CSF samples 
to the clinical status of the patient (Ramirez-Bermudez, Ruiz-Chow et al. 2008, 
Watne, Hall et al. 2014). Several of the studies’ results could have been influenced 
by bias or confounding, and these are reported with their results above. Sample sizes 
were generally small, although more recent collaborative studies collecting CSF at 
the onset of spinal anaesthetic have been larger. A diverse range of populations was 
studied even within the nine main study cohorts. Within Koponen et al (Koponen 
and Riekkinen 1990, Koponen, Leinonen et al. 1994, Koponen, Lepola et al. 1994, 
Koponen, Sirvio et al. 1994) and Caplan et al’s (Caplan, Kvelde et al. 2010) 
heterogeneous elderly delirious populations and the elderly cohorts with hip fracture 
and attendant co-morbidities studied by the Scottish, Dutch and Norwegian research 
groups (Pearson, de Vries et al. 2010, MacLullich, Edelshain et al. 2011, Witlox, 
Kalisvaart et al. 2011, Hall, Ferguson et al. 2013, Westhoff, Witlox et al. 2013, Cape, 
Hall et al. 2014, Watne, Hall et al. 2014), there is likely to be a high proportion of 
unrecognised dementia. The patients studied by Ramirez-Bermudez et al (Ramirez-
Bermudez, Ruiz-Chow et al. 2008) are a more homogeneous, younger cohort (but 
which is less representative of the majority of inpatients with delirium). Where there 
is potential concomitant dementia, it is very difficult to determine whether observed 
changes are related to acute delirium or confounded by underlying dementia 
pathology (Inouye and Ferrucci 2006). A further potential confounding factor in 
these heterogeneous groups of patients is the underlying aetiologies of delirium. 
These are common problems in studies of delirium pathophysiology. It is important 
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that control groups are age-matched, to control for physiological changes with age; 
age-specific reference ranges for most biomarkers in CSF have not been determined, 
and many of these systems including the hypothalamic-pituitary-adrenal axis and 
immune system change with age (Murakami, Nakagawa et al. 1999, Otte, Hart et al. 
2005, Ginaldi, Mengoli et al. 2008). Also, unless a biomarker is known only to 
originate from the CNS, co-measurement  of the biomarker in a paired serum sample 
helps to establish whether it has been produced predominantly in the CNS or whether 
high peripheral levels may have led, in some cases, to increased passage into the 
CNS, for example in the event of blood-brain-barrier compromise in sepsis (Davies 
2002, Ballabh, Braun et al. 2004). Serum values were reported by Pearson et al 
(Pearson, de Vries et al. 2010), Caplan et al (Caplan, Kvelde et al. 2010), MacLullich 
et al (MacLullich, Edelshain et al. 2011), Watne et al (Watne, Hall et al. 2014), Cape 
et al (Cape, Hall et al. 2014) and Westhoff et al (Westhoff, Witlox et al. 2013). 
Interestingly, the direction of change in markers measured in both CSF and serum 
was sometimes at odds. Serum and CSF values are sometimes difficult to compare, 
and the difference in protein composition of the two fluids can lead to technical 
difficulties with certain assays. 
The paucity of studies and their heterogeneous nature make it difficult to draw firm 
conclusions relating to CSF neurochemical disturbances in delirium which might 
shed light on pathophysiological processes. These studies suggest, however, the 
following possibilities in delirium: (1) a transient and reversible fall in both 
somatostatin and beta endorphin signaling, (2) increased serotoninergic signaling, (3) 
increased dopamine signaling involved in psychotic features, (4) high 
acetylcholinesterase as a predictor of poor outcome, (5) increased cortisol levels, (6) 
increased lactate and protein, (8) low neuron-specific enolase, (9) changes in 
inflammatory cytokines and chemokines are unclear; increased IL-1β in one study 
and no different in another, increased IL-8 release in one study and no different in 
another, reduced IL-6 levels, increased IL-1ra in one study and reduced in another, 
(10) increased S100B in one study and no different in another, (11) reduced Flt-3L 
levels, (12) increased α-1-glycoprotein levels, (13) down-regulated apolipoproteins, 
chromogranins and secretogranins, upregulated proteins involved in inflammation 
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including  α-2-macroglobulin, fibrinogen, α-1-antitrypsin, α-1-antichymotrypsin, 
transferrin, complement component 3 and haptoglobin; (14) β-amyloid, tau and 
hyperphosphorylated tau, β-amyloid-40/tau ratio, β-amyloid-42/tau ratio, 
anticholinergic activity, GFAP, TNF-α, TGF-α, IL-10, IL-12p70 G-CSF, IFN-α2, 
IFN-γ, IL-1α, IL-15, IP-10, MCP-1, MCP-3, PDGF-AA, RANTES and sCD40-L 
currently show no associations. 
I now briefly discuss the relevance of these findings to the main hypotheses for 
delirium pathogenesis discussed earlier. For a putative model of causal pathways in 
delirium suggested by the results of this review, please see Figure 3.2.  
i) Direct brain insults 
None of the studies directly tested this theory since the aetiology of delirium is 
usually heterogeneous. Since many direct brain insults lead to a disruption of brain 
energy supply and metabolism, the finding of Caplan et al (Caplan, Kvelde et al. 
2010) of raised CSF lactate suggests that a disruption of the brain’s normal aerobic 
metabolism, either through low-grade ischaemia or a combination of factors, may be 
involved in delirium. Whether this is a cause or effect of delirium, or indeed a 
measure of how unwell the delirious patients are compared to controls, is unclear. 
Lactate is produced during ischaemia, when the lack of oxygen necessitates the 
switching of glycolytic metabolism from aerobic to anaerobic (Karkela, Pasanen et 
al. 1992, Petzold 2007), and high levels have also been found in CSF in dementia 
(Parnetti, Reboldi et al. 2000) and after out of hospital cardiac arrest (Karkela, 
Pasanen et al. 1992). Somewhat surprisingly, one study found low neuron-specific 
enolase in the CSF of patients with delirium. Neuron-specific enolase is a glycolytic 
enzyme released following neuronal cell damage. The investigators suspected that 
the low levels could have resulted from lactate suppressing neuron-specific enolase, 
possibly via glutamate stimulation suppressing glycolysis in neurons, which instead 
gain energy from astrocytic lactate, as described in the astrocyte-neurone-lactate 
shuttle hypothesis (Fillenz 2005). The marker of CNS injury and astrogliosis S100B 
was found to be elevated in those with active delirium after hip fracture (Hall, 
Ferguson et al. 2013), but in a different study it was not found to be different in 
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medical patients with active delirium compared to patients with dementia who were 
not acutely unwell (Caplan, Kvelde et al. 2010).  
ii) Neurotransmitter imbalance 
Several of the studies lend support to this hypothesis. Serotonin, a monoamine 
neurotransmitter, has roles in mood, cognition and wakefulness, and excess or 
deficiency have been hypothesised to be involved in delirium (Flacker and Lipsitz 
1999). The results of Koponen et al support an excess (Koponen, Lepola et al. 1994) 
of serotonin, as does serotoninergic syndrome, similar clinically to delirium, where 
high levels of cerebral serotonin are caused by certain drugs (White 2002). Findings 
of an imbalance in levels of precursor amino acids for serotonin and other 
neurotransmitters also suggest a downstream role for serotonin (van der Mast, 
Fekkes et al. 1991, Pandharipande, Morandi et al. 2009).  
The association of high dopamine metabolites with psychotic features (Ramirez-
Bermudez, Ruiz-Chow et al. 2008) supports a role in these symptoms of delirium, if 
not the whole syndrome. Dopamine has a role in motor activity, attention, memory, 
thought and perception (Trzepacz 2000), all domains which may be affected in 
delirium. The usefulness of D2 receptor inhibitors such as haloperidol in the 
treatment of psychotic symptoms of delirium (Flacker and Lipsitz 1999) lends further 
support.  
Disrupted cholinergic signaling with low acetylcholine has long been held to be one 
of the pathophysiologic mechanisms in delirium (Flacker and Lipsitz 1999), and it 
has a well established role in Alzheimer’s dementia (Talesa 2001, Birks 2006). The 
association of higher acetylcholinesterase with poorer outcomes after delirium may 
be related to a more severe initial delirium with greater acetylcholine release from 
degenerating neurons, or perhaps a tendency to higher levels of the enzyme initially 
leading to more severe delirium and poorer outcomes later on. Interestingly, low 
plasma acetylcholinesterase levels have been found in delirium in older medical in-
patients (White, Calver et al. 2005). Watne et al did not find any association with 
anticholinergic activity in CSF, suggesting that acetylcholine deficiency is not a 
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major mechanism in delirium pathophysiology, at least in the heterogeneous delirium 
seen in elderly patients after hip fracture (Watne, Hall et al. 2014). 
The results for the neuropeptide hormones somatostatin and beta-endorphin 
measured by Koponen et al (Koponen and Riekkinen 1990, Koponen, Leinonen et al. 
1994) lend some support to a disruption in neurotransmission, but also possibly to a 
dysregulation in hypothalamic-pituitary signaling. Somatostatin is a hypothalamic 
peptide hormone with roles in the CNS in locomotion, sedation and excitation, sleep, 
learning and memory (Vecsai and Widerlov 1990, Koponen, Leinonen et al. 1994). 
A transient fall in levels may therefore be associated with acute changes in these 
domains, which may account for some features of delirium. Somatostatin forms part 
of the Growth Hormone Releasing Hormone - Growth Hormone (GH) – Insulin-like 
Growth Factor 1 (IGF-1) axis, whereby somatostatin inhibits GH release from the 
pituitary. GH induces IGF-1 production and the pair work in synergy in target tissues 
(Murray, Kim et al. 2004). IGF-1 has neurotrophic and anti-inflammatory properties 
and has been found to reduce tau-phosphorylation and protect neurons from β-
amyloid (Broadhurst and Wilson 2001), and low serum IGF-1 is associated with 
incident and prevalent delirium (Wilson, Broadhurst et al. 2005, Adamis, Lunn et al. 
2009). 
Beta-endorphin is an endogenous opioid peptide (O'Donahue and Dorsa 1982, 
Wollemann and Benyhe 2004) released with ACTH from the anterior pituitary in 
response to stress (O'Donahue and Dorsa 1982, Zager and Black 1985). In addition 
to its analgesic effect, it has a role in learning and memory (Zager and Black 1985), 
and possibly in sensory processing and selective attention. The locus coeruleus and 
limbic areas (important for these processes) have dense beta-endorphinergic 
innervation (Koponen, Stenback et al. 1989). A transient fall may therefore disrupt 
vulnerable attentional processes and learning and memory. Interestingly, a study by 
McIntosh et al found a prolonged rise in plasma levels of beta-endorphin and cortisol 
in a small cohort of patients with postoperative delirium (McIntosh, Bush et al. 
1985). Decreased beta-endorphin levels have been found in CSF in Parkinson’s 
disease and Alzheimer’s and multi-infarct dementia (Sulkava, Erkinjuntti et al. 1985, 
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Jolkkonen, Soininen et al. 1987), but normal levels have also been found in 
Alzheimer’s dementia (Raskind, Peskind et al. 1986).  
iii) Dysregulation of the Hypothalamic-Pituitary-Adrenocortical axis 
The findings of Pearson et al (Pearson, de Vries et al. 2010) support the hypothesis 
that delirium is associated with elevated cortisol levels. Cortisol, the effector 
hormone of the hypothalamic-pituitary-adrenal (HPA) axis, forms part of the primary 
response of the body to stressful or traumatic insults (Olsson 1999). Ageing and 
dementia are associated with an increased magnitude and duration of cortisol 
response to stress (MacLullich, Ferguson et al. 2008). Prolonged hypercortisolaemia, 
seen in Cushing’s disease, ageing and Alzheimer’s dementia is associated with 
atrophy of the hippocampus (Olsson 1999). The hippocampus is involved in long-
term potentiation, which is involved in the formation of synaptic memory, and an 
intact hippocampus is important in negative feedback in the HPA axis (Olsson 1999, 
MacLullich, Ferguson et al. 2008). Prolonged hypercortisolaemia exacerbates the 
effects on neurons of hypoxia, ischaemia and hypoglycaemia and can increase 
vulnerability to cell damage, with synaptic loss and dendritic atrophy . (Trzepacz 
2000, Tata and Anderson 2010). Higher plasma cortisol levels have been found in 
perioperative delirium (Kudoh, Takese et al. 2005). Intriguingly, recent studies have 
found that in some circumstances, elevated glucocorticoids can have pro-
inflammatory effects in the CNS (Munhoz, Sorrells et al. 2010).  
iv) Hyper-responsiveness of brain immune cells to stimulation from peripheral 
inflammation 
Investigation of markers of inflammation in the central nervous system in delirium 
has produced conflicting results. The findings of MacLullich et al (MacLullich, 
Edelshain et al. 2011) support the idea that peripheral inflammatory insults may lead 
to an exaggerated central inflammatory response with increased sickness behaviour 
(Perry, Cunningham et al. 2007, MacLullich, Ferguson et al. 2008). Hip fracture is 
one such peripheral inflammatory insult, and the CSF levels of IL-8 found in the 
study were greater that those found peripherally, suggesting possible magnified CNS 
production. IL-8 is a generally pro-inflammatory chemokine, with a role in 
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neutrophil chemotaxis. It is produced systemically and in the CNS. In vitro, IL-8 
suppresses cultured septal cholinergic neurotransmission (Puma, Danik et al. 2001), 
and cerebral microinfusion of IL-8 into rats leads to anorexia and pyrexia 
(Platasalaman and Borkoski 1993). IL-8 may also have protective effects, including a 
neuroprotective function, possibly by an antioxidant response pathway or by 
blocking apoptosis (Hanson, Bostick et al. 2006, Hussein, Daoud et al. 2010). 
Westhoff et al did not find any difference in levels of CSF IL-8 however, and also 
found CSF IL-6, which is a key player in the acute phase inflammatory response, to 
be lower (Westhoff, Witlox et al. 2013). The majority of the cytokines and 
chemokines they detected in their study were not different between those who did or 
did not develop delirium. Westhoff et al also found lower CSF IL-1ra levels in those 
about to develop delirium, whereas Cape et al found higher CSF IL-1ra levels in 
those with active delirium. IL-1ra is the endogenous antagonist of the key pro-
inflammatory cytokine IL-1β, and is usually released after IL-1β to limit the 
inflammatory response (Allan, Tyrrell et al. 2005). It it thought to be 
neuroprotective, with higher levels being correlated with better outcomes after brain 
injury (Bartfai, Sanchez-Alavez et al. 2007). The differing results found may indicate 
that a lower baseline level increases the risk of going on to develop delirium whereas 
during active delirium the higher levels may indicate either an endogenous response 
to an initial spike of IL-1β or a neuroprotective response to the insult of delirium or 
the inflammatory and traumatic response. IL-1β has proved difficult to measure, and 
was not detected sufficiently in two studies (MacLullich, Edelshain et al. 2011, 
Westhoff, Witlox et al. 2013), and at low levels in a third (Cape, Hall et al. 2014). 
The higher levels of CSF IL-1β found in those about to develop delirium suggest that 
it might an early player in the central inflammatory response in delirium, and the 
higher ratio of CSF:serum IL-1β in delirium demonstrated by Cape et al is also in 
keeping with a central hyper-responsiveness of the brain’s immune cells to insult in 
delirium (Cape, Hall et al. 2014).  
A CNS inflammatory response is further suggested by the findings of the first 
proteomics analysis of CSF in delirium, with several proteins involved in the 
inflammatory response upregulated in many of those with delirium (Poljak, Hill et al. 
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2014). One of these markers, α-1-glycoprotein, was elevated in those with delirium 
but not in those with dementia, and has the potential to be a specific marker for 
delirium.  
v) Relationship with dementia 
Dementia has been shown to be a strong risk factor for delirium, and patients who 
have delirium are much more likely to develop subsequent dementia (Juliebo, Bjoro 
et al. 2009, Witlox, Eurelings et al. 2010). However, the two studies that examined 
whether levels of established CSF markers for dementia were associated with risk of 
delirium after hip fracture or arthroplasty surgery have been negative, with only the 
lowest quartile of Aβ40/tau and Aβ42/tau ratios associated with an increased rate of 
incident delirium (Witlox, Kalisvaart et al. 2011, Xie, Swain et al. 2014). Indeed, 
dementia is not the only risk factor for delirium, and not all dementia is of Alzheimer 
pathology. 
3.5 Limitations 
The results of this review highlight the scarcity of studies examining CSF in 
delirium. The cross-sectional designs preclude clear conclusions on the important 
question of whether any changes in biomarkers are the cause or the effects of the 
delirium. Results are reported on approximately 60 biomarkers but data may have 
been collected on others, or further data on some of the biomarkers reported here, 
and not published, leading to a publication bias.  
This review was limited to studies published in the English language. We did not 
seek unpublished data. It is always possible to miss articles either with the search 
strategy or in searching the resulting citation lists. However, two individuals 
independently screened 4,870 citations derived from a search of six relevant and 
diverse databases, and we carefully hand-searched bibliographies and performed 
forward citation searches of all short-listed articles. We are therefore confident that 
no significant articles have been missed, and contact with leaders in the field of 
delirium research did not identify any other studies. We believe that the insistence 
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that delirium be diagnosed by formal criteria is a strength of this review. Most of the 
included papers used DSM criteria or the CAM method which is based on DSM 
criteria.  
3.6 Implications for future research 
There is a clear need for further studies in this area, although this research faces 
several significant challenges. Studies attempting to understand the pathophysiology 
of delirium are limited by the heterogeneity of the clinical syndrome, the subjects’ 
background (particularly preexisting, including undiagnosed, cognitive impairment), 
the cause and associated severity of illness, and the high associated mortality. 
Research is further limited by the care that must be taken in research with people 
who often do not have capacity to consent to participation in such studies (Holt, 
Siddiqi et al. 2008), and in particular when an invasive investigation such as CSF 
examination is proposed. CSF sampling at spinal anaesthesia in orthopaedic or other 
surgery where delirium is prevalent affords a good opportunity to obtain CSF with 
minimal additional upset for the patient because the procedure is clinically necessary 
(Pearson, de Vries et al. 2010). It is important though to avoid being too restrictive in 
performing lumbar puncture for research purposes in delirium. Although this is an 
undeniably challenging procedure, the high prevalence and severity of delirium 
warrants this approach. Furthermore, delirium is a CNS disorder, albeit often 
precipitated by peripheral disease or injury. CSF analysis is commonly done for 
research purposes in patients with other CNS disorders (eg. schizophrenia, 
depression, bipolar disorder, dementia, multiple sclerosis, epilepsy, traumatic brain 
injury and Creutzfeldt-Jakob disease (van Everbroeck, Boons et al. 2005, Petzold 
2007, Schwarz and Bahn 2008, Zetterberg 2008, Regenold, Phatak et al. 2009, 
Awad, Hemmer et al. 2010, Gudmundsson, Skoog et al. 2010)), and this has led to 
significant advances of the fundamental knowledge of these disorders. Therefore, 
with sufficient care and selection of patients, studies of the CSF in delirium need not 
be restricted to opportunistic use of clinical samples or only where spinal anaesthesia 
is being performed. Proactive engagement with patient advocacy groups and research 
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ethics committees will be necessary to help develop this crucial third route to 
obtaining CSF for delirium research. 
Future studies need to be informed by prior research, use power calculations to 
ensure they will answer predefined hypotheses, clearly report the baseline 
characteristics of all subjects, and ensure blinding wherever possible. Ideally more 
generalisable populations of medical and surgical patients should be approached, 
with careful, standardised assessment of delirium and its severity and aetiology, and 
as much information on prior cognitive status as possible. 
Future research should be guided by, but not limited to, biomarkers that have already 
been shown to be associated with delirium, and should also take cues from the main 
hypotheses of delirium pathophysiology and seek evidence of disrupted endocrine 
and inflammatory responses to stress as well as neurotransmitter upset. The exciting 
results of the recent proteomics analysis, suggesting potential new avenues for 
inquiry, also need to be further investigated. Of note, particularly in the case of 
neurotransmitters, a solitary CSF measurement provides only a snapshot which does 
not take into account the regional and minute-to-minute changes which may be 
taking place in different parts of the brain and spinal cord (Hyland 2008). Analyses 
may also be limited by technical aspects, such as neurotransmitters which degrade 
too quickly to be accurately measured in vivo e.g. acetylcholine (Bender 1939, 
Frolich, Dirr et al. 1998). 
Given the morbidity and mortality associated with delirium and our increasing 
knowledge of its link with longer-term cognitive decline, information on potentially 
disordered neurotransmission, CNS inflammation and damaging prolonged 
hypercortisolaemia needs to be married with information on markers of CNS damage 
at the site of injury. Improved understanding of delirium pathophysiology, 
particularly with evidence of the mechanism of damage to the CNS will likely 
provide better strategies for prevention and treatment of delirium in the future. 
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4 Chapter 4: Cerebrospinal fluid levels of cortisol and 
DHEA, DHEAS in delirium after hip fracture 
4.1 Introduction 
Delirium is an acute neuropsychiatric syndrome which is common and associated with 
multiple adverse outcomes (Witlox, Eurelings et al. 2010). Delirium pathophysiology has 
been challenging to study and is poorly understood. There has been interest for some time in 
the role of the Hypothalamic-Pituitary-Adrenal (HPA) axis response to stress in delirium, and 
the role of cortisol (Olsson 1999, MacLullich, Ferguson et al. 2008). Multiple different 
stressors such as trauma, surgery, acute illness and even psychological stress may precipitate 
delirium (Fong, Tulebaev et al. 2009). Ageing and dementia may both be associated with 
flattening of cortisol circadian rhythm, elevated evening cortisol levels (Ferrari, Cravello et 
al. 2001), and an increased and prolonged cortisol response to stressors due to impaired 
negative feedback, and consequently “shut-off” of the HPA axis (Olsson 1999, Ferrari, 
Cravello et al. 2001). Delirium may also be associated with impaired negative feedback of the 
HPA axis, as demonstrated by positive dexamethasone suppression tests in patients with 
delirium related to lower-respiratory tract infection (O'Keeffe and Devlin 1994) and delirium 
in dementia (Robertsson, Blennow et al. 2001).  
Previous studies of serum cortisol in delirium are conflicting (Marcantonio, Rudolph et al. 
2006). Several studies have demonstrated elevated serum cortisol in postoperative delirium 
following abdominal surgery (Kudoh, Takese et al. 2005) and cardiac surgery (Mu, Wang et 
al. 2010). However, a recent study by Bisschop et al found elevated serum cortisol in elderly 
patients with delirium after hip fracture, but this relationship was no longer significant after 
adjusting for prior cognitive impairment (Bisschop, de Rooij et al. 2011). Pearson et al 
previously undertook a pilot study examining cerebrospinal fluid (CSF) cortisol in delirium 
after hip fracture, and found it to be elevated in delirium (Pearson, de Vries et al. 2010). 
Dehydroepiandrosterone (DHEA) and its sulphate form, Dehydroepiandrosterone Sulphate 
(DHEAS) work in interplay with cortisol. These neurosteroids have immune-enhancing roles 
(Butcher, Killampalli et al. 2005), in contrast with cortisol, for example protecting 
hippocampal neurones from cortisol neurotoxicity (Kimonides, Spillantini et al. 1998). Their 
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production naturally declines with age (Ferrari, Cravello et al. 2001, Chehab, Ouertani et al. 
2007) including in CSF (Murakami, Nakagawa et al. 1999), and as cortisol production stays 
static and can rise, this can lead to a relative cortisol excess (Ferrari, Cravello et al. 2001, 
Chehab, Ouertani et al. 2007). These age-related changes may be further exaggerated by 
physical trauma; Butcher et al have found an elevated serum cortisol:DHEAS ratio in elderly 
patients with hip fracture, compared to age-matched controls and young fracture patients 
(Butcher, Killampalli et al. 2005). 
Studies examining DHEA levels in dementia have produced variable findings (Maninger, 
Wolkowitz et al. 2009). Previous CSF studies in dementia have revealed low CSF DHEAS in 
multi-infarct dementia (Azuma, Nagai et al. 1999), and high DHEA but low DHEAS in 
Alzheimer’s dementia and Vascular dementia (Kim, Hill et al. 2003). There are no previous 
studies specifically examining DHEA(S) in delirium. Measurement of DHEAS forms part of 
the assessment of allostatic load, which measures a combination of acute and chronic 
stressors and the body’s adaptation to these, low DHEAS suggesting a greater allostatic load. 
Rigney et al found increased allostatic load in a group of older hospital in-patients with 
delirium however no comment was made on DHEAS levels (Rigney 2010). 
This collaborative study aimed to examine the levels of cortisol, DHEA and DHEAS in the 
CSF of elderly patients, with and without delirium following acute hip fracture.  
The research questions were as follows:  
1) Is CSF cortisol increased in delirium? 
2) Are CSF DHEA and DHEAS reduced in delirium? 
3) Is the ratio of CSF cortisol:DHEA(S) elevated in delirium?  
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4.2 Methods 
 
4.2.1 Participant recruitment 
Participants with acute hip fracture aged over 60 were recruited in an opportunistic manner 
by researchers in two related studies. The first was in the Orthopaedic Trauma Unit at the 
Royal Infirmary of Edinburgh. The second was in the Emergency Department of Oslo 
University Hospital and was part of a trial of orthogeriatric versus standard orthopaedic care 
following hip fracture (Oslo Orthogeriatric Trial, OOT) (Watne, Torbergsen et al. 2014). 
Details of subjects in each study are as follows: 
Edinburgh study (CDHIP): Inclusion criteria were age over 60 and preoperative with acute 
hip fracture. Exclusion criteria were: nursing home resident, significant Parkinson’s disease, 
major communication difficulties (aphasia, English not first language), those taking inhaled 
or oral steroids in the last 10 weeks, moribund on admission. I approached and recruited all 
participants. 
Oslo study (OOT): Fractures as a result of high energy or multi-trauma were excluded. As 
with the Edinburgh study, those taking inhaled or oral steroids in the last 10 weeks 
(retrospective exclusion for the purposes of the present analysis), or who were moribund on 
admission were excluded. Participants were approached and recruited by members of the 
Orthopaedic trauma team. 
On both sites, written informed consent was obtained from participants or their nominated 
next of kin if capacity to give informed consent was lacking. Ethical approval was obtained 
from Scotland A Research Ethics Committee (reference no. 09/MRE00/28) and the Regional 
Committee for Ethics in Medical and Health Research, Norway.  
4.2.2 Cognitive assessment 
In both sites, participants were assessed for delirium preoperatively, using a semi-structured 
interview with cognitive testing, review of casenotes and discussion with nursing or medical 
staff to complete the Confusion Assessment Method (Inouye, Vandyck et al. 1990) (CAM). 
The specific additional assessments in each site were as follows: 
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Edinburgh: Conscious level was assessed with the Observational Scale of Level of Alertness 
and Richmond Agitation Sedation Scale, there was additional assessment of attention 
(Edinburgh Delirium Test Box 1 (Brown, Fordyce et al. 2010)) and cognitive testing was 
with the Mini-Mental State Examination (Folstein, Folstein et al. 1975) with assessment of 
delirium severity using the Delirium Rating Scale Revised-98 (Trzepacz, Mittal et al. 2001). I 
performed all in-patient delirium assessments. 
Oslo: Additional cognitive testing and assessment of delirium severity was with the 
Memorial Delirium Assessment Scale (Breitbart, Rosenfeld et al. 1997). Patients were 
classified as delirious if they scored positive on the CAM and fulfilled DSM IV criteria. 
Assessments were performed by a Geriatrician and small team of research nurses. 
In Edinburgh, participants were again assessed for delirium daily from postoperative days 1-4 
and on days 7 and once between days10-14 or until transfer to a rehabilitation unit or 
discharge from hospital if these occurred sooner. In Oslo, participants were assessed daily 
until postoperative day 5 or until delirium-free. 
4.2.2.1 Diagnosis of delirium 
In both sites, patients were classified as delirious if they fulfilled DSM-IV criteria, informed 
by the CAM assessment process.  
4.2.2.2 Delirium severity 
In order to examine any relationship between delirium severity and biomarker level, due to 
the different delirium severity scales used by both centres, MDAS scores were retrospectively 
coded for the Edinburgh participants, using the appropriate component scores, following 
consultation with experts in the field. The peak MDAS score for each delirium case was then 
calculated, and the median of these peak scores (a score of ≥15) used as a cut-off between 
mild and severe delirium, as no published cut-off scores for mild vs. severe delirium could be 
found in common usage for the MDAS. 
The Informant Questionnaire on Cognitive Decline in the Elderly (Jorm and Jacomb 1989) 
(IQCODE), a well-validated and widely used measure of pre-morbid cognition, was 
completed during a meeting with next of kin. I completed these in Edinburgh and Leiv Otto 
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Watne in Oslo. A cut-off score of ≥3.44 (average score) was used to indicate evidence of 
probable prior dementia (Harwood, Hope et al. 1997). 
4.2.3 Assessment of function and co-morbidity 
An assessment was made of participants’ functional level at baseline, using the Katz basic 
activities of daily living score (Katz, Ford et al. 1963) in Edinburgh and the Barthel index 
(Mahoney and Barthel 1965) in Oslo. Participants were deemed to be independent in basic 
activities of daily living if they had a Barthel index score of ≥19/20 or a Katz score of ≥5/6. 
An assessment was made of illness severity and co-morbidity using the APACHE II score 
(Knaus, Draper et al. 1985), Charlson co-morbidity index (Charlson, Pompei et al. 1987) and 
the number of regular medications taken on admission. A modified APACHE II score was 
used, omitting arterial pH (arterial blood gas measurement is not routine in preoperative hip 
fracture patients), and haematocrit (not routinely reported in Oslo).  
4.2.4 Sample collection 
At the time of the operation to repair the hip fracture, if this was performed under spinal 
anaesthetic, the Anaesthetist collected a sample of CSF after placement of the spinal needle 
and prior to the injection of anaesthetic agents. A paired serum sample was collected at the 
same time as the CSF sample, in a serum separator tube. The CSF sample was placed in a 
polypropylene universal container and both samples put on ice. Samples were centrifuged as 
soon as possible (CSF: 1000 rpm, 4 oC for 10 minutes, serum 3000 rpm, 4 oC for 10 minutes) 
and stored in aliquots in polypropylene eppendorfs at -80 oC until assayed (see sections 2.5.1 
and 2.5.2).  
4.2.5 Cerebrospinal fluid and serum assays 
Cortisol, DHEA and DHEAS were measured in CSF by individual commercially-available 
Enzyme-Linked Immunosorbent Assays (Salimetrics, Newmarket, Suffolk) (see sections 
2.9.1 and 2.9.2).  Cortisol was measured in serum with a commercially available Enzyme-
Linked Immunosorbent Assay (MP Biomedicals, USA) (see section 2.10.1). I performed all 
CSF and serum assays in Edinburgh.  
4.2.6 Statistical analysis  
Normality of distribution of the results was checked with histogram and Kolgomorov-
Smirnov test. Non-parametric cortisol levels were compared with Mann-Whitney U test for 
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univariate comparisons and with the Kruskal-Wallis test between those who developed 
prevalent, incident or who never developed delirium. Log10-transformed DHEA and DHEAS 
levels were compared between groups with Student’s t test and ANOVA. Demographic 
characteristics of the patient group were compared using Student’s t test or Mann-Whitney U 
test for parametric or non-parametric numerical variables, and Pearson Chi-Squared for 
categorical variables. Correlations between neurosteroids were performed with Spearman’s 
rho to see whether DHEA and DHEAS were correlated, as would be expected, and to see 
whether cortisol was inversely correlated with DHEA(S). In order to adjust for the effects of 
potential confounders, logistic regression models were built for biomarkers found to be 
significantly different in the univariate analysis, using as co-variates those variables found to 
be significantly different between groups (Table 3.1). Study site was also included in the 
model to ensure that it did not introduce bias. Finally, prediction logistic regression models 
were constructed to see if the level of the biomarkers at the time of surgery predicted delirium 
in the postoperative period. In the prediction models, participants who developed delirium 
prior to surgery were excluded. All statistical analyses were performed with the statistical 
package SPSS version 19.0, and p<0.05 was considered significant. 
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4.3 Results 
Figure 4.1 shows the participants included and excluded at both sites. Cerebrospinal fluid 
samples were available for 167 participants across the two sites (N=66 Royal Infirmary of 
Edinburgh, N=101 Oslo University Hospital). Following exclusion of participants with 
insufficient data on delirium status (N=9) and participants who had received steroid therapy 
preoperatively (N=10), 148 participants remained, 42 men and 106 women. Delirium 
developed at any stage in 68 (45.5%) participants. Prevalent delirium (defined as present 
prior to surgery and sample collection) was diagnosed in 36 (24.8%) participants, and 
incident delirium (developing postoperatively where the participant was not delirious 
preoperatively) in 30 (20.7%) participants. In three participants, no data was available on 
preoperative delirium status and they were excluded from analyses comparing prevalent vs. 
incident vs. never delirium. Forty-nine participants had evidence of prior dementia, based on 
a known diagnosis of dementia and/or an IQCODE average score >3.44. Table 4.1 provides 
additional information on the functional status of the combined sample and other factors. The 
delirium group was more likely to be functionally and cognitively impaired, be taking more 
medications on admission and have a greater degree of illness severity as measured by the 
modified APACHE II score (Table 4.1). Table 4.2 provides a summary of the demographic 
characteristics of the Edinburgh and Oslo cohorts. Patients in Oslo were more functionally 
dependent and more likely to have prior dementia; this was most likely due to the exclusion 
in Edinburgh of patients in institutional care. The Oslo cohort had more prevalent delirium. 
Patients in Edinburgh were on more medication, and waited longer for their operation. This 
may be due to local operating practice, as hip fracture operations are performed “out of 
hours” in Oslo but not in Edinburgh (Table 4.2). 
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  Not meeting inclusion criteria 
(N=291) 
- Nursing home resident - 102 
- Use of steroids - 73 
- Too ill to approach  - 54 
- Nursing staff felt not appropriate 
to approach - 28 
- Previously approached or 
recruited - 4 
- Active alcohol withdrawal - 20 
- Shaft of femur fracture - 8  
- From out-with the area - 2 
   Lack of valid consent 
(N=143) 
  Other reasons (N=144) 
- Communication difficulties - 16 
- Decided not for surgery - 5 
- Norovirus - 3 
- Competing research project – 31 
 
- Missed as first on theatre list - 
65 
- Last minute theatre list changes - 
24 
Excluded (N = 126) 
- Sent to other hospital for 
surgery - 13 
- Epidural - 2 
- General anaesthesia  - 10
Number with CSF sample (N=104) 
Total number of CSF samples analysed 
(N=167) 
Excluded (N = 42) 
- General anaesthesia - 22 
- Not operated - 2 
- CSF not taken - 18 
Excluded (N=97) 
   Not meeting inclusion 
criteria (N=34) 
- Uncertain diagnosis 
(awaiting 
further diagnostics) - 15 
- Too ill to approach - 6 
- Previously approached  
or recruited - 1 
- High energy trauma - 12 
    Lack of valid consent 
(N=19) 
    Other reasons (N=44) 
- Norovirus - 20  
- Cared for at another 
hospital - 10 
- Surgeon forgot study - 11 
- Other - 3 
Number with CSF sample (N=66) Number of CSF samples from Oslo 
analysed (N=101) 
Excluded (N = 3) 
- CSF frozen after >4 hours - 3  
Total number of CSF samples 
included (N=151) 
Excluded (N = 19)-
Insufficient 
delirium data N=9 
- Steroid therapy N=10  
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Table 4.1 Baseline medical, surgical and functional demographics of the combined study 
sample 
 Delirium, N=68 
Median (Interquartile range) 
No delirium, N=80 
Median (Interquartile range) 
p value Test 
statistic 
Age 84.5 years (IQR 79.3-88.0) 83.0 years (IQR 70.3-88.0) 0.084a 2272c  
Female N=46 (67.6%) N=60 (75.0%) 0.323b 0.978d 
IQCODE score Total 59.0 (IQR 50.0-75.0) 
Average 3.69 (IQR 3.13-4.69) 
Total 48.0 (IQR 48.0-53.0) 





Alcohol Units/week  0 (IQR 0-1) 0 (IQR 0-2) 0.077a 2256c 
Type of accommodation House or flat N=48 
Sheltered housing N=3 
Nursing home N=17 
House or flat N=71 
Sheltered housing N=6 
Nursing home N=3 
0.001b 14.37d 
Independent in basic 
ADLs 
N=30 (44.1%) N=66 (82.5%) <0.001b 23.76d 
Katz basic ADL score /6 
(Edinburgh) 
6 (IQR 5-6) 6 (IQR 6-6) 0.034a 401.5c 
Barthel basic ADL score 
/20 (Oslo) 
16 (IQR 13-18) 19 (IQR 18-20) <0.001a 334.5c 
Number of medications 5 (IQR 2.25-7) 3.5 (IQR 1.25-5) 0.013a 2075c 
Modified APACHE II 
score 
9 (IQR 8-10.75) 8 (IQR 6-9) <0.001a 1756c 
Charlson Co-morbidity 
Index 
1 (IQR 0-2) 1 (IQR 0-2) 0.037a 2205c 







Type of surgery Hemiarthroplasty N=35 
Internal fixation N=32 
Total hip replacement N=0 
No operation N=1 
Hemiarthroplasty N=39 
Internal fixation N=36 
Total hip replacement N=5 
No operation N=0 
0.138b 5.515d 
Waiting time for 
operatione 
32.0 hours (IQR 17.6-43.5) 25.0 hours (IQR 19.0-39.6) 0.414a 2407c 
 
aMann-Whitney-U test, bPearson Chi-square 
cMann-Whitney-U test statistic, dPearson Chi-square test statistic 
eTime from triage in Accident and Emergency to operation start time. 
 
Cortisol and inflammation in delirium and cognitive decline after hip fracture 
Cerebrospinal fluid levels of cortisol and DHEA in delirium after hip fracture 185 
Table 4.2 Baseline medical, surgical and functional demographics of the Edinburgh and Oslo 
cohorts 
 Edinburgh, N=66 
Median (Interquartile range) 
Oslo, N=82 
Median (Interquartile range) 
p value Test 
statistic 
Age 83 years (IQR 76.8-87) 84.5 years (IQR 78.5-88.3) 0.299a 2437c  
Female N=44 (66.7%) N=62 (75.6%) 0.230b 1.439d 







IQCODE score Total 48 (IQR 48-52) 
Average 3 (IQR 3-3.25) 
Total 57 (IQR 48-74.8) 





Alcohol Units/week  0 (IQR 0-5) 0 (IQR 0-1) 0.008a 2061c 
Type of accommodation House or flat N=61 
Sheltered housing N=5 
Nursing home N=0 
House or flat N=58 
Sheltered housing N=4 
Nursing home N=20 
<0.001b 18.68d 
Independent in basic 
ADLs* 
N=60 (90.9%) N=36 (43.9%) <0.001b 35.45d 
Number of medications 5 (IQR 3-7.25) 3.5 (IQR 1-6) 0.004a 1969c 
Modified APACHE II 
score* 
8 (IQR 6.75-10) 8 (IQR 7-10) 0.167a 2353c 
Charlson Co-morbidity 
Index  
1 (IQR 0-2) 1 (IQR 0-2) 0.080a 2275c 







Type of surgery Hemiarthroplasty N=33 
Internal fixation N=29 
Total hip replacement N=4 
No operation N=0 
Hemiarthroplasty N=41 
Internal fixation N=39 
Total hip replacement N=1 
No operation N=1 
0.328b 3.446d 
Waiting time for 
operationf 
37 hours (IQR 23-46) 23 hours (IQR 14-35) <0.001a 1573c 
 
aMann-Whitney-U test, bPearson Chi-square 
cMann-Whitney-U test statistic, dPearson Chi-square test statistic 
ePreoperative delirium status missing in 3 Oslo patients 
fTime from triage in Accident and Emergency to operation start time. 
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4.3.1 CSF cortisol 
There was a trend to higher CSF cortisol in the group who ever developed delirium [median 
33.3 nM/L (IQR 22.6-42.8) vs. 27.2 nM/L (18.9-39.0), Mann-Whitney-U test p=0.054]. 
Cerebrospinal fluid cortisol was significantly elevated in those with prevalent delirium 
[median 36.5 nM/L, (IQR 26.3-53.1)] compared to those who developed incident delirium 
[median 30.0 nM/L (IQR 16.8-39.2)] and those who never developed delirium [median 27.2 
nM/L (IQR 18.8-39.3)], Kruskal-Wallis p=0.023 (Table 4.3, Figure 4.2). Post hoc pairwise 
comparisons revealed that this was due to the difference between prevalent delirium and 
never delirium, adjusted p=0.023. 
A sub-group analysis revealed that in participants with evidence of prior dementia, there was 
no difference in CSF cortisol levels between delirium groups (Table 4.3). However, in the 
group without prior dementia, those with prevalent delirium [median 39.6 nM/L (IQR 35.4-
53.3)] had a significantly elevated level of CSF cortisol compared to those with incident 
delirium [median 22.9 nM/L (IQR 13.6-33.7)] and those who never developed delirium 
[median 27.3 nM/L (IQR 18.3-41.5)], Kruskal-Wallis p=0.006 (Table 4.3). Post hoc pairwise 
comparisons revealed that this was due to the difference between prevalent delirium and 
never delirium (p=0.017) and the difference between prevalent delirium and incident delirium 
(p=0.008). 
There was no difference in CSF cortisol level when participants with and without prior 
dementia were compared (Table 4.3). There was also no difference in CSF cortisol level 
between participants with mild or severe delirium (mild group (N=30) median 34.8 nM/L 
(IQR 24.9-47.8) vs. severe group (N=37) median 31.1 nM/L (IQR 22.6-46.9), Mann-Whitney 
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4.3.2 Serum cortisol 
Matched preoperative serum samples were available for N=72 patients (N=63 Edinburgh 
patients, N=9 Oslo patients). There was no difference in serum cortisol levels in those with 
prevalent or incident delirium and those without delirium (Table 2). 
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Table 4.3 Cerebrospinal and serum cortisol levels according to delirium and dementia status  
 
aKruskal-Wallis test 
bMann-Whitney U test 
 
4.3.3 CSF Dehydroepiandrosterone (DHEA) and 
Dehydroepiandrosterone Sulphate (DHEAS) 
There was no difference found in either CSF Log10 DHEA or Log10 DHEAS between the 
groups with prevalent or incident delirium and those without delirium (Table 4.4). There was 
also no difference in CSF Log10 DHEA or Log10 DHEAS between those with mild or severe 
delirium (data not shown). There was also no difference in CSF Log10 DHEA or Log10 
DHEAS in those with and without prior dementia (Table 4.4). Subgroup analysis did not 
demonstrate any difference between delirium groups in those with and without prior dementia 
(Table 4.4). There was also no significant difference in the Log10 molar ratio of cortisol : 
DHEA + DHEAS between those who did and did not develop delirium (Table 4.4). 
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Table 4.4 Cerebrospinal fluid DHEA and DHEAS levels according to delirium and dementia 
status 
 Delirium  
Mean (SD) 
Prior dementia  
Mean (SD) 
Prevalent Incident Never p value Yes No p value 
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bStudent’s t test 
 
4.3.4 Correlations between neurosteroids 
CSF cortisol correlated highly with serum cortisol (Spearman’s rho 0.746, p<0.001). There 
was no significant correlation between CSF cortisol and either CSF Log10 DHEA or DHEAS, 
but serum cortisol level correlated with CSF Log10 DHEA (Spearman’s rho 0.323, p=0.010). 
CSF Log10 DHEA correlated with Log10 DHEAS (Spearman’s rho 0.572, p<0.001).  
4.3.5 CSF cortisol logistic regression analysis: adjusting for potential 
confounders 
The demographic variables shown to be different between groups with and without delirium 
at any stage were independence in ADLs, number of medications, Charlson Co-morbidity 
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Index, modified APACHE II score and IQCODE score (Table 4.2). Study site was also 
included to ensure it did not introduce bias. A logistic regression model was built to adjust for 
the effects of these co-variates on the association between CSF cortisol level and delirium 
status, using an Enter method. Delirium at any stage was the dependent variable. The Wald 
statistic, odds ratios with 95% confidence intervals and p values for the logistic regression 
model are shown in Table 4.5, along with pseudo-R2 values. A second model was built using 
the same co-variates but including cortisol as a dichotomous variable, split on the median 
(29.3nmol/L) (Table 4.6). In both models, modified APACHE II score and total IQCODE 
score remained significantly associated with delirium status. CSF cortisol as a continuous 
variable was not associated with ever delirium after adjusting for the co-variates, but a CSF 
cortisol level above the median was still associated with delirium. There was no evidence of 
collinearity in either model. 
Table 4.5 Logistic regression model for CSF cortisol as a continuous variable 
Co-variate CSF cortisol model 
Wald ORa 95% CIb of 
ORa 
p value 
Study site 1.18 0.56 (0.20-1.59) 0.277 
Independence in ADLcs 0.83 1.68 (0.55-5.17) 0.363 
Number of medications 0.99 0.92 (0.79-1.08) 0.319 
Charlson Comorbidity 
Index 
0.04 0.97 (0.70-1.35) 0.852 
Modified APACHE II 8.92 0.76 (0.64-0.91) 0.003 
Total IQCODE score 13.93 0.89 (0.84-0.95) <0.001 
CSF cortisol (nmol/L) 0.11 1.00 (0.98-1.01) 0.746 
Constant 16.72 8443  <0.001 
 
This table shows the results of the multivariate logistic regression analysis for CSF cortisol as 
a continuous variable, built to adjust for potential confounding variables on delirium status. 
The dependent variable was delirium at any stage.  
aOR: Odds ratio, bCI: Confidence interval. cADLs: activities of daily living.  
Pseudo-R2 values 0.31 (Cox and Snell), 0.42 (Nagelkerke) 
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Table 4.6 Logistic regression model for CSF cortisol split on the median 
Co-variate CSF cortisol model 
Wald ORa 95% CIb of 
ORa 
p value 
Study site 0.66 0.64 (0.22-1.86) 0.415 
Independence in ADLcs 0.20 1.30 (0.41-4.06) 0.655 
Number of medications 1.51 0.90 (0.76-1.06) 0.219 
Charlson Comorbidity 
Index 
0.01 0.98 (0.70-1.37) 0.911 
Modified APACHE II 8.21 0.77 (0.64-0.92) 0.004 
Total IQCODE score 14.61 0.89 (0.84-0.95) 0.000 
CSF cortisol above the 
median (yes/no) 
3.94 0.42 (0.18-0.99) 0.047 
Constant 19.03 39423  0.000 
 
This table shows the results of the multivariate logistic regression analysis for CSF cortisol 
split on the median, built to adjust for potential confounding variables on delirium status. The 
dependent variable was delirium at any stage.  
aOR: Odds ratio, bCI: Confidence interval. cADLs: activities of daily living.  
Pseudo-R2 values 0.33 (Cox and Snell), 0.44 (Nagelkerke) 
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4.3.6 Logistic regression analysis: prediction of postoperative 
delirium 
Logistic regression models were constructed to test whether levels of cortisol, DHEA, 
DHEAS or the Log10 Cortisol: (DHEA+DHEAS) ratio predicted the development of 
postoperative delirium. Participants who developed delirium preoperatively were excluded 
and the development of postoperative delirium was the dependent variable. Co-variates were 
chosen from the results of the univariate analysis and risk factors for delirium from the 
literature. A Forward (Wald) selection method was used. Total IQCODE score and modified 
APACHE II score were the only co-variates that predicted the development of postoperative 
delirium, and none of the biomarkers predicted delirium (Tables 4.7a – 4.7d). There was no 
evidence of collinearity. 
Table 4.7a Logistic regression model for prediction of postoperative delirium by CSF 
cortisol 
Co-variate 
Wald ORa p value 
Modified APACHE II 5.82 0.80 0.016 
Total IQCODE score 11.77 0.91 0.001 
Constant 18.19 2854.7 <0.001 
Variables not in equation 
Co-variate Score p value 
Age 0.640 0.424 
Gender 0.545 0.460 
Independence in ADLsb 0.845 0.358 
Number of medications 2.295 0.130 




Fracture type 0.061 0.804 
Operation type 0.827 0.363 
Waiting time for surgery 1.396 0.237 
CSF cortisol 0.392 0.531 
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These tables shows the results of the multivariate logistic regression analysis for CSF cortisol 
as a continuous variable, built to determine whether CSF cortisol level was predictive of 
delirium development during the postoperative period. The dependent variable was delirium 
developed postoperatively. The percentage of patients who would be correctly identified as 
delirious was 74.8% 
aOR: Odds ratio, bADLs: activities of daily living, cCCI: Charlson co-morbidity index   
Pseudo-R2 values 0.17 (Cox and Snell), 0.24 (Nagelkerke) 
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Table 4.7b Logistic regression model for prediction of postoperative delirium by CSF DHEA 
Co-variate 
Wald ORa p value 
Modified APACHE II 5.25 0.81 0.022 
Total IQCODE score 10.53 0.91 0.001 
Constant 16.34 1772.6 <0.001 
Variables not in equation 
Co-variate Score p value 
Age 1.044 0.307 
Gender 0.392 0.531 
Independence in ADLsb 0.691 0.406 
Number of medications 1.589 0.208 




Fracture type 0.064 0.800 
Operation type 1.277 0.259 
Waiting time for surgery 1.440 0.230 
CSF DHEA 2.253 0.133 
These tables shows the results of the multivariate logistic regression analysis for CSF DHEA 
as a continuous variable, built to determine whether CSF DHEA level was predictive of 
delirium development during the postoperative period. The dependent variable was delirium 
developed postoperatively. The percentage of patients who would be correctly identified as 
delirious was 74.2% 
aOR: Odds ratio, bADLs: activities of daily living, cCCI: Charlson co-morbidity index   
Pseudo-R2 values 0.16 (Cox and Snell), 0.22 (Nagelkerke) 
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Table 4.7c Logistic regression model for prediction of postoperative delirium by CSF 
DHEAS 
Co-variate 
Wald ORa p value 
Modified APACHE II 5.25 0.81 0.022 
Total IQCODE score 10.53 0.91 0.001 
Constant 16.34 1772.6 <0.001 
Variables not in equation 
Co-variate Score p value 
Age 1.044 0.307 
Gender 0.392 0.531 
Independence in ADLsb 0.691 0.406 
Number of medications 1.589 0.208 




Fracture type 0.064 0.800 
Operation type 1.277 0.259 
Waiting time for surgery 1.440 0.230 
CSF DHEAS 0.224 0.636 
These tables shows the results of the multivariate logistic regression analysis for CSF 
DHEAS as a continuous variable, built to determine whether CSF DHEAS level was 
predictive of delirium development during the postoperative period. The dependent variable 
was delirium developed postoperatively. The percentage of patients who would be correctly 
identified as delirious was 74.2% 
aOR: Odds ratio, bADLs: activities of daily living, cCCI: Charlson co-morbidity index   
Pseudo-R2 values 0.16 (Cox and Snell), 0.22 (Nagelkerke) 
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Table 4.7d Logistic regression model for prediction of postoperative delirium by CSF Log10 
Cortisol: (DHEA+DHEAS) ratio 
Co-variate 
Wald ORa p value 
Modified APACHE II 5.25 0.81 0.022 
Total IQCODE score 10.53 0.91 0.001 
Constant 16.34 1772.6 <0.001 
Variables not in equation 
Co-variate Score p value 
Age 1.044 0.307 
Gender 0.392 0.531 
Independence in ADLsb 0.691 0.406 
Number of medications 1.589 0.208 




Fracture type 0.064 0.800 
Operation type 1.277 0.259 
Waiting time for surgery 1.440 0.230 
CSF Log10 Cortisol: 
(DHEA+DHEAS) ratio 
0.148 0.700 
These tables shows the results of the multivariate logistic regression analysis for CSF Log10 
Cortisol: (DHEA+DHEAS) ratio as a continuous variable, built to determine whether CSF 
Log10 Cortisol: (DHEA+DHEAS) ratio was predictive of delirium development during the 
postoperative period. The dependent variable was delirium developed postoperatively. The 
percentage of patients who would be correctly identified as delirious was 74.2% 
aOR: Odds ratio, bADLs: activities of daily living, cCCI: Charlson co-morbidity index   
Pseudo-R2 values 0.16 (Cox and Snell), 0.22 (Nagelkerke) 
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4.4 Discussion 
This relatively large study provides further evidence to support a role for elevated central 
nervous system (CNS) cortisol in the pathogenesis of delirium. Cortisol was found to be 
elevated in CSF where delirium was current, but there was no elevation in baseline serum 
cortisol. There was no evidence to support the hypotheses that levels of CSF DHEA and 
DHEAS are reduced or that the ratio of cortisol:DHEA(S) is elevated.   
A role for CNS cortisol in delirium pathogenesis is plausible. The relationship between 
delirium and cortisol is complex with potentially bidirectional change and the influence of 
illness severity and pre-existing cognitive impairment. Both psychological and physical stress 
will undoubtedly provoke a cortisol response and are known to precipitate delirium 
(MacLullich, Ferguson et al. 2008). Delirium itself may also be stressful, due to consequent 
disorientation, sleep disturbance and psychotic experiences, which could also cause cortisol 
levels to rise.  
The major source of CNS cortisol has always thought to have been diffusion from the blood, 
with a small amount of local synthesis (Bellavance and Rivest 2014). Recently in rodent 
models, substantial local regeneration from inert corticosterone by 11β-HSD-1 in the brain 
has been demonstrated, (Yau, Wheelan et al. 2015). However, the degree of local 
regeneration or recycling between active and inactive isoforms in humans is less clear. A 
recent study in eight healthy adult men found no detectable interconversion between cortisol 
and cortisone (Kilgour, Semple et al. 2015). Glucocorticoid transporters are present in 
different brain regions but do not play a major role in the access of cortisol to the brain 
(Mason, Pariante et al. 2010). Levels in CSF are usually around 5-10% of those in the 
periphery, and sudden peripheral rises in cortisol in response to stress may lead to 
disproportionate rises in CSF cortisol due to the limited binding capacity of corticosteroid-
binding globulin. Here there was elevated CSF cortisol in active delirium but no such 
elevation in the periphery (in the presence of a good correlation between CSF and serum 
cortisol, suggesting the relationship between them was maintained). This may have been due 
to a disproportionate rise in CSF cortisol in response to stress, greatest in those with delirium, 
perhaps exacerbated by the fall in corticosteroid-binding globulin with older age (Herbert, 
Goodyer et al. 2006). It could also have plausibly been due to increases in blood-brain barrier 
permeability due to the acute stresses of hip fracture, consequent immobilisation and surgery, 
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since stress has been shown to promote prolonged blood-brain barrier disruption in various 
CNS disorders (Tomkins, Kaufer et al. 2001). However, it may also have been due to smaller 
numbers in the serum substudy, where the highest levels were seen in the group with 
prevalent delirium. The outcome of ongoing exposure of the brain to elevated cortisol levels 
in delirium is likely to be detrimental at various levels, leading to increased neuronal 
vulnerability to cell damage and death from various insults, including glutamate excess, 
hypoxia, hypoglycaemia and oxidative stress (Kimonides, Spillantini et al. 1998, Herbert, 
Goodyer et al. 2006). 
CSF cortisol was found to be significantly elevated in active (prevalent) delirium, but not in 
postoperative (incident) delirium compared to those without delirium, and CSF cortisol levels 
at the time of operation did not predict the development of postoperative delirium. These 
results suggest that either delirium needs to be established to see a rise in cortisol, that the 
stress of delirium further activates the HPA axis, or that postoperative delirium has a different 
mix of pathological mechanisms to the (potentially more heterogeneous) delirium seen 
preoperatively. These mechanisms might include postoperative dehydration, or the effects of 
anaesthesia or other perioperative drugs. It is unknown whether delirium has any effect on 
CNS 11-βHSD-1, as this has never been studied. The ratio of cortisol : corticosone in CSF in 
those with and without delirium could be measured in the future, as for example increased 
activity of the enzyme in delirium as a contributor towards increased CNS cortisol would 
represent a potential therapeutic target. 
As would be expected from the literature, prior dementia was associated with development of 
delirium in this cohort, with higher IQCODE scores in the delirium group and prior dementia 
remaining significantly associated with delirium in the logistic regression analysis. However, 
an intriguing finding of the present study is that CSF cortisol remained elevated in those with 
prevalent delirium after excluding patients with evidence of prior dementia; in fact, the sub-
group analysis showed that those patients with no prior dementia and active delirium had 
particularly high CSF cortisol levels. This relationship disappeared for those with prior 
dementia. One might have predicted that it would be the group with delirium super-imposed 
on dementia who would have the greatest rise in CSF cortisol, as there is evidence of 
impaired negative feedback of the HPA axis in dementia (Robertsson, Blennow et al. 2001). 
Perhaps delirium is most stressful for those with a usually normal “operating system”, or 
perhaps it takes the greatest, disordered, rise in cortisol to provoke delirium in a healthy 
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brain. These results in CSF differ from the findings in serum of Bisschop et al (Bisschop, de 
Rooij et al. 2011), where serum cortisol was found to be elevated in delirium after hip 
fracture, but not after controlling for prior cognition. This may be due to differing cortisol 
levels or kinetics in the CNS and the periphery, or that dementia causes or associates with 
more 11β-HSD1 in the CNS, as is the case in aged, cognitively impaired rodents (Holmes, 
Carter et al. 2010). 
The levels of cortisol demonstrated here in CSF were lower than those found by Pearson et al 
(Pearson, de Vries et al. 2010) in delirium after hip fracture. This may be due to the Pearson 
study comprising a more unwell or delirious cohort, or the difference in subject numbers. The 
CSF cortisol levels in the present study were slightly higher than elderly patients with 
cognitive impairment and healthy elderly controls (Johansson, Johansson et al. 2011), and 3-4 
fold lower than in bacterial meningitis (Beran, Dzupova et al. 2011). Different assay 
techniques may mean that individual studies are difficult to compare, however. 
The hypothesis that CSF levels of DHEA and DHEAS would be low in delirium was not 
supported by this study. CSF DHEA and DHEAS were strongly correlated, which supports 
the validity of the assay. The study also did not find a difference in the cortisol : DHEA(S) 
ratio, and cortisol was not correlated with DHEA nor DHEAS, suggesting there may not be a 
significant relationship between the neurosteroids in this setting. The untransformed median 
levels of DHEAS found in CSF here were lower than those demonstrated in stroke and 
vascular dementia (Azuma, Nagai et al. 1999), and levels of DHEA were also lower than 
those found in Alzheimer’s dementia and controls (Naylor, Hulette et al. 2008), although 
different assay techniques may impact on this. 
Some limitations of the study must be acknowledged. Delirium was not assessed for every 
day or more than once per day in the postoperative period, in order not to over-burden 
participants; however, this may have missed some brief episodes of delirium. Some 
participants who were assessed preoperatively as not delirious may also have developed 
delirium in the time between assessment and surgery; every effort was made to assess 
patients close to surgery, but this was not always possible. The cohort comprises patients 
from studies at two centres. Although both cohorts are elderly hip fracture patients, differing 
exclusion criteria due to the objectives of the parent studies have meant that the Oslo cohort 
is slightly “frailer”. There was however no difference in any of the biomarkers between 
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groups, and study site was not shown to have caused any significant bias in the logistic 
regression analysis. I believe that combining both cohorts greatly increases the power of the 
study and the conclusions drawn. 
This study confirms the earlier finding of elevated CSF cortisol in prevalent delirium 
(Pearson, de Vries et al. 2010), in a much larger cohort of patients with acute hip fracture. It 
suggests that elevated CNS levels are associated with active delirium, but do not predict 
postoperative delirium. High levels of CSF cortisol seem still to be associated with delirium 
after controlling for the influence of prior dementia, but more work is needed in this complex 
area, and further work is needed examining CSF cortisol levels in delirium in different 
populations. The findings of this study also provide support for a potential means for delirium 
prevention or treatment, for example using 11β-Hydroxysteroid dehydrogenase type-1 
inhibitors to block intracellular amplification of glucocorticoid levels. 
Cortisol and inflammation in delirium and cognitive decline after hip fracture 
CSF levels of inflammatory cytokines in delirium after hip fracture 201 
5 Chapter 5: Exploratory multiplex analysis of CSF levels 
of inflammatory cytokines in delirium after hip fracture 
5.1 Introduction 
Delirium is an acute and distressing neuropsychiatric disorder. It is highly prevalent in 
multiple hospital settings, but particularly in older patients, affecting 11-42% of medical in-
patients, 4-53% of hip fracture patients and 10-80% of intensive care patients (Siddiqi, House 
et al. 2006, Bruce, Ritchie et al. 2007, Ouimet, Kavanagh et al. 2007). There are several 
associated adverse outcomes, including an increased risk of institutionalisation (Siddiqi, 
House et al. 2006) and of subsequent dementia (MacLullich, Beaglehole et al. 2009, Witlox, 
Eurelings et al. 2010), and it is associated with increased mortality independent of age, 
gender, co-morbid illness and baseline dementia (Witlox, Eurelings et al. 2010). The 
pathophysiology of delirium has been challenging to study and remains poorly understood, 
and there are currently no formal specific treatments for delirium.  
There has been interest in the potential role of an abnormal inflammatory response in 
delirium (Perry, Cunningham et al. 2007, MacLullich, Ferguson et al. 2008). This has been 
discussed in detail in section 1.6. Inflammatory processes are complex and involve both 
cellular and humoral components. Peripheral infection is a common precipitant of delirium, 
although the pathway from a seemingly benign peripheral infection in an elderly patient, 
without significant systemic upset, to the neuropsychiatric symptoms of delirium is unclear. 
Sepsis is also a common precipitant of ICU delirium in young, fit patients as well as older 
patients (Ebersoldt, Sharshar et al. 2007). Trauma, surgery and other insults also lead to an 
inflammatory response, as discussed in more detail in section 1.10.4. 
Animal modelling has shown that a rodent with a “fragile” brain such as an older rodent or 
one with neurodegenerative disease such as the ME7 prion disease model mouse, has 
“primed” microglia (Godbout, Chen et al. 2005, Cunningham, Campion et al. 2009). These 
primed microglia, the brain’s resident macrophages, are in a state of enhanced readiness 
compared with non-primed microglia, and when these ME7 animals are given a peripheral 
injection of the bacterial endotoxin lipopolysaccharide, to mimic peripheral infection, they 
respond with an exaggerated, prolonged sickness behaviour and a transient deterioration in 
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cognition, and a greater central nervous system (CNS) inflammatory response (Godbout, 
Chen et al. 2005, Cunningham, Campion et al. 2009).  
Direct administration of cytokines used for cancer chemotherapy, such as Interferon (IFN)-α 
(Capuron, Ravaud et al. 2004) and Interleukin (IL)-2 (Rosenberg, Lotze et al. 1989, Walker, 
Wesnes et al. 1996, Walker, Walker et al. 1997), can lead to acute mental status change, such 
as disorientation, somnolence, reduced reaction times (Rosenberg, Lotze et al. 1989, Walker, 
Wesnes et al. 1996, Walker, Walker et al. 1997) and depressive symptoms (Capuron, Ravaud 
et al. 2004). 
Raised serum levels of IL-6 and IL-8 have been found in patients with delirium following 
acute hip fracture (van Munster, Korevaar et al. 2008). There have been very few previous 
CSF studies of inflammation in delirium (Hall, Shenkin et al. 2011). Katsumata et al found 
elevated CSF IL-6 in those with delirium secondary to neuropsychiatric manifestations of 
Systemic Lupus Erythematosus (Katsumata, Harigai et al. 2007). A previous pilot study 
(n=36) found elevated CSF IL-8 in patients with delirium following acute hip fracture 
(MacLullich, Edelshain et al. 2011). More recently, Westhoff et al have found that in patients 
with acute hip fracture without preoperative delirium, those who went on to develop delirium 
postoperatively had lower levels of CSF IL-6, IL-1ra and Flt-3L (FMS-like tyrosine kinase 3 
ligand) than those who did not (Westhoff, Witlox et al. 2013). A comprehensive review of 
studies of the inflammatory response in delirium is found in section 1.6.6-1.6.7. 
In this exploratory study a multiplex assay approach was used to ask the following research 
questions: :  
1) Are levels of pro-inflammatory cytokines (IL-1β, IL-2, IL-6, IL-7, IL-8, IL-12p70, 
Interferon (IFN)-γ, Granulocyte macrophage colony stimulating factor (GM-CSF) and 
Tumour Necrosis Factor (TNF)-α) elevated in CSF in delirium after hip fracture? 
2) Are levels of anti-inflammatory cytokines (IL-4, IL-5, IL-10, IL-13) reduced in CSF 
in delirium after hip fracture? 
Post hoc subgroup analyses also asked the following question: 
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1) Is there greater elevation in pro-inflammatory cytokines in those with delirium 
superimposed on dementia compared to delirium only, dementia only or neither? 
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5.2 Methods 
 
5.2.1 Participant recruitment 
Participants with acute hip fracture aged over 60 were recruited in an opportunistic manner 
by researchers in two related studies. The first was in the Orthopaedic Trauma Unit at the 
Royal Infirmary of Edinburgh. The second was in the Emergency Department of Oslo 
University Hospital and was part of a trial of orthogeriatric versus standard orthopaedic care 
following hip fracture (Oslo Orthogeriatric Trial, OOT) (Watne, Torbergsen et al. 2014). 
Details of subjects in each study are as follows: 
Edinburgh study (CDHIP): Inclusion criteria were age over 60 and preoperative with acute 
hip fracture. Exclusion criteria were: nursing home resident, significant Parkinson’s disease, 
major communication difficulties (aphasia, English not first language), those taking inhaled 
or oral steroids in the last 10 weeks, moribund on admission. I approached and recruited all 
participants. 
Oslo study (OOT): Fractures as a result of high energy or multi-trauma were excluded. As 
with the Edinburgh study, those taking inhaled or oral steroids in the last 10 weeks 
(retrospective exclusion for the purposes of the present analysis), or who were moribund on 
admission were excluded. Participants were approached and recruited by members of the 
Orthopaedic trauma team. 
On both sites, written informed consent was obtained from participants or their nominated 
next of kin if capacity to give informed consent was lacking. Ethical approval was obtained 
from Scotland A Research Ethics Committee (reference no. 09/MRE00/28) and the Regional 
Committee for Ethics in Medical and Health Research, Norway.  
Seventy-six participants (N=46 from Edinburgh and N=30 from Oslo) were age-matched, 
50% who ever developed delirium during the perioperative period and 50% who never 
developed delirium.  For financial reasons, only one Luminex plate could be purchased at the 
time. Therefore only N=76 participants were included and were age-matched to remove one 
potential confounding factor. 
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5.2.2 Delirium assessment 
In both sites, participants were assessed for delirium preoperatively, using a semi-structured 
interview with cognitive testing, review of casenotes and discussion with nursing or medical 
staff to complete the Confusion Assessment Method (Inouye, Vandyck et al. 1990) (CAM). 
The specific additional assessments in each site were as follows: 
Edinburgh: Conscious level was assessed with the Observational Scale of Level of Alertness 
and Richmond Agitation Sedation Scale, there was additional assessment of attention 
(Edinburgh Delirium Test Box 1 (Brown, Fordyce et al. 2010)) and cognitive testing was 
with the Mini-Mental State Examination (Folstein, Folstein et al. 1975) with assessment of 
delirium severity using the Delirium Rating Scale Revised-98 (Trzepacz, Mittal et al. 2001). I 
performed all in-patient delirium assessments. 
Oslo: Additional cognitive testing and assessment of delirium severity was with the 
Memorial Delirium Assessment Scale (Breitbart, Rosenfeld et al. 1997). Patients were 
classified as delirious if they scored positive on the CAM and fulfilled DSM IV criteria. 
Assessments were performed by a Geriatrician and small team of research nurses. 
In Edinburgh, participants were again assessed for delirium daily from postoperative days 1-4 
and on days 7 and once between days 10-14 or until transfer to a rehabilitation unit or 
discharge from hospital if these occurred sooner. In Oslo, participants were assessed daily 
until postoperative day 5 or until delirium-free. 
5.2.2.1 Diagnosis of delirium 
In both sites, patients were classified as delirious if they fulfilled DSM-IV criteria, informed 
by the CAM assessment process.  
5.2.3 Assessment of prior dementia, function and co-morbidities 
The Informant Questionnaire on Cognitive Decline in the Elderly (Jorm and Jacomb 1989) 
(IQCODE), a well-validated and widely used measure of pre-morbid cognition, was 
completed during a meeting with next of kin or other appropriate informant. I completed 
these in Edinburgh and Leiv Otto Watne in Oslo. A cut-off score of ≥3.44 (average score) 
was used to indicate evidence of probable prior dementia (Harwood, Hope et al. 1997). 
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Illness severity was estimated with the Age, Physiology and Chronic Health Evaluation 
(APACHE) II score (Knaus, Draper et al. 1985), which was modified in both centres in that: 
arterial PO2 was not recorded in either centre because arterial blood gas sampling is not 
routine in patients with hip fracture. In addition in Oslo, haematocrit was not recorded as it is 
not routinely reported locally. Chronic disease burden was estimated with the Charlson Co-
morbidity Index (Charlson, Pompei et al. 1987). Independence in personal activities of daily 
living was assessed with the Katz index of PADL (Katz, Ford et al. 1963) in Edinburgh, as 
discussed in section 2.6.3, and with the Barthel index (Mahoney and Barthel 1965) in Oslo. 
To harmonise these two scales, independence in PADL was defined as a Katz category A or 
B, or a Barthel score of ≥19. Information was also collected on type of fracture and the 
operation performed.  
5.2.4 Sample collection 
At the time of the operation to repair the hip fracture, if this was performed under spinal 
anaesthetic, the anaesthetist collected a sample of CSF after placement of the spinal needle 
and prior to the injection of anaesthetic agents. The sample was placed in a polypropylene 
universal container and put on ice. Samples were centrifuged as soon as possible at 1000 rpm, 
4 oC for 10 minutes and stored in aliquots in polypropylene eppendorfs at -80 oC until 
assayed.  
5.2.5 Cerebrospinal fluid assay 
A high sensitivity Milliplex MAP human cytokine assay (HSCYTO 13-plex, Merck 
Millipore) was performed using a Luminex 200 reader (Biorad), as described in section 2.9.3. 
I completed the assay in Edinburgh. Samples from each participant were measured in 
singlicate due to sample availability and cost. The Luminex assay measured a panel of 13 
cytokines, comprising IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, IL-13, 
Interferon (IFN)-γ, Granulocyte macrophage colony stimulating factor (GM-CSF) and 
Tumour Necrosis Factor (TNF)-α. Assay characteristics are described in section 2.9.3. 
5.2.6 Statistical analysis  
Normality of distribution of the results was checked with histogram and Kolgomorov-
Smirnov test. Any non-normally distributed cytokines were Log10 transformed. Group 
comparisons were performed with Student’s t test for normally distributed variables, with 
Mann-Whitney U test for non-parametric continuous variables, and Pearson Chi-squared for 
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categorical variables. Results are expressed as mean (standard deviation) or median 
(interquartile range). Correlations were tested using Pearson correlation between raw 
cytokine values (if normally distributed) or log-transformed cytokine values (if non-normally 
distributed), to see whether members of the same cytokine groups changed together. In order 
to adjust for potential confounders, a logistic regression analysis model was built for CSF IL-
5, using preoperative delirium as the dependent variable, using an Enter method. Co-variates 
were chosen if they were shown to be different between groups in the univariate analyses. 
The Statistical Package for the Social Sciences (SPSS) version 19.0 was used for data 
analysis. A value of p<0.05 for each analyses was considered significant, because the 
analyses were pre-specified. 
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5.3 Results 
Seventy-six participants were age-matched (N=46 from Edinburgh, N=30 from Oslo), 24 
men and 52 women. Table 5.1 shows the baseline characteristics of the combined sample. 
Median age was 83.5 years (IQR 77.8-87.3) in the delirium group and 83.5 years (IQR 78.0-
88.0) in the no delirium group (p=0.831). Twenty-three participants developed delirium 
preoperatively, and 38 (50%) developed delirium at any stage in the perioperative period. 
Twenty participants had evidence of prior dementia (known diagnosis of dementia and/or 
IQCODE ≥3.44). The delirium group were more likely to have evidence of prior dementia, 
they were less functionally independent, and had higher acute illness severity (modified 
APACHE II) and greater chronic illness burden (CCI). 
IL-1β was not detected by the assay, IL-2 was detected in 14/76 patients, IL-4 in 1/76 
patients, IL-5, IL-6 and IL-8 in 76/76, IL-7 in 75/76, IL-10 in 71/76, IL-12p70 and IL-13 in 
2/76, IFN-γ in 69/76, GM-CSF in 11/76 and TNF-α in 52/76. Further analysis was therefore 
not possible for IL-1β, IL-2, IL-4, IL-12p70, IL-13 or GM-CSF. Where the remaining 
cytokines were not detected, the manufacturer’s reported lower limit of detection was used. 
Analyses were also performed with undetected cytokines set at 0pg/ml, and both approaches 
resulted in the same results in all cases. 
No difference was found between those with and without preoperative delirium for the 
majority of the detected cytokines (Table 5.2). The only statistically significant difference 
was that IL-5 was lower in the group with preoperative delirium [mean 0.770 pg/ml (SD 
0.342)] than in the group without [mean 1.013 pg/ml (SD 0.506)], p=0.045. There was no 
difference found in any of the cytokines between those who developed delirium at any stage 
in the perioperative period compared to those who did not (Table 5.2). IL-8 was higher in 
those with delirium preoperatively compared to those without delirium, but this was not 
significant. Levels of IL-6 were very similar between groups.  
When groups with and without prior dementia were compared, regardless of delirium status, 
no difference was found for any of the detected cytokines between groups (Table 5.3). 
A subgroup analysis of the groups with and without prior cognitive impairment was also 
performed. In those with prior dementia, no difference was found for any of the cytokines 
Cortisol and inflammation in delirium and cognitive decline after hip fracture 
CSF levels of inflammatory cytokines in delirium after hip fracture 209 
between those with and without delirium (Table 5.4a). In those with no evidence of prior 
dementia, there was also no difference found for any of the cytokines between those with and 
without delirium (Table 5.4b). 
Pearson’s correlation between the cytokines revealed that many of the cytokines correlated 
positively with each other. The pro-inflammatory cytokines IL-6 and TNF-α correlated 
significantly, and also correlated with the pro-inflammatory chemokine IL-8. The T-helper 2 
cytokines IL-5 and IL-10 correlated with each other. However, the T-helper 1 cytokines IL-7 
and IFNγ did not correlate significantly with each other.
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Table 5.1 A table showing the baseline characteristics of patients with and without delirium 
at any stage 
 Delirium, N=38 
Median (Interquartile range) 
No delirium, N=38 
Median (Interquartile range) 
p value Test 
statistic 
Age 83.5 years (IQR 77.8-87.3) 83.5 years (IQR 78.0-88.0) 0.831a 702c  
Female N=23 (61%) N=29 (76%) 0.139b 2.19d 
IQCODE score Total 52.5 (IQR 48.8-61.0) 
Average 3.28 (IQR 3.05-3.81) 
Total 48.0 (IQR 48.0-50.5) 





Alcohol Units/week  0 (IQR 0-4.25) 0 (IQR 0-2.50) 0.972a 719c 
Type of 
accommodation 
House or flat N=34 
Sheltered housing N=1 
Nursing home N=3 
Hospital N=0 
House or flat N=34 
Sheltered housing N=3 





N=22 (58%) N=32 (84%) 0.011b 6.40d 
Katz basic ADL score 
/6 (Edinburgh) 
6 (IQR 5-6) 6 (IQR 6-6) 0.030a 194c 
Barthel basic ADL 
score /20 (Oslo) 
18 (IQR 15-19) 19 (IQR 18-20) 0.023a 58.0c 
Modified APACHE II 
score 
9.00 (IQR 7.75-11.00) 8.00 (IQR 6.00-11.00) 0.049a 535c 
Charlson Co-
morbidity Index 
1.00 (IQR 0.75-2.25) 0.50 (IQR 0-1.25) 0.011a 488c 







Type of surgery Hemiarthroplasty N=24 
Internal fixation N=14 
Total hip replacement N=0 
Hemiarthroplasty N=16 
Internal fixation N=19 
Total hip replacement N=3 
0.069b 5.36d 
aMann-Whitney-U test, bPearson Chi-square 
cMann-Whitney-U test statistic, dPearson Chi-square test statistic 
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Table 5.2 CSF levels of cytokines in patients with and without delirium preoperatively, and 
delirium at any stage. Results expressed as mean (standard deviation), Student’s t test p 
value. 













IL-5, pg/ml 0.77 (0.34) 1.01 (0.51) 0.045 0.86 
(0.33) 
1.02 (0.58) 0.150 
IL-6, pg/ml 29.4 (24.0) 28.3 (51.3) 0.882 29.7 
(26.2) 
27.5 (32.1) 0.747 
IL-7, pg/ml 2.19 (1.08) 2.68 (1.35) 0.129 2.42 
(1.18) 
2.65 (1.39) 0.444 











0.74 (0.70) 0.66 (0.58) 0.602 0.75 
(0.58) 
0.63 (0.65) 0.416 
IFN-γ, pg/ml 4.45 (8.36) 3.24 (2.32) 0.331 3.91 
(6.60) 
3.31 (2.46) 0.599 
Log10 TNF-α, 
pg/ml 









TNF: Tumour Necrosis Factor
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Table 5.3 CSF levels of cytokines in patients with and without evidence of prior dementia 
according to IQCODE ≥3.44. Results expressed as mean (standard deviation), Student’s t test 
p value. 






IL-5, pg/ml 0.91 (0.34) 0.95 (0.52) 0.755 
IL-6, pg/ml 20.4 (15.5) 32.0 (32.3) 0.128 
IL-7, pg/ml 2.28 (1.25) 2.63 (1.31) 0.303 
IL-8, pg/ml 115.4 (55.8) 126.9 (98.2) 0.622 
Log10 IL-10, pg/ml 0.73 (0.45) 0.68 (0.67) 0.773 
IFN-γ, pg/ml 2.53 (2.11) 4.00 (5.65) 0.260 
Log10 TNF-α, pg/ml -0.673 (0.417) -0.618 (0.589) 0.704 
IQCODE: Informant Questionnaire of Cognitive Decline in the Elderly 
IL: Interleukin 
IFN: Interferon 
TNF: Tumour Necrosis Factor
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Table 5.4a Subgroup analysis of CSF levels of cytokines in patients with evidence of prior 
dementia (IQCODE ≥3.44), with and without delirium preoperatively, and with and without 
delirium at any stage. Results expressed as mean (standard deviation), Student’s t test p 
value. 
Cytokine Group with prior dementia. 
Preoperative delirium, mean (SD) 
Group with prior dementia. 














IL-5, pg/ml 0.81 (0.33) 1.03 (0.34) 0.153 0.88 (0.31) 1.02 (0.49) 0.512 
IL-6, pg/ml 18.7 (16.9) 22.6 (14.3) 0.590 20.8 (16.3) 19.1 (13.8) 0.848 
IL-7, pg/ml 1.80 (0.89) 2.86 (1.42) 0.058 2.22 (1.33) 2.50 (0.98) 0.701 











0.69 (0.54) 0.78 (0.34) 0.658 0.66 (0.48) 1.00 (0.12) 0.193 










IQCODE: Informant Questionnaire of Cognitive Decline in the Elderly 
IL: Interleukin 
IFN: Interferon 
TNF: Tumour Necrosis Factor 
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Table 5.4b Subgroup analysis of CSF levels of cytokines in patients without evidence of 
prior dementia (IQCODE <3.44), with and without delirium preoperatively, and with and 
without delirium at any stage. Results expressed as mean (standard deviation), Student’s t test 
p value. 
Cytokine Group without prior dementia.  
Preoperative delirium, mean (SD) 
Group without prior dementia. 













IL-5, pg/ml 0.75 (0.37) 1.01 
(0.54) 
0.126 0.85 (0.35) 1.02 (0.60) 0.237 
IL-6, pg/ml 39.2 (25.9) 30.1 
(33.9) 
0.391 36.2 (30.2) 29.3 (33.8) 0.440 
IL-7, pg/ml 2.54 (1.16) 2.65 
(1.36) 
0.805 2.56 (1.06) 2.67 (1.47) 0.753 











0.80 (0.85) 0.65 
(0.63) 
0.505 0.81 (0.66) 0.60 (0.68) 0.263 
IFN-γ, pg/ml 6.21 (11.3) 3.39 
(2.40) 
0.127 4.95 (8.40) 3.37 (2.57) 0.316 
Log10 TNF-α, 
pg/ml 







IQCODE: Informant Questionnaire of Cognitive Decline in the Elderly 
IL: Interleukin 
IFN: Interferon 
TNF: Tumour Necrosis Factor 
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Table 5.5 Pearson’s correlation between raw or Log10-transformed cytokines measured in 
CSF, N=76 
 














































IFNγ      r=0.554 
p<0.001 
r: Pearson’s correlation statistic 
IL: Interleukin 
IFN: Interferon 
TNF: Tumour Necrosis Factor 
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5.3.1 Logistic regression analysis 
The demographic variables shown to be different between groups with and without delirium 
were IQCODE, modified APACHE II score, CCI and independence in activities of daily 
living (Table 5.1). A logistic regression model was built to adjust for the effect of these 
variables on the association between CSF IL-5 level and development of delirium 
preoperatively. The Wald statistic, odds ratios with 95% confidence intervals and p values for 
the logistic regression model are shown in Table 5.6, along with pseudo-R2 values. There was 
only a trend towards significance for CSF IL-5 after adjusting for co-variates (odds ratio 4.00, 
p=0.095) (Table 5.6). There was no evidence of collinearity, and there were no concerns over 
goodness of fit (Hosmer-Lemeshow test p=0.277). 
Table 5.6 Multivariate logistic regression analysis for CSF IL-5, built to adjust for the 
potential confounding effect of illness severity (modified APACHE II), co-morbidity (CCI), 
functional status (Katz or Barthel index) and prior dementia (IQCODE) on delirium status. 
The dependent variable was the development of delirium preoperatively.  
Co-variate CSF IL-5 model 
Wald ORa 95% CIb of ORa p value 
IQCODE total score 3.78 0.92 (0.84-1.00) 0.052 
Modified APACHE 
II score 
1.17 0.88 (0.70-1.11) 0.279 
CCI 1.97 0.74 (0.48-1.13) 0.161 
Independence in 
personal ADLs 
4.32 3.94 (1.08-13.36) 0.038 
CSF IL-5 2.79 4.00 (0.79-20.35) 0.095 
Constant 2.77 0.10   
IQCODE: Informant Questionnaire of Cognitive Decline in the Elderly 
APACHE: Acute Physiology, Age and Chronic Health Evaluation 
CCI: Charlson Co-morbidity Index 
ADL: Activities of Daily Living 
IL: Interleukin 
aOR: Odds ratio, bCI: Confidence interval. Pseudo-R2: Cox and Snell 0.29, Nagelkerke 0.41 
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5.4 Discussion 
 
The findings of this study generally did not support the hypotheses that there would be an 
increase in pro-inflammatory cytokines and a decrease in anti-inflammatory cytokines in CSF 
in delirium after hip fracture. There was evidence of reduced IL-5 levels in the group with 
preoperative delirium, where delirium was active at the time of sample collection. This 
difference was consistent with the study hypothesis, however after adjusting for potential 
confounders, IL-5 was no longer associated with the development of preoperative delirium. 
The results of the logistic regression analysis suggested that in this cohort, loss of 
independence in activities of daily living was associated with preoperative delirium, 
suggesting more dependent, potentially frailer patients were more vulnerable to delirium with 
an odds ratio of 3.94 (p=0.038).  
IL-5 is a primarily anti-inflammatory cytokine. It is part of the T-helper 2 cytokine response 
with IL-4, IL-10 and IL-13. It acts to stimulate B cell proliferation and immunoglobulin 
production to suppress inflammation (Ochi, Osoegawa et al. 2002). It also stimulates 
eosinophils and is a mediator of vascular permeability. The reduction in IL-5 in those with 
active delirium may represent a lack of a healthy anti-inflammatory response, perhaps 
relating to underlying dementia or frailty. Immunosenescence, a complex process in which 
immune function is attenuated by advancing age, includes reduced production of IL-5 and 
other cytokines from T-helper 2 lymphocytes (Gruver, Hudson et al. 2007). However, since 
both groups were age-matched, this should have limited the influence of ageing on results. 
There is also evidence of reduced immune-responsiveness in dementia; peripheral blood cells 
isolated from patients with Alzheimer’s dementia have been found to produce less IL-5 
(along with another T-helper 2 cytokine IL-13 and several pro-inflammatory cytokines) than 
age-matched controls (Richartz, Stransky et al. 2005).  
This study did not replicate the results of MacLullich et al of higher CSF IL-8 in delirium, 
although the direction of change in those with active delirium was towards higher IL-8 in 
delirium. Previous studies of CSF IL-6 in delirium are at odds with the present findings, with 
higher IL-6 in delirium associated with a flare of Systemic Lupus Erythematosus (Katsumata, 
Harigai et al. 2007), and lower IL-6 in those with acute hip fracture who are about to develop 
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delirium postoperatively (Westhoff, Witlox et al. 2013). However, the participants involved 
in those two studies were different, and it may be that different pathophysiological processes 
are involved in delirium in each setting. In particular, neuropsychiatric SLE involves active 
CNS inflammatory processes, particularly during flares (Kasama, Odai et al. 2008). Given 
that our cohort is more comparable to the Westhoff study, one might expect that this study 
would find lower IL-6, however the direction of change in the present study was to higher IL-
6 levels in delirium, but this difference was slight and non-significant.  
There are several potential explanations for the present negative results. The results may 
reflect a genuine lack of changes in the measured cytokines in the CNS in delirium in the 
population of hip fracture patients that can be detected in CSF. This could either be because 
there is no alteration in the central inflammatory response or because changes in cytokine 
signalling are at a brain cellular level and not detectable in CSF. Another possibility is that 
the magnitudes of any changes were too small to be detected in a study of this size, and with 
the relatively insensitive multiplex assay method used. In particular the present study may be 
too small to robustly examine differences in cytokines between those with delirium 
superimposed on dementia, delirium only, dementia only and those with neither delirium nor 
dementia, where the microglial priming hypothesis would suggest that those with delirium 
superimposed on dementia should have the greatest CNS pro-inflammatory response to 
peripheral insults such as hip fracture. However, this study is larger than many of the 
previous studies of CSF biomarkers in delirium, and of a comparable size to other CSF 
studies in other neurological conditions. Another explanation is that the severity of delirium 
was not sufficient, and that changes in CSF cytokines are only measurable in severe delirium 
or after prolonged delirium. Finally, it is possible that there is change in the inflammatory 
profile in CSF in only some patients. Delirium has highly heterogeneous and overlapping 
aetiologies (Laurila, Laakkonen et al. 2008). In the present study, there are several potential 
aetiologies in each patient, including: trauma, concurrent illnesses on admission to hospital 
(infection, etc.), pain, analgesic drugs, psychological stress, dehydration, etc. It is possible 
that inflammatory pathways were only implicated in some patients, and this study was not 
sufficiently large to detect this. The fact that many of the cytokines correlated with each other 
and with other family members suggests that the assay was biologically valid. T-helper 2 
cytokines did not correlate with each other, which may be because different pathways were 
active in these patients. 
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Future studies should involve larger cohorts, and different settings. Control groups for 
comparison could include matched elective surgical patients, since peripheral trauma may be 
associated with elevated CSF IL-8 (hip fracture patients versus elective lower limb surgery) 
(Chuang, Power et al. 2005), and out-patients with dementia, since many patients with 
dementia develop delirium following hip fracture and other acute insults. Since this study did 
not detect all of the cytokines measured at sufficient levels to analyse, future studies could 
employ more sensitive assays and a wider range of cytokines and chemokines. One could 
also attempt to take account of the likely aetiology of delirium. A standardised method 
measuring all the major precipitating factors of delirium and attributing it to the most likely 
cause might also be a way of identifying whether there is a different inflammatory profile in 
delirium due to certain aetiologies. The profile in different motor subtypes could also be 
examined. Patients with sepsis from a peripheral source, with and without associated 
delirium, could also be compared; a search of the literature found little research on CSF 
cytokines in sepsis except in the setting of meningitis, where CSF cytokines including IL-8, 
Il-1β and TNF-α are markedly elevated (Ostergaard, Benfield et al. 1996, Bociaga-Jasik, 
Garlicki et al. 2012).  
In summary, this exploratory study tested the hypothesis that CSF levels of pro-inflammatory 
cytokines would be higher and anti-inflammatory cytokines would be lower in a group of 
age-matched patients with delirium after hip fracture. The results of the study largely did not 
support this hypothesis. The T-helper 2 anti-inflammatory cytokine IL-5 was found to be 
lower in those who developed delirium preoperatively, but this difference was no longer 
significant after adjusting for important confounders in a multivariate analysis. The fact that 
the cytokines largely correlated with each other and within immunological groups lends 
confidence to this being a meaningful result. Future studies could use more sensitive assays 
and measure a wider range of cytokines, and examine the inflammatory profile in delirium of 
different subtypes and different aetiological groups.  
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6 Chapter 6: Levels of cerebrospinal fluid S100B and tau 
in hip fracture patients with delirium versus controls 
6.1 Introduction 
Delirium is a syndrome of acute central nervous system (CNS) dysfunction which may be 
precipitated by diverse acute peripheral and CNS disorders, and drugs. Delirium is associated 
both with immediate adverse effects, and increased risk of future cognitive impairment and 
acceleration of dementia (MacLullich, Beaglehole et al. 2009). Understanding the CNS 
disturbances underlying delirium as well as potential mechanisms linking delirium with new 
or accelerated neurodegeneration is a priority. However, the pathophysiology of delirium 
remains largely obscure (MacLullich, Ferguson et al. 2008). Increases in cerebrospinal fluid 
(CSF) cortisol, inflammatory markers and other potential biomarkers have been reported 
(Hall, Shenkin et al. 2011), and neuroimaging findings in delirium include ventricular 
enlargement and white matter lesions, suggesting possible neuronal and glial changes (Soiza, 
Sharma et al. 2008), but biological evidence of acute CNS dysfunction in delirium remains 
lacking. 
S100B is a calcium-binding protein found primarily in astrocytes, but also in 
oligodendrocytes, neurons, lymphocytes, ependymal cells and epithelial cells of the choroid 
plexus (Michetti, Corvino et al. 2012), and in some non-CNS sites. S100B is secreted by 
astrocytes under metabolic stress, and has cytokine-like properties. S100B is a biomarker of 
CNS damage: increased CSF and serum S100B are linked with adverse CNS outcomes, 
including complications in neurointensive care patients, lesion volume in traumatic brain 
injury, and poorer outcomes in stroke (Michetti, Corvino et al. 2012).  
Elevated serum S100B has been found in delirium in hip fracture patients (van Munster, 
Bisschop et al. 2010) and in elderly general medical inpatients (van Munster, Korevaar et al. 
2010). In another study no differences in CSF S100B levels were found in a group of elderly 
general medical inpatients with persistent delirium compared with outpatients with 
Alzheimer’s dementia (Caplan, Kvelde et al. 2010) though there was no control group of 
acutely unwell people without delirium. 
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There are no published studies which have compared levels of CSF S100B in acutely unwell 
patients with and without delirium. This is important because CSF S100B levels largely 
reflect astroglial activation and are likely more representative of a CNS origin of S100B. 
Tau is a microtubule associated protein which is primarily located in neuronal axons. It may 
undergo several post-translational changes including phosphorylation, and 
hyperphosphorylated tau aggregates are more neurotoxic (Clavaguera, Grueninger et al. 
2014). Several neurodegenerative diseases involve pathological inclusions of tau aggregates, 
most notably Alzheimer’s dementia, but also progressive supranuclear palsy, corticobasal 
degeneration and frontotemporal dementia (Clavaguera, Grueninger et al. 2014). In a mouse 
model, anaesthesia-induced hypothermia induced massive tau hyperphosphorylation, 
suggested as a possible cause of postoperative cognitive dysfunction and acceleration of 
dementia after surgery (Planel, Richter et al. 2007).Tau is widely used as a CSF biomarker 
for Alzheimer’s dementia; a recent meta-review reported that the majority of studies 
demonstrate increased levels of the order of 300% in patients with Alzheimer’s dementia vs. 
healthy controls (Ferrerira, Perestelo-Perez et al. 2014). It is not specific for dementia, 
however, more a reflection of neuronal loss. Tau level correlates with brain atrophy and age 
(Randall, Mosconi et al. 2014). 
In delirium, a borderline significant elevation in serum tau levels has been found in critically 
ill patients with “non-inflamed” delirium (van den Boogaard, Kox et al. 2011). In CSF, 
Witlox et al found no association between tau or phosphorylated-tau and the risk of 
postoperative delirium in patients with hip fracture (Witlox, Kalisvaart et al. 2011). Xie et al 
measured the ratios of β-amyloid-40/tau and β-amyloid-42/tau in CSF in patients undergoing 
elective arthroplasty, and found that those in the lowest quartile of both ratios (suggesting 
lower β-amyloid and/or higher tau, although neither marker is reported alone) had higher 
incidence and greater delirium symptom severity (Xie, Swain et al. 2014). 
This study asked the following research questions: 
1) Are CSF S100B and tau levels higher in elderly patients with delirium following 
acute hip fracture compared to those without delirium? 
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2) Are higher baseline salivary and CSF cortisol levels associated with higher CSF 
S100B levels?  
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6.2 Methods 
 
6.2.1 Participant recruitment and cognitive assessment 
Participants with acute hip fracture aged over 60 years were recruited prospectively but not 
consecutively by a geriatrician (RJH) in an acute orthopaedics ward in Edinburgh, Scotland, 
between 2009 and 2011, as described in chapter 2. Exclusion criteria were: nursing home 
resident, co-morbid disease with prognosis of less than one year, Parkinson’s disease, 
corticosteroid prescription or inability to communicate in English. Informed consent was 
obtained from participants or legal proxies. Ethical approval was obtained from Scotland A 
Research Ethics Committee. Delirium was assessed with a semi-structured interview 
supplemented with assessments of level of consciousness (Richmond Agitation Sedation 
Scale), attention (Edinburgh Delirium Test Box), and cognition (Mini-Mental State 
Examination). Delirium was diagnosed with the Confusion Assessment Method and the 
Delirium Rating Scale Revised-98 (DRS-R98); considered present with a positive CAM 
score or a total DRS-R98 score of >17.75. Assessments took place preoperatively, on the day 
of surgery, and then daily from postoperative days 1-4 and on days 7 and once between days 
10-14 or until transfer to a rehabilitation unit or discharge from hospital. The Informant 
Questionnaire on Cognitive Decline in the Elderly (IQCODE) was used to ascertain prior 
cognitive impairment. The APACHE (Age, Physiology and Chronic Health Evaluation) II 
score was used to estimate acute illness severity preoperatively; the score was modified by 
removing arterial PO2 because arterial blood gas sampling is not routine in patients with hip 
fracture. 
6.2.2 Sample collection 
Saliva was collected preoperatively at two timepoints, 0800-1000 and 1500-1700, if this was 
feasible in the time before hip fracture repair. CSF was collected using the spinal needle prior 
to the injection of anaesthetic agents. A paired serum sample was collected at the time of 
spinal anaesthetic. CSF and serum samples were placed in polypropylene containers and put 
on ice, then centrifuged at 1000 rpm for CSF and 3000 rpm for serum at 4oC for 10 minutes 
and stored at -80 oC. 
Cortisol and inflammation in delirium and cognitive decline after hip fracture 
Cerebrospinal fluid S100B and tau in delirium 224 
6.2.3 Assays 
CSF S100B was measured using a validated in-house Enzyme-Linked Immunosorbent Assay 
(ELISA), and tau using a commercially-available ELISA at the National CJD Surveillance 
Unit, Edinburgh, UK (Green, Keir et al. 1997), by Alison Green and Mary Andrews. The 
original intention had been to also measure CSF β-amyloid and phosphorylated-tau, however 
due to budgetary restrictions, only total tau and S100B were measured. Cortisol was 
measured in CSF, serum and saliva using ELISA (CSF and saliva: Salimetrics, serum: MP 
Biomedicals) by RJH.  
6.2.4 Statistical analysis  
S100B and tau results were log-transformed due to non-parametric distribution, and 
following log-transformation, normality of distribution was checked with Kolgomorov-
Smirnov test. Group comparisons between those with and without delirium during the 
preoperative period, and at any stage in the perioperative period, were then performed with 
Student’s t test. Correlations between raw CSF S100B and tau levels and baseline measures 
of delirium severity (DRS-R98 severity score), illness severity (modified APACHE II score) 
and prior dementia (total IQCODE, total MMSE) were tested with Spearman’s Rho. This was 
to test for any acute relationship between severity of delirium and illness, and active CNS 
damage, and to see whether higher levels of the dementia biomarker tau were associated with 
more severe delirium and with worse tests of global cognition with MMSE and of prior 
dementia with IQCODE. Correlations were also tested between raw CSF S100B levels and 
baseline measures of cortisol in CSF, serum and saliva with Spearman’s Rho, to determine 
whether there is a relationship between CNS damage and astrogliosis as measured with 
S100B and activation of the HPA axis. 
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6.3 Results  
 
Forty-five patients were recruited (Figure 6.1). Table 6.1 provides details of the participants. 
Eight (17.8%) participants developed delirium preoperatively, and 19 (42.2%) during the two 
week perioperative period. Age was not significantly different between those with and 
without delirium. Six participants had prior cognitive impairment, with a diagnosis of 
dementia or average IQCODE score ≥ 3.44; all six were in the delirium group, but only two 
had developed delirium preoperatively.  Five of the six patients in the “prior dementia” group 
had a known diagnosis of dementia, of whom three had a diagnosis of Alzheimer’s dementia, 
and two had no aetiology listed in their medical records. 
6.3.1 CSF S100B and tau 
Mean Log10 CSF S100B concentrations were significantly elevated in those with preoperative 
delirium compared to those without delirium (-0.156 (SD 0.238) vs -0.306 (SD 0.162), 
respectively, Student’s t-test t=2.18, df=43, p=0.035) (Figure 6.2). There was no difference in 
Log10 CSF S100B concentrations in those participants who became delirious during the two 
week perioperative period compared to participants who did not become delirious (mean -
0.239 (SD 0.182) vs. -0.308 (SD 0.184), respectively, Student’s t-test t=1.25, df=43, 
p=0.218). Log10 CSF S100B concentrations in those with and without evidence of prior 
cognitive impairment were not different (mean -0.276 (SD 0.192) vs. -0.230 (SD 0.135), 
respectively, Student’s t-test t=-0.559, df=40, p=0.579). 
Mean Log10 CSF tau concentrations were not significantly different in those with 
preoperative delirium compared to those without delirium (2.57 (SD 0.23) vs 2.55 (SD 0.24), 
respectively, Student’s t-test t=0.227, df=43, p=0.821). There was also no difference in Log10 
CSF tau concentrations in those participants who became delirious during the two week 
perioperative period compared to participants who did not become delirious (mean 2.54 (SD 
0.22) vs. 2.57 (SD 0.25), respectively, Student’s t-test t=-0.353, df=43, p=0.726) (Figure 6.3). 
Log10 CSF tau concentrations in those with and without evidence of prior cognitive 
impairment were not different (mean 2.68 (SD 0.33) vs. 2.56 (SD 0.21), respectively, 
Student’s t-test t=1.19, df=40, p=0.243). 
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6.3.2 Correlations 
Neither CSF S100B (rho=0.095, p=0.536) nor tau (rho=-0.222, p=0.143) correlated with 
preoperative DRS-R98 severity score. CSF S100B did not correlate with modified APACHE 
II score (rho=0.009, p=0.952). CSF tau level did not correlate with baseline total MMSE 
score (rho=0.013, p=0.936) nor total IQCODE score (rho=0.045, p=0.778). There was a trend 
towards positive correlation of CSF tau with age (rho=0.264, p=0.079). 
CSF S100B level did not correlate with any of the baseline cortisol measures (CSF cortisol 
rho=0.108, p=0.480, baseline serum cortisol rho=0.205, p=0.181, baseline AM salivary 
cortisol rho=0.200, p=0.606, baseline PM salivary cortisol rho=0.317, p=0.406).  
CSF S100B and tau did not correlate with each other (rho=0.081, p=0.595).
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Table 6.1 showing baseline medical, surgical and functional demographics of the cohort 




Age 81.3 years (SD 6.7) 78.9 years (SD 9.9) 0.377# 43 0.892 
Female N=12 (63%) N=19 (73%) 0.297£ 1 1.089 
IQCODE score Total 54.79 (SD 8.57) 
Average 3.42 (SD 0.54) 
Total 49.35 (SD 1.99) 







Living alone N=8 (42%) N=19 (73%) 0.091£ 2 4.794 
Package of care N=6 (32%) N=8 (31%) 0.954£ 1 0.003 
Mobility at baseline Independent, no aids N=5 
With a stick N=5 
With 2 sticks N=2 
With a mobilator N=7 
Independent, no aids N=16 
With a stick N=7 
With 2 sticks N=2 
With a mobilator N=1 
0.021£ 3 9.742 
Katz basic ADL 
score /6 









8.63 (SD 2.11) 8.08 (SD 2.80) 0.472# 43 0.725 
Charlson Co-
morbidity Index 
1 (IQR 1-2) 1 (IQR 0-2) 0.383$  MWU 
210.5 






0.098£ 4 7.834 
Type of surgery Hemiarthroplasty N=14 
Internal fixation N=5 
Total hip replacement N= 0 
Hemiarthroplasty N=10 
Internal fixation N=15 
Total hip replacement N=1 
0.057£ 2 5.716 
Type of anesthesia Spinal anesthetic N=19 Spinal anesthetic N=26    
 
#Student’s t-test, £Pearson Chi-square, $Mann-Whitney U test. Mean (Standard Deviation) or 
Median (Interquartile Range). IQCODE – Informant Questionnaire of Cognitive Decline in 
the Elderly. ADL – Activities of Daily Living. *APACHE II (Acute Physiology And Chronic 
Health Evaluation II) score modified by removing Arterial Blood Gas result, since this is not 
routinely performed 
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Figure 6.3 Log10 CSF S100B levels in patients with and without delirium at any stage 
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Figure 6.4 Log10 CSF tau levels in patients with and without preoperative delirium 
 
 
Figure 6.5 Log10 CSF tau levels in patients with and without delirium at any stage 
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6.4 Discussion 
 
These results provide novel evidence that S100B, a marker of astrocyte activation and 
potential CNS dysfunction or damage, is elevated in the CSF in patients with current 
delirium. These findings are consistent with two prior studies reporting elevated serum 
S100B in patients with delirium both following hip fracture and in elderly acute medical 
patients (van Munster, Bisschop et al. 2010, van Munster, Korevaar et al. 2010). In those 
studies, serum S100B levels were highest during or after delirium. Consistent with this I 
found the highest levels in CSF samples collected during delirium, although there was no 
correlation between CSF S100B and severity of delirium, suggesting no linear relationship 
between delirium severity and activation of S100B in the CNS. The origin of S100B in the 
serum is uncertain, however, due to non-CNS sources such as adipose tissue. The present 
study suggests a CNS origin for elevated S100B levels in delirium, because the CNS has by 
far the highest concentration of S100B, and peripheral levels are generally lower than the 
levels I found here (Petzold, Keir et al. 2003). Another study comparing acutely unwell 
delirious patients with stable dementia outpatients did not find higher CSF S100B in delirium 
(Caplan, Kvelde et al. 2010) but that finding is not directly comparable with the present study 
because of the lack of an acute control group. 
This study also replicates the findings of Witlox et al that there was no difference in CSF tau 
levels in delirium, nor any relationship with delirium severity. I therefore did not find 
evidence of greater tau release from neurons in active delirium. Dementia is undoubtedly a 
risk factor for delirium (Juliebo, Bjoro et al. 2009), and all six participants with dementia in 
this study also developed delirium during the perioperative period, but I did not find evidence 
of greater tau pathology when those with dementia or those with delirium were compared to 
those without. There was also no relationship between tau and measures of global cognition 
or prior dementia. This may be because of the relatively small numbers of patients in this 
study, or because of different dementia aetiologies in this study, or because factors other than 
tau pathology are responsible for the increased delirium risk in dementia. 
Elevated CSF S100B in delirium may be due to leakage from damaged or dying astrocytes 
and neurons, in which S100B is normally found. However, S100B may also be actively 
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secreted from astrocytes in response to stimuli which may not induce astrocyte damage or 
even dysfunction. Such stimuli include metabolic stress (oxygen and glucose deprivation), 
lipopolysaccharide, pro-inflammatory cytokines interleukin (IL)-1β and tumor necrosis 
factor-(TNF)-α, β-amyloid, and glutamate; expression may be down-regulated by Interferon-
(IFN)-γ and EGF (Epidermal Growth Factor) (Guerra, Tortorelli et al. 2011, Michetti, 
Corvino et al. 2012). This study did not find any relationship between CSF S100B and CSF, 
serum or salivary levels of cortisol, suggesting that the exaggerated stress response seen in 
delirium as discussed in chapters 4 and 7 may not be involved in the astroglial activation 
suggested by elevation of S100B in active delirium. This concurs with previous research in 
rodents suggesting stress-induced serum S100B release is independent of glucocorticoids 
(Scaccionoce, Del Bianco et al. 2004). 
Following release from astrocytes, S100B may have autocrine effects, triggering the release 
of TNF-α and IL-6. Additional cytokine-like activities of S100B are largely transduced via 
RAGE (Receptor for Advanced Glycation Endproducts). S100B may also have direct effects 
on neurons. At low (nanomolar) concentrations, S100B has been found to be largely 
neurotrophic and neuroprotective. However, at higher (micromolar) concentrations, S100B 
exerts neurotoxic effects, by activating RAGE pathways and through the generation of 
reactive oxygen species (Michetti, Corvino et al. 2012). RAGE activation has been 
implicated in multiple disease pathologies, particularly those involving inflammation 
(Guerra, Tortorelli et al. 2011). After stimulation by TNF-α and acting via RAGE, S100B 
activates microglia, and increases IL-1β, TNF-α, and cyclooxygenase-2 expression, thus 
stimulating CNS inflammation. Aberrant CNS inflammatory responses may be important in 
the pathophysiology of delirium (MacLullich, Ferguson et al. 2008). 
If there are acutely elevated S100B levels in delirium, the resultant neurotoxicity could 
plausibly lead to disruption of neurotransmission in critical cognitive attentional pathways. 
Additionally, the acute elevation demonstrated here in delirium may provide a means by 
which delirium and dementia interact, for example through accelerating Alzheimer’s 
dementia. This may be through an acute neurotoxic effect of S100B during the acute phase of 
delirium leading to irreversible damage, the propagation of a CNS inflammatory response as 
described above, or through the increased generation of β-amyloid plaques and 
hyperphosphorylated tau neurofibrillary tangles (Michetti, Corvino et al. 2012).  
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Some limitations of this study must be acknowledged. The sample size was small. The 
patients were old and had all recently suffered hip fracture. I did not assess participants every 
day in the postoperative period, and may have missed brief episodes of delirium. I only found 
a significantly higher level of S100B in those who were already delirious at the time the 
sample was collected, and not in the whole group who became delirious perioperatively. This 
may be because delirium needs to be established, potentially with acute astrocyte activation 
and ongoing CNS dysfunction and perhaps damage, to see a rise in S100B. Also, 
postoperative delirium in emergency patients is more common than delirium in medical 
patients and has a greater range of aetiologies. I did not measure S100B in the serum due to 
the uncertain origin of peripheral measurement, although the comparison of CSF and serum 
levels would be valuable in interpreting serum S100B levels in future studies.  
Although there was no difference in tau levels at baseline and no relationship with delirium, 
these markers were only measured at one timepoint, and tau or phosphorylated tau may have 
risen with prolonged delirium or following the insult of anaesthetic. It would be very difficult 
in practical and ethical terms to measure these CSF markers repeatedly in patients with 
delirium. Although serum tau and phosphorylated tau measurement may have additional 
sources, it may be a more feasible way to look at their relationship with delirium, 
postoperative cognitive change and anaesthetic insult in future studies, ideally in an elective 
cohort with measurement of premorbid cognition. 
This study suggests that delirium is associated with acute CNS dysfunction as measured by 
increased CSF S100B levels. These findings parallel multiple other studies in other 
neurological conditions demonstrating that CSF S100B elevation is a marker of acute CNS 
dysfunction. Through promoting inflammation and other effects, elevated S100B levels may 
be relevant to both acute delirium and its association with longer-term cognitive decline. 
Future work with larger samples and more diverse precipitants will help to further shed light 
on this promising line of enquiry. 
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7 Chapter 7: The relationship between perioperative 
delirium and serum, salivary and CSF cortisol 
7.1 Introduction 
 
Several lines of evidence suggest that there is an exaggerated and prolonged cortisol response 
to stressors in delirium, and there may be flattening of cortisol diurnal rhythm. This has been 
discussed in more detail in section 1.5. It is well recognised that steroids given in clinical 
practice may precipitate delirium and psychosis (Wolkowitz, Reus et al. 1997). Multiple 
stressors relevant to patients with hip fracture, including trauma, surgery, anaesthesia, 
dehydration, infection, pain and psychological stress, may precipitate delirium and activate 
the hypothalamic-pituitary-adrenal (HPA) axis. Of course, activation of the HPA axis is 
necessary in such a physically and psychologically stressful situation as a frail elderly person 
who has fractured their hip. However, an exaggerated activation of the HPA axis with high 
cortisol levels, potentially due to loss of normal negative feedback of the HPA axis as may be 
seen in aging and dementia, or the effect of the serial insults as listed above, may plausibly 
lead to delirium. Elevation of cortisol may be sustained for at least eight weeks after hip 
fracture (Barton, Horan et al. 2001), where up to 53% of patients develop delirium (Bruce, 
Ritchie et al. 2007), however little is known about the relationship between cortisol and 
delirium past the very acute phase, as detailed below. 
Studies examining cortisol levels in delirium have often measured it in serum at one baseline 
timepoint, but it has been shown to be elevated in postoperative delirium following cardiac 
surgery (Mu, Wang et al. 2010) and non-cardiac surgery (Shi, Wang et al. 2010), and in 
patients with critical illness (van den Boogaard, Kox et al. 2011) and acute coronary 
syndrome (Colkesen, Giray et al. 2013). Studies examining serial cortisol levels have found a 
greater rise between pre- and postoperative serum cortisol levels in those with postoperative 
delirium following elective arthroplasty (Cerejeira, Batista et al. 2013), and higher levels over 
several days encompassing a delirium episode following hip fracture (Bisschop, de Rooij et 
al. 2011).  
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Cortisol diurnal rhythm may also be disrupted in delirium, with elevation of evening cortisol 
levels. Loss of normal diurnal rhythm may be seen in dementia, depression and Cushing’s 
disease (Herbert, Goodyer et al. 2006). This is often accompanied by disruption of sleep-
wake cycle, which is almost universally affected in delirium (Meagher, Leonard et al. 2010). 
Flattening of cortisol diurnal rhythm has been demonstrated in postoperative cognitive 
dysfunction following non-cardiac surgery (Rasmussen, O'Brien et al. 2005). Only one 
previous very small study has examined cortisol diurnal rhythm in delirium, where loss of 
diurnal rhythm was found in 3/7 male patients who developed delirium following non-cardiac 
surgery (McIntosh, Bush et al. 1985). No previous study of the HPA axis in delirium has 
taken the detailed measurements of baseline CSF, serial morning serum cortisol and serial 
cortisol diurnal rhythm in saliva, encompassing a delirium episode, that have been measured 
in the present study.  
This study asked the following research questions:  
1) Is delirium after hip fracture associated with high cortisol levels in serum? 
2) Is delirium associated with loss of cortisol diurnal rhythm measured in saliva, with 
elevation in afternoon salivary cortisol levels? 
3) Are the derangements in cortisol levels and cortisol diurnal rhythm more exaggerated 
in those with delirium superimposed on dementia? 
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7.2 Methods 
Participants were recruited and assessed as described in detail in Chapter 2. Assessment for 
delirium was performed preoperatively, and on postoperative days 1, 2, 3, 4, 7 and once 
between days 10-14, unless participants were discharged or transferred to an orthogeriatric 
rehabilitation ward prior to this point. Delirium assessment comprised a semi-structured 
interview with additional testing of cognition, arousal and attention. The Delirium Rating 
Scale Revised ’98 (DRS-R98) was used to assess severity, the Observational Scale of Level 
of Arousal (OSLA) and the Richmond Agitation Sedation Scale (RASS) to assess level of 
consciousness, the Edinburgh Delirium Test Box-1 (EDTB-1) to assess attention and the 
Mini-Mental State Examination (MMSE) to assess global cognition. Diagnosis of delirium 
was by DSM-IV criteria informed by the Confusion Assessment Method (CAM) protocol.  
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) was used to 
assess for prior dementia, and previous diagnoses of dementia were also documented. An 
IQCODE average score cut-off of ≥3.44 was used to suggest prior dementia, and of ≥3.19 to 
suggest prior mild cognitive impairment (MCI). For subgroup analyses, those with probable 
prior MCI and dementia were collapsed into one group. Other variables considered in this 
study were illness severity with the Acute Physiology, Age and Chronic Health Evaluation 
(APACHE) II score, which was modified by omitting the PO2 score, co-morbid illness 
burden using the Charlson Co-morbidity Index (CCI), frailty using a simple frailty score, the 
Rockwood Frailty Index, and function using the Katz scale for personal activities of daily 
living and the Lawton scale of instrumental activities of daily living.  
CSF was collected at the time of spinal anaesthetic as described in section 2.4.2 and chapter 
4. Serum samples were collected at the time of spinal anaesthetic and between 8-10am on day 
4 and once between days 10-14 postoperatively in patients who were still in the orthopaedic 
trauma ward. Diurnal saliva samples were collected at baseline, and on postoperative days 4, 
7 and between days 10-14 postoperatively in patients who were still in the orthopaedic 
trauma ward. Samples were processed and stored as described in section 2.5. Cortisol was 
measured in duplicate (CSF in singlicate) in batches with ELISA (CSF and Saliva: 
Salimetrics, Serum: MP Biomedicals) as described in section 2.9.1, 2.10.1 and 2.11. 
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7.2.1 Univariate analyses 
Normality of distribution was tested using histogram plots and Kolgomorov-Smirnov tests. 
Group comparisons examined cortisol levels in serum and saliva at each timepoint, 
comparing those who did and did not develop delirium during the perioperative period, with 
the Mann Whitney U test. Group comparisons also examined cortisol levels in those who did 
or did not fulfil criteria for delirium on the day of assessment and sample collection, with 
Mann Whitney U test. Further subgroup analyses compared cortisol levels between 
subgroups with delirium superimposed on MCI/dementia, delirium only, MCI/dementia only 
and neither delirium nor MCI/dementia, with the Kruskal Wallis test. A p value of <0.05 was 
considered significant. 
 
7.2.2 Logistic regression modelling statistical methods 
This analysis was performed by Dan Davis. The analysis considered four of blocks time 
where cortisol exposures could be linked to delirium outcomes:  block 1 (days 0 and 1); block 
2 (days 2, 3 and 4); block 3 (day 7); block 4 (single observation between day 10 and 14). The 
outcome was defined as delirium (yes / no) within any of these time blocks. The exposures 
were absolute cortisol (measured by serum) and cortisol AM:PM ratio in saliva. These 
variables were positively skewed, necessitating Loge transformation. Important covariates 
selected a priori were: age, sex, IQCODE-defined dementia (cut-off >3.44) and Charlson Co-
morbidity Index (to index some co-morbidity related predisposing factors) and APACHE II 
score (to assess acute illness-related precipitating factors). The analysis was therefore 
designed to estimate the effect of cortisol levels on delirium, independent of any associations 
with chronic illness burden and acute illness severity. 
 
Logistic regression models were estimated, considering separately each participant and block. 
These observations are not truly independent as observations within participants are 
correlated. To account for this, robust standard errors were estimated, clustering the estimates 
at the participant level. Complete case analysis was used. Missing data were considered 
missing-at-random and correlation matrices were unstructured. Post-estimation testing for 
violation of assumptions included the Hosmer-Lemeshow test for goodness-of-fit. 
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7.2.3 Correlations  
Correlations were also tested between measures of delirium severity (DRS-R98 severity 
score), inattention (EDTB-1 score), level of arousal (OSLA total score) and global cognition 
(MMSE score) and cortisol levels at each time point during the perioperative period, using 
Spearman’s Rho, to determine whether greater HPA axis activation is associated with worse 
scores on the components of the delirium assessment and of global cognition. Correlations 
were also tested between cortisol measures and baseline predisposing and precipitating 
factors including age, number of hours between triage in Accident and Emergency and 
operation, Charlson Co-morbidity Index, number of prescribed medications, APACHE II 
score, IQCODE average score, Katz scale of personal activities of daily living and Lawton 
scale of instrumental activities of daily living, using Spearman’s Rho. This was to investigate 
whether any of these risk factors for delirium may be acting through activation of the HPA 
axis.  
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7.3 Results 
One hundred and eight participants were recruited to the study. During the perioperative 
period, two participants were excluded because their fracture was managed conservatively, 
and one participant was excluded after day 4 because of a significant and unpredicted 
complication which required ICU admission including steroid therapy. One participant died 
and seven participants withdrew consent to continue participating in the study during the 
perioperative period (up to day 10-14). Data and samples were included for participants until 
the point at which they were excluded, withdrawn or died. No serum, CSF or saliva samples 
were available from an additional two participants due to logistical problems or refusal. 
Participant numbers at the day 10-14 timepoint were smaller due to a large proportion of 
patients either having been discharged or moved to an orthogeriatric rehabilitation ward prior 
to this timepoint.  
 
Table 7.1 shows baseline characteristics of the final included cohort of N=104 participants in 
whom at least one biological sample was available. Delirium was diagnosed in N=42 
participants during the perioperative period, N=13 of whom developed delirium prior to their 
operation, and an additional N=29 who developed delirium postoperatively. The delirium 
group were more likely to have dementia, to be more functionally impaired, to be frailer and 
to be taking a higher number of drugs. They had higher illness severity according to 
APACHE II. The delirium group also waited longer for their operation; this may be because 
the delirium group were more likely to have had preoperative medical complications which 
necessitated delays to surgery, or that waiting longer for surgery increases the risk of 
delirium. By examining waiting times in groups with prevalent (developing preoperatively) 
and incident (postoperative only) versus never delirium, the wait was higher in both delirium 
subgroups [prevalent delirium 43 (30-77) hours, incident delirium 40 (31-48) hours, never 
delirium 28 (19-43) hours, Kruskal-Wallis p=0.004, pairwise comparisons adjusted p=0.042 
and p=0.016 respectively]. 
 
Although patients who were intended to have spinal anaesthesia were included in the study, 
for various reasons, some went on to have general anaesthetic. Of the N=104 included 
participants, N=23 had general anaesthetic, N=77 had spinal anaesthetic, and N=4 had both. 
There were no differences in rates of delirium between groups either pre-operatively (which 
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may have influenced anaesthetic choice; Pearson Chi-square 0.624, p=0.732), on post-
operative day one (Pearson Chi-square 1.95, p=0.745) or at any point during the perioperative 
period (Pearson Chi-square 0.452, p=0.798). Participants were not excluded from the study 
on the basis that they had a general anaesthetic, to limit attrition. 
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Table 7.1 Baseline characteristics of the included cohort 
 Delirium, N=42 
Median (Interquartile range) 
No delirium, N=62 
Median (Interquartile range) 
p value Test 
statistic 
Age 83.0 years (77.0-88.3 IQR ) 80.5 years (70.0-87.0 IQR ) 0.147a 1084c  
Female N=24 (57%) N=41 (66%) 0.353b 0.863d 
IQCODE score Total  50 (IQR 48-54) 
Average 3.13 (IQR 3.00-3.38) 
Total 48 (IQR 48-54) 





Dementia status  
(MCI cut-off IQCODE 








Alcohol Units/week  1.5 (IQR 0-6.25) 0.5 (IQR 0-4.00) 0.523a 1212c 
Type of accommodation House or flat N=38 
Sheltered housing N=4 
House or flat N=54 
Sheltered housing N=8 
0.597b 0.280d 
Katz basic ADL score /6  6 (IQR 5-6) 6 (IQR 6-6) 0.043a 1101c 
Lawton instrumental 
ADL score /8  
6 (IQR 4-8) 7 (IQR 6-8) 0.053a 979c 
Rockwood brief frailty 
index  
Independent N=23 
Bladder incontinence N=4 
≥1 other ADL needs N=10 
Two or three ADL needs N=4 
Independent N=47 
Bladder incontinence N=10 
≥1 other ADL needs N=5 
Two or three ADL needs N=0 
0.003b 14.14d 
Number of medications 6 (IQR 4-8.25) 4 (IQR 3-7) 0.022a 959c 
Modified APACHE II 
total score 
9 (IQR 7-11.25) 8 (IQR 6-10) 0.004a 866c 
Charlson Co-morbidity 
Index 
1 (IQR 0-3) 1 (IQR 0-2) 0.095a 1061c 







Type of surgery Hemiarthroplasty N=21 
Internal fixation N=0 
Total hip replacement N=18 
Open reduction and internal 
fixation N=3 
Hemiarthroplasty N=22 
Internal fixation N=7 
Total hip replacement N=33 
Open reduction and internal 
fixation N=0 
0.012b 11.00d 
Waiting time for 
operatione 
41 (30-49) hours (IQR) 28 (19-43) hours (IQR) 0.001a 721c 







aMann-Whitney-U test, bPearson Chi-square, cMann-Whitney U test statistic, dPearson Chi square test statistic 
eTime from triage in Accident and Emergency to operation start time 
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7.3.1 Cortisol levels during the perioperative period 
Cortisol was not normally distributed in serum, saliva or CSF, so non-parametric statistics 
were used. The relationship between delirium and cortisol in CSF is discussed in full in 
chapter 4. Serum cortisol levels rose postoperatively in those with and without delirium 
(Figure 7.1). This rise may be attributable in part to the fact that the baseline serum sample 
was collected at the time of spinal anaesthetic, which could be between 8am and 5pm, 
whereas the subsequent samples were collected between 8am and 10am, closer to the 
circadian peak of cortisol. Median serum cortisol levels were higher in the delirium group at 
each timepoint during the perioperative period, but this was not significant. Serum cortisol 
levels were generally slightly higher in the groups with delirium only and delirium 
superimposed on MCI/dementia during the perioperative period, but this was not significant 
(Table 7.2). When those who did or did not fulfil criteria for delirium on the day of sample 
collection were compared, morning serum cortisol levels were significantly higher in those 
who fulfilled criteria for delirium on postoperative day 4 (Table 7.4). 
 
Morning salivary cortisol was significantly higher in the delirium group preoperatively, but 
the numbers in both groups were small. Postoperatively, morning salivary cortisol levels rose 
in both groups (Figure 7.2), but there was no significant difference between those with and 
without delirium. There was evidence of flattening of cortisol diurnal rhythm in the delirium 
group with a rise in afternoon salivary cortisol; this difference was significant at days 4 and 7 
postoperatively in the whole delirium group, and on postoperative day 4 in those fulfilling 
criteria for delirium on the day of sampling. The AM:PM salivary cortisol ratio was lower in 
the whole delirium group throughout the postoperative period, which was significant on 
postoperative day 4 (Table 7.3), and there was a trend towards significance in those with 
delirium on the day of sampling on postoperative day 4 (Table 7.4). This suggests loss of 
diurnal rhythm, which here persisted past the immediate perioperative period (see chapter 9). 
Subgroup comparisons based on the combination of delirium and MCI/dementia status 
revealed significant differences between salivary cortisol levels measured preoperatively in 
the morning and on day 4 in the afternoon, and in the AM:PM cortisol ratio on day 4. The 
highest cortisol levels were in those with delirium superimposed on MCI/dementia at both 
timepoints, with pairwise comparisons finding a significant difference between subgroups 
with delirium superimposed on MCI/dementia and neither delirium nor MCI/dementia 
(preoperative AM cortisol adjusted p=0.047, day 4 PM cortisol adjusted p=0.020). The 
lowest and therefore most abnormal AM:PM salivary cortisol ratio on day 4 was in the group 
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with delirium only (median ratio 1.4), with similar ratios in the group with delirium 
superimposed on MCI/dementia (median ratio 1.7) and the group with MCI/dementia only 
(median ratio 1.8). Pairwise comparisons did not demonstrate a significant difference 
between subgroups, although there was a trend towards significance between the groups with 
delirium only and neither delirium nor dementia, adjusted p=0.064. 
 
Table 7.2 Morning serum cortisol levels during the perioperative period in those with and 
without delirium, and subgroups with delirium superimposed on MCI/dementia, delirium 
only, MCI/dementia only and neither delirium nor MCI/dementia. Group comparisons are 
with Mann-Whitney U or Kruskal-Wallis at each timepoint. 
Timepoint Median serum cortisol in nmol/L (interquartile range) 
Delirium at any stage Delirium and dementia subgroups 


















































































MWU: Mann-Whitney U test 
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Table 7.3 Diurnal salivary cortisol levels during the perioperative period in those with and 
without delirium, and subgroups based on delirium and dementia status. Group comparisons 
are with Mann-Whitney U or Kruskal-Wallis. 
Timepoint Median salivary cortisol in nmol/L (interquartile range) 
Delirium at any stage Delirium and dementia subgroups 






































































































































































































































MWU: Mann-Whitney U test 
K-W: Kruskal-Wallis test 
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Table 7.4 Cortisol measures during the perioperative period, grouped by those who did or did 
not fulfil criteria for delirium on the day of sampling 
Cortisol measure Delirium on the day, Median cortisol in nmol/L (IQR) 
Yes No MWU, p 
Preoperative AM saliva 8.2, 9.7 N=2 8.2 (6.2-12.4) N=25 20, p=0.689 
Preoperative PM saliva N=0 5.7 (3.7-11.4) N=22  
Preoperative saliva AM:PM ratio N=0 1.42 (1.00-2.48) N=12  
Preoperative  serum 490.7 (389.3-603.8) N=11 463.0 (358.2-606.0) N=77 371, p=0.508 
Day 4 AM saliva 20.1 (12.9-35.4) N=17 15.4 (10.4-26.7) N=63 433, p=0.228 
Day 4 PM saliva 13.0 (10.7-21.9) N=18 8.2 (5.7-11.5) N=54 234, p=0.001 
Day 4 saliva AM:PM ratio 1.6 (1.0-2.6) N=17 2.0 (1.3-2.9) N=52 315, p=0.077 
Day 4 serum 679.4 (517.1-736.5) N=17 524.1 (455.1-654.8) N=66 365, p=0.027 
Day 7 AM saliva 11.6 (10.1-20.0) N=5 14.2 (11.5-23.1) N=57 111, p=0.434 
Day 7 PM saliva 8.0 (4.1-15.8) N=5 7.7 (4.7-12.3) N=53 131, p=0.979 
Day 7 saliva AM:PM ratio 2.1 (0.8-2.7) N=4 1.7 (1.1-2.8) N=47 84, p=0.748 
Day 10-14 AM saliva 9.5, 14.8 N=2 13.0 (9.2-18.2) N=37 33, p=0.826 
Day 10-14 PM saliva 6.8, 8.3 N=2 6.6 (4.2-11.5) N=32 26, p=0.699 
Day 10-14 saliva AM:PM ratio 1.0, 2.0 N=2 1.7 (1.2-2.5) N=31 26, p=0.706 
Day 10-14 serum 478.8, 561.7 N=2 493.3 (419.8-561.5) N=32 24, p=0.602 
MWU: Mann Whitney U test statistic 
IQR: Interquartile range 
Cortisol and inflammation in delirium and cognitive decline after hip fracture 
Perioperative delirium and cortisol in serum, salivary and CSF 246 
Figure 7.1 Serum cortisol levels during the perioperative period, delirium at any stage 































Preoperative serum cortisol ever vs. never delirium MWU=777, p=0.227, postoperative day 4 
serum cortisol ever vs. never delirium MWU=669, p=0.133, postoperative day 10-14 serum 
cortisol ever vs. never delirium MWU=90, p=0.062.  
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Figure 7.2 Cortisol diurnal rhythm (saliva) during the perioperative period, delirium at any 
stage 

























No delirium AM cortisol
No delirium PM cortisol
 
Preoperative AM salivary cortisol ever vs. never delirium MWU=39, p=0.016, PM salivary cortisol ever vs. 
never delirium MWU=56, p=0.867. Postoperative day 4 AM salivary cortisol ever vs. never delirium 
MUW=758, p=0.802, PM salivary cortisol ever vs. never delirium MWU=332, p=0.001. Postoperative day 7 
AM salivary cortisol ever vs. never delirium MWU=488, p=0.945, PM salivary cortisol ever vs. never delirium 
MWU=261, p=0.031. Postoperative day 10-14 AM salivary cortisol ever vs. never delirium MWU=179, 
p=0.886, PM salivary cortisol MWU=102, p=0.147. 
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7.3.2 Logistic regression analysis 
Complete data for logistic regression were available in 73 participants, contributing to 99 
blocks of analysis. Loge-transformation normalised the cohort at the majority of timepoints. 
Serum cortisol was associated with delirium, even after adjustment for predisposing and 
precipitating factors (for each standard deviation increase in Loge-cortisol in serum, odds 
increased 10.9, 95% CI 1.56 to 75.7, p=0.02). The AM:PM cortisol ratio was inversely 
associated with delirium (that is, the lower and more abnormal the AM:PM ratio, the greater 
the risk of delirium), but this was not statistically significant (for each SD increase in cortisol 
AM:PM ratio, OR 0.42, 95% CI 0.15 to 1.23, p=0.11). The presence of dementia (known or 
as ascertained by IQCODE) was associated with an 8.7 fold increase in rate of delirium 
(p<0.01). There were no concerns about goodness-of-fit (p=0.30). 
 
Table 7.5 Logistic regression analysis with delirium as the outcome variable 
Variable Odds ratio Robust SE Z P 95% CI 
Loge of salivary 
cortisol AM:PM ratio 
0.42 0.23 -1.58 0.11 0.15 – 1.23 
Loge of serum cortisol 10.87 10.77 2.41 0.02 1.56 – 75.71 
Dementia (IQCODE) 8.72 6.52 2.90 <0.01 2.02 – 37.75 
CCI 1.04 0.17 0.24 0.81 0.76 – 1.43 
Age 1.02 0.05 0.44 0.66 0.92 – 1.13 
Sex 0.84 0.55 -0.26 0.80 0.24 – 3.01 
APACHE II score 1.09 0.19 0.52 0.60 0.78 – 1.52 
Constant 3.48e-09 2.11e-08 -3.21 <0.01 2.39e-14 – 0.0005 
SE – standard error 
CI – confidence interval 
IQCODE – Informant Questionnaire of Cognitive Decline in the Elderly 
CCI – Charlson co-morbidity index 
APACHE II – Age, Physiology and Chronic Health Evaluation II  
Number of observations – 99 
Pseudo-R2 – 0.204 
 
 
7.3.3 Correlations between the HPA axis and delirium features 
Tables 7.6 and 7.7 show correlations between measures of the HPA axis during the 
perioperative period and features of delirium (delirium severity, level of arousal, inattention 
and global cognition) at each time-point. At baseline, morning salivary cortisol correlated 
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negatively with MMSE score (higher cortisol with worse global cognition). Serum cortisol at 
time of anaesthetic correlated positively with delirium severity (DRS-R98) and level of 
arousal (OSLA) (higher cortisol with worse delirium and more abnormal level of arousal) 
measured at the baseline assessment. Cortisol measured in CSF at the same timepoint also 
correlated positively with DRS-R98 and OSLA. At day 4, DRS-R98 correlated positively 
with afternoon salivary cortisol, and OSLA correlated positively with morning serum cortisol 
and morning and afternoon salivary cortisol. EDTB-1 score correlated with AM:PM salivary 
cortisol ratio (more inattention with a lower and more abnormal ratio). MMSE correlated 
negatively with afternoon salivary cortisol. At day 7, no cortisol measures correlated with any 
of the measures of delirium, arousal, attention or cognition. At day 10-14, DRS-R98 and 
OSLA correlated positively with afternoon salivary cortisol, suggesting less of the normal 
afternoon dip in cortisol with more severe delirium and abnormal arousal.  
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Table 7.6 Correlations between baseline and day 4 measures of cortisol in serum, saliva and CSF, and measures of delirium severity, level of 
arousal, inattention and global cognition 
Cortisol measure Baseline Day 4 
DRS-R98 OSLA EDTB-1 MMSE DRS-R98 OSLA EDTB-1 MMSE 
Morning serum 

















































































































    
 
R = Spearman’s Rho 
DRS-R98 = Delirium Rating Scale Revised ’98; OSLA = Observational Scale of Level of Alertness 
EDTB-1 = Edinburgh Delirium Test Box-1; MMSE = Mini-Mental State Examination 
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Table 7.7 Correlations between postoperative day 7 and day 10-14 measures of cortisol in serum and saliva, and measures of delirium severity, 
level of arousal, inattention and global cognition 
Cortisol measure Day 7 Day 10-14 
DRS-R98 OSLA EDTB-1 MMSE DRS-R98 OSLA EDTB-1 MMSE 






















































































R = Spearman’s Rho 
DRS-R98 = Delirium Rating Scale Revised ‘98 
OSLA = Observational Scale of Level of Alertness 
EDTB-1 = Edinburgh Delirium Test Box-1 
MMSE = Mini-Mental State Examination 
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7.3.4 Correlations between cortisol measures and delirium 
predisposing and precipitating factors 
There was a positive correlation between age and CSF cortisol (rho=0.289, p=0.019), and 
serum cortisol at baseline (rho=0.347, p=0.001), and also with PM salivary cortisol on day 7 
(rho=0.334, p=0.010) and AM salivary cortisol on day 14 (rho=0.371, p=0.020). Number of 
hours from triage in Accident and Emergency to operation correlated with preoperative 
cortisol AM:PM ratio (rho=0.662, p=0.019) and with preoperative serum cortisol (rho=0.234, 
p=0.031). APACHE II score at baseline correlated positively with afternoon salivary cortisol 
on postoperative days 4 (rho=0.297, p=0.011) and 7 (rho=0.347, p=0.008). IQCODE average 
score correlated inversely with AM:PM cortisol ratio on day 4 (rho= -0.258, p=0.033). Katz 
personal ADL score correlated inversely with preoperative serum cortisol (rho= -0.272, 
p=0.010) and negatively with postoperative day 4 afternoon salivary cortisol (rho= -0.231, 
p=0.049). Lawton instrumental ADL score correlated inversely with CSF cortisol (rho= -
0.301, p=0.016) and with postoperative day 10-14 afternoon salivary cortisol (rho= -0.463, 
p=0.006) and AM:PM ratio (rho=0.459, p=0.007). Charlson co-morbidity index did not 
correlate with any of the cortisol measures, and the number of prescribed medications on 
admission did not correlate with baseline cortisol measures. 
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7.4 Discussion 
This study found several significant relationships between cortisol and delirium. These 
findings will now be summarised, followed by a discussion of their implications. 
Morning serum cortisol was elevated in the delirium group throughout the perioperative 
period, peaking on day 4 postoperatively. This difference was statistically significant only for 
those with active delirium on postoperative day 4. When longitudinal serum cortisol 
measures were examined in the multivariate logistic regression analysis, it was found to be 
associated with delirium after adjusting for age, gender, illness severity, co-morbidity and 
dementia status. However, due to the number of participants, although several important co-
variates were included, there may have been other factors influencing cortisol profile such as 
waiting time for operation, type of anaesthetic or functional level which could not be 
accounted for. 
Morning salivary cortisol was higher in the delirium group preoperatively, and rose in both 
groups postoperatively. Afternoon salivary cortisol levels were significantly higher in the 
delirium group on postoperative days 4 and 7, and in those with active delirium on 
postoperative day 4. There was consequent flattening of the cortisol diurnal rhythm (as 
indicated by a lower AM:PM ratio), with an attenuation of the diurnal nadir, with a lower 
AM:PM ratio in the delirium group throughout the perioperative period, which was 
significant on postoperative day 4. The highest afternoon cortisol levels were in the group 
with delirium superimposed on dementia/MCI and then the delirium only group, and the 
lowest AM:PM ratio was in the delirium only group, followed by the delirium on 
dementia/MCI group. The multivariate logistic regression analysis found a trend towards 
significance for a lower cortisol AM:PM ratio in the delirium group after adjusting for co-
variates. Baseline APACHE II score was shown to correlate with afternoon salivary cortisol 
level on postoperative days 4 and 7, and it may be that illness severity has an influence on the 
loss of cortisol diurnal rhythm in delirium. 
Cortisol in CSF and serum at baseline correlated with delirium severity and level of arousal. 
Postoperatively, on days 4 and 10-14, afternoon salivary cortisol correlated positively with 
delirium severity and level of arousal, suggesting more severe delirium and more abnormal 
arousal with higher and therefore abnormal afternoon cortisol levels There were more 
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consistent relationships between cortisol measures and measures of arousal and delirium 
severity than with inattention or global cognition, suggesting HPA axis activation may be 
more involved in some features of delirium than others. 
The results of the correlations tested between predisposing and precipitating factors of 
delirium and cortisol measures suggest that the longer a patient waits from arrival in hospital 
to operation, the greater the activation of the HPA axis, potentially due to more opportunity 
for exposure to stress, pain and other activators of the HPA axis, which would likely impact 
on delirium risk. Higher illness severity scores, worse IQCODE (prior dementia) scores and 
worse functional ADL scores were all associated with greater failure of cortisol diurnal 
rhythm to reach its nadir, and may be factors influencing this loss of diurnal rhythm in 
delirium or in acute illness. Co-morbidity and polypharmacy do not seem to have a particular 
impact on the HPA axis in this cohort. 
In summary, these findings provide support for the hypothesis that there is an exaggerated 
and sustained hypothalamic-pituitary-adrenal axis cortisol response to stress in delirium. This 
elevation in cortisol release was both central in CSF (see chapter 4) and peripheral as 
measured in serum and saliva. This study is also the first I am aware of to examine cortisol 
diurnal rhythm in delirium longitudinally, and suggests that there is maintained circadian 
drive in the AM, with a failure to shut down cortisol release in the PM. There are several 
possible reasons for this change which are not mutually exclusive, including the effects of 
stress or acute illness, impaired negative feedback on the HPA axis or impaired metabolism 
or clearance of cortisol. 
In previous studies where cortisol has been measured at a single timepoint, usually 
preoperatively or on admission, it has been shown to be associated with postoperative 
delirium after cardiac surgery (Mu, Wang et al. 2010) and non-cardiac surgery (Shi, Wang et 
al. 2010), and to be elevated in those with delirium associated with acute coronary syndrome 
(Colkesen, Giray et al. 2013), elective cardiac surgery (Plaschke, Fichtenkamm et al. 2010) 
and critical illness (Pfister, Siegemund et al. 2008, van den Boogaard, Kox et al. 2011). 
Longitudinal studies have shown that high preoperative levels of serum cortisol before 
elective cardiac surgery predict risk of postoperative delirium (Kazmierski, Banys et al. 
2013). Those who develop delirium post-abdominal surgery have higher cortisol levels 
(Kudoh, Takese et al. 2005), and in patients undergoing elective arthroplasty, a greater rise in 
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serum cortisol from pre-op to post-op was associated with a greater risk of developing 
delirium (Cerejeira, Batista et al. 2013). In hip fracture, CSF cortisol taken at induction of 
anaesthetic has been shown to be elevated in those who develop delirium perioperatively 
(Pearson, de Vries et al. 2010), and in serial serum samples encompassing a delirium episode, 
to be higher in those with delirium but not after adjusting for prior dementia (Bisschop, de 
Rooij et al. 2011).  
There are several potential consequences of sustained elevation in cortisol levels. 
Peripherally, this elevated cortisol promotes a pro-catabolic state which may hamper physical 
and functional recovery from hip fracture and increase vulnerability to infection. These 
catabolic effects could be expected to be worse in those who had delirium. In the CNS, 
sustained elevation of cortisol levels over weeks to months may be associated with 
hippocampal atrophy, and on a cellular level cortisol increases neuronal vulnerability to cell 
damage from other insults, and reduces neuronal cell dendritic length and cell volume (Tata 
and Anderson 2010). Increased HPA axis activity (morning plasma cortisol) has also been 
shown to be associated with more rapid deterioration in cognitive test scores in patients with 
Alzheimer’s dementia (Csernansky, Dong et al. 2006). 
Failure of cortisol levels to fall in the PM  could potentially disrupt sleep-wake cycle, and 
such disruption  is extremely common in delirium (Meagher, Moran et al. 2007). It would 
also mean that the potentially harmful effects of exposure of cells to elevated cortisol levels 
for sustained periods would be more prolonged, without the normally observed reduction of 
levels in the evening. Indeed, higher evening cortisol levels in a population-based study have 
been shown to be associated with cognitive impairment (Johar, Emeny et al. 2015). Cortisol 
diurnal rhythm has not been examined in detail before in delirium. However in an early study 
McIntosh et al demonstrated loss of circadian rhythm of cortisol and β-endorphin in three of 
seven male patients who developed delirium in surgical intensive care after non-cardiac 
surgery (McIntosh, Bush et al. 1985). Dysregulation of cortisol and control of the HPA axis 
in delirium is further suggested by the demonstration of abnormal dexamethasone 
suppression tests in delirium in patients with lower respiratory tract infection (O'Keeffe and 
Devlin 1994) and delirium superimposed on dementia (Robertsson, Blennow et al. 2001), 
with failure of dexamethasone to suppress cortisol levels. In elderly patients with delirium 
associated with a lower respiratory tract infection, this loss of negative feedback of the HPA 
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axis persisted up to eight weeks later, even when the acute illness and delirium episode had 
resolved (O'Keeffe and Devlin 1994). 
In postoperative cognitive dysfunction, Rasmussen et al found a similar pattern of change in 
cortisol diurnal rhythm with elevation in both morning and afternoon levels and significant 
flattening of the circadian rhythm at one week after non-cardiac surgery in patients who 
developed postoperative cognitive dysfunction (Rasmussen, O'Brien et al. 2005). Although 
the Rasmussen study did not assess specifically for postoperative delirium, it is possible that 
some of these patients had delirium as well as POCD. Comparable perioperative timepoints 
in this study and the Rasmussen study are preoperative and postoperative day 7; given the 
small numbers of preoperative samples in this study, these values are difficult to compare. At 
day 7, median morning salivary cortisol values are very similar in those with delirium, POCD 
and no delirium/POCD. Median day 7 afternoon salivary cortisol, which was elevated in 
POCD in the Rasmussen study, is higher still in delirium as measured in this study.  
There are some limitations of this study which must be acknowledged. Although participants 
were assessed regularly for delirium, with timings aimed to balance accurate and sensitive 
delirium diagnosis with the burden to participants, due to the fluctuating nature of delirium, 
some mild or short episodes may have been missed. Although the multivariate logistic 
regression analysis aimed to adjust for known important predisposing and precipitating 
factors for delirium, due to the numbers of participants and datapoints it was not possible to 
include all co-variates, and the influence of waiting time for operation, type of anaesthetic 
and functional level in particular could not be accounted for. There are also missing serum 
and saliva samples at all timepoints, but in particular the preoperative saliva samples and day 
10-14 samples. Preoperatively, because patients were often recruited on the morning of 
surgery, and were fasting, it was often only possible to attempt one saliva sample collection 
(if any, due to requisite AM and PM sample time windows), and these were sometimes dry or 
declined. By day 10-14, participants were often either discharged or transferred to an 
orthogeriatric rehabilitation facility. To address this, an ethical amendment was submitted 
early in the study to widen the time window of this assessment from day 14 only to days 10-
14. This increased the number of participants assessed at this time-point, but numbers were 
still relatively small. Numbers in subgroups with dementia only and delirium superimposed 
on dementia are also small, and the subgroup analyses must be viewed as exploratory. The 
majority of participants with probable dementia in this study developed delirium. Although 
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patients intended for spinal anaesthesia were included in the study, for various reasons some 
went on to have general anaesthesia and a small number had both. There was no difference in 
rates of delirium based on anaesthetic type, in keeping with a recent systematic review and 
meta-analysis which did not find any difference in the odds ratio of developing post-operative 
delirium between patients who had regional or general anaesthesia (Mason, Noel-Storr et al. 
2010). There is some evidence that regional anaesthesia reduces surgical stress 
intraoperatively and during the immediate postoperative period. Patients undergoing total hip 
replacement under combined spinal and epidural anaesthesia had lower intraoperative cortisol 
than those under general anaesthesia (Lattermann, Belohlavek et al. 2005), a small trial of 
spinal versus general anaesthesia in laparoscopic cholecystectomy also found lower 
intraoperative cortisol levels (Das, Bhattacharya et al. 2015), and high spinal blockade for 
cardiac surgery has been shown to be associated with lower cortisol levels until 4h post-
operatively (Lee, Grocott et al. 2003). However, epidural versus general anaesthesia was not 
found to influence urinary corticol excretion during the intraoperative period or over the first 
24h postoperatively in patients undergoing lower limb revascularisation (Breslow, Parker et 
al. 1993), and no difference was found in cortisol levels 24h after haemorroidectomy in those 
who had spinal or general anaesthesia (Buyukkocak, Caglayan et al. 2006). Kudoh et al 
examined HPA axis response to epidural versus general anaesthetic in patients with 
schizophrenia undergoing abdominal surgery. They found lower cortisol levels in the epidural 
group 15 minutes after skin incision and at the end of surgery, but by post-operative days 1 
and 2 there was no longer any difference (Kudoh, Takese et al. 2003). There is therefore 
some evidence that the immediate cortisol stress response to surgery is lower with regional 
anaesthesia, however less is known about the effects after 24-48h postoperatively. At the 
timepoints tested in this study, anaesthetic type may be less likely to have had a signficiant 
impact. With greater participant numbers, it would be ideal to account for anaesthetic type in 
multivariate analysis, and further research is needed into the influence of anaesthetic type on 
stress reponse to surgery beyond the immediate perioperative period. 
This is an observational study, and causation cannot be firmly established. This is important 
because delirium itself is stressful, and could therefore plausibly lead to increased cortisol 
release. The results of the logistic regression analysis suggest that cortisol level is predictive 
of delirium status at the next time it was assessed. The fact that this relationship was still 
significant after adjusting for important covariates including acute illness severity and 
chronic illness burden also suggest that the elevation of cortisol seen in delirium is not 
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necessarily just a marker of how “sick” someone is. Due to the relatively small sample size, I 
was unable to adjust for other covariates which have been shown to particularly affect 
salivary cortisol measurement, such as season, smoking and sociodemographic status 
(Vreeburg, Kruijtzer et al. 2009, Arsenault-Lapierre, Chertkow et al. 2010).  
In conclusion, this study lends further support to the hypothesis that there is greater activation 
of the HPA axis in delirium. Serum cortisol was elevated in those with delirium on the day of 
sampling postoperatively, and serum cortisol level predicted delirium development after 
adjusting for important predisposing and precipitating factors. Cortisol levels in serum 
correlate with measures of delirium severity and arousal. This study is unusual in that it has 
assessed cortisol levels longitudinally in delirium, and in multiple modalities. It concurs with 
previous longitudinal studies of serum cortisol in delirium following hip fracture (Bisschop, 
de Rooij et al. 2011) and elective arthroplasty (Cerejeira, Batista et al. 2013), but I found that 
the relationship was independent of the co-variates measured including prior cognition. This 
is also the most detailed study to date of longitudinal cortisol diurnal rhythm in delirium. 
There is evidence of flattening of cortisol diurnal rhythm in delirium, with elevated afternoon 
levels, and lower AM:PM cortisol ratio. There was a trend to significance for the relationship 
between delirium and AM:PM cortisol ratio after adjusting for covariates. Subgroup analyses 
suggest that this loss of diurnal rhythm is in those with delirium alone and delirium 
superimposed on dementia. Future studies could compare these cortisol levels with patients 
with and without dementia undergoing elective surgery, to assess the impact of the hip 
fracture trauma on the HPA axis, and also with out-patients with dementia. It would also be 
possible to make a more detailed assessment of cortisol diurnal rhythm with more salivary 
cortisol measurements through the 24hour period, with additional samples collected on 
wakening and at bedtime. This could perhaps be done in a more focussed study of cortisol 
diurnal rhythm to minimise any additional burden on participants, either during elective 
surgery with accurate baseline assesement or in medical in-patients, patients with stroke or 
patients with hip fracture during a delirium episode.  
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8 Chapter 8: The relationship between delirium and 
peripheral inflammatory markers 
 
8.1 Introduction 
This study explores the peripheral (serum) inflammatory response in patients with delirium 
after hip fracture. Infection and trauma, including surgery, are common precipitants of 
delirium and induce an inflammatory response in the host. Features of sickness behaviour 
have much in common with delirium in the elderly, and delirium has been proposed as a 
maladaptive sickness behaviour response (Cunningham and MacLullich 2013). Animal 
modelling has shown delirium-like behavioural changes in older mice and mice with 
neurodegenerative disease in response to a peripheral inflammatory stimulus (Godbout, Chen 
et al. 2005, Cunningham, Campion et al. 2009). In the central nervous system in these mice, 
the peripheral inflammatory stimulus leads to an exaggerated central inflammatory response, 
due to the activation of “primed” microglia. 
Studies examining serum cytokines and chemokines in delirium have found mixed results. In 
hip fracture specifically, the pro-inflammatory cytokine interleukin (IL)-6 and pro-
inflammatory chemokine IL-8 have been shown to be elevated in serum in those with 
delirium (Beloosesky, Hendel et al. 2007, van Munster, Bisschop et al. 2010, MacLullich, 
Edelshain et al. 2011), but not in all studies (Lemstra, Kalisvaart et al. 2008). Delirium after 
cardiac surgery is associated with higher levels of chemokines (Rudolph, Ramlawi et al. 
2008), and delirium after elective arthroplasty with a higher pro/anti-inflammatory ratio 
(Cerejeira, Nogueira et al. 2012). 
Some of these studies only measured inflammatory markers at a single timepoint, and few 
have measured inflammatory profile after the immediate perioperative period; CRP and IL-8 
have been measured up to 30 days post-hip fracture in one study (Beloosesky, Hendel et al. 
2007). By measuring several serum cytokines and chemokines at three timepoints during the 
perioperative period, with frequent and detailed assessments for delirium, this study aims to 
capture any change in inflammatory profile during delirium. Also, by examining 
inflammatory profile up to one year post-hip fracture, this study will be able to explore 
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whether there might be evidence of a persistent inflammatory response after delirium, and 
explore the relationship with persistent symptoms of delirium. 
This study therefore asked the following research questions: 
1) Is delirium after hip fracture associated with derangements of inflammatory markers 
in serum, specifically:  
 1a) High levels of pro-inflammatory cytokines? 
 1b) Low levels of anti-inflammatory cytokines? 
 1c) High levels of chemokines? 
2) Is there an imbalance in the ratio of pro to anti-inflammatory cytokines, in favour of a 
pro-inflammatory state? 
3) Do any differences in inflammatory profile persist in the delirium group during the 
year post-hip fracture? 
4) What is the relationship between inflammatory markers and morning serum cortisol 
and cortisol AM:PM ratio measured at the same timepoints?  
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8.2 Methods 
Patients were recruited and assessed for delirium as described in Chapter 2. Serum samples 
were collected at the time of  anaesthetic induction (baseline) and between 8-10am on day 4 
and once between days 10-14 postoperatively, and between 8-10am at the follow-up visits at 
3, 6 and 12 months after hip fracture. Saliva samples for cortisol were collected between 
0800-1000 (AM) and between 1500-1700 (PM) at baseline, postoperative days 4, 7, and 10-
14, and at 3, 6 and 12 months. Samples were processed and stored as described in section 
2.5.2. Ten cytokines and chemokines were measured by Luminex assay (R&D) as described 
in section 2.10.2. The manufacturers’ (R&D) recommendations on sample collection and 
storage for measurement of cytokines in serum are that samples are allowed to clot for 30 
minutes at room temperature, centrifuged and stored immediately; samples were processed 
and stored as soon as possible. Cortisol was also measured with ELISA in serum (MP 
Biomedicals) and saliva (Salimetrics) as described in sections 2.10.1 and 2.11 respectively.  
The cytokines and chemokines measured in the Luminex assay were as follows:  
 IL-1 (interleukin-1), a pro-inflammatory cytokine 
 IL-1ra (interleukin-1 receptor antagonist), the endogenous antagonist of IL-1β 
 IL-5, a T-helper 2 anti-inflammatory cytokine that stimulates B cell growth and 
immunoglobulin production 
 IL-6, a pro-inflammatory cytokine 
 IL-8 (also known as CXCL8), a chemokine produced by macrophages that induces 
chemotaxis of neutrophils and other granulocytes towards infection 
 IL-10, a T-helper 2 anti-inflammatory cytokine 
 MIP-1 (macrophage inflammatory protein 1, also known as CCL3), produced by 
macrophages after stimulation with bacterial endotoxin 
 MIP-1 (macrophage inflammatory protein 1, also known as CCL4), produced by 
macrophages after stimulation with bacterial endotoxin  
 MCP-1 (monocyte chemoattractant protein 1, also known as CCL2), which recruits 
monocytes, memory T cells and dendritic cells to the site of inflammation 
 TNF- (tumour necrosis factor ), a pro-inflammatory cytokine, a key player in the 
acute phase response 
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The minimum detectable dose (MDD) for the respective inflammatory markers were as 
follows: IL-1: 0.27pg/ml, IL-1ra: 4.05pg/ml, IL-5: 0.33pg/ml, IL-6: 0.36pg/ml, IL-8: 
0.39pg/ml, IL-10: 0.13pg/ml, MCP-1: 0.16pg/ml, MIP-1: 8.11pg/ml, MIP-1: 0.44pg/ml, 
TNF-: 0.60pg/ml.  
8.2.1 Group comparisons 
Normality of distribution was tested using histogram plots and Kolgomorov-Smirnov tests. 
Group comparisons first examined individual raw cytokine or chemokine levels in serum at 
each timepoint, comparing those who did and did not develop delirium at any stage during 
the perioperative period, with Mann Whitney U test. The pro/anti-inflammatory ratio of 
cytokines was also calculated as previously described by Cerejeira et al, with the following 
formula, using raw values: (IL-1β+TNF-α+IL-6+IL-8)/IL-10 (Cerejeira, Nogueira et al. 
2012). The difference between pro/anti-inflammatory ratio during the perioperative period 
was then tested with Mann-Whitney U test. In addition to group comparisons between the 
whole group who developed delirium during the perioperative period versus the group who 
did not, group comparisons were also performed at each sampling timepoint between those 
who did or did not have active delirium on that day.  
Group comparisons were also performed for individual cytokines and chemokines during the 
follow-up period, and this grouping took into account whether or not the patient had 
developed delirium during the preceding time period, i.e. up until 3, 6 or 12 months. 
Subgroup comparisons were also tested between patients with delirium superimposed on 
dementia/mild cognitive impairment (MCI), delirium only, dementia/MCI only, and neither 
delirium nor dementia/MCI, with Kruskal-Wallis test.  
Further exploratory analyses were also performed where a difference was found in levels of 
inflammatory markers, in order to adjust for the effects of potentially important confounding 
variables including important predisposing and precipitating risk factors for delirium. 
Analysis of covariance was used with the log-normalised cytokine or chemokine value as the 
dependent variable, delirium status as the fixed factor, and age, gender, prior dementia 
(known diagnosis or IQCODE ≥3.44), Charlson co-morbidity index and modified-APACHE 
II score as covariates. A full factorial model was used with Type IV sum of squares to take 
account of missing values. Individual models were constructed for each significant result. 
The models used for cytokines and chemokines measured during the follow-up period did not 
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include baseline APACHE II score as a covariate, since this was an acute measure of illness 
severity at baseline. 
8.2.2 Inflammatory marker subgrouping 
Following the precedent of a study by Rudolph et al which investigated whether there was a 
difference in the postoperative inflammatory response of patients with and without delirium 
after cardiac surgery, cytokines and chemokines were divided into subgroups and analysed 
further (Rudolph, Ramlawi et al. 2008). The three subgroups, chosen a priori and based on 
the known roles of the cytokines and chemokines within the inflammatory response were: 
1. Pro-inflammatory cytokines: IL-1, IL-6, TNF- 
2. Anti-inflammatory cytokines: IL-1ra, IL-5, IL-10 
3. Chemokines: IL-8, MIP-1, MIP-1, MCP-1 
 
Due to skewed data, all cytokines and chemokines were first log-normalised. At each 
timepoint, the log-normalised cytokines were standardised to the mean of the no-delirium 
group at the same timepoint, to produce a marker Z score, with the following equation:  
Marker Z score = (Log-cytokine value – Mean of no delirium group at same timepoint) / 
standard deviation of no delirium group at same timepoint 
A class Z score was then calculated for each subgroup of cytokines or chemokines, at each 
timepoint, by calculating the mean marker Z score for each subgroup. Student’s t-test was 
then applied, comparing the class Z scores between those with and without delirium at any 
stage. 
To investigate the inflammatory response to the hip fracture surgery, the postoperative 
change in cytokine or chemokine level was calculated, by subtracting the log-normalised 
cytokine value at baseline from the log-normalised cytokine value at postoperative day 4. 
This postoperative change was then standardised to the mean change in the no delirium group 
to produce the Change Z score, using the following equation: 
Change Z = (postoperative change in log-normalised cytokine – no delirium group mean 
postoperative change) / no delirium group standard deviation of postoperative change 
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Class Change Z scores were then calculated for the three subgroups, and Student’s t test 
applied to compare the standardised postoperative change in cytokine and chemokine classes 
between those with and without delirium at any stage. 
8.2.3 Correlations 
Finally, correlations were tested between measures of delirium severity (DRS-R98 severity 
score), inattention (EDTB-1 score), level of arousal (OSLA total score) and global cognition 
(MMSE score) and the individual cytokines and chemokines measured contemporaneously at 
baseline, day 4 and days 10-14 postoperatively, and at 3, 6 and 12 months follow-up, using 
Spearman’s Rho. This was to determine whether worse scores on components of the delirium 
assessment were associated with more disruption in the inflammatory profile, i.e. higher pro-
inflammatory cytokines and chemokines and lower anti-inflammatory cytokines. Correlations 
were also tested with Spearman’s Rho among the cytokines and chemokines themselves at 
each timepoint to assess whether markers with a biological relationship change together, 
which would increase the likelihood that any findings were biologically plausible. 
Correlations were also tested with serum cortisol, collected at the same time, and AM:PM 
cortisol ratio measured in saliva on the same day, with Spearman’s Rho, to assess the 
relationship between HPA axis activation and loss of diurnal rhythm with activation of 
inflammation. Finally, correlations were tested between CSF (as measured in a different 
Luminex assay as described in chapter 5) and baseline serum cytokines with Spearman’s 
Rho, to examine whether the relationship between the central and peripheral release of 
cytokines is maintained, or lost, the latter suggesting different central and peripheral 
processes, in keeping with the neuroinflammatory hypothesis This is limited by the use of 
different assays, however. 
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8.3 Results 
One-hundred and eight participants were enrolled into the study. Two participants were 
excluded due to non-operative treatment as they would not be comparable to the rest of the 
cohort, and a further participant was excluded after day 4 due to an unpredictable and 
significant complication which required ICU admission and steroid therapy. During the 
perioperative period, one participant died and N=7 participants withdrew consent to continue 
participating. As discussed in Chapter 7, although patients intended for spinal anaesthesia 
were included, some went on to have general anaesthesia or both; these participants were not 
excluded from further follow-up on this basis. Data and all available samples were used for 
participants up until the point of withdrawal, exclusion or death. Serum samples were 
available for N=84 participants at baseline, N=83 at day 4 and N=34 between days 10-14. 
Delirium was diagnosed in N=42 participants, N=13 preoperatively (prevalent delirium) and 
N=29 postoperatively (incident delirium). Table 7.1 in chapter 7 shows demographic 
characteristics at baseline of the included cohort of N=104 participants who had at least one 
biological sample. As discussed in chapter 7, the delirium group was more likely to have 
dementia, to be more functionally impaired, frailer and be on more medication. They had 
higher illness severity according to APACHE II. The delirium group also waited longer for 
their operation, which may have been both a cause (longer wait increasing risk of incident 
delirium) and effect of delirium (longer wait due to medical complications delaying surgery 
in those with prevalent delirium). During the follow-up period, two participants who had not 
developed delirium during the perioperative period were found to have developed new 
delirium at one of the follow-up assessments, one participant at 3 months and one at 6 
months. 
8.3.1 Detection of inflammatory markers 
During the perioperative period, the majority of cytokines were detected in most or all 
samples. IL-5 and MIP-1α were detected in around a half to two thirds of samples. During the 
follow-up period, levels of most cytokines and chemokines were lower, and in particular 
levels of IL-5, IL-10 and MIP-1α were very low or undetected. All original values were used 
in the analysis.  
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8.3.2 Inflammatory profile during the perioperative period 
All the cytokines and chemokines were not normally distributed so non-parametric statistics 
were used for raw data group comparisons. Table 8.2 shows the results of group comparisons 
for individual cytokines and chemokines and the pro/anti-inflammatory ratio between those 
who did or did not develop delirium during the perioperative period. Figures 8.1 to 8.10 show 
individual serum cytokine and chemokine levels during the perioperative period, comparing 
the groups who did or did not develop delirium at any stage. 
 
8.3.2.1 Univariate analyses 
IL-1ra and IL-6 levels were significantly higher in the delirium group at baseline and at day 
10-14. IL-8 levels were significantly higher in the delirium group throughout the 
perioperative period (day 0 – day 10-14). MIP-1β levels were higher in the delirium group at 
day 10-14. The pro/anti-inflammatory ratio rose slightly in both groups postoperatively, and 
it was higher in the delirium group throughout the perioperative period, suggesting a shift to a 
pro-inflammatory state. There was no difference in IL-1β, TNF-α, IL-5, IL-10, MCP-1 and 
MIP-1α between those who did or did not develop delirium at any stage in the perioperative 
period.  
Levels of serum inflammatory markers at each timepoint were also compared between those 
who did or did not have active delirium on the day of sampling, as shown in Table 8.3. At 
baseline, those with active delirium had lower levels of MIP-1β than those who did not. On 
postoperative day 4, those with active delirium had higher levels of IL-6, IL-8 and TNF-α, 
and a higher pro/anti-inflammatory ratio than those without delirium. On postoperative day 
10-14, numbers with active delirium were very small (N=2), however levels of IL-1β were 
still significantly higher in delirium than in those without.  
8.3.2.2 Multivariate analyses 
As an exploratory analysis, cytokines where there was a group difference in the initial 
univariate analysis were chosen for Analysis of Covariance to adjust for potential 
confounders. The log-normalised cytokine or chemokine value was the dependent variable, 
delirium status the fixed factor, and age, gender, prior dementia, Charlson co-morbidity index 
and modified-APACHE II score were covariates. The results of the ANCOVA tests are 
shown in Table 8.4 for group comparisons between those with delirium at any stage from day 
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0 to day 10-14 postoperatively, and Table 8.5 for group comparisons between those with and 
without active delirium on the day of assessment. 
After adjusting for covariates, delirium at any stage from day 0 – day 10-14 remained 
significantly associated with LogIL-6 and LogMIP-1β at postoperative day 10-14. 
After adjusting for covariates, LogMIP-1β was still associated with active delirium at 
baseline, there was a trend towards significance between LogIL-6 and active delirium on day 
4, and LogIL-1β was still associated with active delirium on day 10-14. 
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Table 8.2 Serum cytokine or chemokine levels (raw values) during the perioperative period 
in those with and without delirium at any stage during the perioperative period* 
Cytokine or 
chemokine Baseline, Median (IQR), pg/ml Postoperative day 4, Median 
(IQR), pg/ml 


















































































































































































































































MWU: MannWhitney U test statistic 
*Perioperative period from baseline (time of operation) to day 10-14 postoperatively 
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Table 8.3 Serum cytokine or chemokine levels (raw values) during the perioperative period 
in those with and without active delirium on the day of sampling during the perioperative 
period 
Cytokine or 
chemokine Baseline, Median (IQR), pg/ml Postoperative day 4, Median 
(IQR), pg/ml 



























































































































































0 (0-75.3) 545 
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MWU: MannWhitney U test statistic 
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Table 8.4 Exploratory Analysis of Covariance to adjust for confounders for those cytokines 
and chemokines where there was a significant difference between groups in the univariate 
analysis; delirium at any stage from baseline to day 10-14  
Timepoint Inflammatory 
marker 
Delirium at any 
stage Y/N 
(1, N-1) F 
Delirium at any 
stage Y/N 
P 
Baseline LogIL-1ra (1,75) 1.38 0.244 
LogIL-6 (1,75) 2.78 0.100 
LogIL-8 (1,75) 1.26 0.266 
LogPro/Anti Ratio (1,72) 0.17 0.680 
Day 4 LogIL-8 (1,81) 2.05 0.157 
LogPro/Anti Ratio (1,74) 3.70 0.059 
Day 10-14 LogIL-1ra (1,33) 0.45 0.511 
LogIL-6 (1,33) 5.07 0.033 
LogIL-8 (1,33) 1.55 0.224 
LogMIP-1β (1,30) 4.76 0.039 
LogPro/Anti Ratio (1,30) 0.99 0.329 
 
Analysis of Covariance, with log-normalised cytokine or chemokine as the dependent 
variable, delirium at any stage during the perioperative period as the fixed factor, and age, 
gender, prior dementia (known or IQCODE ≥3.44), modified APACHE II score and Charlson 
comorbidity index as covariates.  
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Table 8.5 Exploratory Analysis of Covariance to adjust for confounders for those cytokines 
and chemokines where there was a significant difference between groups in the univariate 
analysis; delirium active on the day the serum sample was collected  
Timepoint Inflammatory 
marker 
Delirium on the 
day Y/N 
(1, N-1) F 
Delirium on the 
day Y/N 
P 
Baseline LogMIP-1β (1,72) 4.63 0.035 
Day 4 LogIL-6 (1,80) 3.65 0.060 
LogIL-8 (1,80) 0.42 0.519 
LogTNF-α (1,78) 0.42 0.518 
LogPro/Anti Ratio (1,73) 0 0.995 
Day 10-14 LogIL-1β (1,31) 7.34 0.012 
 
Analysis of Covariance, with log-normalised cytokine or chemokine as the dependent 
variable, delirium active on the day of sampling as the fixed factor, and age, gender, prior 
dementia (known or IQCODE ≥3.44), modified APACHE II score and Charlson comorbidity 
index as covariates 
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Figure 8.1 Median serum IL-1β during the perioperative period in those with and without 
delirium at any stage 




























Figure 8.2 Median serum IL-1ra during the perioperative period in those with and without 
delirium at any stage 
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Figure 8.3 Median serum IL-5 during the perioperative period in those with and without 
delirium at any stage 



























Figure 8.4 Median serum IL-6 during the perioperative period in those with and without 
delirium at any stage 
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Figure 8.5 Median serum IL-8 during the perioperative period in those with and without 
delirium at any stage 






























Figure 8.6 Median serum IL-10 during the perioperative period in those with and without 
delirium at any stage 
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Figure 8.7 Median serum MCP-1 during the perioperative period in those with and without 
delirium at any stage 






























Figure 8.8 Median serum MIP-1α during the perioperative period in those with and without 
delirium at any stage 
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Figure 8.9 Median serum MIP-1β during the perioperative period in those with and without 
delirium at any stage 































Figure 8.10 Median serum TNF-α during the perioperative period in those with and without 
delirium at any stage 
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8.3.3 Inflammatory marker subgroup profile during the perioperative 
period 
Table 8.6 shows the Class Z scores for the delirium and no delirium groups for the three 
inflammatory marker subgroups. There was a trend towards a higher Class Z score in 
delirium in the pro-inflammatory subgroup at baseline, and this was significant at day 10-14. 
There was also a trend towards a higher Class Z score in delirium in the anti-inflammatory 
subgroup at day 10-14. There was no significant difference in the chemokine subgroup at any 
timepoint. Table 8.7 shows the Change Z scores (baseline to postoperative day 4) in those 
with and without delirium for the three inflammatory marker subgroups. There was greater 
change between baseline and day 4 in all three subgroups of cytokines and chemokines in the 
delirium group, which was significant in the pro-inflammatory and chemokine subgroups. 
Analysis of covariance, with Class Z score or Change Z score as the dependent variable, 
delirium at any stage during the perioperative period as the fixed factor and age, gender, prior 
dementia (known or IQCODE ≥3.44), Charlson comorbidity index and modified APACHE II 
score as covariates was performed to account for the effect of potentially confounding 
precipitating and predisposing risk factors for delirium. There was no significant relationship 
between delirium and pro-inflammatory Class Z score at day 10-14 after adjusting for 
covariates (F (1,33) 2.22, p=0.148). There was a trend towards significance for 
proinflammatory Change Z score (F (1,64) 3.33, p=0.073). There was no significant 
relationship between delirium and chemokine Change Z score after adjusting for covariates 
(F (1,64) 2.55, p=0.116). 
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Table 8.6 The difference by Student’s t test between class Z scores for the three cytokine and 
chemokine subgroups, between those with and without delirium during the perioperative 
period.  
Inflammatory marker subgroup Timepoint Delirium 
Class Z score 
mean (SD) 
No delirium 






IL-1β, IL-6, TNF-α 
Baseline 0.305 (0.615) 0.008 (0.734) 1.90 0.061 
Day 4 -0.025 (0.904) -0.020 (0.746) -0.03 0.977 
Day 10-14 0.642 (0.759) 0.000 (0.798) 2.40 0.023 
Anti-inflammatory 
IL-1ra, IL-5, IL-10 
Baseline 0.241 (0.721) -0.048 (0.806) 1.65 0.104 
Day 4 -0.328 (0.802) -0.069 (0.731) -1.51 0.134 
Day 10-14 0.765 (1.436) -0.054 (0.882) 2.03 0.051 
Chemokine 
IL-8, MIP-1α, MIP-1β, MCP-1 
Baseline 0.080 (0.452) -0.004 (0.096) 0.59 0.554 
Day 4 -0.012 (0.693) 0.001 (0.683) -0.09 0.932 
Day 10-14 0.359 (0.645) -0.024 (0.817) 1.50 0.143 
 
Table 8.7 The difference by Student’s t test between Change Z scores from baseline to day 4 
for the three cytokine and chemokine subgroups, between those with and without delirium 
during the perioperative period. 
Inflammatory marker subgroup Delirium N=23 
Change Z score mean 
(SD) 
No delirium N=43 






IL-1β, IL-6, TNF-α 
-0.420 (0.842) -0.002 (0.652) -2.24 0.029 
Anti-inflammatory 
IL-1ra, IL-5, IL-10 
-0.371 (0.675) 0.000 (0.806) -1.88 0.065 
Chemokine 
IL-8, MIP-1α, MIP-1β, MCP-1 
-0.405 (0.734) 0.037 (0.890) -2.03 0.046 
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8.3.4 Inflammatory profile during the follow-up period 
8.3.4.1 Univariate analyses 
Table 8.8 shows the results of group comparisons for individual cytokines and chemokines 
measured during the follow-up period, between those who did or did not develop delirium 
during the perioperative period or were found to be delirious at follow-up at assessment at 3, 
6 or 12 months. Figures 8.11 to 8.20 show individual serum cytokine and chemokine levels 
during the follow-up period for the delirium and no delirium groups. As would be expected, 
levels of most of the cytokines and chemokines were lower during the follow-up period than 
in the acute phase post-hip fracture and operation, and some were virtually undetected during 
the follow-up period. Since IL-10 was often undetected during the follow-up period, the 
pro/anti-inflammatory ratio could not be calculated. There was no significant difference 
between groups for most of the inflammatory proteins. Serum IL-6 was significantly elevated 
in the delirium group at 3 months post-hip fracture, and there was a trend towards significant 
elevation at 6 months, but levels were much lower by 12 months. Serum IL-8 remained 
elevated in the delirium group throughout the follow-up period, which was significant at 3 
and 6 months, and a trend towards significance at 12 months. TNF-α also remained elevated 
in the delirium group during the follow-up period, a difference which was significant at 3, 6 
and 12 months.  
8.3.4.2 Multivariate analyses 
Table 8.9 shows the results of the exploratory analysis of covariance tests. After adjusting for 
potential confounders, delirium remained significantly associated with LogIL-8 at 3 months. 
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Table 8.8 Serum cytokine levels during the follow-up period in those who did or did not 
develop delirium during the perioperative period, or during the intervening 3, 6 or 12 months  
Cytokine or 









































































































IL-10 1.0 (0-1.4) 0.4 (0-1.3) 698 
0.371 
0 (0-0.2) 0 (0-0) 577 
0.402 


























MIP-1α 0 (0-37.8) 0 (0-29.8) 719 
0.419 
0 (0-57.1) 0 (0-0) 529 
0.134 
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Table 8.9 Exploratory ANCOVA results for follow-up period cytokines and chemokines 
where there was a group difference in the univariate analysis, delirium at any stage from day 
0 until the timepoint at which the serum sample was collected 
Timepoint Inflammatory 
marker 
Delirium up until 
timepoint Y/N 
(1, N-1) F 
Delirium up until 
timepoint Y/N 
P 
3 months LogIL-6 (1,78) 1.16 0.286 
LogIL-8 (1,78) 5.29 0.024 
LogTNF-α (1,77) 0.30 0.589 
6 months LogIL-8 (1,71) 0.30 0.589 
LogTNF-α (1,69) 0.13 0.719 
12 months LogTNF-α (1,54) 2.18 0.147 
 
Analysis of Covariance, with log-normalised cytokine or chemokine as the dependent 
variable, delirium at any point until the time assessed (i.e. 3, 6 or 12 months) as the fixed 
factor, and age, gender, prior dementia (known or IQCODE ≥3.44) and Charlson comorbidity 
index as covariates. 
Cortisol and inflammation in delirium and cognitive decline after hip fracture 
The relationship between delirium and peripheral inflammatory markers 282 
Figure 8.11 Median serum IL-1β during the study period in those with and without delirium 
at any stage 
 
Figure 8.12 Median serum IL-1ra during the study period in those with and without delirium 
at any stage 
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Figure 8.13 Median serum IL-5 during the study period in those with and without delirium at 
any stage 
 
Figure 8.14 Median serum IL-6 during the study period in those with and without delirium at 
any stage 
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Figure 8.15 Median serum IL-8 during the study period in those with and without delirium at 
any stage 
 
Figure 8.16 Median serum IL-10 during the study period in those with and without delirium 
at any stage 
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Figure 8.17 Median serum MCP-1 during the study period in those with and without 
delirium at any stage 
 
Figure 8.18 Median serum MIP-1α during the study period in those with and without 
delirium at any stage 
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Figure 8.19 Median serum MIP-1β during the study period in those with and without 
delirium at any stage 
 
Figure 8.20 Median serum TNF-α during the study period in those with and without delirium 
at any stage 
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8.3.5 Subgroup analyses of inflammatory profile by delirium and 
dementia status 
Since there were only N=10 participants with likely dementia (known or as defined by 
IQCODE ≥3.44) in the study, and only N=2 of those did not develop delirium, this analysis 
was expanded to include participants with mild cognitive impairment based on IQCODE 
≥3.19 (Li, Jia et al. 2012). Levels of individual cytokines or chemokines were compared 
between subgroups with delirium superimposed on dementia/MCI (IQCODE ≥3.19), 
delirium only, dementia/MCI only and neither delirium nor dementia/MCI, at each timepoint 
with Kruskal-Wallis test. 
8.3.5.1 Inflammatory profile in the perioperative period by delirium and dementia 
status 
At baseline, there was a significant difference in MIP-1α between subgroups, with higher 
MIP-1α in those with neither delirium nor MCI/dementia (delirium on dementia/MCI N=15, 
0pg/ml (0-24.0), delirium only N=13, 0pg/ml (0-53.6), dementia/MCI only N=10, 0pg/ml (0-
7.5), neither N=38, 36.8pg/ml (0-91.5), Kruskal-Wallis p=0.027). Pairwise comparisons did 
not demonstrate any significant differences. There was also a difference in the pro/anti-
inflammatory ratio between subgroups, with the highest ratios in those with delirium 
superimposed on dementia/MCI, similar ratios in those with delirium only or dementia/MCI 
only, and the lowest ratios in those with neither (delirium on dementia/MCI N=14, 28.4pg/ml 
(23.2-45.0), delirium only N=13, 26.1pg/ml (20.5-37.3), dementia/MCI only N=10, 
25.6pg/ml (14.2-33.0), neither N=38 20.0pg/ml (12.5-30.5), Kruskal-Wallis p=0.045). 
Pairwise comparisons did not demonstrate any significant differences, but there was a trend 
towards a difference between delirium superimposed on dementia/MCI and neither (adjusted 
p=0.081). 
At day 4, there were no significant differences in any of the individual cytokines or 
chemokines between subgroups. There was a difference in the pro/anti-inflammatory ratio, 
however, with the same pattern as at baseline (delirium on dementia/MCI N=16, 39.7pg/ml 
(27.9-46.4), delirium only N=15, 30.5pg/ml (22.0-36.7), dementia/MCI only N=13, 
33.6pg/ml (21.0-54.8), neither N=37 21.6pg/ml (15.9-32.7), Kruskal-Wallis p=0.009). 
Pairwise comparisons revealed that this was due to the difference between those with 
delirium superimposed on dementia/MCI and those with neither (adjusted p=0.007).  
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At day 10-14, there was a significant difference between subgroups in serum IL-6, with 
higher levels in both delirium subgroups (delirium on dementia/MCI N=9, 9.8pg/ml (7.4-
16.5), delirium only N=7, 8.7pg/ml (6.7-19.9), neither N=13, 5.2pg/ml (2.6-6.4), 
dementia/MCI only N=5, 3.7pg/ml (2.1-7.6), Kruskal-Wallis p=0.043). Pairwise comparisons 
did not demonstrate any significant differences. There was no significant difference in 
pro/anti-inflammatory ratios between subgroups at day 10-14, but the same pattern was 
evident between groups. 
8.3.5.2 Inflammatory profile in the follow-up period by delirium and dementia status 
At 3 months, there was a significant difference between subgroups in IL-6, with the highest 
levels in those with delirium superimposed on dementia/MCI (delirium on dementia/MCI 
N=17, 7.9pg/ml (4.8-12.8), delirium only N=17, 4.3pg/ml (3.3-8.5), dementia/MCI only 
N=10, 5.4pg/ml (3.6-11.1), neither N=35, 3.9pg/ml (3.4-5.4), Kruskal-Wallis p=0.044). 
Pairwise comparisons revealed that this was due to the difference between those with 
delirium superimposed on dementia/MCI and those with neither (adjusted p=0.030). There 
was also a significant difference between subgroups in serum IL-8, with higher levels in both 
delirium subgroups (delirium on dementia/MCI N=17, 16.1pg/ml (13.0-28.5), delirium only 
N=17, 20.5pg/ml (15.1-26.6), dementia/MCI only N=10, 11.4pg/ml (10.7-17.5), neither 
N=35, 13.2pg/ml (9.6-19.3), Kruskal-Wallis p=0.013). Pairwise comparisons revealed that 
this was due to the difference between those with delirium only and neither delirium nor 
dementia/MCI (adjusted p=0.047).  
At 6 months, there was a difference between subgroups in IL-6, with the same pattern as at 3 
months (delirium on dementia/MCI N=13, 7.8pg/ml (4.2-10.0), delirium only N=14, 
3.5pg/ml (2.7-11.4), dementia/MCI only N=11, 5.4pg/ml (5.0-6.6), neither N=34, 3.9pg/ml 
(2.3-4.5), Kruskal-Wallis p=0.015). Pairwise comparisons revealed that there was a 
significant difference between those with delirium superimposed on dementia/MCI and those 
with neither delirium nor dementia/MCI (adjusted p=0.030). There was also a difference 
between subgroups in IL-8 at 6 months, again with higher levels in both delirium groups 
(delirium on dementia/MCI N=13, 17.8pg/ml (13.1-29.1), delirium only N=14, 17.3pg/ml 
(13.3-20.7), dementia/MCI only N=11, 14.0pg/ml (10.5-19.2), neither N=34, 11.5pg/ml (8.5-
16.7), Kruskal-Wallis p=0.019). Pairwise comparisons again revealed that there was a 
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significant difference between those with delirium superimposed on dementia/MCI and those 
with neither delirium nor dementia/MCI (adjusted p=0.043). 
There were no significant differences between these subgroups in any of the cytokines or 
chemokines at 12 months. 
 
8.3.6 Correlations between serum inflammatory markers and 
measures of delirium, and with cortisol 
8.3.6.1 Correlations between serum inflammatory markers and contemporaneous 
measures of delirium during the perioperative period 
At baseline, DRS-R98 severity score correlated inversely with serum MCP-1 (rho= -0.234, 
p=0.032). There was also a trend towards positive correlations between DRS-R98 and serum 
IL-6 (rho=0.202, p=0.065). OSLA score at baseline correlated inversely with serum MIP-1 
(rho= -0.237, p=0.030). Baseline MMSE and EDTB-1 scores did not correlate with any of the 
inflammatory markers. 
At day 4, DRS-R98 correlated inversely with MIP-1 (rho= -0.321, p=0.003). There was a 
trend towards an inverse correlation between DRS-R98 and IL-1ra (rho= -0.199, p=0.073), 
and a positive correlation with IL-6 (rho=0.194, p=0.080). OSLA score correlated inversely 
with IL-1ra (rho= -0.235, p=0.035) and MIP-1 (rho= -0.228, p=0.041). MMSE did not 
correlate with any of the inflammatory markers, though there were trends towards positive 
correlations with IL-5 and MIP-1, and an inverse correlation with IL-6. There were trends 
towards correlations between EDTB-1 score and IL-1ra, IL-10 and MIP-1. 
At day 10-14, there were no significant correlations between DRS-R98 severity score and any 
of the inflammatory markers; there was a trend towards correlation between DRS-R98 and 
IL-6 (rho=0.329, p=0.058). There was a trend towards correlation between OSLA score and 
IL-1ra (rho=0.317, p=0.072) and TNF-α (rho=0.325, p=0.065). Neither MMSE nor EDTB-1 
score correlated with any of the markers. 
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8.3.6.2 Correlations between serum inflammatory markers and contemporaneous 
measures of delirium during the follow-up period 
At 3 months, serum IL-6 was positively correlated with DRS-R98 severity score (rho=0.449, 
p<0.001), and inversely correlated with MMSE score (rho= -0.399, p<0.001). Serum IL-8 
also correlated positively correlated with DRS-R98 (rho=0.224, p=0.046). TNF-α was 
positively correlated with DRS-R98 severity score (rho=0.294, p=0.008), and inversely 
correlated with MMSE score (rho= -0.261, p=0.020). Neither EDTB-1 score nor OSLA score 
correlated with any of the inflammatory markers. 
At 6 months, DRS-R98 severity score correlated positively with serum IL-1β (rho=0.239, 
p=0.042), IL-1ra (rho=0.286, p=0.014), IL-6 (rho=0.446, p<0.001), IL-8 (rho=0.291, 
p=0.012) and TNF-α (rho=0.406, p<0.001). MMSE score was inversely correlated with IL-6 
(rho= -0.364, p=0.002). OSLA score correlated positively with IL-6 (rho=0.236, p=0.045), 
IL-10 (rho=0.246, p=0.036) and TNF-α (rho=0.400, p<0.001). EDTB-1 score correlated 
positively with MCP-1 (rho=0.369, p=0.002).   
At 12 months, DRS-R98 severity score correlated positively with serum IL-6 (rho=0.323, 
p=0.007) and TNF-α (rho=0.239, p=0.050). MMSE score correlated inversely with IL-6 
(rho= -0.304, p=0.012). OSLA score correlated positively with IL-6 (rho=0.288, p=0.017) 
and IL-8 (rho=0.314, p=0.009). EDTB-1 score did not correlate with any of the inflammatory 
markers. 
8.3.6.3 Correlations between baseline serum inflammatory markers and CSF 
inflammatory markers 
There were N=41 participants who had both a baseline serum sample and a CSF sample in 
which CSF cytokines were measured by a different Luminex assay as described in chapter 5. 
Of the cytokines measured, IL-5 did not correlate (rho=0.199, p=0.212), IL-6 was positively 
correlated (rho=0.490, p=0.001), IL-8 did not correlate (rho=0.076, p=0.638), IL-10 was 
positively correlated (rho=0.347, p=0.026), and TNF-α did not correlate (rho= -0.239, 
p=0.133). 
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8.3.6.4 Correlations among serum inflammatory markers during the perioperative 
period 
Tables 8.10 to 8.11 in appendix 10 show Spearman’s Rho correlations among serum 
inflammatory markers measured at baseline, and on days 4 and 10-14. At baseline, the 
majority of inflammatory markers correlated with each other, except MIP-1α which only 
correlated inversely with IL-1β. By postoperative day 4, MIP-1α correlated inversely with 
many of the other inflammatory markers. By postoperative day 10-14, there were fewer 
significant correlations, but the pro-inflammatory IL-6, IL-8 and TNF-α correlated with each 
other. 
8.3.6.5 Correlations among serum inflammatory markers during the follow-up period 
Tables 8.12 to 8.14 in appendix 10 show Spearman’s Rho correlations among serum 
inflammatory markers measured at 3, 6 and 12 months after hip fracture. There were fewer 
significant correlations between the inflammatory markers during the follow-up period, 
particularly at 12 months after hip fracture; TNF-α correlated with many of the pro-
inflammatory cytokines and chemokines, and IL-6 with IL-8.  
 
8.3.6.6 Correlations between inflammatory markers, serum cortisol and cortisol 
AM:PM ratio 
At baseline, serum cortisol correlated positively with serum IL-1β (rho=0.233, p=0.033), IL-
1ra (rho=0.311, p=0.004) and IL-10 (rho=0.226, p=0.039). Cortisol AM:PM ratio at baseline 
correlated inversely with serum TNF-α (rho= -0.781, p=0.050), meaning a lower and more 
abnormal cortisol diurnal rhythm with higher TNF-α. On postoperative day 4, serum cortisol 
correlated inversely with MCP-1 (rho= -0.251, p=0.022), and there was a trend towards 
positive correlation with IL-6 (rho=0.213, p=0.053). Cortisol AM:PM ratio on day 4 
correlated with IL-10 (rho=0.300, p=0.017). On day 10-14, serum cortisol did not correlate 
with any of the inflammatory markers. Cortisol AM:PM ratio on day 10-14 correlated 
inversely with serum IL-1β (rho= -0.578, p=0.001). 
At 3 and 12 months, neither serum cortisol nor cortisol AM:PM ratio correlated with any of 
the inflammatory markers. At 6 months, serum cortisol did not correlate with any of the 
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inflammatory markers, but cortisol AM:PM ratio correlated inversely with IL-1β (rho= -
0.360, p=0.008), IL-6 (rho= -0.328, p=0.015) and IL-10 (rho= -0.350, p=0.009).  
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8.4 Discussion 
 
This study lends further support to the hypothesis that there is an exaggerated inflammatory 
response in delirium, with higher pro-inflammatory cytokines and chemokines, but it did not 
find lower levels of anti-inflammatory cytokines in delirium. The results support an 
imbalance in pro/anti-inflammatory ratio in delirium, with a shift towards a pro-inflammatory 
state. I will now discuss the key results for the different cytokine and chemokine families. 
8.4.1 Interleukin-1 family 
This study found elevated levels of IL-1ra in the delirium group at baseline and at day 10-14 
postoperatively. Serum IL-1ra has been shown to be elevated in delirium in critical illness 
(van den Boogaard, Kox et al. 2011), and in delirium after hip fracture in a cohort related to 
this hip fracture cohort (Cape, Hall et al. 2014). It has also been shown to be a protective 
modifier of delirium risk (Adamis, Lunn et al. 2009). IL-1ra is the endogenous antagonist of 
the key pro-inflammatory cytokine IL-1β, and it is released after IL-1β. It is thought to have a 
neuroprotective role (Loddick, Wong et al. 1997), and is in fact being trialled as a therapy in 
subarachnoid haemorrhage and traumatic brain injury (Galea, Ogungbenro et al. 2011, 
Clinical Trials Register 2013). On day 4, there was an inverse correlation between OSLA 
score and IL-1ra, suggesting higher IL-1ra with more normal level of arousal, and a trend to 
an inverse correlation with delirium severity, which may indicate a greater IL-1ra response at 
this point as protective or restorative. Elevated IL-1ra seen here may therefore be in response 
to IL-1β release, although levels of IL-1β largely did not change, except in the two patients 
who still had delirium at day 10-14 postoperatively, where levels were very high. Although 
these were small numbers and the analyses must be viewed as exploratory, the relationship 
remained after adjusting for confounders. IL-1β is often difficult to detect, although in this 
study the majority of samples were above the minimum detectable concentration. I did not 
measure IL-1α, a further member of the IL-1 family which may have a role here. 
8.4.2 Interleukin-6 
This study has replicated the findings of previous studies of elevated IL-6 in delirium after 
hip fracture (Beloosesky, Hendel et al. 2007, van Munster, Korevaar et al. 2008, MacLullich, 
Edelshain et al. 2011). After adjusting for potential confounders including illness severity, 
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comorbid disease burden and prior dementia, IL-6 was still associated with delirium when 
measured towards the end of a delirium episode, 10-14 days after hip fracture surgery. IL-6 
was also markedly elevated in patients with active delirium on postoperative day 4, and after 
adjusting for confounders there was a trend towards a significant relationship remaining with 
delirium. There were trends towards positive correlations between IL-6 and DRS-R98 
delirium severity score, also suggesting more severe the delirium with greater IL-6 elevation.  
IL-6 also remained elevated in the delirium group at 3 months post-hip fracture, although this 
was no longer significant after adjusting for covariates, It also correlated positively with 
DRS-R98 score and inversely with MMSE score throughout the follow-up period (higher IL-
6 with worse delirium and cognition) and positively with OSLA score at 6 and 12 months 
(higher IL-6 with more abnormal arousal), suggesting sustained elevation may be related to 
persistence of delirium symptoms or worse cognition.Subgroup analyses found that the 
highest levels were in those with delirium superimposed on dementia/MCI, so it may be that 
persistence of IL-6 production was due to the cumulative effect of delirium and 
dementia/MCI, or that the immune response was dysregulated in this subgroup of patients. 
IL-6 is a key player in the acute phase response, and is released in reponse to bacterial 
endotoxin and other inflammatory insults (Reichenberg, Yirmiya et al. 2001). It is a 
pleiotropic cytokine with endocrine, autocrine and paracrine roles, and it is produced by 
several different types of immune cell and adipocytes. It stimulates activity of the 
hypothalamic-pituitary-adrenal axis, and production of IL-6 is suppressed by glucocorticoids. 
In this study, IL-6 did not correlate with any of the cortisol measures, with only a trend 
towards a positive correlation between the two serum measures on postoperative day 4. IL-6 
has a circadian rhythm of release, which correlates with level of sleepiness, and it has been 
suggested to have a pathological role in disorders characterised by excessive daytime 
sleepiness (Vgontzas, Bixler et al. 2005). Delirium is almost universally associated with 
sleep-wake cycle disturbance (Meagher, Moran et al. 2007), and IL-6 could plausibly have a 
role in this disturbance. In addition to hip fracture, it has been found to be elevated in 
delirium in other settings including delirium following cardiac surgery (Plaschke, 
Fichtenkamm et al. 2010), non-cardiac surgery (Liu, Ya-wei et al. 2013, Capri, Yani et al. 
2014), in elderly medical patients (de Rooij, van Munster et al. 2007) and in critical illness 
(van den Boogaard, Kox et al. 2011). It would be very interesting to examine IL-6 levels in 
delirium subtypes, to see whether it is higher in those with hypoactive delirium as opposed to 
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hyperactive, or whether it correlates with the degree of sleep-wake cycle disturbance 
exhibited. 
8.4.3 Tumour Necrosis Factor-α 
TNF-α is an early and key player in the acute phase response, released in response to 
bacterial endotoxin and other inflammatory stimuli (Reichenberg, Yirmiya et al. 2001, 
Grigoleit, Oberbeck et al. 2010). It has been shown to be elevated in delirium after cardiac 
surgery (Kazmierski, Banys et al. 2014) and delirium in critical illness (van den Boogaard, 
Kox et al. 2011, Ritter, Tomasi et al. 2014), but in each case this was no longer significant 
after controlling for covariates. TNF-α levels were generally higher in the delirium group 
during the perioperative period, and this was significant for those with active delirium on 
postoperative day 4. TNF-α also stayed significantly elevated in the delirium group 
throughout the year follow-up period, and correlated positively with delirium severity (DRS-
R98), level of arousal (OSLA) and inversely with MMSE score, in keeping with higher TNF-
α with worse delirium and global cognition, and more abnormal arousal. This is the first time 
that such a sustained inflammatory response has been demonstrated in delirium. The 
relationship between TNF-α and delirium was no longer significant after adjusting for 
covariates, however, and it is possible that it is a function of illness severity or comorbidity. 
8.4.4 Balance of pro/anti-inflammatory cytokines 
This study found a higher ratio of pro/anti-inflammatory cytokines in those with delirium, 
replicating the findings of Cerejeira et al in patients with delirium after elective arthroplasty 
(Cerejeira, Nogueira et al. 2012). Given the results of the analyses for individual cytokines, 
this is likely to be predominantly due to higher levels of pro-inflammatory cytokines. There 
was also a greater postoperative change in pro-inflammatory cytokines in those with 
delirium, suggesting that those with delirium had a more exaggerated response to the surgical 
insult, although it is possible that this was due to perioperative complications. Subgroup 
analyses suggested that the imbalance in the pro/anti-inflammatory ratio was greatest in those 
with delirium superimposed on dementia/MCI throughout the perioperative period. This may 
be due to the cumulative effect of delirium and dementia, both bringing with it an 
inflammatory pathology, or that those with delirium and dementia/MCI are more likely to 
produce a greater pro-inflammatory response to trauma and surgery. 
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8.4.5 Chemokines 
This study replicated previous studies which demonstrated elevated serum IL-8 in delirium 
after hip fracture (Beloosesky, Hendel et al. 2007, van Munster, Korevaar et al. 2008) and in 
other settings such as ICU (van den Boogaard, Kox et al. 2011). This study is the first to 
show persistent elevation of IL-8 after a month post-hip fracture (Beloosesky, Hendel et al. 
2007), and IL-8 levels here were significantly higher in the delirium group up to 6 months 
post-hip fracture. At 3 months, this relationship was still significant after adjusting for 
potential confounders including age, gender, prior dementia and comorbidity. This might be 
related to persistent symptoms of delirium, and serum IL-8 level was positively correlated 
with DRS-R98 severity score at both 3 and 6 months. Subgroup analysis found comparable 
higher levels in both subgroups with delirium only and delirium superimposed on 
dementia/MCI, suggesting that it may be more related to delirium than the cumulative effect 
of both pathologies or the influence of delirium on dementia. IL-8 is generally pro-
inflammatory, with one of its main roles being chemotaxis of neutrophils (Semple, Kossmann 
et al. 2010). It is primarily produced by monocytes and macrophages, and is produced early 
in the inception of an inflammatory response, but may also persist for days or weeks as seen 
here (Remick 2005). Its persistent elevation in the delirium group may be due to continued or 
new foci of inflammation.  
This study is one of the first to measure macrophage inflammatory protein (MIP)-1α and 
MIP-1β in delirium. MIP-1α and MIP-1β are chemotactic proteins produced by neutrophils to 
recruit and activate macrophages (Solana, Tarazona et al. 2012). As a group, these and other 
chemokines were shown to be elevated in delirium after cardiac surgery (Rudolph, Ramlawi 
et al. 2008). MIP-1β was significantly lower in patients with active delirium preoperatively 
and was inversely correlated with delirium severity and abnormal level of arousal on day 4, 
but was thenhigher in the whole delirium group at day 10-14. Both of these relationships 
were independent of age, gender, prior dementia, illness severity and comorbidity. When 
those with active delirium were compared with those without at days 4 and 10-14, there was 
no difference in levels. It may be that those who developed delirium preoperatively had a 
poor initial immune response to the trauma with lack of macrophage recruitment, but that this 
occurred later on and persisted as delirium was resolving, as seen in the higher levels in the 
delirium group at day 10-14, or it may have been related to intercurrent infective illness and 
macrophage activation at a later stage postoperatively. The results in general at day 10-14 are 
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interesting; patients who were still in the Orthopaedic unit at 10-14 days postoperatively were 
often those who had had a complicated postoperative course and were not well enough to go 
to the Orthogeriatric Rehabilitation unit yet, or those who were about to go home. Higher 
levels were seen at that timepoint in the chemokines MCP-1 (non-significant) and MIP-1β in 
the group who had been delirious. This may be because the patients in the delirium group 
assessed at that time were more unwell, or because the inflammatory response in more 
prolonged delirium evolves with more chemokine activity, recruiting monocytes and 
macrophages. 
Where levels of cytokines were measured in CSF and serum at the baseline timepoint, IL-6 
and IL-10 were correlated, whereas IL-5, IL-8 and TNF-α were not correlated. This suggests 
that the central and peripheral inflammatory profile may be different, however there were 
only small numbers and a different Luminex assay was used, which limits the conclusions 
that can be drawn. Future studies could assay paired serum and CSF together. Correlations 
among the serum inflammatory markers during the perioperative period found that generally 
pro-inflammatory cytokines and chemokines (IL-1β, IL-6, IL-8, TNF-α) were positively 
correlated and T-helper 2 cytokines IL-5 and IL-10 were correlated, which adds to the 
biological validity of the findings. Interestingly, IL-1β and its endogenous antagonist IL-1ra 
were only correlated at baseline, perhaps due to different metabolism or clearance of one of 
the markers. Also, although many of the chemokines correlated with each other, MIP-1α did 
not correlate with MIP-1β throughout the perioperative period, although similar pathways 
would be expected in their generation; the results for these chemokines should therefore be 
viewed with some caution, particularly MIP-1α which did not correlate with many other 
inflammatory markers, suggesting there may have been a problem with its detection. During 
the follow-up period, where levels of many of the inflammatory markers were much lower, 
there are fewer correlations. Levels of IL-6, IL-8 and TNF-α, which remained elevated in the 
delirium group, were all positively correlated, which may suggest a persistent pro-
inflammatory shift. Finally, although there were some correlations between cortisol measures 
and inflammatory markers, these were not very consistent. At baseline, there was a positive 
correlation between the IL-1 family and cortisol, and inverse between TNF-α and AM:PM 
ratio, in keeping with a greater acute phase response with more activation of the HPA axis 
and loss of diurnal rhythm. After the acute phase, the relationships are less clear, suggesting a 
possible divergence of stress and inflammatory pathways. 
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There are some important limitations to this study which should be discussed. Although 
participants were assessed regularly throughout the perioperative period, the fluctuating 
nature of delirium means that some brief episodes may have been missed. During the follow-
up period, some participants in both groups may have had episodes of delirium during 
intercurrent illnesses. It is difficult to capture the complexity of the relationship between the 
inflammatory response of elderly patients to the dual insults of hip fracture and surgery, and 
the fluctuating syndrome of delirium, which is often superimposed on dementia. Some of 
these cytokines are fleeting and change over minutes to hours, whereas some persist longer 
such as IL-8. By examining levels of these inflammatory proteins in the delirium group as a 
whole and comparing those with and without active delirium on a day-to-day basis, and by 
seeking trends in cytokine and chemokine families as well as the profiles of individual 
inflammatory proteins, this study has attempted to map the inflammatory profile of delirium 
after hip fracture. The significant relationship between some inflammatory markers after 
controlling for important confounding variables suggests that there is an altered inflammatory 
response in delirium. It is plausible that this may be causative, in the case of IL-6, and the 
new finding of persistent elevation of pro-inflammatory cytokines and chemokines after 
delirium may be related to persistent delirium symptoms or to cognitive or physical sequaelae 
of delirium.  
Delirium is a heterogeneous syndrome, often with multiple contributing precipitants and 
mechanisms. In order to overcome the “noise” generated by these multiple mechanisms, 
larger studies are now required that can take account of multiple covariates, including 
functional level, waiting time for surgery and anaesthetic type, which could not be accounted 
for here. In the case of anaesthetic type, no consistent difference in inflammatory response to 
surgery could be found in the literature for those receiving general or regional anaesthesia. A 
small study comparing spinal plus epidural to general anaesthesia in total hip replacement 
found higher TNF-α levels 6h and 20h after surgery, which was just significant at 6h, but no 
difference in IL-6 and very little detectable IL-1β (Hogevold, Lyberg et al. 2000). A further 
small study found no difference in IL-6, TNF-α or CRP at 24h post-operatively in those 
undergoing haemorrhoidectomy under spinal or general anaesthesia (Buyukkocak, Caglayan 
et al. 2006). Kudoh et al in their trial of regional versus general anaesthesia in patients with 
schizophrenia found lower IL-6 levels at the end of surgery and 24h later in their group with 
schizophrenia who received epidural anaesthesia than in the control group who received 
general anaesthesia, but no difference at all between the two groups with schizophrenia who 
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received general versus epidural anaesthesia. It is therefore difficult to conclude that 
anaesthetic type was responsible for this difference (Kudoh, Takese et al. 2003).  
This study had some predefined hypotheses, but there was also an exploratory element, in 
order to generate hypotheses for future work.Future studies could examine the relationship 
between these cytokines and chemokines and delirium subgroups and symptom profiles, 
particularly the relationship between IL-6 and sleep-wake cycle disturbance, including blood 
sampling at two or three points during the day to examine circadian rhythm, with 
comtemporaneous assessment of delirium symptoms and severity. Additional members of the 
IL-1 family such as IL-1α could be measured to complement measurements of IL-1β and IL-
1ra. Soluble receptors of some cytokines such as TNF and IL-6 can be measured, and this 
may give an idea of the relationship between the inflammatory ligands and their receptors in 
delirium. Also, there has been little previous research on the function of cells of the immune 
system such as neutrophils and macrophages in delirium, which would need to be examined 
in the context of immunosenescence.  
In conclusion, this study has found evidence of elevated pro-inflammatory cytokines and 
chemokines in delirium after hip fracture, with a shift towards a pro-inflammatory state. 
There was persistent elevation in the delirium group of IL-6, IL-8 and TNF-α during the 
months after hip fracture, which for IL-8 at 3 months was independent of age, gender, prior 
dementia and co-morbidity. For IL-6, those with delirium superimposed on dementia/MCI 
had a cumulative or exaggerated response, whereas for IL-8, both delirium subgroups had 
higher levels. This persistent inflammatory response should be examined further in the 
context of the physical, functional and cognitive sequaelae of delirium. 
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9 Chapter 9: The relationships among persistent delirium, 




There is evidence from several sources of hypothalamic-pituitary-adrenal (HPA) axis 
dysfunction in delirium. This is discussed in more detail in Section 1.5. An aberrant response 
to stress has been suggested, leading to an increased and prolonged cortisol response to 
stressors, and possibly a loss of diurnal rhythm (McIntosh, Bush et al. 1985, Olsson 1999). 
Studies have shown elevated serum cortisol in delirium in several settings, and elevated CSF 
cortisol in delirium after hip fracture, but the relationship is sometimes lost after adjusting for 
prior dementia (Mu, Wang et al. 2010, Pearson, de Vries et al. 2010, Bisschop, de Rooij et al. 
2011, Colkesen, Giray et al. 2013). Cortisol levels may be elevated for at least 8 weeks after 
hip fracture. Roberts et al found median morning serum cortisol levels of 0.38μM (380nM/L) 
in mobile elderly controls, 0.38μM (380nM/L) in immobile elderly controls, 0.60μM 
(600nM/L) two weeks after hip fracture and 0.58μM (580nM/L) eight weeks after hip 
fracture (Roberts, Barton et al. 1990). However, it is not known if this is sustained, and 
whether there is any relationship between persistent delirium and derangement of the HPA 
axis. 
Persistent delirium is common in many settings. A systematic review of studies of persistent 
delirium in hospitalised patients reported combined rates of 44.7% at hospital discharge, 
32.8% at 1 month, 25.6% at 3 months and 21% at 6 months (Cole, Ciampi et al. 2009). In a 
cohort of patients with acute hip fracture where 41% developed delirium perioperatively, 
Marcantonio found rates of persistent delirium of 39% at hospital discharge, 32% at 1 month 
and 6% at 6 months (Marcantonio, Flacker et al. 2000). Risk factors for persistent delirium in 
general medical patients and palliative care patients include older age, male gender, 
dementia, infection, terminal illness, brain cancer, visual impairment, functional impairment, 
high co-morbidity and use of physical restraints during delirium (Inouye, Zhang et al. 2007, 
Boettger, Jenewein et al. 2014). Outcomes for those with persistent delirium are consistently 
worse than for those whose delirium resolves (Cole, Ciampi et al. 2009), including the risk of 
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increased mortality (Kiely, Marcantonio et al. 2009). However, the pathophysiological 
mechanisms of persistent delirium, which often continues after the original trigger has been 
treated, are poorly understood, and little is known of the role of the HPA axis. 
Among the adverse outcomes of delirium and persistent delirium is an increased risk of 
dementia (MacLullich, Beaglehole et al. 2009, Witlox, Eurelings et al. 2010, Davis, Muniz 
Terrera et al. 2012). Patients with dementia often deteriorate cognitively and functionally 
after a hospital admission or episode of delirium, and a delirium episode has been shown to 
accelerate the trajectory of cognitive decline in out-patients with Alzheimer’s Dementia 
(Fong, Jones et al. 2009). It is currently not clear whether the increased risk of incident 
dementia following delirium is due to the unmasking of a dementia process which had begun 
but had not yet been recognised, or whether new pathological processes are begun in the 
brain. Incident dementia with a preceding documented episode of delirium in an 
epidemiological study has been shown to have no relationship with standard 
neuropathological markers (Davis, Muniz Terrera et al. 2012). Critical illness has been shown 
in a large study to be followed by significant long-term cognitive impairment, even in young, 
fit people, and longer delirium duration was associated with worse global cognition and 
executive function in that study (Pandharipande, Girard et al. 2013). Detailed studies of the 
cognitive sequelae of delirium in elderly patients and of their pathophysiological mechanisms 
are few.Witlox et al found in a cohort of patients with hip fracture that at three months post-
fracture, the delirium group had worse episodic memory, global cognition and more cognitive 
decline (Witlox, Slor et al. 2013). Postoperative cognitive dysfunction is an important and 
related construct, but it is poorly defined and most of the studies of this construct did not 
screen for delirium (Nadelson, Sanders et al. 2014). 
There is also a relationship between cortisol and long-term cognitive impairment and 
dementia as discussed in more detail in section 1.5.8, although there is some heterogeneity of 
findings in the literature. There is evidence supporting hyperactivity of the HPA axis in 
dementia, with positive dexamethasone suppression tests (Robertsson, Blennow et al. 2001), 
and this is related to disease severity and cerebral atrophy (Giubilei, Patacchioli et al. 2001). 
The hippocampus is the primary site of higher cortical feedback of the HPA axis and has a 
dense population of glucocorticoid receptors. It is also important in long-term potentiation 
and memory formation, and is atrophied in Alzheimer’s dementia (Olsson 1999, Ferrari and 
Magri 2008).  
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This study therefore examined the relationships between both elevated cortisol in the 
perioperative period, and sustained derangement of the HPA axis, with persistent delirium, 
and between sustainment of HPA axis activity following a delirium episode. It also examined 
the relationships between delirium during the perioperative period, the HPA axis and 
cognition in the year after hip fracture. 
The questions addressed in this study were as follows: 
1) Is the elevation in cortisol seen after hip fracture sustained during the subsequent year 
in the whole cohort? 
2) Are the higher levels of morning cortisol and loss of cortisol diurnal rhythm seen in 
the delirium group during the postoperative period sustained during the year after hip 
fracture? 
3) Is any sustained dysregulation of the HPA axis in the year after hip fracture, with 
higher morning cortisol and loss of diurnal rhythm, greater in those with persistent 
delirium in the year after hip fracture, compared to those whose delirium resolves and 
those who never develop delirium? 
4) Is any sustained dysregulation of the HPA axis in the year after hip fracture greater in 
those with delirium superimposed on dementia or mild cognitive impairment (MCI), 
compared to those with delirium only, dementia or MCI only, and neither? 
5) Is the trajectory of cognitive decline different in the delirium group, the delirium 
superimposed on dementia or MCI group, and the no delirium group, and is it worse 
in those with delirium only and delirium superimposed on dementia/MCI? 
6) Is the trajectory of cognitive decline different for those with high cortisol and low 
cortisol during the perioperative period? 
7) Is cognitive decline over the year after hip fracture greater in those with (a) higher 
cortisol during the baseline perioperative period, and in those with (b) greater loss of 
diurnal rhythm, with elevated afternoon salivary cortisol levels and lower AM:PM 
ratio at baseline.? 
8) Is cognitive decline greater in those with (a) sustained elevation of cortisol during the 
year after hip fracture, and (b) a more abnormal cortisol rhythm during the year after 
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hip fracture, as shown by elevated afternoon salivary cortisol and lower AM:PM ratio 
at follow-up? 
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9.2 Methods 
9.2.1 Baseline assessment 
Patients with acute hip fracture were recruited and assessed during the perioperative period as 
described in chapter 2. At baseline, the Informant Questionnaire on Cognitive Decline in the 
Elderly was used as a proxy measure for premorbid dementia (Jorm and Jacomb 1989). 
Those with an average IQCODE score of ≥3.44 (Harwood, Hope et al. 1997) or a prior 
diagnosis of dementia were deemed to have evidence of prior dementia, and those with an 
average IQCODE score of ≥3.19 were deemed to have evidence of mild cognitive 
impairment (MCI) (Li, Jia et al. 2012). The National Adult Reading Test was performed 
during the perioperative period and was used as an estimate of crystallised intelligence 
(Nelson 1982). The Mini-Mental State Examination (Folstein, Folstein et al. 1975), which is 
a commonly used test of global cognition, was used as part of the delirium assessment 
performed at each visit.  
9.2.2 Follow-up assessments 
Follow-up visits were performed at 3, 6 and 12 months after hip fracture. Prior to arranging 
each follow-up visit, I contacted the participant’s General Practitioner to check whether the 
participant was still living and well enough to be contacted to arrange a follow-up visit. The 
participant or, if appropriate, their next of kin was then contacted and a visit arranged. These 
took place either at the participant’s home or at the Wellcome Trust Clinical Research 
Facility at the Royal Infirmary of Edinburgh. The majority of visits were conducted by me, 
and a small proportion (17 visits out of a total of 237) by two Community Research Nurses, 
Catherine Beveridge and Avril Cairns, during the last four months of the study when I was on 
maternity leave. The nurses accompanied me on several visits each while training, I provided 
training on delirium assessment and cognitive testing, and they each completed one visit 
themselves in my presence. 
9.2.2.1 Assessment for persistent delirium 
Participants were assessed for any persisting features of delirium, or a new diagnosis of 
delirium, at each follow-up visit at 3, 6 and 12 months. Delirium assessment followed the 
same structure as during the perioperative period, as described in Chapter 2. This involved a 
semi-structured interview with cognitive testing using the MMSE, delirium severity 
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assessment using the Delirium Rating Scale Revised ’98 (DRS-R98), testing of attention with 
the Edinburgh Delirium Test Box-1 (EDTB-1), assessment of level of arousal with the 
Richmond Agitation Sedation Score (RASS) and the Observational Scale of Level of Arousal 
(OSLA), and completion of the Confusion Assessment Method (CAM) algorithm. New 
delirium was defined as CAM positive fulfilling DSM-IV criteria, and persistent delirium 
features was defined as the ongoing presence of at least one CAM positive feature, or the 
presence of an abnormal RASS score (any score other than 0) in a participant who was 
delirious during the perioperative period or developed syndromal delirium during the follow-
up period. The DRS-R98 score was not used to define persistent delirium because this may 
have been confounded by cognitive impairment, due to the inclusion of memory questions. 
9.2.2.2 Assessment of cognition 
Participants also completed a cognitive test battery at each follow-up visit. The cognitive test 
battery took 45-60 minutes to complete; this was curtailed if participants were unable to 
complete it due to fatigue, frailty or advanced dementia, and some tests were omitted if 
participants’ vision was too poor. In particular, a colour vision test was performed prior to 
administration of Victoria Stroop, and the test omitted if the participant was unable to 
distinguish between the colours. A full description of the cognitive test battery is in section 
2.7.1. A list of the included tests and the score used in statistical analysis is in table 9.1. 
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Table 9.1 A summary of the follow-up cognitive test battery 
Test Score(s) used 
Digit Span Forwards Total score 
Digit Span Backwards Total score 
Victoria Stroop Difference score 
Interference score 
HVLT-R List Learning Total recall 
Recognition Discrimination Index 
Visual Reproduction Recall I score 
Recall II score 
% retention 
Digit Symbol Substitution Test Number in 90 seconds 
Verbal Fluency FAS (letters F, A and S) total in 60 seconds 
Animals total in 60 seconds 
 
9.2.2.3 Assessment of function and quality of life 
At each follow-up visit, information was collected on current medication, new medical 
problems, and current mobility and living situation. The Katz PADL (Katz, Ford et al. 1963) 
and Lawton IADL (Lawton and Brody 1969) scores were completed to assess current 
functional level (Appendix 5). The 15-item Geriatric Depression Scale (Appendix 6) was 
used to assess for co-morbid depression (Brown, Woods et al. 2007). The EQ-5D 
questionnaire (Appendix 7) was used to estimate quality of life (Cheung, Oemar et al. 2009). 
9.2.3 Sample collection 
Morning serum samples and diurnal saliva samples were collected for measurement of 
cortisol at each follow-up visit at 3, 6 and 12 months. They were processed and stored as 
described in section 2.5. Samples were processed at the Wellcome Trust Clinical Research 
Facility, Royal Infirmary of Edinburgh by research nurses, or by me at the Queens Medical 
Research Institute, Royal Infirmary of Edinburgh out of hours. Cortisol was measured in 
duplicate using ELISA as described in sections 2.10 and 2.11. I performed all cortisol assays. 
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9.2.4 Statistical analysis 
Normality of distribution was tested for each variable using histogram plots and 
Kolgomorov-Smirnov tests. 
9.2.4.1 Morning serum cortisol and AM:PM ratio 
To explore the pattern of cortisol levels in the whole cohort in the year after hip fracture, 
median cortisol levels in morning serum and morning and afternoon saliva were plotted on 
line graphs. 
In order to test whether levels of cortisol remained higher and whether there was still loss of 
cortisol diurnal rhythm during the follow-up period in those who had developed delirium at 
baseline, group comparisons were performed between those who did or did not develop 
delirium at baseline for cortisol measures at each follow-up timepoint, with Mann-Whitney U 
test. Participants with new syndromal delirium were excluded from this analysis since they 
may have had new dysregulation of the HPA axis. 
To test whether persistent delirium influenced persistent dysregulation of the HPA axis, 
participants were divided into three groups. “Resolved delirium” included those who had 
developed syndromal delirium during the perioperative period or at follow-up assessment 
visits but which had subsequently fully resolved with no CAM positive features and a RASS 
of 0, “persistent delirium” where participants who had had syndromal delirium still had at 
least one CAM positive feature or a RASS other than 0 at follow-up but did not have new 
syndromal delirium, and “never delirium” where participants never developed (or at that 
point hadn’t yet developed) syndromal delirium. Group comparisons were performed for 
cortisol measures at each follow-up timepoint with Kruskal-Wallis test (post hoc pairwise 
comparisons). 
To test whether persistent dysregulation of the HPA axis was greater in those with prior 
delirium superimposed on dementia/MCI, participants were divided into groups with delirium 
at any stage superimposed on dementia/MCI, delirium only, dementia/MCI only and neither. 
Those with new syndromal delirium at follow-up were excluded from these analyses to 
reduce any influence of active delirium, but were included at later timepoints if they no 
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longer met criteria for syndromal delirium. Group comparisons for cortisol measures at 
follow-up were performed with Kruskal-Wallis test (post hoc pairwise comparisons). 
To explore the relationship between persistent delirium features and cortisol, DRS-R98 
severity score, and the EDTB-1 score (as a measure of inattention) and OSLA score (as a 
measure of abnormal arousal) were correlated with contemporaneous measures of cortisol 
(morning serum cortisol, AM and PM salivary cortisol and the AM:PM cortisol ratio). 
9.2.4.2 Cognitive tests 
In order to account for any influence of persistent delirium on cognitive test performance at 
follow-up, group differences were tested in cognitive test scores between the “resolved”, 
“persistent” and “never” groups with ANOVA (post hoc pairwise comparisons with 
Dunnett’s T3 test) or Kruskal-Wallis test (post hoc pairwise comparisons), at each follow-up 
timepoint. Participants with new syndromal delirium were excluded from these analyses, but 
were included at later timepoints if they no longer met criteria for syndromal delirium. 
To explore the relationship between cognition and cortisol, cognitive test scores were also 
correlated with contemporaneous measures of cortisol (morning serum cortisol, AM and PM 
salivary cortisol and the AM:PM cortisol ratio) with Spearman’s Rho. 
In order to explore the effects of cortisol, delirium status and other important co-variates such 
as dementia and age on the trajectory of cognition during the follow-up period, a linear latent 
growth model trajectory analysis was constructed. Since the cognitive test battery involved 
seven individual tests, a principal components analysis was performed with the results of the 
first administration of the cognitive tests at the 3 month follow-up assessment. Six variables 
were included in the principal components analysis, which were Digit Span total score (Digit 
Span Forwards plus Digit Span Backwards), Verbal Fluency FAS total score, HVLT-R List 
Learning Recognition Discrimination Index, Visual Reproduction Percent Retention, Digit 
Symbol Substitution Test total score and Victoria Stroop interference score. There were no 
significant outliers and tests of assumption were satisfactory; the Kaiser-Meyer-Olkin 
measure of sampling adequacy statistic was 0.637 and Bartlett’s test of sphericity was highly 
significant. This showed that there was one principal component explaining 53% of the 
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variation at this wave, and we were therefore able to use a composite score of cognition for 
the trajectory analysis modelling. 
Professor Ian Deary and Dr Zoё Tieges gave advice on performing and interpreting the 
principal components analysis and Dr Mike Allerhand performed the trajectory analysis, and 
gave advice on its interpretation. 
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9.3 Results 
One-hundred and eight participants were recruited to the study. Ninety-seven completed the 
perioperative period of the study, and their GP was contacted regarding follow-up. Seven 
participants had died between the last visit of the perioperative period and the three month 
follow-up visit. Five participants declined to continue participating in the study, and one 
declined the three month visit but asked that they be contacted regarding the next visit, and 
did rejoin the study for the six and twelve month visits. Eighty-four participants took part in 
an assessment at three months. Between three and six months, four participants died, one 
declined to participate further and two were excluded (one due to new steroid prescription 
and one due to a move to a Nursing Home in the north of Scotland). Seventy-eight 
participants took part in an assessment at six months. Between six and twelve months, two 
participants died and one declined to participate further in the study. All samples and data 
were included for all participants until they withdrew, were excluded or died. Figure 9.1 
further describes study attrition according to delirium status. Of forty-four participants who 
developed delirium during the perioperative period, twenty-nine (66%) completed the study; 
ten died and five withdrew consent to continue participation. Seventy-two percent (46/64) of 
the no delirium group completed the study.  
The presence of a new diagnosis of delirium at follow-up was rare, as I was required to check 
with the participants’ GP (or hospital team where they were still in hospital or had been 
readmitted) that they were well enough to participate in follow-up testing. However, 
persistence of delirium features was relatively common. At three months, N=1 participant had 
full syndromal delirium, N=19 had persistent features of delirium as outlined in section 9.2.4, 
N=16 had resolved delirium and N=48 had never had delirium. At six months, N=2 had 
syndromal delirium, N=8 had persistent features of delirium, N=22 had resolved delirium and 
N=46 had never had delirium. At twelve months, N=2 had syndromal delirium, N=7 had 
persistent features of delirium, N=21 had resolved delirium and N=45 had never had 
delirium. Those with persistent features of delirium were more likely to have underlying 
dementia or mild cognitive impairment. 
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Dementia status according to IQCODE 
Normal MCI Dementia pa 
3 months Syndromal 0 1 0 0.006 
Persistent 8 4 6 
Resolved 9 5 2 
Never 37 10 1 
6 months Syndromal 1 0 1 0.016 
Persistent 3 2 3 
Resolved 11 10 1 
Never 35 10 1 
12 months  Syndromal 0 0 2 <0.001 
Persistent 1 2 4 
Resolved 13 6 1 
Never 34 10 1 
IQCODE: Informant Questionnaire of Cognitive Decline in the Elderly, ≤3.19 = “normal”, 3.20-3.43 = “mild 
cognitive impairment”, ≥3.44 = “dementia”  
aPearson Chi-Square 
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N=97 GP +/-patient contacted 
regarding 3 month follow-up 
Excluded – no operation N=2 (N=2 no delirium) 
Excluded – complication N=1 (no delirium) 
Withdrew consent N=7 (N=4 delirium, N=3 no delirium) 
Died N=1 (no delirium) 
Withdrew consent N=5 (N=1 delirium, N=4 no delirium) 
Declined 3 month visit but rejoined at 6 months N=1 (no 
delirium) 
Died N=7 (N=5 delirium, N=2 no delirium) 
Seen at 3 months – N=84 
Seen at 6 months – N=78 
Seen at 12 months – N=75 
Withdrew consent N=1 (no delirium) 
Declined 3 month visit but rejoined at 6 months N=1 (no 
delirium) 
Excluded N=2 (N=1 delirium at 3/12, N=1 no delirium) 
Died N=4 (N=3 delirium, N=1 no delirium) 
Withdrew consent N=1 (no delirium) 
Died N=2 (N=2 delirium) 
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9.3.1 Function, depression and quality of life 
Preoperatively, the group who went on to develop delirium were more functionally impaired 
in personal and instrumental activities of daily living (Table 9.3). Postoperatively, this 
difference was starker and persisted throughout the year after fracture. Only community-
dwelling people were recruited to this study. At baseline, there was no difference between 
groups in place of living, however during the year after hip fracture there was a significant 
difference between groups, with fewer participants who had developed delirium returning to 
their own homes, and new Nursing Home or NHS in-patient continuing care admissions 
among this group. 
There was no difference between groups with and without delirium at any stage in self-
reported overall health status (EQ-VAS). However, within the EQ-5D subdimensions, at 
three months the delirium group self-reported significantly worse mobility and ability to do 
their usual activities, but no difference in ability to do self-care, pain / discomfort, nor anxiety 
/ depression. At six months the delirium group still reported significantly more difficulty with 
their usual activities and there was a trend towards worse mobility and self care, but the other 
subdimensions were no different. At twelve months, there were no significant differences 
between groups in any of the subdimensions. This may have been due to some slow 
improvement in the function and mobility of the delirium group, attrition of some frailer and 
more functionally dependent participants, or adjustment in self-perception of quality of life 
within the delirium group to their new baseline. 
Scores on the 15-item Geriatric Depression Scale were generally low. There was a significant 
difference between groups at six months only, with higher scores in the delirium group, but 
the median and interquartile range were within the range which may be interpreted as 
suggestive of possible depression. 
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Table 9.3 Functional status, place of living, quality of life and depressive symptoms 
throughout the year after hip fracture for the whole cohort and between those with and 
without delirium at any stage 
 Whole group 
Median (IQR) 








Baseline: 6 (6-6) N=106 
3 months: 6 (5-6) N=84 
6 months: 6 (6-6) N=78 
12 months: 6 (5-6) N=75 
Baseline: 6 (5-6) N=43 
3 months: 6 (3-6) N=36 
6 months: 6 (3-6) N=32 
12 months: 5 (3-6) N=30 
Baseline: 6 (6-6) N=62 
3 months: 6 (6-6) N=48 
6 months: 6 (6-6) N=46 








Baseline: 7 (5-8) N=104 
3 months: 5 (4-7) N=84 
6 months: 6 (4-8) N=78 
12 months:6 (4-8) N=75  
Baseline: 6 (4-8) N=42 
3 months: 4 (2-6) N=36 
6 months: 4 (2-7) N=32 
12 months: 4 (2-7) N=30 
Baseline: 7 (6-8) N=61 
3 months: 6 (5-7) N=48 
6 months: 7 (5-8) N=46 









Sheltered Housing: N=14 
House/flat: N=38 
Sheltered Housing: N=6 
House/flat: N=54 






Sheltered Housing: N=9  
Nursing Home: N=2 
Still in NHS rehab: N=13 
House/flat: N=21 
Sheltered Housing: N=1  
Nursing Home: N=2 
Still in NHS rehab: N=12 
House/flat: N=39 
Sheltered Housing: N=8  
Nursing Home: N=0 






Sheltered Housing:  N=12 
Nursing Home: N=7 
House/flat: N=23 
Sheltered Housing: N=3  
Nursing Home: N=7 
House/flat: N=37 
Sheltered Housing: N=9  






Sheltered Housing: N=10  
Nursing Home: N=5 
NHS IPCC: N=1 
House/flat: N=21 
Sheltered Housing: N=3  
Nursing Home: N=5 
NHS IPCC: N=1 
House/flat: N=38 
Sheltered Housing: N=7  
Nursing Home: N=0 





3 months: 70 (50-80), N=78 
6 months: 70 (53-80), N=76 
12 months: 70 (50-80), N=73 
3 months: 70 (50-80), N=32 
6 months: 70 (60-80), N=31 
12 months: 60 (50-77), N=29 
3 months: 70 (60-80), N=46 
6 months: 70 (50-80), N=45 








3 months: 3 (3-4), N=74 
6 months: 3 (2-5), N=70 
12 months: 3 (1-4), N=68 
3 months: 3 (3-6), N=29 
6 months: 3 (2-5), N=26 
12 months: 3 (2-5), N=23 
3 months: 3 (2-4), N=45 
6 months: 2 (1-4), N=44 




aStudent’s t test, bMann-Whitney U test, cPearson Chi-square 
PADL: Personal Activities of Daily Living, IADL: Instrumental Activities of Daily Living, NHS IPCC: 
National Health Service In-Patient Continuing Care; EQ-5D: European Quality of Life Scale with 5 
components; EQ-VAS: EQ-5D visual analogue scale; Geriatric Depression Score: ≥5 suggestive of depression, 
≥10 almost always indicates depression 
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9.3.2 The HPA axis in the year after hip fracture 
Figures 9.2 and 9.3 show the median cortisol levels in morning serum and morning and 
afternoon saliva in the whole cohort during the year after hip fracture. Table 9.4 shows the 
median values and interquartile range for the cohort. Morning serum levels steadily fell 
during the year after hip fracture. Salivary cortisol levels had fallen by 3 months post-hip 
fracture, rose again at 6 months and fell again by 12 months. This may have been due to 
intercurrent illness in some patients at 6 months. 
Cortisol and inflammation in delirium and cognitive decline after hip fracture 
The relationships among persistent delirium, cognition and the HPA axis 316 
Figure 9.2  Median morning serum cortisol level during the year after hip fracture for the 
whole cohort 
 
Figure 9.3 Median morning and afternoon salivary cortisol level during the year after hip 
fracture for the whole cohort 
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9.3.3 The HPA axis in the year after hip fracture and its relationship 
with delirium 
Figures 9.4 and 9.5 show serum and diurnal salivary cortisol respectively, viewed over the 
study period in those who did and did not develop delirium during the perioperative period 
after hip fracture, excluding those who had new or syndromal delirium when seen at follow-
up. At three months, serum cortisol level was similar to that observed at baseline at the time 
of anaesthetic. Peak morning serum cortisol gradually fell over the course of the year in both 
groups, but remained at a slightly higher level in the delirium group at each timepoint, 
although this difference was not significant (Table 9.4). Cortisol circadian rhythm appeared 
to still show derangement at three and six months in the group who had delirium 
perioperatively, with a trend towards higher afternoon salivary cortisol at three months in the 
delirium group (p=0.061). This was in the absence of any continuing or new syndromal 
delirium. By twelve months the levels in the two groups are very similar. This may be 
because the sustained derangement in the cortisol axis in the delirium group has 
“normalised”, or it may be because those in the delirium group who survived to one year and 
were well enough to be seen and give samples were those with a lower cortisol level. 
 
When the influence of persistent delirium features was explored, by comparing those with 
resolved delirium, persistent CAM features or RASS other than 0, or never delirium, in the 
absence of new or syndromal delirium, those with persistent features of delirium had 
significantly higher morning serum cortisol at three months (Table 9.5). This group tended to 
have higher cortisol levels at three and six months, and slightly higher afternoon salivary 
cortisol levels particularly at six months, but this was not significant. By twelve months after 
hip fracture, very few participants remained who had persistent features of delirium, and 
cortisol levels in serum and saliva were very similar between groups. 
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Table 9.4 Cortisol levels in serum and saliva at 3, 6 and 12 months for the whole group, and 
group comparisons of serum and salivary cortisol levels at 3, 6 and 12 months after hip 
fracture, between those who did or did not develop delirium during the perioperative period, 





Median (IQR) serum or salivary cortisol in nmol/L 
Delirium during 
perioperative period 
No delirium MWU p 




475.5 (397.2-558.7) N=33 453.3 (377.3-498.9) N=46 638 
0.229 
3 months AM 
saliva 
8.2 (5.9-11.3) N=65 9.4 (5.8-14.8) N=21 7.8 (6.0-10.7) N=44 383 
0.268 
3 months PM saliva 4.2 (2.6-5.5) N=56 5.4 (2.8-8.1) N=22 3.6 (2.3-4.8) N=34 263 
0.061 
3 months AM:PM 
ratio 
2.2 (1.3-3.0) N=52 1.5 (1.3-3.0) N=19 2.2 (1.3-3.0) N=33 273 
0.442 




457.2 (416.6-511.8) N=27 430.2 (337.8-485.4) N=45 511 
0.262 




11.9 (6.9-16.2) N=20 8.6 (6.9-13.6) N=41 331 
0.231 
6 months PM saliva 5.2 (3.5-7.1) N=60 6.0 (3.3-8.1) N=19 4.8 (3.5-6.6) N=41 328 
0.328 
6 months AM:PM 
ratio 
1.9 (1.4-2.7) N=56 2.1 (1.5-2.7) N=17 1.7 (1.3-2.7) N=39 294 
0.504 




432.4 (381.2-457.3) N=24 409.3 (340.5-478.8) N=44 497 
0.686 
12 months AM 
saliva 
8.2 (6.4-11.3) N=63 7.3 (6.6-10.9) N=19 8.3 (5.9-11.4) N=43 390 
0.778 
12 months PM 
saliva 
4.3 (2.8-6.7) N=58 4.7 (3.5-8.6) N=19 4.2 (2.8-5.8) N=39 313 
0.341 
12 months AM:PM 
ratio 
1.6 (1.2-3.1) N=53 1.5 (1.2-3.4) N=15 1.7 (1.2-3.0) N=38 276 
0.859 
MWU: Mann Whitney U test 
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Figure 9.4 Median morning serum cortisol level throughout the study period, in those with 
and without delirium during the perioperative period, excluding at follow-up those with new 
or syndromal delirium 
 
Figure 9.5 Diurnal salivary cortisol levels during the study period in those who did and did 
not develop delirium during the perioperative period, excluding at follow-up those with new 
or syndromal delirium 
 
Cortisol and inflammation in delirium and cognitive decline after hip fracture 
The relationships among persistent delirium, cognition and the HPA axis 320 
Table 9.5 Group comparisons of cortisol levels between those with delirium perioperatively 
which had resolved, those with persistent delirium features and those with no delirium, 
excluding those with new syndromal delirium at follow-up 
Timepoint Median serum or salivary cortisol (IQR) in nmol/L 
Resolved Persistent 
excluding new 
Never K-W p 





















3 months AM:PM ratio 2.3 (1.1-3.2) 
N=13 
1.4 (1.2-2.1) N=6 2.2 (1.3-3.0) 
N=33 
0.502 







6 months AM saliva 11.9 (7.6-16.9) 
N=18 
9.6 (6.4-9.6) N=2 8.6 (6.9-13.6) 
N=41 
0.391 
6 months PM saliva 6.0 (3.2-7.7) 
N=17 
7.2 (5.9-7.2) N=2 4.8 (3.5-6.6) 
N=41 
0.422 
6 months AM:PM ratio 2.2 (1.6-2.8) 
N=15 
1.3 (1.1-1.3) N=2 1.7 (1.3-2.7) 
N=39 
0.180 







12 months AM saliva 7.3 (6.6-11.1) 
N=17 
7.2 (6.2-7.2) N=3 8.4 (5.8-11.7) 
N=42 
0.923 
12 months PM saliva 4.7 (3.6-8.7) 
N=17 
3.6 (2.3-3.6) N=2 4.2 (2.8-5.8) 
N=39 
0.445 
12 months AM:PM ratio 1.6 (1.2-3.4) 
N=14 
N=1 1.7 (1.2-3.1) 
N=38 
0.840 
K-W: Kruskal-Wallis test 
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Figure 9.6 Median serum cortisol levels during the follow-up period in those with resolved 
delirium, persistent features of delirium and never delirium, excluding those with new 
syndromal delirium during the follow-up period 
 
Figure 9.7 Median morning and afternoon salivary cortisol levels during the follow-up 
period in those with resolved delirium, persistent features of delirium and never delirium, 
excluding those with new syndromal delirium during the follow-up period 
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9.3.3.1 The HPA axis and persistence of delirium components 
At 3 months, there was a correlation between morning salivary cortisol level and delirium 
severity as measured with the DRS-R98. There was also a moderate negative correlation 
between EDTB-1 score and morning serum cortisol, in keeping with higher serum cortisol 
being linked with worse inattention. At 6 months, there were significant correlations between 
afternoon salivary cortisol level and DRS-R98, EDTB-1 and OSLA, with a higher afternoon 
salivary cortisol level (suggesting loss of diurnal rhythm) correlated with worse delirium 
severity, inattention and abnormal level of arousal. DRS-R98 also correlated positively with 
both morning salivary and serum cortisol levels. At 12 months, contemporaneous cortisol 
measures were not correlated with any of the measures of delirium severity, inattention or 
arousal.
Cortisol and inflammation in delirium and cognitive decline after hip fracture 
The relationships among persistent delirium, cognition and the HPA axis 323 
 
Table 9.6 Spearman’s Rho correlations between cortisol measures at follow-up with contemporaneous measures of persistent delirium severity 















R= Spearman’s Rho 
DRS-R98: higher score indicating more severe delirium 
EDTB-1: lower score indicating more inattention, higher score indicating better performance 
OSLA: higher score indicating more abnormal level of arousal 
Cortisol 
measure 
3 months 6 months 12 months 
DRS-R98 EDTB-1 OSLA DRS-R98 EDTB-1 OSLA DRS-R98 EDTB-1 OSLA 
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9.3.4 The HPA axis after hip fracture, and its relationship with 
delirium and dementia 
There were no significant differences in serum or salivary cortisol levels based on delirium 
and dementia or mild cognitive impairment (MCI) status at 3, 6 or 12 months (Table 9.7). In 
line with my hypothesis, at 3 and 6 months, serum cortisol was highest in those with delirium 
superimposed on dementia/MCI, but this was not significant. Also in line with my 
hypothesis, afternoon salivary cortisol levels were higher in the groups with delirium 
superimposed on dementia/MCI and delirium only at 3 and 6 months, but this was not 
significant. At 12 months, serum and salivary cortisol levels were very similar between 
groups. 
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Table 9.7 Group comparisons of cortisol levels in serum and saliva at 3, 6 and 12 months 
after hip fracture, based on delirium and dementia/MCI status, excluding those with new 
syndromal delirium at follow-up 
Timepoint Median serum or salivary cortisol (IQR) in nmol/L 
Delirium on 
MCI/dementia 
Delirium only MCI/dementia 
only 
Neither K-W p 


















































































































K-W: Kruskal-Wallis test 
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9.3.5 Cognition, delirium and the HPA axis 
There was no difference preoperatively in crystallised intelligence (NART) nor years in full 
time education between those who did or did not go on to develop delirium (Table 9.2). The 
delirium group was more likely to have evidence of prior dementia as assessed by the 
IQCODE. MMSE scores were lower in the delirium group preoperatively and throughout the 
year after hip fracture. MMSE scores rose slightly in the delirium group during the year after 
hip fracture; this may represent attrition of more impaired participants, a learning effect from 
repeated administration, or slow recovery from delirium. MMSE score preoperatively in the 
whole cohort was slightly lower than during the follow-up period, which may have 
represented the influence of delirium and in those without delirium the effects of analgesia, 
pain or anxiety. 
 
Table 9.2 Baseline cognitive assessments of crystallised intelligence (NART), prior cognition 
(IQCODE) and serial assessment of global cognition (MMSE) over the year after hip fracture 
 Whole group 
Mean (SD) or Median (IQR) 
Delirium 
Mean (SD) or Median (IQR) 
No delirium 




31.5 (10.7) N=83 30.3 (10.1) N=27 32.1 (10.9) N=56 0.494a 
Years in 
education 





Total 49 (48-52) N=97 




Total 51 (48-54) N=40 




Total 48 (48-54) N=57 









Preoperative 27 (25-28) 
N=105 
3 months: 29 (26-30) N=83 
6 months: 29 (27-30) N=77 
12 months: 29 (27-30) N=75 
Preoperative: 25 (22-28) N=43 
3 months: 26 (24-29) N=35 
6 months: 27 (23-29) N=31 
12 months: 28 (22-29) N=30 
Preoperative: 28 (25-29) 
N=60 
3 months: 29 (27-30) N=48 
6 months: 29 (28-30) N=46 





aStudent’s t test 
bMann Whitney U test 
cPearson Chi-Square 
NART: National Adult Reading Test 
IQCODE: Informant Questionnaire on Cognitive Decline in the Elderly, “normal” ≤3.18, “MCI” 3.19-3.43, 
“dementia” ≥3.44 
MMSE: Mini Mental State Examination 
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There was a large degree of missing data for the cognitive test battery. Although the battery 
was chosen to be relatively quick (administration took 45-60 minutes), many frailer 
participants found this too long and the testing was curtailed. The reasons for limiting the 
cognitive test battery were fatigue, distractibility, that participants felt they were not doing 
well and asked to finish or skip tests, and a small number of participants who had had prior 
dementia were too cognitively impaired later at follow-up to complete any or all of the tests. 
This, combined with the attrition through death (predominantly in the delirium group) or 
withdrawal (in both groups) mean that the numbers with complete cognitive test data are 
fairly small, and more of the fitter group who had not had delirium or had mild delirium were 
able to be tested. Results are therefore presented first as individual test scores for each 
cognitive test. These are raw cognitive test scores which have not been adjusted for IQCODE 
or NART. Tables 9.8 to 9.10 show mean or median scores on the cognitive test battery in the 
whole cohort at 3, 6 and 12 months after hip fracture. In order to explore the influence of 
persistent delirium on cognition, group differences in cognitive test scores were tested 
between participants who had had delirium which had resolved at reassessment (“resolved”), 
those who had persistent features of delirium (“persistent”) and those who never developed 
syndromal delirium (“never”). Those participants with new or full syndromal delirium were 
excluded, as these were very small numbers (N=1 at 3 months, N=2 at 6 and 12 months) and 
may have had a significant confounding influence. 
 
9.3.5.1 Digit span 
Scores on digit span forwards and backwards stayed stable in the whole cohort throughout the 
follow-up period. At 3, 6 and 12 months there was a significant difference in digit span 
backwards total scores between those with resolved, persistent and never delirium. Scores 
were lower in those with persistent delirium, and post hoc pairwise comparisons suggested 
that this was due to the difference between the persistent and never groups (Tables 9.8-9.10). 
 
9.3.5.2 Victoria Stroop 
Victoria Stroop interference and difference scores improved slightly in the whole cohort 
between 3 and 6 months, which may have been a learning effect (Tables 9.8 and 9.9). There 
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was no significant difference between delirium groups in either score throughout the follow-
up period. 
 
9.3.5.3 HVLT-R List Learning 
HVLT-R list learning total recall (the total number of words recalled in the first three 
learning trials) improved slightly in the whole cohort during the follow-up period. Different 
test sheets (of equivalent difficulty) were used so this is unlikely to be a learning effect. 
Recognition discrimination index (the number of true positive words from the original list 
recognised, minus semantically related and unrelated false negatives) stayed fairly stable in 
the whole cohort. There was a significant difference in both scores between delirium groups 
throughout the follow-up period, with the lowest scores in those with persistent delirium and 
scores in those with resolved delirium slightly lower than the never delirium group. At 3 
months the scores on total recall were significantly different between all groups (Table 9.8), 
at 6 months both delirium groups were significantly different to the never group (Table 9.9), 
and at 12 months, the resolved delirium group was significantly different to the never 
delirium group (Table 9.10). At 3 and 12 months, recognition discrimination index was 
significantly lower in those with persistent delirium compared to those with never delirium. 
This suggests worse verbal learning and memory in those with persistent delirium, but also in 
those with resolved delirium. 
 
9.3.5.4 Visual Reproduction 
Scores on the visual reproduction test improved slightly in the whole cohort during the 
follow-up period. This may have been a learning effect, or may be due to attrition of more 
cognitively impaired participants. There were significant differences between delirium groups 
on immediate and delayed visual memory (recall I and II), with the worst scores in those with 
persistent delirium. At 3 months, post hoc testing suggested this was due to the difference 
between the persistent and never delirium groups (Table 9.8), whereas at 6 and 12 months, 
the difference was between those with resolved and never delirium, and there were small 
numbers in the persistent delirium group (Tables 9.9.and 9.10).  
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9.3.5.5 Digit Symbol Substitution Test 
Scores on digit symbol substitution test remained stable in the whole cohort during the year 
after hip fracture. Scores tended to be lower in both delirium groups than in those who never 
developed delirium, in keeping with worse processing speed, but these differences were not 
significant (Tables 9.8-9.10). 
 
9.3.5.6 Verbal Fluency 
Verbal fluency scores for both letter (FAS) and category (animals) fluency stayed stable in 
the whole cohort throughout the follow-up period (Tables 9.8-9.10). Verbal fluency FAS 
score was significantly lower in those with persistent delirium at 6 months, with post hoc 
testing confirming significant differences compared with both resolved and never delirium 
groups. Verbal fluency animals scores were significantly different between groups at 3, 6 and 
12 months (Tables 9.8-9.10). At 3 and 6 months, post hoc testing found a trend towards 
significance between persistent and never delirium groups, whereas at 12 months the 
persistent delirium group had significantly lower scores compared to the resolved and never 
delirium groups. 
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Table 9.8 Group differences in raw cognitive test scores at 3 months between participants 
who had delirium at baseline which had resolved, those with persistent delirium features, or 
who never developed delirium  
Cognitive test Whole group 
mean (SD) or 
median (IQR) 
Delirium status at 3 months, mean (SD) or median (IQR) 
Resolved Persistent excluding 
new delirium 
Never p value 
Digit Span forwards 
total 
9 (8-10) N=69 8 (7-10) N=12 9 (7-10) N=12 9 (8-10) N=45 0.091b 
Digit Span backwards 
total 























List learning total 
recall 
19.1 (7.0) N=76 17.3 (5.0) N=15 11.7 (6.1) N=13 21.6 (6.1) N=48 <0.001a 
List learning RDI 10 (8-11) N=72 9 (7-10) N=14 8 (5-10) N=12 10 (9-12) N=46 0.003b 
Visual Reproduction 
recall I 
56 (17) N=60 52 (16) N=11 42 (17) N=8 60 (16) N=41 0.016a 
Visual Reproduction 
recall II 
35 (19) N=54 33 (8) N=8 17 (15) N=7 38 (19) N=39 0.019a 
Visual Reproduction 
% retention 





33 (27-38) N=9 26 (20-36) N=6 36 (29-43) N=35 0.140b 
Verbal fluency FAS 
total 
30 (13) N=74 32 (14) N=15 23 (15) N=11 31 (12) N=47 0.124a 
Verbal fluency 
animals total 
14 (6) N=74 14 (5) N=15 9 (7) N=11 15 (5) N=48 0.007a 
aANOVA, bKruskal-Wallis test, Post hoc tests: pairwise comparisons for Kruskal-Wallis; post hoc Dunnett’s T3 
test for ANOVA 
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Table 9.9 Group differences in raw cognitive test scores at 6 months between participants 
who had delirium at baseline which had resolved, those with persistent delirium features, or 
who never developed delirium 
Cognitive test Whole group 
mean (SD) or 
median (IQR) 
Delirium status at 6 months, mean (SD) or median (IQR) 
Resolved Persistent excluding 
new delirium 
Never p value 
Digit Span forwards 
total 
9 (8-10) N=68 9 (8-9) N=19 8 (6-9) N=4 9 (6-9) N=44 0.127b 
Digit Span backwards 
total 























List learning total 
recall 
20.0 (7.1) N=72 17.7 (5.6) 
N=20 
10.2 (7.5) N=6 22.7 (5.9) N=45 <0.001a 
List learning RDI 9 (7-11) N=70 9 (7-11) N=20 7 (6-9) N=5 9 (8-11) N=44 0.063b 
Visual Reproduction 
recall I 
61 (17) N=56 55 (15) N=15 37 (13) N=2 66 (13) N=38 0.001a 
Visual Reproduction 
recall II 
42 (18) N=55 35 (17) N=15 23 (16) N=2 47 (15) N=37 0.011a 
Visual Reproduction 
% retention 
66 (21) N=55 60 (22) N=15 59 (21) N=2 70 (17) N=37 0.202a 
Digit symbol 
substitution test 
32 (27-41) N=52 29 (25-34) 
N=12 
29 (15-29) N=2 36 (29-42) 
N=38 
0.182b 
Verbal fluency FAS 
total 
31 (13) N=72 34 (11) N=19 15 (12) N=6 33 (13) N=46 0.003a 
Verbal fluency 
animals total 
14 (5) N=72 13 (4) N=19 9 (7) N=6 15 (5) N=46 0.004a 
aANOVA, bKruskal-Wallis test, Post hoc tests: pairwise comparisons for Kruskal-Wallis; post hoc Dunnett’s T3 
test for ANOVA 
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Table 9.10 Group differences in raw cognitive test scores at 12 months between participants 
who had delirium at baseline which had resolved, those with persistent delirium features, or 
who never developed delirium 
Cognitive test Whole group 
mean (SD) or 
median (IQR) 
Delirium status at 12 months, mean (SD) or median (IQR) 
Resolved Persistent excluding 
new delirium 
Never p value 
Digit Span forwards 
total 
9 (8-10) N=70 8 (8-10) N=21 8 (4-8) N=3 9 (8-11) N=45 0.195b 
Digit Span backwards 
total 























List learning total 
recall 
21.0 (6.8) N=70 18.6 (5.1) N=20 9.0 (7.0) N=4 23.4 (5.6) N=45 <0.001a 
List learning RDI 10 (8-11) N=69 9 (7-11) N=20 6 (3-8) N=4 10 (9-12) N=45 0.002b 
Visual Reproduction 
recall I 
65 (15) N=53 56 (16) N=15 N=1 70 (13) N=37 0.004a 
Visual Reproduction 
recall II 
49 (20) N=52 34 (18) N=15 N=1 55 (18) N=36 0.002a 
Visual Reproduction % 
retention 
72 (22) N=52 59 (24) N=15 N=1 77 (19) N=36 0.027a 
Digit symbol 
substitution test 
34 (26-43) N=52 31 (25-37) 
N=12 
N=1 37 (27-43) 
N=39 
0.160b 
Verbal fluency FAS 
total 
32.0 (13.3) N=70 32.2 (12.9) 
N=19 
20.2 (11.0) N=5 33.4 (13.1) 
N=45 
0.102a 
Verbal fluency animals 
total 
14.3 (5.4) N=70 13.8 (4.0) N=19 5.4 (3.1) N=5 15.7 (5.0) N=45 <0.001a 
aANOVA, bKruskal-Wallis test, Post hoc tests: pairwise comparisons for Kruskal-Wallis; post hoc Dunnett’s T3 
test for ANOVA 
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9.3.6 Correlations 
Spearman’s Rho correlations between cognitive test scores and cortisol measures from the 
same timepoint are shown in Tables 9.11a and 9.11b. AM:PM salivary cortisol ratio did not 
correlate with any cognitive test scores at 3 or 12 months, and only correlated with verbal 
fluency FAS score at 6 months (Rho 0.291, p=0.033), in keeping with with a better verbal 
fluency score with a higher and therefore more intact cortisol diurnal rhythm. There was no 
consistent pattern in correlations between cognitive test scores and cortisol measures, but 
scores on HVLT-R list-learning and Visual Reproduction tended to correlate inversely with 
cortisol (higher cortisol level with worse verbal and visual memory scores). At 6 and 12 
months, higher serum cortisol correlated inversely with Digit Symbol Substitution Test, in 
keeping with higher cortisol with worse processing speed. At 3 months, higher morning 
cortisol correlated inversely with Verbal Fluency Animals score, in keeping with higher 
cortisol with worse category verbal fluency. 
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Table 9.11a Correlations between contemporaneous cortisol measures and cognitive test scores, Digit Span, Victoria Stroop and List Learning 
Cognitive test 3 months cortisol measures,   
Rho, p value 
6 months cortisol measures,   
Rho, p value 
12 months cortisol measures, 




































































































































ρ: Spearman’s Rho correlation co-efficient 
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Table 9.11b Correlations between contemporaneous cortisol measures and cognitive test scores, Visual Reproduction, DSST and Verbal 
Fluency 
Cognitive test 3 months cortisol measures,   
Rho, p value 
6 months cortisol measures,   
Rho, p value 
12 months cortisol measures, 






































































































































ρ: Spearman’s Rho correlation co-efficient 
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9.3.7 Trajectory analysis 
The trajectory analysis was performed by Dr Mike Allerhand at the Centre for Cognitive 
Ageing and Cognitive Epidemiology. The six cognitive scores used for the trajectory analysis 
were: Digit Span total score (Digit Span Forwards plus Digit Span Backwards), Verbal 
Fluency FAS total score, HVLT-R List Learning Recognition Discrimination Index, Visual 
Reproduction Percent Retention, Digit Symbol Substitution Test total score and Victoria 
Stroop interference score. The sample distributions of the six measures were assessed 
graphically and judged to be acceptably normal. The measures were standardised into units of 
the respective baseline (3 months) standard deviation, and centred on the respective baseline 
mean. Sample estimates of the mean and its standard error at each wave indicated that three 
of the cognitive measures did not have any systematic change over the three waves (3/6/12 
months). These were dropped leaving three variables for subsequent analysis: Verbal Fluency 
FAS total score, Visual Reproduction Percent Retention, and Victoria Stroop interference 
score. A preliminary principal components analysis of these three variables indicated 53%, 
48%, and 41% of the total variation at waves 1, 2, and 3 respectively could be explained by 
one factor at each wave. Preliminary growth curves fitted to each variable indicated no 
significant curvature. A linear (straight line) latent growth curve model was fitted to the three 
variables over three waves. The model’s path diagram is shown in Figure 9.8. 
Contemporaneous loadings and intercepts were held equal for longitudinal measurement 
invariance. Time-invariant covariates were added as controls and to test their intercept and 
slope effects. Each covariate was centered on its sample mean. Model parameters were 
estimated using full information maximum likelihood by the Mplus program.The model fitted 
acceptably well, (RMSEA=0.08, CFI=0.85). An extract of the parameter estimates is shown 
in Table 9.12. 
 
Using the three cognitive measures (Victoria Stroop, Visual Reproduction percent retention, 
and Verbal Fluency FAS score) there was a significant positive slope (0.255, p<0.001), 
indicating improvement of cognitive functioning over time. The units of change were 
standard deviations of Victoria Stroop interference score at wave 1 (3 month follow-up) per 6 
months. This was non-significant using all six cognitive measures. None of the covariates, 
including CSF cortisol, day 4 cortisol AM:PM ratio or delirium status, had a significant effect 
on the slope. National Adult Reading Test and dementia status had a significant effect on the 
intercept.
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Figure 9.8 Path diagram of trajectory analysis 
AGE SEX COR NAR DEM DEL





F1/F2/F3: Composite cognitive ability at each wave, based on the three measures.  
I: Intercept 
S: Slope 
Age (at baseline) and sex are time-invariant covariates centred on their respective means.  
COR: Baseline cortisol level in cerebrospinal fluid or day 4 AM:PM ratio in saliva 
NAR: National Adult Reading Test  
DEM: Dementia status  
DEL: Delirium status 
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Table 9.12 Parameter estimates of the trajectory analysis, CSF cortisol model 
  EST SE SE/EST p value 
Intercepts Slope 0.255 0.073 3.485 <0.001 
Intercept on Age -0.002 0.011 -0.188 0.851 
Intercept on Sex 0.084 0.197 0.426 0.670 
Intercept on CSF cortisol 0.003 0.005 0.656 0.512 
Intercept on NART 0.035 0.010 3.475 0.001 
Intercept on Dementia 1.013 0.411 2.468 0.014 
Intercept on Delirium 0.255 0.208 1.226 0.220 
Slope on Age 0.005 0.006 0.766 0.444 
Slope on Sex -0.115 0.111 -1.031 0.303 
Slope on CSF cortisol 0.001 0.003 0.259 0.796 
Slope on NART -0.009 0.006 -1.367 0.172 
Slope on Dementia -0.354 0.259 -1.368 0.171 
Slope on Delirium -0.077 0.116 -0.666 0.505 
EST:  
SE: standard error 
NART: National Adult Reading Test 
CSF cortisol: Cerebrospinal fluid cortisol at baseline 
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Table 9.13 Parameter estimates of the trajectory analysis, salivary cortisol AM:PM ratio 
model 
  EST SE SE/EST p value 
Intercepts Slope 0.254 0.074 3.429 0.001 
Intercept on Age <0.001 0.011 0.047 0.963 
Intercept on Sex 0.047 0.190 0.248 0.804 
Intercept on AM:PM cortisol 0.021 0.061 0.340 0.734 
Intercept on NART 0.038 0.010 3.942 <0.001 
Intercept on Dementia 1.083 0.398 2.721 0.007 
Intercept on Delirium 0.248 0.209 1.184 0.236 
Slope on Age 0.006 0.006 0.861 0.389 
Slope on Sex -0.126 0.109 -1.159 0.247 
Slope on AM:PM cortisol 0.004 0.034 0.110 0.913 
Slope on NART -0.009 0.006 -1.332 0.138 
Slope on Dementia -0.326 0.248 -1.314 0.189 
Slope on Delirium -0.088 0.116 -0.752 0.452 
EST:  
SE: standard error 
NART: National Adult Reading Test 
AM:PM cortisol: Postoperative day 4 morning:afternoon salivary cortisol ratio 
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9.4 Discussion 
This study has demonstrated several interesting findings regarding the hypothalamic-
pituitary-adrenal (HPA) axis after delirium, and the cognitive profile of persistent and 
resolved delirium post-hip fracture.  
In the whole cohort, median serum cortisol levels were still elevated at 3 months, being only 
slightly lower than preoperative levels. Cortisol then steadily fell throughout the year after 
hip fracture. Cortisol has previously been shown to be elevated for eight weeks after hip 
fracture (Roberts, Barton et al. 1990), but this study suggests that this elevation might persist 
for even longer. 
Although persistent syndromal delirium was rare in this study, persistent features of delirium 
were common at 3 and 6 months after hip fracture, and this group of patients had evidence of 
persistent activation of the HPA axis and worse performance on cognitive tests. At 3 months, 
morning serum cortisol was still elevated at “stress” levels (similar to perioperative levels) in 
those who had evidence of persistent delirium in the absence of full syndromal delirium. At 3 
months, the results of correlations between HPA axis measures and delirium components 
were in keeping with worse delirium and worse inattention with higher peak cortisol levels, 
suggesting persistence of delirium features is associated with persistent high cortisol. At 6 
months, this relationship with delirium severity scores and ongoing high morning cortisol 
persisted, and also, worse scores on delirium testing (severity, inattention and abnormal 
arousal) were correlated with higher afternoon salivary cortisol, suggesting those with 
persistent delirium features may have persistent loss of diurnal rhythm. There was a 
suggestion of a sustained increase in HPA axis activity and loss of diurnal rhythm in those 
who had had delirium during the baseline perioperative period, but this was not significant.  
Those with features of persistent delirium performed poorly on many of the cognitive tests, 
with evidence of impairment in working memory (digit span backwards), verbal learning and 
memory (HVLT-R list learning), visual memory (visual reproduction) and executive function 
(verbal fluency). These impairments may have been due to persisting inattention or short-
term memory impairments related to their persistent delirium, or due to an abnormal level of 
arousal. A phenomenological study of persistent versus resolving delirium has shown that 
short and long-term memory impairment as well as inattention, disorientation, delusions, 
Cortisol and inflammation in delirium and cognitive decline after hip fracture 
The relationships among persistent delirium, cognition and the HPA axis 341 
agitation and thought process abnormalities persist (Meagher, Adamis et al. 2012). Since I 
was unable to fully test participants’ cognition at baseline due to the study design, it is 
difficult to know whether some or all of these impairments were pre-existing, due to known 
or undiagnosed dementia. Alternatively, these impairments may have been new and a 
consequence of their delirium, or of preceding and/or sustained HPA axis hyperactivity. 
Those who had had delirium at baseline but which had resolved showed impairment in verbal 
learning and memory and visual memory. These participants no longer exhibited any features 
of delirium, and had a normal level of arousal. As discussed above, these impairments may 
have been pre-existing or may be new and related to their delirium or from exposure to 
dysregulated cortisol. Although not always consistent, the results of the correlations between 
cognitive test scores and cortisol measures suggest some of the impairments may be related to 
HPA axis activation, with higher morning cortisol levels correlating with worse verbal and 
visual memory, processing speed and category fluency, and higher afternoon cortisol levels 
with worse verbal memory scores. Loss of cortisol diurnal rhythm with higher afternoon 
cortisol levels was also associated with more executive dysfunction at 6 months. 
These findings are broadly consistent with a different study of neuropsychological and 
cognitive outcomes of delirium after hip fracture, which tested patients three months after hip 
fracture (Witlox, Slor et al. 2013). They also excluded patients with syndromal delirium at 
follow-up, and found that 10/22 patients who had had delirium perioperatively had at least 
one positive CAM feature, compared with 3/26 of those who had not developed delirium. 
They found that the delirium group had poorer global cognition (Mini Mental State 
Examination), episodic memory (Fifteen Words Test) and more cognitive decline (IQCODE 
based on the past 3 months). In those with no CAM positive features, they also found poorer 
performance on the Fifteen Words Test, which is similar in structure to HVLT-R List 
Learning, than non-delirious controls (Witlox, Slor et al. 2013). 
Over the year after hip fracture there was in fact a general trajectory of cognitive 
improvement. This was not in keeping with my hypotheses, and there are several potential 
reasons for this finding. This may be a learning effect due to the repeated administration of 
some of the same cognitive tests at the 3, 6 and 12 month follow-up assessments. As shown 
in section 9.3.5, those with persistent delirium performed worse on most cognitive tests. The 
numbers of those with persistent features fell with each wave of follow-up. Therefore some 
participants were likely still recovering from their delirium, and when tested at the later 
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waves at 6 and 12 months may therefore have performed better than in previous waves. Some 
participants died during the study period, and these participants were predominantly in the 
delirium group, so numbers in the delirium subgroups of many of the analyses fell as the 
study progressed. These factors combined may have led to the overall improvement seen in 
the trajectory analysis. Postoperative cognitive improvement has been suggested to occur in 
the literature, in the context of recovery from delirium or early transient postoperative 
cognitive dysfunction, or where surgery alleviates chronic pain or disease (Nadelson, Sanders 
et al. 2014). Neither the development of delirium during the perioperative period nor baseline 
cortisol measures including cerebrospinal fluid cortisol at baseline and salivary AM:PM 
cortisol ratio on postoperative day 4 influenced cognitive trajectory during the year after hip 
fracture. Crystallised intelligence as estimated by the National Adult Reading Test and 
dementia status did influence the intercept of the model, suggesting these factors may have a 
more powerful influence on the trajectory of cognition in this setting.  
The hypotheses of the study have been difficult to test, for several reasons. Attrition of 
participants, predominantly in the delirium group, meant that those who survived to be tested 
tended to be fitter and less likely to have had severe delirium at baseline, and many of the 
frailer or more cognitively impaired participants in the study could not complete the full 
cognitive test battery. Some participants may have had new episodes of delirium in the 
intervening months between assessments, which they were recovering from when next seen. 
These factors which have all led to missing data in the cognitive test battery has meant that 
the full picture of the cognitive sequaelae of delirium after hip fracture may not be 
represented in this study. Undoubtedly the functional, physiological and cognitive trajectory 
of a proportion of patients with hip fracture who develop no, mild or brief delirium, is of 
improvement over the year after hip fracture. However, some patients who develop severe 
delirium with significant comorbid illness and complications and suffer prolonged hospital 
stays, are more likely to have a deteriorating cognitive trajectory, or to plateau at a new lower 
level. The design of this study, to recruit community-dwelling patients with hip fracture, 
aimed to minimise attrition in order to gain as full a follow-up dataset of cognitive and HPA 
axis measures as possible. However, it may be that this has meant that the influence of 
severe, prolonged delirium on cognitive trajectory could not be assessed here. It may also be 
that assessment of cognition alone does not capture the full breadth of central nervous system 
related outcomes that follow delirium. For example, psychological or emotional distress may 
persist as a consequence of the delirium experience, and psychomotor changes or dyspraxia 
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might contribute to slower recovery of mobility after delirium. Another limitation which 
needs to be discussed is that although patients intended for spinal anaesthesia were included 
in the study, for various reasons some went on to have general anaesthesia and some had 
both. Although a recent systematic review and meta-analysis did not find any significant 
influence of anaesthetic type on incidence of post-operative delirium, it did find that general 
anaesthetic conferred a marginal, but non-significant increased risk of postoperative cognitive 
dysfunction, with an odds ratio of 1.34 (95% confidence interval 0.93-1.95) (Mason, Noel-
Storr et al. 2010). It is therefore possible that anaesthetic type may have had a small influence 
on the results of cognitive testing at follow-up, although persistent delirium, prior dementia 
and crystallised intelligence are likely still to have had a greater influence. Ideally, 
anaesthetic type might have been included in the trajectory analysis but this would not have 
been possible with the participant numbers in the present study. 
Future studies could use a simpler and more inclusive study design and focus on one or two 
areas of cognition such as verbal memory, working memory or executive function, using a 
brief cognitive battery which could be tested preoperatively in patients with hip fracture, 
along with detailed capture of delirium, and follow these areas of cognition over the year 
after fracture. The influence of biomarkers measured in cerebrospinal fluid at baseline, 
medication exposure, perioperative hypotension or hypoxia could be examined. Elderly 
medical patients with delirium could be followed over the same timecourse as this study to 
see if the cognitive trajectory is the same, and to examine the HPA axis in a different cohort, 
using salivary cortisol measurement which is generally well accepted. Other elective surgical 
cohorts with a high risk of postoperative delirium such as cardiac or vascular surgery could 
be studied, with a detailed preoperative cognitive battery, perioperative delirium assessment, 
and postoperative assessment for persistent delirium and cognitive change. This could be 
combined with neuroimaging to explore the influence of regional or global cerebral atrophy 
or white matter change. 
 
In summary, this study has shown that cortisol levels remain elevated up to three months 
post-hip fracture in those with persistent delirium features but without syndromal delirium, 
and suggests there may be ongoing loss of diurnal rhythm at three months. Persistent features 
of delirium are common after hip fracture, and these patients show impairments of working 
memory, verbal learning and memory, visual memory and executive dysfunction. After 
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delirium resolution, patients show impairment of verbal learning and memory. The overall 
cognitive trajectory demonstrated in this study was of improvement, which may be due to 
attrition of frailer and more cognitively impaired participants, recovery from delirium and a 
learning effect of the cognitive tests. Baseline cortisol measures and delirium status did not 
influence the cognitive trajectory in the subset of the sample with full prospective data. 
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10 General Discussion 
The studies described in this thesis aimed to explore the relationships between the HPA axis 
and inflammation with delirium, persistent delirium and post-delirium cognitive change in 
patients aged over 60 with acute hip fracture. Specifically, I aimed to determine whether 
cortisol levels are elevated acutely, with loss of diurnal rhythm during delirium after hip 
fracture, whether this HPA axis dysfunction is sustained, and whether it predicts persistent 
delirium and deterioration in cognition over the year after hip fracture. This thesis also 
investigated whether CSF levels of cortisol, the CNS damage marker S100B, the Alzheimer’s 
dementia marker tau and pro-inflammatory cytokines are elevated in delirium, and whether 
anti-inflammatory cytokines are reduced in delirium after hip fracture.  
 
Since this was a cohort with acute hip fracture, there was consequent evidence of a stress and 
inflammatory response in the whole cohort, but this response was generally greater in those 
who developed delirium. This thesis has described evidence of HPA axis dysfunction in 
delirium, with elevated CSF cortisol in active delirium, elevated morning serum cortisol in 
the early postoperative period which was predictive of delirium, and loss of cortisol diurnal 
rhythm in the acute phase. Where delirium persisted, there was evidence of sustained HPA 
axis activity with elevated morning serum cortisol three months after hip fracture and a trend 
towards persistent loss of diurnal rhythm. There was little evidence of any change in CNS 
inflammatory response in delirium. However, in the periphery there was an acute shift 
towards a pro-inflammatory state in delirium, with persistent elevation of pro-inflammatory 
cytokines IL-6 and TNF-α and the chemokine IL-8 for several months after hip fracture in 
those who had developed delirium. There was also evidence of acute CNS damage and 
astrogliosis in delirium with elevated S100B in CSF, although this was not related to cortisol 
levels.  
 
Since these studies were observational, causation cannot be inferred. It may be the case that 
those participants who were more unwell with greater trauma responses and less 
physiological reserve to withstand the insults of fracture and operation, had more 
dysfunctional HPA axis responses, loss of cortisol diurnal rhythm and a shift to a pro-
inflammatory state, and developed delirium because they were more acutely unwell with 
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greater underlying co-morbidity. Where possible I adjusted for confounding factors such as 
age, illness severity, comorbidity and prior dementia, and cortisol remained independently 
predictive of delirium during the perioperative period. Cortisol and several of the 
inflammatory cytokines also correlated with delirium severity, suggesting that the more 
severe the delirium the more deranged the biology.The association between persistent 
delirium and persistent elevation of cortisol, and the persistence of a pro-inflammatory state 
with raised IL-6, IL-8 and TNF-α in those who had had delirium during the perioperative 
period also suggest that it is not just the acute insults that lead to these stress responses and 
also lead to delirium, but rather that HPA axis dysfunction and a pro-inflammatory state are 
among the underlying mechanisms of delirium. Indeed, several of the findings are 
biologically plausible mechanisms for delirium pathogenesis; within the CNS, elevation of 
cortisol and S100B may both lead to neurotoxicity with disruption of important cognitive 
attentional pathways. Disruption of cortisol diurnal rhythm and elevation in IL-6 could both 
plausibly contribute to sleep-wake cycle disturbance.  
The relationship between delirium and post-delirium cognitive trajectory has been the most 
challenging to study and led to some unexpected results. Although at first glance the group 
who had had delirium perioperatively appeared to have performed worse on most cognitive 
tests, when the effect of persistent features of delirium was taken into account, those whose 
delirium had resolved only performed worse on tests of verbal and visual memory. The latter 
is a consistent finding in post-hip fracture delirium (Witlox, Slor et al. 2013), and both 
findings merit further investigation. The overall cognitive trajectory in this cohort was of 
cognitive improvement during the year after hip fracture, which was the opposite response to 
that hypothesised; I suspect that this was due to a combination of attrition of frailer and more 
cognitively impaired participants and recovery from delirium or early postoperative cognitive 
dysfunction. Those participants who did not develop syndromal delirium perioperatively 
were still exposed to the same insults which precipitated delirium in their peers, and may 
have been recovering cognitively in the same way that they were recovering physically and 
functionally during the year after fracture.  
The studies described in this thesis have several important limitations which must be 
acknowledged. This was an observational study and causation cannot be inferred. Since I was 
the sole investigator for many aspects of the study, I could only recruit participants in an 
opportunistic manner. Since I performed all the delirium assessments during the perioperative 
period and it was not possible for me to do this every day, I may have missed some brief 
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episodes of delirium. I also performed many of the biological assays and may have 
introduced bias. The small numbers for some of the substudies mean that these must be 
viewed as exploratory and hypothesis-generating. The hypotheses in relation to cognitive 
trajectory following delirium were in particular difficult to test, due to attrition and missing 
data. 
 
Through undertaking the studies in this thesis, my wider reading, discussion with other 
investigators in the delirium field, and my clinical practice, I have come to increasingly 
believe that delirium is a heterogeneous syndrome, and it seems unlikely that there is a single 
final common pathway in its pathogenesis. I believe that some episodes of delirium involve 
significant dysfunction of the HPA axis and some episodes involve a significant 
inflammatory response, which can be very persistent and damaging. Some episodes of 
delirium may have a specific trigger such as medication which can be reversed relatively 
quickly. Importantly, the clinical management of frail, older patients varies substantially, and 
so the balance of preventable risks for delirium such as dehydration, uncontrolled pain, etc., 
is different from patient to patient. This means that the relative contribution of HPA axis 
dysfunction and/or inflammatory pathways to a given patient’s delirium varies according to 
the contribution of other risk factors. Additionally, the response of patients to similar insults 
is also heterogeneous, depending perhaps on their degree of frailty, polypharmacy (well-
tolerated drugs when people are well which significantly exacerbate the effects of 
physiological insults when people become unwell), cognitive resilience and reserve or other 
unknown CNS factors. This may explain the inconsistent results particularly in recent CSF 
studies in delirium including the studies described in this thesis.  
 
In the context of the wider literature, this thesis describes cohesively one of the most detailed 
longitudinal studies of the HPA axis and inflammation in delirium, and it is the largest study 
to have explored cortisol diurnal rhythm in delirium. One of the study’s strengths has been 
that it has investigated both central and peripheral cortisol and inflammatory responses in 
delirium. The studies reported here will add significantly to the previously small literature on 
CSF biomarkers in delirium (Hall, Shenkin et al. 2011). It adds further detail to other studies 
which have found a pro-inflammatory milieu in delirium (van Munster, Korevaar et al. 2008, 
van den Boogaard, Kox et al. 2011), and that cortisol is predictive of delirium (Mu, Wang et 
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al. 2010, Nguyen, Huyghens et al. 2014). It also expands our knowledge of the possible 
cognitive trajectories after delirium, with one of the most detailed assessments of the 
cognitive deficits in persistent and resolved delirium which has potentially important 
implications for rehabilitation, follow-up and decision-making following delirium. It has 
several implications for future studies and clinical practice, which will be discussed in 
Section 10.1.  
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10.1  Implications for clinical practice and future work 
The results described in this thesis have several important implications for clinical practice, 
and new avenues for future studies have also been revealed, both in delirium pathophysiology 
and potential new treatments. 
 
10.1.1 Implications for clinical practice 
In terms of clinical practice, the demonstration of raised CSF cortisol and S100B in active 
delirium is important, given that both mechanisms are potentially damaging to the CNS in the 
longer term if sustained, and reinforce the idea that delirium itself may be dangerous, or a 
marker of a dangerous process which should be prevented, mitigated and managed urgently. 
In the future, it might be possible to incorporate collection of a small CSF sample during 
routine care for high risk procedures under spinal anaesthetic, with analysis of biomarkers to 
predict those at high risk of delirium, persistent delirium or incipient dementia. 
 
Both prevalent and incident delirium were associated in this study with longer waiting time 
for operation, highlighting the importance of avoiding long waits for surgery in patients with 
acute hip fracture and other settings where elderly patients undergo urgent surgery. 
Measurement of cortisol diurnal rhythm using blood or saliva samples would be low risk and 
generally well tolerated in delirium, and might give very useful information on those patients 
who have particular disruption of the HPA axis. Indeed, the findings of this study suggest that 
those with delirium, particularly where it persists, may have a form of catabolic state with 
elevated cortisol and a sustained pro-inflammatory milieu. Therefore, these patients are likely 
to benefit clinically from attention to good sleep hygiene, nutrition, skin integrity, wound 
healing and physiotherapy. It would also be prudent to avoid the prescription of steroids 
unless absolutely necessary. 
 
The demonstration of executive dysfunction, and deficits in verbal and visual learning and 
memory in those with persistent features of delirium has potentially very important 
implications for clinicians, nursing staff and allied health professionals caring for these 
patients and those involved in making decisions about their future care. Attention should be 
paid to the way information is presented, minimising distraction and maintaining clarity, 
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information and instructions should be repeated where necessary, and patients should be 
given both adequate time to respond and also in more general terms, adequate time to 
recover. In particular, the persistence of executive dysfunction even after syndromal delirium 
has resolved means that patients may have difficulty participating in complex rehab tasks and 
in making life-changing decisions about their future care. Given the trajectory of cognitive 
improvement demonstrated here for some patients, these deficits may improve over several 
months, meaning that decisions should not be taken too early or should be kept under review. 
Patients recovering from delirium should have follow-up assessment of their cognition, with 
particular attention paid to the deficits highlighted here, not only to seek evidence of 
underlying dementia but also to seek signs of improvement. 
 
10.1.2 Future studies 
Cerebrospinal fluid studies in delirium are costly and difficult to perform, with several 
practical and ethical challenges. I approached almost three times as many patients as I 
recruited, and samples were collected from 60% of the final cohort, with several hours of 
researcher time for each successful recruit. Due to the time pressures of hip fracture repair, 
there were huge challenges in gaining informed consent, performing preoperative delirium 
assessments and arranging for sample collection when the time window was often only a few 
hours, and the urgent and unpredictable nature of the trauma theatre list was an added 
challenge. The collaborative nature of the recent studies of cerebrospinal fluid biomarkers in 
delirium, including those described in this thesis, between centres in Scotland, The 
Netherlands, Norway and Australia, has greatly increased our understanding of delirium 
pathophysiology, but there is still much more work on CSF needed. An international 
collaborative biobank could maximise the potential of these difficult to obtain and precious 
samples. In future it might also be possible to operationalise collection of a small sample of 
cerebrospinal fluid during routine clinical care where spinal anaesthetic is performed for high 
risk surgical procedures, with consent built-in to the main surgical consent form. These 
samples could also be biobanked and linked with diagnostic data from ISD (Information 
Services Division) on postoperative delirium and dementia 
 
There are several other lines of enquiry which could be followed in CSF biomarker research 
in delirium. Amino acids such as the serotonin precursor tryptophan, the dopamine and 
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norepinephrine precursors tyrosine and phenylalanine and glutamate could be investigated, to 
test the neurotransmitter hypothesis of delirium (Flacker and Lipsitz 1999). Prostaglandins, 
which are small inflammatory molecules whose synthesis is induced by the action of pro-
inflammatory cytokines such as IL-1β at the blood brain barrier would also be interesting to 
investigate as an important branch of the inflammatory cascade. Given that there is 
preliminary evidence that incident dementia that follows delirium may have a different 
mechanism to “standard” dementia neuropathology (Davis, Muniz Terrera et al. 2012), 
further investigation is warranted into potential mechanisms for this and CNS injury during 
and after delirium. For example, nucleosomes are strands of cell-free DNA, and their 
presence is thought to represent a pro-inflammatory response and cell death. After hip 
fracture, there is a rise in nucleosomes in serum, with different levels before, during and after 
delirium (de Rooij, Zeerleder et al. 2014); it could be hypothesised that levels would also rise 
in CSF in delirium. 
 
Studies of delirium pathophysiology sometimes produce contradictory or counterintuitive 
results. Future studies investigating delirium mechanisms should include detailed aetiological 
characterisation of the predisposing and precipitating factors in the delirium episode. A 
standardised risk factor model for assigning a delirium episode to one or more aetiological 
classes would be useful, which could be used across delirium studies. This might mean that 
more firm conclusions can be drawn on the mechanisms of different aetiological classes of 
delirium, and limit the contradictory results found in several areas of delirium 
pathophysiological research. Performing research studies in units whose baseline practice 
involves good delirium prevention and management will help to reduce the influence of 
simple direct causes of delirium such as opioid toxicity, therefore improving the signal-noise 
ratio when examining particular biomarkers. 
 
Hospitalisation, particularly in the frail elderly and even more so following trauma such as 
hip fracture, is a stressful experience, with patients in unfamiliar surroundings, in pain and 
fearful of the need for surgery. Delirium compounds this stressful and distressing experience 
with disorientation, delusions and hallucinations (Partridge, Martin et al. 2012). 
Psychological stress for example the Trier Social Stress Test leads to cortisol elevation, with 
higher levels in older women and more elevation in salivary cortisol in older men (Kudielka, 
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Buske-Kirschbaum et al. 2004). This psychological distress might therefore contribute to the 
stress response, leading to more severe or more prolonged delirium. A study of how to 
improve patient experience in conditions such as hip fracture, with quantifcation of cortisol 
diurnal rhythm and delirium, would be very interesting. 
 
The evidence for dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in delirium 
and persistent delirium has been further strengthened by the results of the studies described 
here. A randomised placebo-controlled clinical trial of an 11β-hydroxysteroid dehydrogenase 
inhibitor, to limit the effects of the dysregulated HPA axis response, could be undertaken. 
Given the pro-inflammatory milieu in delirium, there might also be a role for anti-
inflammatory medication, which would address not only potential mechanisms in delirium 
but also the acute injury and trauma response, which may be more exaggerated and damaging 
in the frail elderly. These drugs could either be trialled prophylactically in high-risk groups 
such as patients with hip fracture or critical illness, or could be started in confirmed delirium 
to limit its duration. Outcome measures could include delirium duration and severity, with 
parallel assessment of cortisol diurnal rhythm and inflammatory profile.  
 
The studies described in this thesis therefore add significantly to the literature on the role of 
the HPA axis and inflammation in delirium, in particular within the CNS, providing evidence 
of potential CNS damage, elevated CSF and peripheral cortisol during delirium and a 
persistent HPA axis and inflammatory response that follows delirium. This thesis also 
describes cognitive deficits in persistent and resolved delirium which have the potential for 
particular clinical importance and should be further investigated. New avenues for research 
and potential therapeutic targets have been identified which may be of great benefit in this 
common and potentially devastating syndrome. 
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11.1 Appendix 1 Schedule of assessments CDHIP cohort 
Timepoint Preoperative visit Perioperative visits days 1, 2, 3, 4, 7, 10-14 Follow-up visits 3, 6, 12 months 
Delirium 
assessment 
Delirium Rating Scale-revised ‘98 
Confusion Assessment Method 
Edinburgh Delirium Test Box-1 
Observational Scale of Level of Alertness 
Richmond Agitation Sedation Scale 
Delirium Rating Scale-revised ‘98 
Confusion Assessment Method 
Edinburgh Delirium Test Box-1 
Observational Scale of Level of Alertness 
Richmond Agitation Sedation Scale 
Delirium Rating Scale-revised ‘98 
Confusion Assessment Method 
Edinburgh Delirium Test Box-1 
Observational Scale of Level of Alertness 
Richmond Agitation Sedation Scale 
Cognitive 
assessment 
Mini-Mental State Examination Mini-Mental State Examination  
Informant Questionnaire of COgnitive 
Decline in the Elderly 
National Adult Reading Test 
Mini-Mental State Examination  
Verbal Fluency 
Digit span forwards and backwards 
HVLT-R list learning 
Visual reproduction 
Victoria Stroop 
Digit Symbol Substitution Test 
Assessment of 
function and other 
domains 
Katz personal activities of daily living scale 
Lawton Instrumental activities of daily living scale 
Acute Physiology and Chronic Health Evaluation II 
Charlson Co-morbidity Index 
Rockwood Brief Frailty Score 
 Katz personal activities of daily living scale 
Lawton Instrumental activities of daily living 
scale 
Geriatric Depression Score 
EQ-5D 
Apathy Evaluation Scale 
Biological samples AM and PM saliva 
Serum at anaesthetic induction 
CSF at anaesthetic induction  
AM and PM saliva days 4, 7, 10-14 
Serum on days 4 and 10-14 
AM and PM saliva 3, 6 and 12 months 
Serum at 3, 6 and 12 months 
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11.2 Appendix 2. Search strategy for systematic literature review of 
CSF biomarkers in delirium (chapter 3) 
EMBASE and EMBASE classic search: 1564 abstracts on 5th January 2015 
Database: 1947 to 2014 December 30 
1. delir$.tw OR Delirium/ OR  “acute confusional state”.tw OR (acute adj3 conf$).tw OR 
“acute brain failure”.tw OR Acute Confusion/ OR Confusion/ 
2. delirium tremens.ti 
3. 1 NOT 2 
4. cerebrospinal fluid/ OR cerebrospinal fluid.tw OR CSF.tw OR spinal puncture.mp OR 
lumbar puncture/ OR lumbar puncture.tw 
5. 3 AND 4 
Medline search: 347 abstracts on 5th January 2015 
Database: 1946 to 5th January 2015 
1. delir$.tw OR “acute confusional state”.tw OR (acute adj3 conf$).tw OR “acute brain 
failure”.tw OR exp Confusion/ (includes Delirium/) 
2. delirium tremens.ti 
3. 1 NOT 2 
4. exp Cerebrospinal Fluid/ OR cerebrospinal fluid.mp OR csf.tw OR Spinal Puncture/ OR 
lumbar puncture.tw OR spinal puncture.tw 
5. 3 AND 4 
Psychinfo search: 75 abstracts on 5th January 2015 
Database: 1806 to December week 5 2014 
1. delir$.tw OR delirium/ OR mental confusion/ OR “acute confusional state”.tw OR (acute 
adj3 conf$).tw OR “acute brain failure”.tw 
2. delirium tremens.ti 
3. 1 NOT 2 
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4. csf.tw OR cerebrospinal fluid/ OR cerebrospinal fluid.tw OR lumbar puncture.tw OR 
spinal puncture.tw 
5. 3 AND 4 
Cochrane Library: 52 results using Pubmed search strategy on 5th January 2015, none 
relevant. 
Web of science (including conference papers) 1864 – 2015-01-05: 1287 abstracts 
Advanced search: 
TS=(delirium OR “acute confusional state” OR confusion OR “acute brain failure” OR 
“acute confusion”) AND TS=(CSF OR “cerebrospinal fluid” OR “spinal puncture” OR 
“lumbar puncture”) 
PubMed search: 1545 abstracts on 5th January 2015 
(((delirium or “acute confusional state” or “acute brain failure” or “acute confusion”) AND 
(csf or “cerebrospinal fluid” or “spinal fluid”)) NOT (“case report” or “delirium tremens”)) 
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11.3 Appendix 3 Flow diagram for systematic literature review of 
CSF biomarkers in delirium (chapter 3) 
This flow diagram demonstrates the results of the electronic database searches, the 















Totals articles retrieved  
N=177 
Excluded N=158
Case reports N=5 
Delirium Tremens or alcohol-related N=11 
Delirium not appropriately diagnosed N=7 
Reviews N=25 
Short conference abstract N=18 
Serum study N=7 
Animal study N=1 
Study not available in English N=4 
Study discussing appropriateness of LP in clinical setting N=4 
No diagnosis of delirium made N=33 
Mixed Neuropsychiatric SLE, no identifiable delirium subgroup N=37 
Delirium secondary to SLE and other causes excluded N=6 

















reports, exclude older 
papers N=4 
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11.4 Appendix 4 Patient Information Sheet and Consent Form 
 
Version #6 
Date 26th November 2009 
 
PATIENT INFORMATION SHEET PART 1 
Study title: Cortisol and delirium in patients with hip fracture 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully and talk to others if you wish.   
Part 1 tells you the purpose of the study and what will happen if you take part 
Part 2 gives you more detailed information about the conduct of the study 
Ask us if there is anything that is not clear or if you would like to know more.  Take time to 
decide whether or not you wish to take part. 
 
What is the purpose of the study? 
People who have had a hip fracture sometimes have short-term problems with thinking and 
memory after having surgery. This study is trying to find out more about what types of 
changes in thinking and memory happen after surgery. This is also an educational study 
contributing towards a PhD for Dr Roanna Hall. 
 
Why have I been chosen? 
We are asking you to take part simply because you have had a hip fracture and are over the 
age of 60.  
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you do decide to take part you will 
be given this Part 1 and Part 2 of the information sheet to keep and be asked to sign a 
consent form. You can decide to stop your involvement at any time. A decision to withdraw 
at any time, or a decision not to take part, will not affect the standard of care you receive. 
 
What will happen to me if I take part?  
What do I have to do? 
You will be asked to do some standard short tests of thinking and memory. These tests will 
last around 15 minutes. We will also take specimens of saliva to measure the stress 
hormone cortisol. This involves chewing on a small cotton swab and placing it in a sterile 
plastic container. We will also examine your medical notes and speak to the ward nurses 
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and doctors about your case. With your consent we would also like to contact your GP to 
inform them that you are taking part in the study. 
At the time of your operation when the spinal anaesthetic is administered, we will take a 
small sample of the fluid which bathes the brain and spinal cord, to measure levels of 
cortisol and markers of inflammation and damage. A blood sample will also be taken at that 
time. 
We will also visit you after your surgery each day until the fourth day, and after one week 
and after ten days to two weeks to repeat the tests of thinking and memory. On the fourth 
day and after one week and after ten days to two weeks we will take further saliva samples. 
We will also take two blood samples to measure markers of inflammation.  
After your discharge we will either invite you to come to Hospital for further tests of thinking 
and memory, or offer to visit you where you are living. With your permission we will contact 
your GP prior to arranging these meetings to check on your health at the time. We will 
assess your memory and thinking. We will also take saliva samples and a blood sample. 
The blood and CSF samples will be stored anonymously for 5 years for future analysis. This 
is because with new scientific advances in the field of thinking and memory research, we will 
be keen to do new tests on the samples in the coming years, which will hopefully give us 
more information on the causes of thinking and memory problems. This will not include tests 
on DNA. 
What are the possible disadvantages and risks of taking part? 
There are minimal risks involved in the study, because we are not testing new treatments. 
However, you may find doing memory tests upsetting or irritating if you are not sure of the 
answers.  
What are the possible benefits of taking part? 
With your permission, we will inform the medical and nursing team responsible for your care 
about the results of your tests. This may add more detailed information than they have 
already, and it may help you for them to know this. 
What happens when the research study stops? 
No further involvement is required.  
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or possible harm 
you might suffer will be addressed. 
Will my taking part in this study be kept confidential? 
Yes. All the information about your participation in this study will be kept strictly 
confidential. The details are included in Part 2. 
 
Contact Details 
Dr. Roanna Hall, Clinical Research Fellow, Geriatric Medicine, Room S1642, New Royal 
Infirmary of Edinburgh.  Tel. 0131 242 6481. 
That completes Part 1 of the Information Sheet. You will be given a copy of Parts 
1 and 2 of the Information Sheet and a signed consent form to keep. 
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PATIENT INFORMATION SHEET PART 2 
 
What if there is a problem? 
Complaints: 
If you have a concern about any aspect of the study, you should ask to speak with the 
researchers who will do their best to answer your questions. If you remain unhappy and 
wish to complain formally, you can do this through the complaints procedure in the hospital. 
Details can be obtained from the hospital. 
Harm: 
If you are harmed by taking part in this research project, there are no special compensation 
arrangements.  If you are harmed due to someone’s negligence, then you may have 
grounds for a legal action but you may have to pay for it.  Regardless of this, if you wish to 
complain, or have any concerns about any aspect of the way you have been approached or 
treated during the course of this study, the normal hospital complaints mechanisms will be 
available to you. 
What will happen to the results of the research study? 
The results will be published in international journals to help doctors and nurses across the 
world have a better idea of the causes of memory and thinking problems in patients who 
have had hip fracture. The results will also contribute towards the PhD thesis of Dr Roanna 
Hall. 
Who is organising and funding the research? 
Research into Ageing, the research department of Help the Aged is funding this study. The 
study is being organised by a team of doctors and researchers working in the Royal 
Infirmary of Edinburgh and the University of Edinburgh. 
Will my taking part in this study be kept confidential? 
Yes. All information which is collected about you during the course of the research will be 
kept strictly confidential. The information will be stored securely and any identifying 
information will be removed. The information will be retained for ten years and then 
disposed of securely. 
 
Who has reviewed the study? 
The study has been approved by the Scotland A Research Ethics Committee. 
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Title of Project: Cortisol and delirium in patients with hip fracture 
 
Name of Researcher:  
 
          Please tick box 
 
1. I confirm that I have read and understand the information sheet dated ............................  
 (version ............) for the above study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time,  
 without giving any reason, without my medical care or legal rights being affected. 
 
3. I understand that sections of any of my medical notes may be looked at by responsibleindividuals 
from the University of Edinburgh or from regulatory authorities where it is relevant to my taking 
part in research.  I give permission for these individuals to have access to my records and to 
contact my GP to inform them of my participation in the study and to enquire about my health 
status prior to arranging follow-up visits in the future.      
 
4. I agree to the samples of blood and CSF that are taken being stored anonymously and analysed 
in future studies of thinking and memory (except DNA).      
 
5. I agree to take part in the above study.        
 
________________________ ________________ ____________________ 
Name of Participant Date Signature 
 
_________________________ ________________ ____________________ 
Researcher Date Signature 
 1 for patient;  1 for researcher;  1 to be kept with hospital notes 
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11.6 Appendix 6 Geriatric Depression Score 
Geriatric Depression Score 
 
Choose the best answer for how you have felt over the past week:  
 
1. Are you basically satisfied with your life? YES / NO  
2. Have you dropped many of your activities and interests? YES / NO  
3. Do you feel that your life is empty? YES / NO  
4. Do you often get bored? YES / NO  
5. Are you in good spirits most of the time? YES / NO  
6. Are you afraid that something bad is going to happen to you? YES / NO  
7. Do you feel happy most of the time? YES / NO  
8. Do you often feel helpless? YES / NO  
9. Do you prefer to stay at home, rather than going out and doing new things? YES / NO  
10. Do you feel you have more problems with memory than most? YES / NO 
11. Do you think it is wonderful to be alive now? YES / NO  
12. Do you feel pretty worthless the way you are now? YES / NO  
13. Do you feel full of energy? YES / NO  
14. Do you feel that your situation is hopeless? YES / NO  
15. Do you think that most people are better off than you are? YES / NO  
 
Answers in bold indicate depression.  Score 1 point for each bolded answer.  
A score > 5 points is suggestive of depression.  
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11.7 Appendix 7 EQ-5D 
By placing a tick in one box in each group below, please indicate which statements best describe your 
own health state today. 
 
Mobility 
I have no problems in walking about  
I have some problems in walking about  
I am confined to bed  
 
Self-Care 
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
 
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
 
Pain/Discomfort 
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
 
Anxiety/Depression 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed  
 





To help people say how good or bad a health state is, we  
have drawn a scale (rather like a thermometer) on which 
the best state you can imagine is marked 100 and the  
worst state you can imagine is marked 0. 
 
We would like you to indicate on this scale how good 
or bad your own health is today, in your opinion. 
Please do this by drawing a line from the box below to  
Whichever point on the scale indicates how good or 


































   Worst 
    imaginable 
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11.8 Appendix 8 Permission to use “A systematic literature review 
of cerebrospinal fluid (CSF) biomarkers in delirium 
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11.9 Appendix 9 Permission to use “Levels of cerebrospinal fluid 
S100B in hip fracture patients with delirium versus controls” 
From: Copyright Clearance Center rightslink@marketing.copyright.com Subject: Thank you for your RightsLink / Elsevier 
transaction  
Date: 5 February 2015 09:55 To: roanna.hall@gmail.com 
 
To view this email as a web page, go here.  
Do Not Reply Directly to This Email  
To ensure that you continue to receive our emails, 
please add rightslink@marketing.copyright.com to your address book.  
Thank You For Your Order!  
Dear Dr. Roanna Hall,  
Thank you for placing your order through Copyright Clearance Center's RightsLink service. Elsevier has 
partnered with RightsLink to license its content. This notice is a confirmation that your order was successful.  
Your order details and publisher terms and conditions are available by clicking the link below:  
http://s100.copyright.com/CustomerAdmin/PLF.jsp?ref=33f653da-6b43-4042-a123-748020f59da7  
Order Details  
Licensee: Roanna Hall 
License Date: Feb 5, 2015 
License Number: 3562400379872 
Publication: The American Journal of Geriatric Psychiatry 
Title: Delirium and Cerebrospinal Fluid S100B inHip Fracture Patients: A Preliminary Study Type Of Use: reuse in 
a thesis/dissertation 
Total: 0.00 GBP  
To access your account, please visit https://myaccount.copyright.com.  
Please note: Online payments are charged immediately after order confirmation; invoices are issued daily and 
are payable immediately upon receipt.  
To ensure that we are continuously improving our services, please take a moment to complete our  
customer satisfaction survey.  
B.1:v4.2  
+1-855-239-3415 / Tel: +1-978-646-2777 customercare@copyright.com 
http://www.copyright.com  
This email was sent to: roanna.hall@gmail.com Please visit Copyright Clearance Center for more information.  
This email was sent by Copyright Clearance Center 222 Rosewood Drive Danvers, MA 01923 USA  
To view the privacy policy, please go here.  
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11.10 Appendix 10 Correlations among serum inflammatory markers 
Table 8.10 Spearman’s Rho correlations among cytokines and chemokines in serum at baseline, N=84 


























































































MCP-1         rho=0.459 
p<0.001 
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Table 8.11 Spearman’s Rho correlations among cytokines and chemokines in serum on postoperative day 4, N=83 


























































































MCP-1         rho=0.591 
p<0.001 
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Table 8.12 Spearman’s Rho correlations among cytokines and chemokines in serum on postoperative day 10-14, N=34 
 


























































































MCP-1         rho=0.336 
p=0.052 
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Table 8.13 Spearman’s Rho correlations among cytokines and chemokines in serum at 3 months after hip fracture N=80 
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Table 8.14 Spearman’s Rho correlations among cytokines and chemokines in serum at 6 months after hip fracture, N=73 
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Table 8.15 Spearman’s Rho correlations among cytokines and chemokines in serum at 12 months after hip fracture, N=68. Interleukin-5 was 
detected in small amounts, and correlations were not possible. 
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MCP-1         rho=0.144 
p=0.241 
 
 
